data_7jxg_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 7jxg _Structure_validation_residue.Date_analyzed 2020-11-20 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 11.7 p . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.593 0.235 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.573 ' OE1' ' HA ' ' A' ' 3' ' ' GLN . 11.7 mm-40 -100.22 116.27 31.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.443 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.634 ' CB ' HG13 ' A' ' 26' ' ' VAL . . . -164.41 157.53 17.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.792 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.674 ' CD1' ' O ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -124.89 145.38 49.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.011 0.434 . . . . 0.0 111.67 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.671 ' OH ' ' NE2' ' A' ' 113' ' ' GLN . 1.4 t80 -96.07 76.03 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.711 ' SD ' ' ND1' ' A' ' 18' ' ' HIS . 73.7 mtm . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.732 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.711 ' ND1' ' SD ' ' A' ' 7' ' ' MET . 65.4 m170 . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.996 0.427 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.649 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -91.17 102.14 5.1 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.302 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.68 ' O ' ' N ' ' A' ' 23' ' ' GLY . 12.3 Cg_endo -58.74 161.15 15.71 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.77 2.314 . . . . 0.0 111.687 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.599 ' OD1' ' C ' ' A' ' 21' ' ' ASP . 13.5 t0 -119.37 101.68 48.88 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.575 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.536 ' C ' ' O ' ' A' ' 20' ' ' PRO . 12.9 Cg_exo -66.9 158.04 81.88 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.516 -1.452 . . . . 0.0 112.375 -0.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -82.94 152.21 29.67 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.608 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -152.68 119.85 3.09 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.296 0.569 . . . . 0.0 111.315 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 56.2 Cg_endo -74.75 157.44 43.81 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 123.028 2.485 . . . . 0.0 111.294 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.634 HG13 ' CB ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -57.23 147.64 5.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.912 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 30' ' ' GLN . . . -97.89 102.24 2.64 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.575 ' HB2' ' CG1' ' A' ' 2' ' ' VAL . 7.4 tt -46.06 -47.78 17.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.834 0.35 . . . . 0.0 110.358 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.52 -34.39 78.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.174 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 93.7 mt-30 -62.33 -40.98 98.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.678 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 6.6 mt -69.8 -38.68 76.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.345 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -55.98 -41.09 74.28 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.319 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -63.32 -32.33 73.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 26.2 tp -64.91 -23.9 67.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.938 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.649 ' O ' ' CG ' ' A' ' 128' ' ' PRO . . . 112.31 18.26 7.75 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 t -96.21 129.55 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 0.0 111.054 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.606 HD12 ' NH2' ' A' ' 59' ' ' ARG . 30.9 mt -120.48 141.06 50.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.131 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.689 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -139.78 139.45 36.44 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.836 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.689 ' CE3' ' O ' ' A' ' 38' ' ' TYR . 1.9 m95 -109.53 133.65 52.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.497 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.505 ' NZ ' ' HH ' ' A' ' 38' ' ' TYR . 11.7 mtmt -105.99 102.74 12.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.809 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.629 ' O ' ' OH ' ' A' ' 97' ' ' TYR . 5.1 mp -142.76 156.49 45.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.247 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 45' ' ' LYS . 87.7 m-20 -90.32 122.29 33.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.512 ' O ' ' HD1' ' A' ' 46' ' ' TYR . . . -42.01 -43.25 3.11 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.166 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD2' ' HB3' ' A' ' 42' ' ' ASP . 5.5 p-10 -66.88 -32.8 74.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.688 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.648 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 70.4 mttt -85.04 -11.59 55.01 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.2 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.722 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -71.86 -56.7 5.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.639 -0.424 . . . . 0.0 109.925 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.722 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 83.9 tt0 -67.04 -36.81 82.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.44 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.584 ' CG ' ' HA ' ' A' ' 45' ' ' LYS . 17.6 p-10 -78.67 -11.74 59.99 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.497 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' ' O ' ' A' ' 45' ' ' LYS . 10.2 t0 -130.94 83.26 61.66 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.82 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.1 Cg_endo -46.4 -8.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 123.535 2.824 . . . . 0.0 112.049 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 49' ' ' ASP . 96.9 mt-10 -46.05 -34.46 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.397 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.71 ' C ' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -59.06 -32.4 69.74 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.682 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 84.8 tt0 -64.06 -35.26 80.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.685 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -59.18 -40.62 86.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.699 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.681 ' CG2' ' NE1' ' A' ' 39' ' ' TRP . 84.3 mt -59.85 -37.24 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.505 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.664 ' NH2' ' C ' ' A' ' 62' ' ' SER . 70.5 mtp180 -59.43 -40.83 88.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.603 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.97 -41.14 86.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.07 -32.54 74.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.694 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.723 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 39.0 mmt180 -99.41 7.42 45.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.218 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.682 ' O ' ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER 59.91 46.39 11.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.75 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.723 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 22.7 m-85 -105.49 113.03 26.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.279 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.664 ' C ' ' NH2' ' A' ' 56' ' ' ARG . 1.4 t -99.73 -21.45 15.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.248 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.562 ' HB3' ' O ' ' A' ' 149' ' ' PHE . 70.5 t90 -109.42 127.88 54.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.837 0.351 . . . . 0.0 111.041 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 56' ' ' ARG . 8.8 ptm -143.14 147.58 35.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.321 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 66' ' ' ILE . 46.3 t0 -159.47 166.76 30.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.433 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.526 HG12 ' HG2' ' A' ' 146' ' ' MET . 59.2 mt -108.39 122.25 62.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 145' ' ' ALA . 72.6 mt -119.42 138.46 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.372 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.555 ' OG1' ' HG3' ' A' ' 144' ' ' LYS . 36.1 m -119.41 142.48 48.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.617 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.674 ' C ' ' SG ' ' A' ' 70' ' ' CYS . 64.2 mt -105.76 125.7 61.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.0 111.028 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.674 ' SG ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -169.1 135.4 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.657 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -57.96 -45.67 86.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.983 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.675 ' OD1' ' N ' ' A' ' 73' ' ' LYS . 55.6 p30 -77.21 -33.17 56.28 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.675 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 80.3 tttt -98.29 -3.66 36.76 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.459 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.653 ' N ' ' O ' ' A' ' 70' ' ' CYS . 1.1 tp -125.58 73.46 68.75 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.124 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.58 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 48.2 Cg_exo -49.97 154.14 5.55 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 121.892 1.728 . . . . 0.0 109.611 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.632 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 63.5 t-20 70.18 32.54 2.89 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.34 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.651 ' CE1' HG13 ' A' ' 81' ' ' ILE . 27.4 t80 -62.38 -45.7 91.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.434 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 49.0 tp10 -54.82 -54.18 45.6 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.632 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 97.7 mt-10 -76.34 -45.13 33.57 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.398 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.595 ' HD3' ' CD2' ' A' ' 74' ' ' LEU . 23.2 tttp -60.45 -49.52 77.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.281 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.725 ' CD1' ' CE1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -70.46 -37.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.391 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.594 ' CD ' ' HA ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -70.8 -37.22 73.28 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.617 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.615 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 87.0 mtp -56.68 -48.73 76.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.663 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.672 ' CZ ' ' CD1' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -87.19 -14.85 40.01 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.653 179.535 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.725 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -56.54 -46.32 80.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.97 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -75.93 146.42 39.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.959 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.551 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -80.51 135.51 36.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.292 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.442 ' CD2' ' C ' ' A' ' 88' ' ' HIS . 2.5 p-80 -144.87 170.67 15.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.007 0.432 . . . . 0.0 110.979 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.645 ' HB2' ' CE1' ' A' ' 132' ' ' TYR . 28.3 tp -124.55 153.32 42.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.576 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.568 ' CE1' ' HE1' ' A' ' 133' ' ' HIS . 1.7 p80 -170.81 165.85 7.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.992 0.425 . . . . 0.0 110.897 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.554 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 49.0 mt -85.09 16.24 3.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.585 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.522 ' C ' ' HB1' ' A' ' 129' ' ' ALA . 88.2 m-20 -107.65 149.29 28.26 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.369 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.605 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 49.2 p30 -83.88 164.95 19.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.427 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.605 ' OE2' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -125.71 114.83 19.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.918 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.72 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 2.7 mp -120.41 116.32 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.149 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.715 ' NH1' ' CG ' ' A' ' 135' ' ' PHE . 68.1 mtt180 -131.62 138.37 48.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.011 0.434 . . . . 0.0 110.77 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.629 ' OH ' ' O ' ' A' ' 41' ' ' LEU . 1.3 t80 -127.42 128.71 46.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.384 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.603 ' CD1' ' HB2' ' A' ' 145' ' ' ALA . 23.8 mm -96.69 95.64 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.311 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.685 ' CD1' ' SD ' ' A' ' 146' ' ' MET . 16.9 mt -71.49 -35.62 70.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.0 109.851 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . 20.2 t70 -157.44 162.81 38.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.339 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 143' ' ' THR . . . 90.86 175.68 44.11 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.541 ' OG ' ' CZ ' ' A' ' 118' ' ' PHE . 41.1 t -129.37 142.98 50.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.716 0.293 . . . . 0.0 110.696 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.507 ' HA3' HG11 ' A' ' 137' ' ' VAL . . . -173.23 179.24 44.78 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.706 ' CZ ' ' OG1' ' A' ' 136' ' ' THR . 50.3 p90 -140.13 150.13 43.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.925 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 133' ' ' HIS . 3.7 t80 -110.52 141.43 43.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.993 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.544 ' CB ' ' HB3' ' A' ' 134' ' ' ARG . 60.2 t0 -94.5 124.22 38.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.571 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.538 ' CG2' HD12 ' A' ' 117' ' ' ILE . 21.8 m -128.1 154.55 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.602 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.648 ' NH2' ' CD2' ' A' ' 132' ' ' TYR . 24.0 ttp180 -123.71 143.1 50.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 55.4 t0 -99.51 156.8 16.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.466 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.533 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -60.54 -25.06 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.086 0.469 . . . . 0.0 110.48 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.588 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 46.5 tp10 -76.16 11.1 1.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.043 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 110' ' ' LYS . 83.7 m-20 62.81 42.84 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.367 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.671 ' NE2' ' OH ' ' A' ' 6' ' ' TYR . 25.3 mt-30 -120.46 149.19 42.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.092 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.635 ' CZ3' ' HB2' ' A' ' 108' ' ' ARG . 94.2 m95 -111.44 133.06 54.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.982 0.42 . . . . 0.0 111.134 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.631 HD12 ' CE2' ' A' ' 6' ' ' TYR . 69.1 mt -121.05 134.94 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.509 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 116' ' ' ARG . 8.1 ptm180 -91.08 114.37 26.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.582 ' O ' ' HB2' ' A' ' 104' ' ' TYR . 45.0 mt -108.38 129.63 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.678 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.541 ' CZ ' ' OG ' ' A' ' 102' ' ' SER . 74.1 t80 -94.72 128.83 41.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.913 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.573 ' HE3' ' CG1' ' A' ' 125' ' ' VAL . 89.0 mtp -100.43 122.55 43.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.354 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.543 ' HG2' ' N ' ' A' ' 121' ' ' LYS . 84.7 tt0 -111.61 160.2 17.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.566 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -55.48 133.39 50.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.607 ' CA ' ' O ' ' A' ' 41' ' ' LEU . . . 88.92 -12.91 64.46 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -95.22 123.46 38.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.879 0.371 . . . . 0.0 111.306 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.688 ' CE ' ' CD1' ' A' ' 39' ' ' TRP . 5.1 ttp -107.11 151.38 25.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.609 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.573 ' CG1' ' HE3' ' A' ' 119' ' ' MET . 12.1 p -138.43 143.31 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.302 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 41.2 m -126.38 133.22 51.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.046 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.598 ' CD2' ' CG ' ' A' ' 133' ' ' HIS . 7.6 tp -115.59 113.53 42.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.918 0.39 . . . . 0.0 110.808 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.649 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 36.9 Cg_exo -52.91 141.57 55.43 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.646 2.231 . . . . 0.0 111.926 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.554 ' HB2' ' C ' ' A' ' 91' ' ' LEU . . . -67.82 146.07 54.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.908 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.643 ' C ' ' CD1' ' A' ' 89' ' ' LEU . . . 98.36 3.13 57.67 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.52 ' N ' HD11 ' A' ' 89' ' ' LEU . 71.2 mt -119.57 131.61 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.732 0.301 . . . . 0.0 110.616 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.648 ' CD2' ' NH2' ' A' ' 108' ' ' ARG . 98.9 m-85 -62.09 146.05 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.201 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 105' ' ' PHE . 22.7 p-80 -160.42 156.44 26.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 0.0 111.247 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.643 ' NE ' ' O ' ' A' ' 85' ' ' TYR . 41.0 ttt180 -141.74 128.21 20.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.065 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.715 ' CG ' ' NH1' ' A' ' 96' ' ' ARG . 68.9 t80 -107.09 124.04 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.836 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.706 ' OG1' ' CZ ' ' A' ' 104' ' ' TYR . 16.5 p -138.06 154.36 49.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.646 ' CG1' ' O ' ' A' ' 136' ' ' THR . 17.2 m -165.05 25.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.198 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.655 ' OD2' ' N ' ' A' ' 139' ' ' GLU . 51.2 p30 -65.0 -24.64 67.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.618 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.655 ' N ' ' OD2' ' A' ' 138' ' ' ASP . 60.2 mp0 -55.17 -34.48 63.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.77 0.319 . . . . 0.0 111.175 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.52 ' HG2' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -100.46 -28.18 13.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.581 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 58.18 27.38 15.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.616 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -173.15 96.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.437 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.485 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 42.4 m -136.17 139.05 42.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.954 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.555 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 71.2 tttt -117.24 116.03 26.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.603 ' HB2' ' CD1' ' A' ' 98' ' ' ILE . . . -141.69 154.62 45.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.014 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.685 ' SD ' ' CD1' ' A' ' 99' ' ' LEU . 6.5 mtp -96.16 146.8 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.223 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.639 ' HB3' ' CE1' ' A' ' 149' ' ' PHE . 21.3 mmt85 -120.08 136.55 54.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.535 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 148' ' ' LEU . 5.8 mp -118.6 119.38 34.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.527 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.639 ' CE1' ' HB3' ' A' ' 147' ' ' ARG . 96.7 m-85 -129.98 159.38 36.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.563 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.555 ' CG1' ' HD2' ' A' ' 61' ' ' TYR . 15.7 m -112.23 131.59 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.28 -162.08 41.79 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' A' ' 152' ' ' GLU . 0.1 OUTLIER -68.35 144.07 96.22 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.829 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.526 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 31.4 Cg_exo -55.46 96.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.891 2.394 . . . . 0.0 112.172 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.4 -39.33 83.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.254 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.481 ' CE3' ' O ' ' A' ' 155' ' ' TRP . 9.0 t90 -55.1 -33.22 62.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.789 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.526 ' OG1' ' HB2' ' A' ' 153' ' ' PRO . 42.4 m -45.64 -43.88 12.79 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.32 101.01 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.345 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -142.0 158.45 43.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 20.3 m120 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.08 179.6 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.518 ' HA ' ' CD2' ' A' ' 174' ' ' PHE . 7.9 t80 . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.936 0.398 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.68 -38.06 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.604 ' O ' ' OE1' ' A' ' 177' ' ' GLN . 56.2 mttp -55.99 -35.15 66.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.682 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.57 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 96.3 m-85 -58.2 -36.75 73.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.433 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.538 ' O ' ' HB ' ' A' ' 178' ' ' THR . 60.9 mt -61.33 -35.44 77.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.828 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.16 96.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.695 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.604 ' OE1' ' O ' ' A' ' 173' ' ' LYS . 8.2 mp0 -64.35 -32.65 74.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.555 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 175' ' ' LEU . 10.7 m . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.574 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 2' ' ' VAL . 14.2 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.735 0.302 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.481 ' N ' HG22 ' A' ' 2' ' ' VAL . 50.4 tt0 -80.68 134.96 35.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.324 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.634 ' C ' HG11 ' A' ' 26' ' ' VAL . . . -148.54 137.74 21.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.657 ' CZ3' ' HB3' ' A' ' 25' ' ' PRO . 3.5 t-105 -137.87 154.12 49.5 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.681 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.551 ' HD2' ' NH2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.7 110.52 22.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.398 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.652 ' HE2' ' CE1' ' A' ' 18' ' ' HIS . 88.8 mtp . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.652 ' CE1' ' HE2' ' A' ' 7' ' ' MET . 73.3 m-70 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.637 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -126.0 95.63 39.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.677 ' O ' ' C ' ' A' ' 22' ' ' PRO . 60.5 Cg_endo -78.09 120.27 4.93 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.749 2.299 . . . . 0.0 111.368 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.578 ' OD2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -61.59 118.48 38.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.328 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.677 ' C ' ' O ' ' A' ' 20' ' ' PRO . 4.4 Cg_exo -77.04 125.71 12.3 Favored 'Cis proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.37 -1.512 . . . . 0.0 111.43 -1.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.76 166.09 46.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.551 ' NH2' ' HD2' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -153.17 117.41 2.82 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 121.11 0.481 . . . . 0.0 111.04 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.657 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 74.3 Cg_endo -77.42 165.67 27.09 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 123.119 2.546 . . . . 0.0 111.239 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.634 HG11 ' C ' ' A' ' 4' ' ' ALA . 10.5 p -126.95 159.3 37.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.286 0.565 . . . . 0.0 110.884 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.604 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -128.62 172.03 19.52 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.574 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 22.8 tp -53.66 -36.62 62.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.656 0.265 . . . . 0.0 110.774 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -55.08 -41.34 71.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.789 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.601 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 99.4 mm-40 -64.12 -40.94 97.27 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.521 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.604 ' CD2' HD11 ' A' ' 115' ' ' ILE . 25.5 mt -72.61 -32.11 65.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.447 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.598 ' NH1' HD22 ' A' ' 37' ' ' LEU . 19.1 mmm180 -54.7 -41.77 70.66 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -70.99 -27.21 63.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.585 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.598 HD21 ' CG1' ' A' ' 107' ' ' VAL . 13.1 tp -66.47 -9.97 39.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.752 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.637 ' O ' ' CG ' ' A' ' 128' ' ' PRO . . . 95.44 13.29 52.04 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.4 t -97.78 134.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.072 0.463 . . . . 0.0 110.545 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.645 HD12 ' CE2' ' A' ' 39' ' ' TRP . 3.1 tm? -103.95 128.71 51.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.951 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.502 ' N ' HD13 ' A' ' 37' ' ' LEU . 73.8 t80 -116.07 125.26 52.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 0.0 110.893 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.724 ' CE3' ' CE ' ' A' ' 124' ' ' MET . 1.5 m-90 -110.62 134.87 52.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.132 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.59 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 1.7 ptpt -99.37 105.3 17.25 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.772 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 43.7 mt -140.2 160.61 39.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.963 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 45' ' ' LYS . 58.5 t0 -119.79 139.28 52.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 46' ' ' TYR . . . -55.07 -43.68 74.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.122 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -66.84 -33.69 76.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.784 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.62 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 45.7 mttp -87.26 -6.0 58.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.355 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.723 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -76.72 -58.5 3.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.905 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.723 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 84.3 tt0 -70.68 -38.14 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 9.8 p-10 -74.1 -16.91 61.0 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.871 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.65 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 2.9 t0 -130.2 83.94 61.54 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.057 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 53' ' ' GLU . 77.7 Cg_exo -42.95 -8.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 123.36 2.707 . . . . 0.0 112.557 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 49' ' ' ASP . 84.2 tt0 -42.69 -34.58 0.93 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 52' ' ' LEU . 2.3 tm? -54.63 -41.03 69.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' OE2' ' HD3' ' A' ' 56' ' ' ARG . 46.7 tp10 -61.06 -34.83 75.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.981 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 25.1 mttm -58.49 -41.79 86.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.407 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -61.93 -33.75 59.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.658 ' NH2' ' O ' ' A' ' 62' ' ' SER . 60.2 ttt180 -54.98 -42.81 72.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.699 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -67.23 -39.14 86.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.543 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -63.59 -38.53 91.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.262 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.692 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 37.9 mmt180 -92.86 -2.18 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 110.527 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 62.33 51.08 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.15 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.692 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 57.3 m-85 -100.27 112.26 24.58 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.159 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.658 ' O ' ' NH2' ' A' ' 56' ' ' ARG . 61.2 m -83.85 -15.72 47.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.849 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.699 ' CZ2' ' OD2' ' A' ' 65' ' ' ASP . 48.2 t90 -130.65 128.02 40.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.731 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.629 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 16.7 ptm -153.56 133.2 12.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.545 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.699 ' OD2' ' CZ2' ' A' ' 63' ' ' TRP . 97.2 m-20 -145.85 172.04 13.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.527 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.19 123.13 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.048 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 74' ' ' LEU . 19.8 tt -133.0 148.36 31.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.629 ' OG1' ' O ' ' A' ' 143' ' ' THR . 5.1 t -127.04 148.02 50.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.186 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.706 ' CD1' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -83.02 107.95 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 74' ' ' LEU . 12.8 t -170.11 113.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.082 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.569 ' HB3' ' CB ' ' A' ' 77' ' ' TYR . 7.4 pttm -59.87 -30.97 69.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.386 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -61.79 -40.29 94.7 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.639 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -109.66 -41.19 4.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 111.174 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.617 ' CD1' ' CD1' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -113.3 90.68 17.41 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.771 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.622 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 5.6 Cg_endo -51.18 166.84 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.581 2.187 . . . . 0.0 110.587 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.622 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 61.3 t-20 86.1 22.13 0.08 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.362 . . . . 0.0 110.593 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.631 ' CE2' HG23 ' A' ' 81' ' ' ILE . 15.2 t80 -59.82 -40.36 88.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.577 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 59.4 mp0 -59.3 -56.04 27.21 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.531 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.654 ' O ' ' CG ' ' A' ' 83' ' ' MET . 96.9 mt-10 -73.59 -30.56 63.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.49 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 8.3 tptt -56.85 -55.53 33.22 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.569 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.644 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -71.6 -44.71 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.759 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 20.5 mttt -57.33 -35.99 70.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.73 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -57.84 -45.05 86.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.145 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.513 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 97.6 m-85 -77.61 -27.52 51.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.566 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.644 ' CE2' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -54.09 -47.32 71.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.555 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -87.56 132.62 33.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.775 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' HG2' ' HB2' ' A' ' 134' ' ' ARG . 98.0 mt-10 -61.77 135.72 57.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.137 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -136.0 155.92 49.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.685 ' CD1' ' N ' ' A' ' 131' ' ' ILE . 43.9 tp -121.45 164.24 17.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.293 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.637 ' CE1' ' HE1' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -168.03 142.83 3.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.237 0.541 . . . . 0.0 110.515 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.685 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.5 OUTLIER -65.78 -19.54 65.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.096 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.634 ' C ' ' CB ' ' A' ' 129' ' ' ALA . 58.4 t0 -107.79 148.36 29.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.226 0.536 . . . . 0.0 111.36 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.62 ' OD2' ' O ' ' A' ' 127' ' ' LEU . 61.2 t0 -84.48 128.29 34.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.651 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.613 ' OE2' ' CB ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -100.95 139.49 36.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.707 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.611 HG12 ' CG2' ' A' ' 126' ' ' THR . 67.8 mt -115.19 132.34 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.446 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -133.33 146.02 50.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.399 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.671 ' CD1' ' HB2' ' A' ' 124' ' ' MET . 1.2 t80 -127.72 127.53 43.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.97 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.678 ' CG2' ' O ' ' A' ' 101' ' ' GLY . 1.5 mp -93.91 99.09 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 111.0 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.568 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 19.0 mt -74.82 -34.44 62.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.482 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.549 ' HA ' ' HG3' ' A' ' 121' ' ' LYS . 58.6 t0 -146.8 -31.79 0.33 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.226 -0.59 . . . . 0.0 112.062 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.678 ' O ' ' CG2' ' A' ' 98' ' ' ILE . . . -56.57 161.83 7.06 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.592 ' HB2' ' CD ' ' A' ' 140' ' ' LYS . 66.8 m -145.95 148.7 33.06 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.184 -0.508 . . . . 0.0 109.888 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.513 ' HA3' HG12 ' A' ' 137' ' ' VAL . . . 170.92 -168.07 41.21 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.687 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.608 ' CE2' ' HD2' ' A' ' 118' ' ' PHE . 94.6 m-85 -113.91 133.22 55.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.748 0.308 . . . . 0.0 110.502 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.64 ' CD2' HG23 ' A' ' 107' ' ' VAL . 65.5 t80 -106.7 124.96 50.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.289 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.548 ' OD2' ' CE3' ' A' ' 114' ' ' TRP . 61.2 t0 -91.14 121.34 32.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.64 HG23 ' CD2' ' A' ' 105' ' ' PHE . 28.7 t -121.87 138.61 51.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.589 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.641 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 29.2 ttp180 -113.55 137.99 50.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.525 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 56.8 t0 -97.74 156.72 16.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.704 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.561 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 0.8 OUTLIER -61.49 -24.07 66.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.557 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.657 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 86.0 tt0 -77.41 11.33 2.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.319 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 111' ' ' GLU . 84.2 m-20 64.85 43.88 3.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.966 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.657 ' NE2' ' OE1' ' A' ' 111' ' ' GLU . 51.9 mt-30 -124.32 149.89 46.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.422 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.641 ' CZ3' ' HB2' ' A' ' 108' ' ' ARG . 95.1 m95 -111.71 136.15 51.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' A' ' 31' ' ' LEU . 64.3 mt -118.61 133.99 63.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.579 ' O ' HD13 ' A' ' 117' ' ' ILE . 69.6 ttt180 -90.68 111.2 22.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.579 HD13 ' O ' ' A' ' 116' ' ' ARG . 16.9 mm -115.9 134.58 58.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.937 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.608 ' HD2' ' CE2' ' A' ' 104' ' ' TYR . 83.6 t80 -101.07 132.37 46.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.549 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . 21.8 mmt -95.33 117.63 30.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.39 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.596 ' O ' ' CG ' ' A' ' 123' ' ' ASP . 84.4 tt0 -108.96 150.43 27.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.177 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 18.0 tttp -51.25 128.96 23.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.254 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 41' ' ' LEU . . . 94.31 -3.38 69.21 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.604 ' O ' ' OD1' ' A' ' 123' ' ' ASP . 41.8 p-10 -95.64 119.18 33.7 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.633 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.724 ' CE ' ' CE3' ' A' ' 39' ' ' TRP . 52.8 ttp -111.52 127.15 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.228 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.06 148.15 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.991 0.424 . . . . 0.0 111.605 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.611 ' CG2' HG12 ' A' ' 95' ' ' ILE . 93.9 m -113.81 135.49 53.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.282 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.711 ' CD1' ' CG ' ' A' ' 133' ' ' HIS . 0.2 OUTLIER -112.61 110.2 52.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.637 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 33.2 Cg_exo -55.97 142.16 85.33 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.942 2.428 . . . . 0.0 112.013 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.66 ' CB ' ' C ' ' A' ' 91' ' ' LEU . . . -71.61 149.19 45.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.653 ' C ' ' CD1' ' A' ' 89' ' ' LEU . . . 101.38 -1.58 53.77 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.685 ' N ' ' CD1' ' A' ' 89' ' ' LEU . 69.4 mt -120.57 132.72 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.781 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.645 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 95.6 m-85 -78.29 143.96 36.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.265 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.711 ' CG ' ' CD1' ' A' ' 127' ' ' LEU . 9.0 p-80 -158.03 157.6 33.23 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.162 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.618 ' CD ' ' O ' ' A' ' 85' ' ' TYR . 21.8 ttp180 -131.56 130.66 42.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.599 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.711 ' CE1' ' CG1' ' A' ' 137' ' ' VAL . 81.3 t80 -113.76 131.21 56.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.741 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.655 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 17.6 p -127.7 153.64 46.26 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.711 ' CG1' ' CE1' ' A' ' 135' ' ' PHE . 6.0 m -165.55 18.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.212 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.665 ' OD1' ' N ' ' A' ' 139' ' ' GLU . 51.7 p30 -63.79 -25.41 68.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.627 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.665 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 49.6 mt-10 -56.28 -38.73 71.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.592 ' CD ' ' HB2' ' A' ' 102' ' ' SER . 59.7 mtpt -96.69 -7.44 34.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.616 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.0 t30 47.48 11.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.747 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 140' ' ' LYS . 45.8 t80 -150.02 120.54 7.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.466 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.629 ' O ' ' OG1' ' A' ' 68' ' ' THR . 44.1 m -134.79 132.74 39.06 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.61 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.564 ' H ' ' CA ' ' A' ' 101' ' ' GLY . 31.0 tttt -126.8 108.7 11.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 97' ' ' TYR . . . -141.97 152.21 43.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.0 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 56.7 ttp -101.27 137.39 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.801 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.593 ' NH2' HG23 ' A' ' 67' ' ' ILE . 81.6 mtm-85 -123.35 146.6 47.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 111.158 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.592 ' N ' HD11 ' A' ' 148' ' ' LEU . 5.1 mp -115.37 134.39 55.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.41 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' TRP . 2.3 m-85 -152.72 161.78 42.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.756 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.29 140.22 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.402 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.23 -166.25 40.18 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 5.3 pm0 -65.73 149.61 97.21 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.473 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.642 ' O ' ' CG2' ' A' ' 156' ' ' THR . 35.2 Cg_exo -53.15 125.75 19.36 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.721 2.28 . . . . 0.0 112.035 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.522 ' CG1' ' N ' ' A' ' 155' ' ' TRP . 5.6 p -92.41 -43.95 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.514 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.73 ' CZ2' ' CB ' ' A' ' 83' ' ' MET . 3.3 t90 -57.44 -36.47 71.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.619 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.642 ' CG2' ' O ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -36.92 -53.84 0.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.467 ' H ' HG21 ' A' ' 156' ' ' THR . . . -147.07 101.75 3.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.304 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -134.51 158.71 43.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.407 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.098 179.635 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.434 ' N ' ' CD2' ' A' ' 171' ' ' TYR . 13.8 m-30 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.772 0.32 . . . . 0.0 110.569 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.472 HG23 HD13 ' A' ' 91' ' ' LEU . 71.4 t -60.7 -39.79 82.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.615 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.57 -34.85 71.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.627 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -56.61 -41.58 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.522 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.673 ' CD2' ' N ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -60.92 -35.33 76.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.571 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.74 -32.78 73.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.562 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.75 -32.64 74.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.519 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.5 m . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.585 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.599 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 14.7 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.758 0.313 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.579 ' OE1' ' CD2' ' A' ' 118' ' ' PHE . 49.6 tt0 -100.18 114.7 28.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.878 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.678 ' CB ' ' CG1' ' A' ' 26' ' ' VAL . . . -164.3 171.82 14.35 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.568 ' O ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -121.24 142.15 50.19 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.659 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.581 ' CE1' ' OE1' ' A' ' 30' ' ' GLN . 22.8 t80 -104.42 68.58 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.463 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.58 ' HB2' ' O ' ' A' ' 114' ' ' TRP . 87.8 mtp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.753 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.5 m80 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.615 0.245 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.561 ' CD ' ' HZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -121.88 96.2 47.13 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.467 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.636 ' O ' ' C ' ' A' ' 22' ' ' PRO . 36.2 Cg_endo -68.88 125.41 12.57 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.557 2.171 . . . . 0.0 111.18 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.41 118.53 44.85 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.809 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.636 ' C ' ' O ' ' A' ' 20' ' ' PRO . 1.6 Cg_endo -81.71 143.67 57.91 Favored 'Cis proline' 0 C--N 1.309 -1.537 0 C-N-CA 123.615 -1.41 . . . . 0.0 111.966 -0.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.56 161.06 43.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -133.58 117.54 14.29 Favored Pre-proline 0 C--N 1.332 -0.183 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.131 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.38 157.31 61.58 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 123.058 2.506 . . . . 0.0 111.467 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.678 ' CG1' ' CB ' ' A' ' 4' ' ' ALA . 1.7 p -57.37 142.61 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.761 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 30' ' ' GLN . . . -82.89 100.41 2.2 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.599 ' HB2' ' CG1' ' A' ' 2' ' ' VAL . 21.4 tp -47.15 -43.12 20.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.725 0.298 . . . . 0.0 110.317 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.8 -35.34 80.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.021 0.439 . . . . 0.0 109.946 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.595 ' O ' HD12 ' A' ' 34' ' ' LEU . 93.5 mt-30 -61.38 -41.73 97.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.097 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 10.3 mt -69.49 -34.41 74.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.43 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -42.12 65.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 33' ' ' ARG . 19.9 ttp180 -64.8 -31.21 72.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.018 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 34' ' ' LEU . 10.3 mp -65.3 -18.13 65.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.026 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.88 23.13 11.03 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 HG11 ' CE2' ' A' ' 38' ' ' TYR . 92.3 t -99.28 132.24 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 0.0 110.742 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 55.3 mt -108.75 141.21 41.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.633 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.54 ' OH ' HD13 ' A' ' 31' ' ' LEU . 54.0 m-85 -118.01 123.55 45.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.623 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.536 ' HZ3' ' OG1' ' A' ' 126' ' ' THR . 2.3 m-90 -121.23 132.3 54.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.179 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -105.84 104.98 14.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.062 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.634 ' C ' ' OH ' ' A' ' 97' ' ' TYR . 1.3 mp -140.58 153.34 46.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.95 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 46' ' ' TYR . 85.9 m-20 -102.92 133.07 48.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.531 ' O ' ' HD1' ' A' ' 46' ' ' TYR . . . -49.52 -43.98 45.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.69 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.683 ' OD2' ' N ' ' A' ' 45' ' ' LYS . 56.6 p30 -65.79 -31.6 72.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.673 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.683 ' N ' ' OD2' ' A' ' 44' ' ' ASP . 12.0 ttmm -85.38 -19.39 31.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.268 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.721 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -61.56 -56.48 19.47 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.822 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.721 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 84.9 tt0 -72.01 -40.86 68.18 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.584 -0.446 . . . . 0.0 109.984 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.618 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 17.8 m120 -66.77 -22.92 66.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.806 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.659 ' O ' ' N ' ' A' ' 51' ' ' GLU . 23.4 t0 -124.32 84.64 56.09 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.305 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 53' ' ' GLU . 75.0 Cg_exo -41.05 -8.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.59 2.86 . . . . 0.0 112.584 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 49' ' ' ASP . 12.4 tm-20 -41.87 -32.53 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -54.28 -41.03 68.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 50' ' ' PRO . 96.9 mt-10 -60.97 -35.89 77.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.266 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -59.64 -44.73 93.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.949 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.0 mt -62.01 -32.82 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.664 ' HG3' ' CZ ' ' A' ' 61' ' ' TYR . 27.2 ttt180 -55.74 -42.02 74.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.702 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -61.42 -41.46 97.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.779 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -67.48 -44.79 77.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.536 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.593 ' NH2' ' HB ' ' A' ' 95' ' ' ILE . 46.7 mtp85 -76.38 -19.48 58.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.534 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 56' ' ' ARG . 14.5 t-20 60.34 44.5 12.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.706 ' O ' ' CD2' ' A' ' 61' ' ' TYR . 4.2 p90 -112.0 126.15 54.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.094 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.555 ' C ' HH21 ' A' ' 56' ' ' ARG . 51.8 p -94.51 0.2 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.311 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.772 ' CE3' ' CE2' ' A' ' 149' ' ' PHE . 49.1 t90 -123.35 133.39 54.13 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.72 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.643 ' CB ' ' CD2' ' A' ' 148' ' ' LEU . 8.6 ptm -154.49 145.37 22.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.256 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.564 ' HB3' ' CH2' ' A' ' 63' ' ' TRP . 49.9 t0 -159.27 162.9 36.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 0.0 110.83 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 65.7 mt -114.06 127.96 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.497 HG12 ' N ' ' A' ' 68' ' ' THR . 5.3 tt -130.69 154.37 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 111.496 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.533 ' OG1' ' HG2' ' A' ' 144' ' ' LYS . 42.0 m -117.02 142.14 47.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.331 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.615 ' C ' ' SG ' ' A' ' 70' ' ' CYS . 2.2 mt -104.22 125.71 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.147 0.499 . . . . 0.0 111.168 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.615 ' SG ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -171.12 128.27 0.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.459 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -57.32 -46.03 83.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.889 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -67.72 -40.83 84.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.848 0.356 . . . . 0.0 111.033 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 70' ' ' CYS . 30.5 tttt -69.51 -41.22 76.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.034 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.619 ' O ' ' O ' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -133.47 87.41 37.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.777 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 74' ' ' LEU . 72.3 Cg_exo -41.01 176.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.22 1.947 . . . . 0.0 110.418 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.645 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 59.5 t-20 69.94 36.48 1.98 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.322 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.641 ' CE2' HG13 ' A' ' 81' ' ' ILE . 24.2 t80 -65.33 -51.45 60.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.567 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.647 ' O ' ' CD ' ' A' ' 82' ' ' LYS . 97.0 mt-10 -69.35 -46.97 65.74 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.643 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 98.7 mt-10 -65.17 -42.26 93.88 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.443 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.646 ' HE3' ' CE2' ' A' ' 155' ' ' TRP . 14.4 tptt -71.71 -45.73 60.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.15 0.5 . . . . 0.0 109.933 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.673 ' O ' ' CB ' ' A' ' 85' ' ' TYR . 14.1 mm -61.56 -58.13 8.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.799 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.647 ' CD ' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -54.21 -32.64 56.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.488 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 76.8 mmm -59.47 -61.15 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.254 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 81' ' ' ILE . 46.0 p90 -86.96 -16.31 36.21 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.695 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.673 ' CB ' ' O ' ' A' ' 81' ' ' ILE . 19.9 t80 -61.92 -46.26 90.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.14 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -65.47 142.49 58.14 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.231 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.6 139.47 31.7 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.149 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -164.79 170.36 15.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.032 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.633 HD23 ' CG ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.08 171.83 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.529 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.628 ' HE1' ' CD2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -170.41 154.68 4.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.673 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.582 HD11 ' CG1' ' A' ' 172' ' ' VAL . 0.3 OUTLIER -74.55 5.05 5.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.916 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.567 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 49.7 p30 -108.98 152.2 25.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.474 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.607 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 50.1 p30 -81.76 146.96 29.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.653 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.567 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 7.3 mm-40 -105.88 116.07 31.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.826 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.646 ' CD1' ' OG1' ' A' ' 126' ' ' THR . 6.3 tp -127.78 119.95 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.353 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.537 ' NH2' HG23 ' A' ' 143' ' ' THR . 63.4 ttt180 -134.65 137.41 43.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.478 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.661 ' CD1' ' HB2' ' A' ' 124' ' ' MET . 1.6 t80 -114.61 129.02 56.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.179 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.659 ' CG2' ' O ' ' A' ' 101' ' ' GLY . 20.0 mm -86.08 99.87 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.423 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.644 HD23 ' CD2' ' A' ' 97' ' ' TYR . 1.7 mt -82.81 -43.87 16.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.893 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.625 ' OD2' ' O ' ' A' ' 99' ' ' LEU . 91.3 m-20 -144.88 -21.08 0.51 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.896 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.659 ' O ' ' CG2' ' A' ' 98' ' ' ILE . . . -82.8 -176.7 51.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.507 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 49.0 m -151.23 158.05 43.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.547 ' C ' ' CD2' ' A' ' 104' ' ' TYR . . . 176.45 178.37 46.17 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.287 -0.958 . . . . 0.0 111.694 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.765 ' CE2' ' CD1' ' A' ' 118' ' ' PHE . 2.8 m-85 -124.32 140.4 52.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.613 0.244 . . . . 0.0 110.384 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.771 ' CD1' ' SD ' ' A' ' 119' ' ' MET . 18.5 m-30 -109.09 128.92 55.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 110.723 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.699 ' OD1' ' CE3' ' A' ' 114' ' ' TRP . 23.8 t70 -93.6 121.32 34.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.472 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.564 ' CG1' HD12 ' A' ' 117' ' ' ILE . 13.0 p -131.85 145.92 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.626 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.643 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 20.8 ttp180 -116.81 143.2 45.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 110.749 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.462 ' C ' ' OD2' ' A' ' 109' ' ' ASP . 49.3 p30 -101.55 174.41 5.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.423 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 112' ' ' ASP . 87.3 mttt -56.98 -31.66 65.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.046 0.451 . . . . 0.0 110.337 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 112' ' ' ASP . 84.5 tt0 -59.81 -9.14 2.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.105 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 111' ' ' GLU . 85.2 m-20 69.33 38.36 1.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.473 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.575 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 95.5 mm-40 -120.62 154.39 35.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.87 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.699 ' CE3' ' OD1' ' A' ' 106' ' ' ASP . 98.6 m95 -104.25 137.23 42.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.17 0.51 . . . . 0.0 111.387 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.568 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 72.3 mt -119.07 134.19 63.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.981 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.557 ' NH2' ' HD1' ' A' ' 104' ' ' TYR . 13.5 tpt180 -90.49 124.67 35.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.587 HG23 ' CE ' ' A' ' 119' ' ' MET . 21.9 mt -113.33 134.18 56.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.878 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.765 ' CD1' ' CE2' ' A' ' 104' ' ' TYR . 65.1 t80 -101.48 129.87 47.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.953 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.771 ' SD ' ' CD1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -115.13 123.9 50.13 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.446 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 123' ' ' ASP . 12.7 pt-20 -102.75 169.99 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.568 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.589 ' HA ' ' CG2' ' A' ' 98' ' ' ILE . 18.3 ptpt -64.79 123.7 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.953 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 95.93 -1.94 63.66 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.568 ' O ' HG12 ' A' ' 98' ' ' ILE . 60.2 t0 -93.89 119.96 33.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 0.0 111.007 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.661 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . 21.7 ttt -108.52 132.4 53.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.304 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 14.8 p -135.65 146.53 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 110.83 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.646 ' OG1' ' CD1' ' A' ' 95' ' ' ILE . 42.1 m -119.72 139.37 52.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.336 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.566 ' CD2' ' HB2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -114.71 143.36 29.86 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.005 0.431 . . . . 0.0 110.841 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.566 ' HG3' ' O ' ' A' ' 34' ' ' LEU . 32.4 Cg_endo -66.65 154.39 74.59 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.053 2.502 . . . . 0.0 112.238 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 92' ' ' ASP . . . -94.14 138.95 31.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.586 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.62 -0.18 61.11 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.517 HD13 ' HG2' ' A' ' 128' ' ' PRO . 70.6 mt -116.82 142.38 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.684 0.278 . . . . 0.0 110.277 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.633 ' CG ' HD23 ' A' ' 89' ' ' LEU . 99.7 m-85 -52.2 131.94 33.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.419 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.628 ' CD2' ' HE1' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -156.09 134.57 11.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.449 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.571 ' HG3' ' O ' ' A' ' 85' ' ' TYR . 23.3 ttp180 -139.81 136.81 34.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.871 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.66 ' CD2' ' CD2' ' A' ' 105' ' ' PHE . 21.6 m-30 -112.68 134.07 54.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.351 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.555 ' C ' HG12 ' A' ' 137' ' ' VAL . 56.9 m -126.6 136.28 52.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.926 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.555 HG12 ' C ' ' A' ' 136' ' ' THR . 1.3 m -147.83 6.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.189 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.621 ' O ' ' OD1' ' A' ' 141' ' ' ASN . 22.2 t70 -55.65 -38.23 69.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.398 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.48 -42.6 96.63 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.227 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 142' ' ' TYR . 10.6 mmtm -66.59 -33.23 75.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.725 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.621 ' OD1' ' O ' ' A' ' 138' ' ' ASP . 87.5 m-20 68.32 -10.99 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.616 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.539 ' H ' ' C ' ' A' ' 140' ' ' LYS . 49.4 t80 -151.55 117.38 5.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.367 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.537 HG23 ' NH2' ' A' ' 96' ' ' ARG . 46.4 m -136.22 127.25 27.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.874 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.533 ' HG2' ' OG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -117.54 103.1 9.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.614 ' CB ' ' O ' ' A' ' 97' ' ' TYR . . . -141.82 154.58 45.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.589 ' SD ' ' HE3' ' A' ' 64' ' ' MET . 0.1 OUTLIER -97.48 143.14 28.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.618 ' NH2' ' CD2' ' A' ' 149' ' ' PHE . 67.5 ttp85 -115.61 140.69 48.94 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.819 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.646 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 48.2 mt -118.57 134.26 55.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.721 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.772 ' CE2' ' CE3' ' A' ' 63' ' ' TRP . 6.3 p90 -149.8 160.46 43.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.374 . . . . 0.0 110.597 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.5 ' CG2' ' HA ' ' A' ' 61' ' ' TYR . 31.1 t -115.87 130.69 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.1 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.433 ' O ' ' CE1' ' A' ' 149' ' ' PHE . . . 80.08 -164.17 47.84 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 152' ' ' GLU . 2.4 pt-20 -73.11 126.45 90.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.452 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.569 ' HG3' ' CZ ' ' A' ' 149' ' ' PHE . 25.1 Cg_exo -58.94 124.23 15.25 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.79 2.327 . . . . 0.0 112.295 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.4 -34.13 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.447 . . . . 0.0 109.973 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.701 ' CE3' ' O ' ' A' ' 155' ' ' TRP . 1.7 t-105 -58.94 -29.95 67.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.759 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 153' ' ' PRO . 38.3 m -44.49 -46.31 9.66 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.291 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.93 100.89 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.453 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.69 ' CD1' ' C ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -157.0 166.64 32.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.709 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.594 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 86.7 m-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.994 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.782 0.325 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.582 ' CG1' HD11 ' A' ' 91' ' ' LEU . 5.1 p -54.84 -34.58 31.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.416 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.572 ' CE ' HD13 ' A' ' 91' ' ' LEU . 47.2 mttt -58.22 -35.1 71.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.509 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.34 -41.19 75.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.686 ' CD2' ' N ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -61.28 -35.07 76.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.505 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.02 72.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.603 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -63.83 -32.95 74.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.518 HG21 ' O ' ' A' ' 175' ' ' LEU . 1.7 t . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.584 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 14.6 p . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.801 0.334 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.432 ' N ' HG23 ' A' ' 2' ' ' VAL . 97.8 mm-40 -102.72 115.77 31.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.63 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -163.88 155.96 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.758 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.639 ' CZ3' ' HB3' ' A' ' 25' ' ' PRO . 0.9 OUTLIER -128.24 141.22 51.52 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.191 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.682 ' CE1' ' CD1' ' A' ' 115' ' ' ILE . 2.1 t80 -96.13 -6.01 39.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.11 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.591 ' HG3' ' CD ' ' A' ' 20' ' ' PRO . 85.4 mmm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.265 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.554 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.146 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.81 107.42 1.13 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.854 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.68 ' O ' ' N ' ' A' ' 23' ' ' GLY . 35.1 Cg_endo -68.0 159.45 52.93 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.864 2.376 . . . . 0.0 111.62 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 107.39 55.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.697 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 20' ' ' PRO . 63.2 Cg_endo -78.11 150.02 88.1 Favored 'Cis proline' 0 C--N 1.309 -1.55 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.355 -0.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -95.85 173.49 30.73 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -152.91 117.65 2.89 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 111.08 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.639 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 55.7 Cg_endo -74.11 152.8 45.98 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.158 2.572 . . . . 0.0 111.756 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.63 HG11 ' CB ' ' A' ' 4' ' ' ALA . 1.3 p -58.66 144.75 11.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 30' ' ' GLN . . . -94.69 104.56 3.16 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.556 ' HB2' ' CG1' ' A' ' 2' ' ' VAL . 8.4 tt -45.27 -44.29 11.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.73 -34.55 77.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 27' ' ' GLY . 50.3 tt0 -61.89 -40.85 96.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.264 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.576 HD13 ' CG2' ' A' ' 26' ' ' VAL . 9.0 mp -63.39 -39.41 94.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.636 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 54.2 ttt85 -57.23 -44.05 83.43 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.521 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -75.17 -30.51 60.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.627 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 30.8 tp -68.73 -7.24 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.127 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.572 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . 102.65 -0.3 49.25 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 32' ' ' ARG . 93.1 t -101.8 126.56 55.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.362 . . . . 0.0 110.557 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.567 ' CD2' ' HG3' ' A' ' 32' ' ' ARG . 79.8 mt -111.53 147.56 35.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.612 ' CD2' ' HE2' ' A' ' 40' ' ' LYS . 32.8 t80 -114.22 124.28 51.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.142 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.683 ' CZ3' ' OG1' ' A' ' 126' ' ' THR . 1.5 m0 -113.1 138.63 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.757 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.612 ' HE2' ' CD2' ' A' ' 38' ' ' TYR . 61.8 mmtt -98.65 105.92 18.12 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.656 ' O ' ' CA ' ' A' ' 122' ' ' GLY . 31.8 mt -138.27 139.11 39.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.207 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 46' ' ' TYR . 87.6 m-20 -108.46 128.72 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 99' ' ' LEU . . . -50.36 -42.8 53.77 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.956 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.14 -33.69 76.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.573 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 49' ' ' ASP . 2.2 mtpt -88.07 -17.53 30.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.001 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.687 ' CZ ' ' CD2' ' A' ' 97' ' ' TYR . 0.1 OUTLIER -58.55 -49.1 78.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.764 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -82.8 -44.18 15.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.057 0.456 . . . . 0.0 109.927 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -66.78 -23.38 66.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.612 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 45' ' ' LYS . 1.9 t0 -127.18 84.34 63.7 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.572 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.7 Cg_endo -49.47 -8.69 0.1 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 123.083 2.522 . . . . 0.0 111.288 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.535 ' H ' ' C ' ' A' ' 49' ' ' ASP . 84.5 tt0 -43.81 -35.96 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.47 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.686 ' C ' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -59.17 -33.31 70.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.651 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 1.5 tp10 -64.74 -35.82 82.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.925 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -58.64 -40.18 82.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.069 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.89 -44.47 90.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.667 ' NE ' ' O ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -66.62 -36.47 82.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.439 179.332 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.633 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 70.3 ttp85 -62.52 -42.78 99.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.297 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.18 -35.62 80.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.614 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -85.03 0.33 51.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.429 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.49 42.3 14.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.181 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.667 ' O ' ' NE ' ' A' ' 56' ' ' ARG . 19.3 m-85 -80.22 122.67 27.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.971 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.26 -31.74 12.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.203 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.708 ' CH2' ' CG ' ' A' ' 65' ' ' ASP . 37.7 t90 -113.07 121.47 44.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 111.3 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.655 ' SD ' HD23 ' A' ' 148' ' ' LEU . 83.4 mmm -146.61 139.48 25.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.523 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.708 ' CG ' ' CH2' ' A' ' 63' ' ' TRP . 21.1 p30 -163.13 165.04 25.04 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.841 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.572 ' CG1' ' HE2' ' A' ' 146' ' ' MET . 65.8 mt -115.17 131.8 66.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.267 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.673 ' CG2' ' NH1' ' A' ' 147' ' ' ARG . 10.7 tp -129.15 158.87 41.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.403 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.584 ' CA ' ' HG3' ' A' ' 144' ' ' LYS . 5.5 t -123.55 153.15 41.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.533 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -104.09 103.48 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.433 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 72' ' ' ASP . 20.9 t -172.06 110.18 0.26 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.522 ' HB3' ' CB ' ' A' ' 77' ' ' TYR . 0.8 OUTLIER -58.65 -35.32 72.36 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.295 -179.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 90.3 m-20 -59.19 -39.42 82.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.444 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -97.36 -41.29 8.31 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.313 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -123.95 85.69 54.05 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.99 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.588 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 2.7 Cg_exo -40.74 172.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.451 2.1 . . . . 0.0 110.316 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.631 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 62.6 t-20 72.4 29.53 2.13 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.358 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.704 ' C ' ' CD2' ' A' ' 77' ' ' TYR . 1.6 t80 -64.23 -45.83 86.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.574 ' O ' HG13 ' A' ' 81' ' ' ILE . 20.1 pt-20 -71.44 -47.52 55.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.631 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 98.2 mt-10 -66.78 -40.12 88.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.386 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.537 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 57.4 tttp -67.99 -47.75 67.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.557 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.732 ' CD1' ' CE1' ' A' ' 85' ' ' TYR . 2.7 pp -67.4 -42.41 87.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.568 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.538 ' N ' ' CD1' ' A' ' 81' ' ' ILE . 55.4 tttp -55.87 -39.57 71.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.132 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.579 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 61.8 mtt -59.78 -44.25 94.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.94 0.4 . . . . 0.0 110.695 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.672 ' CE2' ' CZ2' ' A' ' 155' ' ' TRP . 95.5 m-85 -73.51 -33.57 64.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.615 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.732 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 11.4 m-30 -60.04 -45.66 92.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.542 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 83' ' ' MET . 20.4 pt-20 -64.66 129.74 40.95 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.329 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.633 ' OE2' ' CH2' ' A' ' 114' ' ' TRP . 96.1 mt-10 -63.61 137.9 58.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.552 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.666 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.5 OUTLIER -150.91 171.94 16.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.452 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.717 ' CD2' ' CE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.81 -179.91 5.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.273 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.648 ' O ' ' CB ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -170.71 146.48 2.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 179.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.584 ' CD2' ' HD2' ' A' ' 173' ' ' LYS . 6.3 mp -65.82 -24.77 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.329 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.576 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 48.6 p30 -108.22 150.54 27.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 111.261 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.618 ' OD1' ' O ' ' A' ' 127' ' ' LEU . 49.2 t0 -84.32 128.9 34.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.967 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.631 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -107.93 140.38 41.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.87 0.367 . . . . 0.0 110.667 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.643 HD13 ' CE1' ' A' ' 61' ' ' TYR . 15.3 pt -113.75 133.2 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.478 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.728 ' NH1' ' CZ ' ' A' ' 105' ' ' PHE . 42.3 ttm180 -123.27 138.89 54.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.382 . . . . 0.0 110.686 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.687 ' CD2' ' CZ ' ' A' ' 46' ' ' TYR . 17.5 t80 -118.49 129.84 55.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.474 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.594 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 11.4 mm -91.14 94.22 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.169 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.586 ' CD1' ' CB ' ' A' ' 43' ' ' ALA . 12.8 tp -80.15 -33.21 38.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.524 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.684 ' CG ' ' N ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -66.53 -68.64 0.36 Allowed 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.633 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.684 ' N ' ' CG ' ' A' ' 100' ' ' ASP . . . 157.86 -28.11 0.47 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.517 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.644 ' O ' ' CG2' ' A' ' 143' ' ' THR . 97.1 p -113.64 141.72 46.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.681 0.741 . . . . 0.0 111.237 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.527 ' HA2' ' CZ ' ' A' ' 135' ' ' PHE . . . -173.75 125.41 1.12 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.564 ' OH ' ' HG3' ' A' ' 116' ' ' ARG . 81.1 t80 -115.89 131.29 56.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.727 0.298 . . . . 0.0 110.815 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.728 ' CZ ' ' NH1' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -137.73 157.01 47.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.707 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.567 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 49.5 p30 -144.88 151.27 38.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.358 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.61 141.96 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.967 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.64 ' HB2' ' CH2' ' A' ' 114' ' ' TRP . 38.2 ttt180 -106.4 137.35 44.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.406 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 56.7 t0 -103.35 156.56 17.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.552 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 26.6 mttp -59.28 -30.74 68.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.058 0.456 . . . . 0.0 110.328 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.631 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 96.0 mt-10 -68.99 -0.63 5.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.214 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.648 ' C ' ' OD2' ' A' ' 112' ' ' ASP . 0.0 OUTLIER 76.62 32.09 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.52 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.631 ' NE2' ' OE1' ' A' ' 111' ' ' GLU . 54.8 mt-30 -110.19 146.0 36.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.046 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.64 ' CH2' ' HB2' ' A' ' 108' ' ' ARG . 82.7 m95 -113.66 139.54 48.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.969 0.414 . . . . 0.0 111.175 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.682 ' CD1' ' CE1' ' A' ' 6' ' ' TYR . 60.5 mt -114.14 125.19 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.224 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 71.6 ttp85 -93.3 114.1 26.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.24 128.3 73.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.602 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.48 ' CE2' ' OE2' ' A' ' 139' ' ' GLU . 67.8 t80 -103.33 131.04 50.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.267 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.605 ' SD ' ' HD1' ' A' ' 105' ' ' PHE . 88.4 mtp -100.11 127.57 46.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.627 ' OE2' ' OD2' ' A' ' 123' ' ' ASP . 3.6 mp0 -110.76 159.65 17.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 0.0 110.76 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.619 ' CA ' ' HA2' ' A' ' 101' ' ' GLY . 8.0 pttm -45.67 121.2 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.143 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.656 ' CA ' ' O ' ' A' ' 41' ' ' LEU . . . 89.25 6.56 71.09 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.774 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.627 ' OD2' ' OE2' ' A' ' 120' ' ' GLU . 87.4 m-20 -92.18 119.46 31.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.705 ' SD ' ' O ' ' A' ' 96' ' ' ARG . 1.2 tpt -113.88 129.78 56.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.182 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 37' ' ' LEU . 12.6 p -134.28 144.68 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.836 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.683 ' OG1' ' CZ3' ' A' ' 39' ' ' TRP . 82.8 m -105.51 132.7 51.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.043 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.618 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -102.49 122.68 45.52 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.9 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 20.7 Cg_endo -63.89 144.51 88.48 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.954 2.436 . . . . 0.0 112.107 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.648 ' CB ' ' O ' ' A' ' 90' ' ' HIS . . . -75.9 142.33 42.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.058 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.12 11.3 61.48 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.514 HD11 ' HG2' ' A' ' 128' ' ' PRO . 1.2 mt -115.47 148.78 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.766 0.317 . . . . 0.0 110.716 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.717 ' CE2' ' CD2' ' A' ' 89' ' ' LEU . 7.8 m-30 -94.75 131.31 40.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.179 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.624 ' HE1' ' CE1' ' A' ' 90' ' ' HIS . 20.0 p-80 -154.64 167.74 29.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.58 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.562 ' HG2' ' OD1' ' A' ' 106' ' ' ASP . 16.1 ptp180 -149.41 150.78 32.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.632 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.69 ' O ' ' CD2' ' A' ' 85' ' ' TYR . 68.8 t80 -114.42 132.41 56.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 104' ' ' TYR . 46.5 m -125.54 137.11 53.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.023 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.559 HG13 ' CB ' ' A' ' 143' ' ' THR . 15.3 m -117.77 12.0 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.594 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.459 ' H ' HG22 ' A' ' 136' ' ' THR . 56.3 t0 -57.61 -23.19 49.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.151 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 84.4 tt0 -44.71 -34.77 2.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.289 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 19.6 mtpt -159.95 4.28 0.08 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.6 m120 58.71 33.27 22.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.902 0.382 . . . . 0.0 110.555 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.473 ' O ' ' OG ' ' A' ' 102' ' ' SER . 62.3 t80 -151.99 97.65 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.178 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.653 ' O ' ' N ' ' A' ' 69' ' ' ILE . 53.3 m -135.25 130.76 35.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.386 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.617 ' HB3' ' CB ' ' A' ' 100' ' ' ASP . 29.3 tttt -130.43 117.16 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.594 ' HB1' ' CD1' ' A' ' 98' ' ' ILE . . . -141.51 156.88 45.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.635 ' SD ' ' HE1' ' A' ' 64' ' ' MET . 44.2 ttm -92.19 135.17 34.21 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.673 ' NH1' ' CG2' ' A' ' 67' ' ' ILE . 50.2 mtm-85 -111.27 149.23 31.34 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.084 0.469 . . . . 0.0 111.256 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.655 HD23 ' SD ' ' A' ' 64' ' ' MET . 1.8 tm? -119.92 119.32 33.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.862 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.611 ' HD1' ' CZ3' ' A' ' 63' ' ' TRP . 98.1 m-85 -129.8 153.55 48.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.984 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.48 129.86 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.074 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.32 -159.43 38.99 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.47 148.37 98.1 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 110.633 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.424 ' HB2' ' CG2' ' A' ' 156' ' ' THR . 38.0 Cg_endo -69.51 95.25 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.884 2.39 . . . . 0.0 112.294 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 155' ' ' TRP . 16.5 m -76.32 -27.41 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.688 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.672 ' CZ2' ' CE2' ' A' ' 84' ' ' PHE . 43.6 t90 -56.3 -34.05 66.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.424 ' CG2' ' HB2' ' A' ' 153' ' ' PRO . 53.7 p -46.32 -43.83 16.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.56 100.55 3.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.25 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.654 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -151.12 159.99 44.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.67 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.98 179.166 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.6 t80 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.824 0.345 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 73.2 t -58.26 -38.98 71.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.602 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.584 ' HD2' ' CD2' ' A' ' 91' ' ' LEU . 60.5 mtpt -57.75 -34.89 70.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.678 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -56.72 -41.33 77.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.499 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.0 tp -57.26 -37.68 72.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.632 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.34 72.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.655 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -63.59 -33.06 74.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.527 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.6 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 10.5 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.733 0.301 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.567 ' OE1' ' HA ' ' A' ' 3' ' ' GLN . 13.2 mm-40 -94.25 114.58 26.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.497 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.674 ' CB ' ' CG1' ' A' ' 26' ' ' VAL . . . -163.55 162.7 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.891 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.524 ' HE3' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -126.95 148.21 50.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.064 0.459 . . . . 0.0 111.685 -178.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.598 ' CE2' HG12 ' A' ' 115' ' ' ILE . 1.2 t80 -108.71 77.29 1.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.238 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.411 ' H ' ' HG2' ' A' ' 7' ' ' MET . 17.1 ptm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.566 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.58 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 62.0 m-70 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.91 0.386 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.483 ' CD ' ' CZ2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -89.48 100.56 2.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.253 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.629 ' O ' ' C ' ' A' ' 22' ' ' PRO . 16.1 Cg_endo -60.91 153.68 61.7 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.608 2.205 . . . . 0.0 111.73 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -105.55 112.31 64.71 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.622 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.629 ' C ' ' O ' ' A' ' 20' ' ' PRO . 37.8 Cg_endo -73.33 156.76 99.5 Favored 'Cis proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.144 -1.607 . . . . 0.0 112.348 -0.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 20' ' ' PRO . . . -68.57 143.64 40.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.496 ' HG3' ' HG2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -152.71 121.05 3.18 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.222 0.534 . . . . 0.0 111.225 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.73 156.32 63.74 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.161 2.574 . . . . 0.0 111.327 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.674 ' CG1' ' CB ' ' A' ' 4' ' ' ALA . 1.2 p -57.33 144.7 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.54 103.02 2.92 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.6 ' HB2' ' CG1' ' A' ' 2' ' ' VAL . 9.2 tt -48.64 -40.34 27.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.809 0.337 . . . . 0.0 110.348 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -59.37 -36.98 76.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.168 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.575 ' OE1' ' HA ' ' A' ' 30' ' ' GLN . 15.1 mm-40 -61.33 -43.59 98.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.693 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.577 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 18.2 mt -71.77 -34.54 69.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.22 -43.11 70.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.286 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.536 ' CG ' HH11 ' A' ' 33' ' ' ARG . 2.6 ttt-85 -65.29 -31.05 71.99 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.577 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 28.2 tp -65.13 -18.55 65.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.888 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' A' ' 128' ' ' PRO . . . 102.83 17.24 19.44 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.51 128.97 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.263 0.554 . . . . 0.0 110.979 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 126' ' ' THR . 35.5 mt -123.89 143.0 50.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.15 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 124' ' ' MET . 30.6 p90 -144.46 150.97 38.52 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.871 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.635 ' CZ3' ' HE2' ' A' ' 124' ' ' MET . 24.3 m-90 -123.13 141.21 52.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.575 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 4.1 ttpm? -99.37 104.42 16.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.898 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.651 ' CB ' ' OH ' ' A' ' 97' ' ' TYR . 1.1 mt -141.32 150.83 43.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.288 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.639 ' OD1' ' NZ ' ' A' ' 45' ' ' LYS . 84.4 m-20 -102.23 132.54 48.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB3' ' CA ' ' A' ' 99' ' ' LEU . . . -47.09 -44.1 20.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.16 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -62.57 -33.22 74.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.738 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.639 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 18.0 mttp -86.6 -8.18 57.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.319 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.692 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -71.42 -56.09 6.63 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.692 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 48.8 tp10 -76.09 -42.23 47.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.555 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.482 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -66.85 -23.51 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.633 ' CB ' ' O ' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -124.02 85.29 54.51 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.829 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.1 Cg_endo -44.06 -9.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.395 2.73 . . . . 0.0 112.008 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.615 ' HG3' ' NZ ' ' A' ' 54' ' ' LYS . 83.7 tt0 -42.9 -35.55 1.24 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.458 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.602 ' C ' ' CD1' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -57.31 -38.23 73.71 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' HD12 ' A' ' 52' ' ' LEU . 84.0 tt0 -59.51 -34.35 72.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.709 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.615 ' NZ ' ' HG3' ' A' ' 51' ' ' GLU . 7.8 ttpm? -57.28 -45.44 84.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.768 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.2 mt -62.19 -39.87 85.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.629 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 64' ' ' MET . 69.4 ttt180 -60.84 -44.29 97.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.336 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -64.29 -42.06 96.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.537 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -62.95 -41.07 99.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.643 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.729 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 38.5 mmt180 -82.97 -12.02 57.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.019 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 65.4 50.12 1.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.866 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.729 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 25.9 m-85 -99.48 115.53 29.53 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.117 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.536 ' C ' HH21 ' A' ' 56' ' ' ARG . 59.9 p -88.04 -16.9 32.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.218 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.669 ' CH2' ' HB2' ' A' ' 65' ' ' ASP . 1.6 t-105 -114.07 110.6 20.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.002 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 56' ' ' ARG . 25.0 ttt -146.15 138.23 25.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.35 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.669 ' HB2' ' CH2' ' A' ' 63' ' ' TRP . 21.9 t70 -159.98 179.21 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.583 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.525 ' HA ' ' HG2' ' A' ' 146' ' ' MET . 52.8 mt -106.85 126.2 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.486 HG22 HD13 ' A' ' 67' ' ' ILE . 1.8 mm -117.15 135.6 57.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.337 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.516 ' OG1' ' HG3' ' A' ' 144' ' ' LYS . 47.6 m -125.43 141.18 52.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.656 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 142' ' ' TYR . 45.8 mt -109.74 122.03 63.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.199 0.524 . . . . 0.0 111.128 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.663 ' O ' ' N ' ' A' ' 74' ' ' LEU . 1.1 t -164.63 118.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.612 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -57.4 -42.79 82.94 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.093 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -62.94 -40.3 97.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.738 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -105.2 1.65 28.42 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.427 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.663 ' N ' ' O ' ' A' ' 70' ' ' CYS . 0.7 OUTLIER -130.25 83.08 64.04 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.838 0.351 . . . . 0.0 111.227 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.588 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 14.1 Cg_endo -59.23 161.37 16.68 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.194 1.929 . . . . 0.0 109.607 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.649 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 56.7 t-20 70.86 38.03 1.23 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.169 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.647 ' CZ ' HG13 ' A' ' 81' ' ' ILE . 7.4 t80 -64.97 -48.03 75.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.602 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.592 ' CG ' ' HE3' ' A' ' 82' ' ' LYS . 84.1 tt0 -61.89 -56.74 16.18 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.636 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 97.8 mt-10 -64.92 -41.5 95.51 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.214 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.68 ' O ' ' CD2' ' A' ' 84' ' ' PHE . 26.3 tttp -67.08 -37.97 84.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.173 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.707 ' CD1' ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -71.3 -54.41 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.119 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.647 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 98.3 mttt -50.1 -30.1 10.37 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.424 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.646 ' HE3' ' CH2' ' A' ' 155' ' ' TRP . 74.0 mtm -74.46 -58.77 3.08 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.738 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 18.3 p90 -87.29 -49.75 7.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.692 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.738 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -52.72 -47.12 67.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.039 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.722 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 84.6 tt0 -55.64 141.62 37.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 110.813 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -57.44 136.02 56.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.645 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -157.46 -172.25 3.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.478 HD23 ' HE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -145.33 178.97 7.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.416 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.661 ' CE1' ' CE1' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -170.7 140.71 1.73 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.044 0.449 . . . . 0.0 110.676 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.444 ' HA ' HD22 ' A' ' 91' ' ' LEU . 66.3 mt -80.67 2.33 26.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.421 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -108.89 153.36 23.64 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.551 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -61.33 134.95 57.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.412 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.564 ' O ' HG21 ' A' ' 126' ' ' THR . 31.0 tt0 -108.32 116.99 32.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.748 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.605 HG12 ' CG2' ' A' ' 126' ' ' THR . 10.1 mt -129.24 129.84 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.4 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.435 ' CZ ' ' CZ ' ' A' ' 105' ' ' PHE . 14.0 ptm180 -139.72 148.41 42.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.015 0.435 . . . . 0.0 110.721 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.651 ' OH ' ' CB ' ' A' ' 41' ' ' LEU . 2.2 t80 -122.75 138.71 54.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.593 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.641 ' O ' ' N ' ' A' ' 122' ' ' GLY . 12.5 mm -104.1 114.55 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.143 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.589 HD13 ' CG ' ' A' ' 146' ' ' MET . 17.3 mt -84.22 -43.61 14.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.159 0.504 . . . . 0.0 109.971 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.47 162.41 38.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.33 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.55 173.93 45.85 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.703 ' OG ' ' CZ ' ' A' ' 118' ' ' PHE . 33.3 t -123.2 141.2 52.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.814 0.34 . . . . 0.0 110.492 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.92 150.04 20.04 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.72 ' CE1' ' CE1' ' A' ' 118' ' ' PHE . 88.8 m-85 -116.82 127.36 54.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.478 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.665 ' CE2' ' CD1' ' A' ' 135' ' ' PHE . 98.6 m-85 -123.77 149.22 45.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.002 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.602 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 53.8 p30 -133.35 144.48 49.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.462 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.61 146.38 31.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.701 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.646 ' HB2' ' CH2' ' A' ' 114' ' ' TRP . 76.2 ttt180 -113.06 125.67 54.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.008 0.432 . . . . 0.0 110.737 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.76 156.69 22.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.408 ' C ' ' H ' ' A' ' 112' ' ' ASP . 39.5 ttpt -56.23 -32.67 64.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 110.417 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 85.1 tt0 -66.35 -2.52 4.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.217 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 111' ' ' GLU . 59.8 t0 76.17 40.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.31 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.497 ' NE2' ' CD ' ' A' ' 111' ' ' GLU . 93.9 mt-30 -113.8 144.3 43.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.183 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.646 ' CH2' ' HB2' ' A' ' 108' ' ' ARG . 87.1 m95 -111.2 130.65 55.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.014 0.435 . . . . 0.0 111.182 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.598 HG12 ' CE2' ' A' ' 6' ' ' TYR . 64.9 mt -117.95 133.96 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.524 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.562 ' C ' HD13 ' A' ' 117' ' ' ILE . 59.4 ttp180 -91.94 116.7 29.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.595 HG21 ' CE ' ' A' ' 119' ' ' MET . 11.9 mm -112.0 127.23 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.422 . . . . 0.0 110.539 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 104' ' ' TYR . 80.1 t80 -106.32 133.13 51.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.917 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.623 ' HG3' ' CE1' ' A' ' 105' ' ' PHE . 16.2 mmt -107.0 126.28 52.12 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.443 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 84.8 tt0 -108.35 148.51 29.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.703 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -44.68 138.03 3.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.123 0.487 . . . . 0.0 111.072 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 79.12 1.04 84.83 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.567 ' O ' HG12 ' A' ' 98' ' ' ILE . 57.2 t0 -94.92 119.7 33.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.867 0.365 . . . . 0.0 111.266 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.635 ' HE2' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -97.32 136.49 37.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.663 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.484 HG21 ' N ' ' A' ' 126' ' ' THR . 12.8 p -137.32 143.72 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.303 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.605 ' CG2' HG12 ' A' ' 95' ' ' ILE . 95.9 m -122.54 131.54 53.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.006 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.414 HD23 ' HB ' ' A' ' 131' ' ' ILE . 0.4 OUTLIER -112.9 120.05 41.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.904 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.583 ' O ' HD11 ' A' ' 131' ' ' ILE . 38.9 Cg_exo -57.11 155.47 28.74 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.806 2.338 . . . . 0.0 111.877 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.6 147.43 29.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 131' ' ' ILE . . . 94.88 9.25 58.62 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.583 HD11 ' O ' ' A' ' 128' ' ' PRO . 3.4 mp -114.55 151.26 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.478 ' HE2' HD23 ' A' ' 89' ' ' LEU . 51.6 m-85 -101.26 135.76 42.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.225 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.661 ' CE1' ' CE1' ' A' ' 90' ' ' HIS . 13.4 p-80 -148.0 158.63 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.123 0.487 . . . . 0.0 111.188 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.552 ' NH1' ' OG1' ' A' ' 136' ' ' THR . 74.0 ttp85 -134.02 132.68 40.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.0 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.665 ' CD1' ' CE2' ' A' ' 105' ' ' PHE . 17.1 t80 -106.38 131.03 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.896 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.552 ' OG1' ' NH1' ' A' ' 134' ' ' ARG . 41.5 m -126.39 131.09 51.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.975 0.417 . . . . 0.0 110.913 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 141' ' ' ASN . 15.0 m -126.9 13.68 3.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.213 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.567 ' HA ' ' OD1' ' A' ' 141' ' ' ASN . 91.6 m-20 -63.32 -23.08 67.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.47 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.644 ' HG3' ' CE2' ' A' ' 104' ' ' TYR . 75.2 mm-40 -56.57 -35.53 68.29 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.286 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.502 ' HG3' ' H ' ' A' ' 142' ' ' TYR . 0.8 OUTLIER -140.66 -22.89 0.8 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.525 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 137' ' ' VAL . 87.0 m-20 59.12 38.5 23.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.715 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.515 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 65.9 t80 -157.71 97.0 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.442 HG21 ' N ' ' A' ' 144' ' ' LYS . 39.6 m -133.44 143.17 48.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.0 110.907 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.516 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 66.7 tttt -126.41 109.83 12.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.746 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.598 ' HB2' ' CD1' ' A' ' 98' ' ' ILE . . . -141.88 154.4 45.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.184 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.589 ' CG ' HD13 ' A' ' 99' ' ' LEU . 69.8 mtm -94.74 146.68 24.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.184 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.543 ' HB3' ' CE2' ' A' ' 149' ' ' PHE . 19.4 mmm-85 -113.91 140.43 48.38 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.378 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 148' ' ' LEU . 5.1 mp -113.85 115.35 27.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.532 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.569 ' HB2' ' CD1' ' A' ' 63' ' ' TRP . 94.5 m-85 -135.25 156.19 49.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.614 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.54 ' O ' ' CG2' ' A' ' 150' ' ' VAL . 1.3 p -127.7 74.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.945 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.62 -173.0 43.26 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.541 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 71.3 tt0 -73.1 143.4 83.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.901 0.382 . . . . 0.0 110.672 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 152' ' ' GLU . 36.6 Cg_exo -57.53 71.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.867 2.378 . . . . 0.0 112.11 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 152' ' ' GLU . 8.6 p -61.63 -32.78 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.152 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.655 ' HA ' ' CD1' ' A' ' 158' ' ' TYR . 5.2 t90 -54.88 -29.29 55.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.786 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 42.7 m -45.61 -43.11 11.98 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.33 100.89 3.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.366 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.655 ' CD1' ' HA ' ' A' ' 155' ' ' TRP . 21.6 p90 -151.91 164.8 36.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.608 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 85.7 m-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.119 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.1 t80 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.938 0.399 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.0 m -67.84 -26.12 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.798 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.585 ' C ' ' HD2' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -60.59 -29.69 69.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.664 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.509 ' N ' ' HG3' ' A' ' 173' ' ' LYS . 69.5 t80 -57.01 -41.96 79.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.561 ' C ' HD21 ' A' ' 175' ' ' LEU . 9.6 tt -57.72 -37.72 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.45 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.679 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.68 -32.72 74.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.549 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.558 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.584 ' CB ' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.747 0.308 . . . . 0.0 110.719 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.655 ' OE1' ' CD2' ' A' ' 118' ' ' PHE . 63.4 tt0 -104.35 113.72 27.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.062 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.623 ' HB1' ' CB ' ' A' ' 26' ' ' VAL . . . -164.4 157.76 17.79 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.485 ' CZ3' ' HB3' ' A' ' 25' ' ' PRO . 1.4 t-105 -133.22 148.91 52.03 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.686 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.659 ' CE2' ' HA ' ' A' ' 26' ' ' VAL . 14.8 m-85 -98.8 87.87 3.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.785 ' SD ' ' CH2' ' A' ' 114' ' ' TRP . 86.1 mtp . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.351 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 5.9 mtt180 -61.57 112.26 5.74 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.869 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.8 Cg_exo -56.84 161.06 10.93 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.862 2.375 . . . . 0.0 111.71 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -124.3 97.44 40.03 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.496 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.568 ' O ' ' HB2' ' A' ' 20' ' ' PRO . 11.4 Cg_exo -67.32 153.98 85.5 Favored 'Cis proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.484 -0.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -90.8 179.81 43.03 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -152.86 117.52 2.89 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 111.144 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.485 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 73.1 Cg_endo -81.83 158.56 18.58 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.331 2.687 . . . . 0.0 111.745 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.659 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 1.4 p -57.99 147.31 6.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.159 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.14 108.93 3.66 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.584 HD12 ' CB ' ' A' ' 2' ' ' VAL . 26.2 tp -47.25 -41.26 18.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.847 0.356 . . . . 0.0 110.269 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -70.16 -31.52 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.248 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.564 ' HG2' ' OH ' ' A' ' 6' ' ' TYR . 66.3 tp60 -62.93 -46.51 87.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.426 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 9.3 mt -69.44 -34.22 74.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.532 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -52.54 -43.68 65.33 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -66.54 -32.01 73.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.831 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 35.5 tp -64.5 -25.72 68.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.924 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.585 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . 110.04 23.63 6.05 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.606 HG11 ' CZ ' ' A' ' 38' ' ' TYR . 24.4 t -100.76 128.68 52.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.269 0.557 . . . . 0.0 111.138 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.648 ' HB3' ' CH2' ' A' ' 39' ' ' TRP . 3.0 mt -125.59 141.55 51.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.128 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.663 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -126.84 134.11 50.6 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.853 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.686 ' NE1' ' CG2' ' A' ' 55' ' ' ILE . 1.2 m95 -101.2 128.46 47.3 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -97.84 105.64 17.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.619 ' O ' ' OH ' ' A' ' 97' ' ' TYR . 3.1 mp -139.66 147.34 40.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.696 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.671 ' O ' ' N ' ' A' ' 45' ' ' LYS . 84.1 m-20 -97.72 123.81 41.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 46' ' ' TYR . . . -41.88 -44.64 3.45 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.583 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -62.8 -33.91 76.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.048 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 42' ' ' ASP . 66.9 mttm -85.26 -14.8 45.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.318 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.791 ' CZ ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -55.92 -49.09 74.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -83.14 -41.65 18.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.094 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.514 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 2.8 m120 -67.11 -22.85 65.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.737 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 45' ' ' LYS . 3.1 t0 -127.12 84.65 62.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.961 0.41 . . . . 0.0 111.524 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.0 Cg_endo -48.7 -8.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 123.23 2.62 . . . . 0.0 111.448 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.58 ' CD ' ' HD2' ' A' ' 54' ' ' LYS . 45.6 tp10 -42.59 -33.54 0.72 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.717 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.723 ' CD2' ' CE2' ' A' ' 46' ' ' TYR . 24.6 tp -55.32 -41.08 71.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.007 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 50' ' ' PRO . 75.3 mm-40 -63.16 -34.18 77.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.306 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.58 ' HD2' ' CD ' ' A' ' 51' ' ' GLU . 37.8 mttm -59.06 -41.82 88.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.527 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.686 ' CG2' ' NE1' ' A' ' 39' ' ' TRP . 87.6 mt -62.82 -36.26 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.598 ' NH2' ' HA ' ' A' ' 63' ' ' TRP . 72.1 ttt180 -58.09 -41.54 83.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.234 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.48 HH11 ' HA ' ' A' ' 54' ' ' LYS . 77.4 mtt85 -61.82 -36.01 79.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.446 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -60.28 -39.08 85.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.656 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HG2' ' CZ ' ' A' ' 61' ' ' TYR . 8.8 tpt180 -99.99 -11.16 20.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 110.296 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' ARG . 30.5 t-20 58.08 51.58 8.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.531 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.671 ' CE2' HG13 ' A' ' 95' ' ' ILE . 58.9 m-85 -70.05 124.24 23.59 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.228 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.487 ' C ' HH21 ' A' ' 56' ' ' ARG . 24.2 m -60.8 -36.9 80.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.809 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.692 ' CD1' ' O ' ' A' ' 63' ' ' TRP . 0.0 OUTLIER -138.26 149.93 46.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.379 . . . . 0.0 110.854 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.731 ' SD ' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -145.47 117.57 8.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.321 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.659 ' OD2' ' CZ3' ' A' ' 63' ' ' TRP . 90.1 m-20 -143.03 169.62 17.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.838 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.624 ' HB ' ' CG ' ' A' ' 146' ' ' MET . 14.5 tt -121.49 144.44 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.93 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 68' ' ' THR . 9.8 tp -133.91 157.38 41.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.852 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.48 ' O ' ' CD1' ' A' ' 74' ' ' LEU . 54.3 m -117.06 138.41 51.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.017 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 142' ' ' TYR . 1.1 mp -90.52 96.47 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.335 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.644 ' O ' ' N ' ' A' ' 74' ' ' LEU . 45.8 t -154.53 128.04 8.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.945 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -57.72 -41.5 81.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.953 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.96 -40.17 96.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.437 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.58 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 40.7 tptt -100.12 -6.77 25.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 111.204 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -126.45 76.63 73.45 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.393 . . . . 0.0 111.163 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.531 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 10.8 Cg_endo -56.42 152.5 39.44 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.365 2.043 . . . . 0.0 110.061 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.604 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 39.3 t-20 74.65 39.13 0.45 Allowed 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.209 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.64 ' CZ ' HG13 ' A' ' 81' ' ' ILE . 58.1 t80 -59.66 -40.7 88.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.509 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.639 ' O ' ' CB ' ' A' ' 82' ' ' LYS . 97.0 mt-10 -60.13 -56.89 16.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.708 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.604 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 75.6 mm-40 -71.87 -38.21 70.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.589 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 10.2 tptp -64.64 -56.58 12.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.165 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.726 ' CG2' ' CE1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -71.71 -35.66 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.117 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.639 ' CB ' ' O ' ' A' ' 78' ' ' GLU . 26.1 tptt -59.48 -41.45 89.82 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.74 ' SD ' ' CH2' ' A' ' 155' ' ' TRP . 59.1 mtt -60.02 -42.15 93.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.537 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 80' ' ' LYS . 80.0 m-85 -69.24 -36.74 77.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.658 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.726 ' CE1' ' CG2' ' A' ' 81' ' ' ILE . 15.0 m-30 -61.0 -45.19 95.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.589 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.75 138.08 58.13 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.87 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -90.74 121.16 32.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.733 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.719 ' ND1' ' CE1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -141.63 173.92 11.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.04 0.448 . . . . 0.0 111.178 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.649 HD12 ' CE1' ' A' ' 132' ' ' TYR . 3.5 mp -130.38 159.89 35.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.109 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.557 ' O ' ' HB2' ' A' ' 129' ' ' ALA . 4.0 p80 -170.81 153.38 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.095 0.474 . . . . 0.0 110.838 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.663 ' CD1' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -67.78 16.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.823 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 90' ' ' HIS . 59.0 t0 -108.53 148.32 30.44 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.616 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.637 ' OD2' ' NH2' ' A' ' 59' ' ' ARG . 83.1 m-20 -83.93 142.34 30.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.514 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.612 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 16.2 mm-40 -99.35 118.25 35.57 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.697 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.674 ' CD1' ' CG2' ' A' ' 126' ' ' THR . 32.9 mm -122.2 119.41 58.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.309 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.641 ' HD2' ' CE2' ' A' ' 105' ' ' PHE . 38.8 mtt85 -139.18 138.27 36.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.31 0.576 . . . . 0.0 111.452 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.791 ' CD2' ' CZ ' ' A' ' 46' ' ' TYR . 25.8 t80 -125.82 129.92 50.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 120' ' ' GLU . 14.0 mm -89.02 93.31 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.52 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.595 HD21 ' CD1' ' A' ' 66' ' ' ILE . 10.4 tp -72.65 -38.93 67.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.202 0.525 . . . . 0.0 109.651 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . 54.7 t0 -155.2 154.43 32.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.211 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 100' ' ' ASP . . . 82.14 -166.49 46.35 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 50.2 m -121.01 147.33 45.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.304 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -132.21 149.09 19.35 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.648 ' CE2' ' HG3' ' A' ' 116' ' ' ARG . 81.2 t80 -125.81 131.3 52.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.344 . . . . 0.0 110.615 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.641 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -122.08 146.25 47.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 133' ' ' HIS . 23.2 t70 -124.67 128.33 48.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.416 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.14 144.4 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.505 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 114' ' ' TRP . 21.3 ttp180 -122.77 130.67 53.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.652 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 110' ' ' LYS . 57.8 t0 -85.73 156.23 20.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.695 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.571 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -60.79 -25.53 66.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.893 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.543 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 96.2 mt-10 -63.77 2.89 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.877 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 111' ' ' GLU . 54.3 t0 76.51 41.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 110.327 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.543 ' NE2' ' OE1' ' A' ' 111' ' ' GLU . 13.4 pt20 -143.37 165.83 26.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.857 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.785 ' CH2' ' SD ' ' A' ' 7' ' ' MET . 25.1 p-90 -133.69 149.84 51.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.025 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.56 ' CD1' ' HE1' ' A' ' 6' ' ' TYR . 68.7 mt -117.7 136.63 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.186 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.648 ' HG3' ' CE2' ' A' ' 104' ' ' TYR . 56.9 ttt180 -90.25 120.35 31.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.528 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 105' ' ' PHE . 27.4 pt -120.8 128.67 76.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.655 ' CD2' ' OE1' ' A' ' 3' ' ' GLN . 71.2 t80 -109.79 136.71 48.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.614 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.466 ' SD ' ' HB ' ' A' ' 125' ' ' VAL . 16.0 mmt -106.37 133.44 51.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.724 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.556 ' O ' ' HB ' ' A' ' 98' ' ' ILE . 94.6 mt-10 -107.51 168.36 9.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.431 ' HA ' HG22 ' A' ' 98' ' ' ILE . 36.1 ttpt -64.82 127.5 31.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.691 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.585 ' HA2' ' OH ' ' A' ' 97' ' ' TYR . . . 94.4 -15.42 63.3 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -95.98 121.46 37.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.701 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.615 ' HG3' ' CA ' ' A' ' 97' ' ' TYR . 18.1 ttt -102.64 150.2 23.67 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.466 ' HB ' ' SD ' ' A' ' 119' ' ' MET . 12.7 p -134.91 141.26 43.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.257 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.674 ' CG2' ' CD1' ' A' ' 95' ' ' ILE . 87.9 m -125.31 132.35 52.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.052 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.424 ' CD1' ' CE1' ' A' ' 105' ' ' PHE . 4.1 mt -121.18 127.42 26.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.888 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.59 ' HG2' ' CD1' ' A' ' 131' ' ' ILE . 12.8 Cg_endo -59.36 141.44 97.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.797 2.331 . . . . 0.0 111.902 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 90' ' ' HIS . . . -69.76 148.94 48.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.104 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.89 3.58 56.98 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.59 ' CD1' ' HG2' ' A' ' 128' ' ' PRO . 70.4 mt -116.25 137.15 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.305 . . . . 0.0 110.635 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.649 ' CE1' HD12 ' A' ' 89' ' ' LEU . 88.8 m-85 -58.4 128.3 36.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.145 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.564 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 45.0 p-80 -146.15 146.51 30.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.97 0.414 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.619 ' NE ' ' O ' ' A' ' 85' ' ' TYR . 77.9 ttt180 -135.7 134.34 39.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.111 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.573 ' HD2' ' CE2' ' A' ' 105' ' ' PHE . 70.5 t80 -106.7 124.72 50.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.757 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.641 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 18.5 p -130.81 155.45 46.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.592 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.641 ' CG1' ' O ' ' A' ' 136' ' ' THR . 34.7 m -164.96 17.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.271 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.641 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 48.1 p30 -70.8 -15.09 62.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 75.7 mm-40 -59.25 -39.45 82.88 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.33 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.509 ' HD3' ' HB2' ' A' ' 102' ' ' SER . 9.5 mtpm? -110.25 -19.33 13.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 138' ' ' ASP . 10.6 m120 59.6 30.47 20.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.347 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 66.3 t80 -172.94 96.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.196 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 56.9 m -136.16 134.4 38.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.13 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 5.8 ttmt -117.88 114.89 23.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.915 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 97' ' ' TYR . . . -142.07 155.21 45.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.067 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.653 ' SD ' ' HE2' ' A' ' 46' ' ' TYR . 5.9 mtt -93.64 145.82 24.28 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.016 0.436 . . . . 0.0 110.679 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -129.89 138.89 51.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.738 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.731 ' CD2' ' SD ' ' A' ' 64' ' ' MET . 41.0 mt -110.98 132.49 54.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.78 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.669 ' CE1' ' O ' ' A' ' 152' ' ' GLU . 62.4 t80 -132.97 152.93 51.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 110.878 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.56 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 11.7 t -116.02 129.66 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.763 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.5 -162.35 37.9 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.669 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 1.8 mm-40 -69.08 155.36 93.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.927 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.406 ' HB2' HG23 ' A' ' 156' ' ' THR . 27.8 Cg_endo -65.02 78.8 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.909 2.406 . . . . 0.0 112.184 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.57 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.0 p -60.61 -30.39 46.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.74 ' CH2' ' SD ' ' A' ' 83' ' ' MET . 43.3 t90 -52.5 -35.92 54.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.96 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 153' ' ' PRO . 47.6 p -48.9 -43.42 39.21 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.61 101.19 3.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.963 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.719 ' CE1' ' ND1' ' A' ' 88' ' ' HIS . 18.9 p90 -136.18 155.62 49.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.356 179.448 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.0 t80 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.71 0.291 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.23 -39.74 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.578 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -58.28 -34.63 70.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.575 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -56.5 -41.49 76.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.646 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.3 tp -57.37 -37.78 73.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.527 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.11 72.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.586 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -63.78 -33.05 74.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.551 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.5 -179.952 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 11.7 p -127.9 140.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.541 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.573 ' OE1' ' HA ' ' A' ' 3' ' ' GLN . 11.7 mm-40 -100.22 116.27 31.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.443 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.634 ' CB ' HG13 ' A' ' 26' ' ' VAL . . . -164.41 157.53 17.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.792 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.674 ' CD1' ' O ' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -124.89 145.38 49.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.011 0.434 . . . . 0.0 111.67 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.671 ' OH ' ' NE2' ' A' ' 113' ' ' GLN . 1.4 t80 -96.07 76.03 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.711 ' SD ' ' ND1' ' A' ' 18' ' ' HIS . 73.7 mtm -61.12 -2.44 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.732 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.628 ' OD1' ' CD ' ' A' ' 113' ' ' GLN . 54.3 t0 -53.1 -34.41 56.5 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.987 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -113.03 8.28 18.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.406 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.597 ' HB3' ' CA ' ' A' ' 18' ' ' HIS . . . -106.08 156.95 35.91 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.873 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.26 142.06 53.98 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.834 2.356 . . . . 0.0 112.287 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.38 -30.51 64.84 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.51 ' O ' ' NE2' ' A' ' 18' ' ' HIS . 1.7 m-20 -49.41 115.41 4.84 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.95 0.405 . . . . 0.0 110.512 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.86 -34.67 48.11 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.911 2.407 . . . . 0.0 112.368 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -56.14 -36.05 67.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.571 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.496 ' CD ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -71.54 157.42 89.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.378 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.597 ' HB2' ' CG ' ' A' ' 19' ' ' ARG . 51.2 Cg_endo -75.76 -5.2 16.19 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.624 2.216 . . . . 0.0 111.381 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.711 ' ND1' ' SD ' ' A' ' 7' ' ' MET . 65.4 m170 62.6 35.56 14.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.118 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.649 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -91.17 102.14 5.1 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.302 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.68 ' O ' ' N ' ' A' ' 23' ' ' GLY . 12.3 Cg_endo -58.74 161.15 15.71 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.77 2.314 . . . . 0.0 111.687 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.599 ' OD1' ' C ' ' A' ' 21' ' ' ASP . 13.5 t0 -119.37 101.68 48.88 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.575 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.536 ' C ' ' O ' ' A' ' 20' ' ' PRO . 12.9 Cg_exo -66.9 158.04 81.88 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.516 -1.452 . . . . 0.0 112.375 -0.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -82.94 152.21 29.67 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.608 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -152.68 119.85 3.09 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.296 0.569 . . . . 0.0 111.315 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 56.2 Cg_endo -74.75 157.44 43.81 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 123.028 2.485 . . . . 0.0 111.294 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.634 HG13 ' CB ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -57.23 147.64 5.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.912 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 30' ' ' GLN . . . -97.89 102.24 2.64 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.575 ' HB2' ' CG1' ' A' ' 2' ' ' VAL . 7.4 tt -46.06 -47.78 17.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.834 0.35 . . . . 0.0 110.358 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.52 -34.39 78.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.174 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 93.7 mt-30 -62.33 -40.98 98.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.678 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 6.6 mt -69.8 -38.68 76.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.345 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -55.98 -41.09 74.28 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.319 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -63.32 -32.33 73.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 26.2 tp -64.91 -23.9 67.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.938 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.649 ' O ' ' CG ' ' A' ' 128' ' ' PRO . . . 112.31 18.26 7.75 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 t -96.21 129.55 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 0.0 111.054 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.606 HD12 ' NH2' ' A' ' 59' ' ' ARG . 30.9 mt -120.48 141.06 50.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.131 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.689 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -139.78 139.45 36.44 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.836 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.689 ' CE3' ' O ' ' A' ' 38' ' ' TYR . 1.9 m95 -109.53 133.65 52.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.497 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.505 ' NZ ' ' HH ' ' A' ' 38' ' ' TYR . 11.7 mtmt -105.99 102.74 12.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.809 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.629 ' O ' ' OH ' ' A' ' 97' ' ' TYR . 5.1 mp -142.76 156.49 45.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.247 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 45' ' ' LYS . 87.7 m-20 -90.32 122.29 33.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.512 ' O ' ' HD1' ' A' ' 46' ' ' TYR . . . -42.01 -43.25 3.11 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.166 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD2' ' HB3' ' A' ' 42' ' ' ASP . 5.5 p-10 -66.88 -32.8 74.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.688 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.648 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 70.4 mttt -85.04 -11.59 55.01 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.2 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.722 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -71.86 -56.7 5.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.639 -0.424 . . . . 0.0 109.925 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.722 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 83.9 tt0 -67.04 -36.81 82.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.44 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.584 ' CG ' ' HA ' ' A' ' 45' ' ' LYS . 17.6 p-10 -78.67 -11.74 59.99 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.497 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' ' O ' ' A' ' 45' ' ' LYS . 10.2 t0 -130.94 83.26 61.66 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.82 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.1 Cg_endo -46.4 -8.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 123.535 2.824 . . . . 0.0 112.049 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 49' ' ' ASP . 96.9 mt-10 -46.05 -34.46 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.397 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.71 ' C ' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -59.06 -32.4 69.74 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.682 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 84.8 tt0 -64.06 -35.26 80.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.685 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -59.18 -40.62 86.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.699 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.681 ' CG2' ' NE1' ' A' ' 39' ' ' TRP . 84.3 mt -59.85 -37.24 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.505 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.664 ' NH2' ' C ' ' A' ' 62' ' ' SER . 70.5 mtp180 -59.43 -40.83 88.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.603 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.97 -41.14 86.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.07 -32.54 74.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.694 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.723 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 39.0 mmt180 -99.41 7.42 45.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.218 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.682 ' O ' ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER 59.91 46.39 11.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.75 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.723 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 22.7 m-85 -105.49 113.03 26.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.279 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.664 ' C ' ' NH2' ' A' ' 56' ' ' ARG . 1.4 t -99.73 -21.45 15.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.248 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.562 ' HB3' ' O ' ' A' ' 149' ' ' PHE . 70.5 t90 -109.42 127.88 54.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.837 0.351 . . . . 0.0 111.041 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 56' ' ' ARG . 8.8 ptm -143.14 147.58 35.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.321 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 66' ' ' ILE . 46.3 t0 -159.47 166.76 30.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.433 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.526 HG12 ' HG2' ' A' ' 146' ' ' MET . 59.2 mt -108.39 122.25 62.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.455 ' O ' ' O ' ' A' ' 145' ' ' ALA . 72.6 mt -119.42 138.46 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.372 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.555 ' OG1' ' HG3' ' A' ' 144' ' ' LYS . 36.1 m -119.41 142.48 48.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.617 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.674 ' C ' ' SG ' ' A' ' 70' ' ' CYS . 64.2 mt -105.76 125.7 61.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.0 111.028 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.674 ' SG ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -169.1 135.4 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.657 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -57.96 -45.67 86.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.983 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.675 ' OD1' ' N ' ' A' ' 73' ' ' LYS . 55.6 p30 -77.21 -33.17 56.28 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.675 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 80.3 tttt -98.29 -3.66 36.76 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.459 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.653 ' N ' ' O ' ' A' ' 70' ' ' CYS . 1.1 tp -125.58 73.46 68.75 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.124 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.58 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 48.2 Cg_exo -49.97 154.14 5.55 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 121.892 1.728 . . . . 0.0 109.611 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.632 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 63.5 t-20 70.18 32.54 2.89 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.34 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.651 ' CE1' HG13 ' A' ' 81' ' ' ILE . 27.4 t80 -62.38 -45.7 91.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.434 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 49.0 tp10 -54.82 -54.18 45.6 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.632 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 97.7 mt-10 -76.34 -45.13 33.57 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.398 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.595 ' HD3' ' CD2' ' A' ' 74' ' ' LEU . 23.2 tttp -60.45 -49.52 77.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.281 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.725 ' CD1' ' CE1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -70.46 -37.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.391 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.594 ' CD ' ' HA ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -70.8 -37.22 73.28 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.617 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.615 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 87.0 mtp -56.68 -48.73 76.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.663 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.672 ' CZ ' ' CD1' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -87.19 -14.85 40.01 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.653 179.535 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.725 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -56.54 -46.32 80.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.97 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' OE2' ' NE ' ' A' ' 160' ' ' ARG . 92.5 mt-10 -75.93 146.42 39.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.959 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.551 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -80.51 135.51 36.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.292 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.442 ' CD2' ' C ' ' A' ' 88' ' ' HIS . 2.5 p-80 -144.87 170.67 15.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.007 0.432 . . . . 0.0 110.979 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.645 ' HB2' ' CE1' ' A' ' 132' ' ' TYR . 28.3 tp -124.55 153.32 42.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.576 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.6 ' HA ' ' CB ' ' A' ' 162' ' ' ALA . 1.7 p80 -170.81 165.85 7.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.992 0.425 . . . . 0.0 110.897 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.554 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 49.0 mt -85.09 16.24 3.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.585 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.522 ' C ' ' HB1' ' A' ' 129' ' ' ALA . 88.2 m-20 -107.65 149.29 28.26 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.369 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.605 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 49.2 p30 -83.88 164.95 19.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.427 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.605 ' OE2' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -125.71 114.83 19.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.918 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.72 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 2.7 mp -120.41 116.32 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.149 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.715 ' NH1' ' CG ' ' A' ' 135' ' ' PHE . 68.1 mtt180 -131.62 138.37 48.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.011 0.434 . . . . 0.0 110.77 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.629 ' OH ' ' O ' ' A' ' 41' ' ' LEU . 1.3 t80 -127.42 128.71 46.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.384 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.603 ' CD1' ' HB2' ' A' ' 145' ' ' ALA . 23.8 mm -96.69 95.64 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.311 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.685 ' CD1' ' SD ' ' A' ' 146' ' ' MET . 16.9 mt -71.49 -35.62 70.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.0 109.851 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . 20.2 t70 -157.44 162.81 38.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.339 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 143' ' ' THR . . . 90.86 175.68 44.11 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.541 ' OG ' ' CZ ' ' A' ' 118' ' ' PHE . 41.1 t -129.37 142.98 50.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.716 0.293 . . . . 0.0 110.696 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.507 ' HA3' HG11 ' A' ' 137' ' ' VAL . . . -173.23 179.24 44.78 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.706 ' CZ ' ' OG1' ' A' ' 136' ' ' THR . 50.3 p90 -140.13 150.13 43.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.925 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 133' ' ' HIS . 3.7 t80 -110.52 141.43 43.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.993 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.544 ' CB ' ' HB3' ' A' ' 134' ' ' ARG . 60.2 t0 -94.5 124.22 38.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.571 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.538 ' CG2' HD12 ' A' ' 117' ' ' ILE . 21.8 m -128.1 154.55 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.602 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.648 ' NH2' ' CD2' ' A' ' 132' ' ' TYR . 24.0 ttp180 -123.71 143.1 50.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 55.4 t0 -99.51 156.8 16.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.466 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.533 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -60.54 -25.06 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.086 0.469 . . . . 0.0 110.48 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.588 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 46.5 tp10 -76.16 11.1 1.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.043 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 110' ' ' LYS . 83.7 m-20 62.81 42.84 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.367 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.671 ' NE2' ' OH ' ' A' ' 6' ' ' TYR . 25.3 mt-30 -120.46 149.19 42.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.092 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.635 ' CZ3' ' HB2' ' A' ' 108' ' ' ARG . 94.2 m95 -111.44 133.06 54.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.982 0.42 . . . . 0.0 111.134 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.631 HD12 ' CE2' ' A' ' 6' ' ' TYR . 69.1 mt -121.05 134.94 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.509 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 116' ' ' ARG . 8.1 ptm180 -91.08 114.37 26.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.582 ' O ' ' HB2' ' A' ' 104' ' ' TYR . 45.0 mt -108.38 129.63 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.678 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.541 ' CZ ' ' OG ' ' A' ' 102' ' ' SER . 74.1 t80 -94.72 128.83 41.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.913 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.573 ' HE3' ' CG1' ' A' ' 125' ' ' VAL . 89.0 mtp -100.43 122.55 43.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.354 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.543 ' HG2' ' N ' ' A' ' 121' ' ' LYS . 84.7 tt0 -111.61 160.2 17.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.566 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -55.48 133.39 50.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.607 ' CA ' ' O ' ' A' ' 41' ' ' LEU . . . 88.92 -12.91 64.46 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -95.22 123.46 38.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.879 0.371 . . . . 0.0 111.306 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.688 ' CE ' ' CD1' ' A' ' 39' ' ' TRP . 5.1 ttp -107.11 151.38 25.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.609 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.573 ' CG1' ' HE3' ' A' ' 119' ' ' MET . 12.1 p -138.43 143.31 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.302 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 41.2 m -126.38 133.22 51.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.046 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.598 ' CD2' ' CG ' ' A' ' 133' ' ' HIS . 7.6 tp -115.59 113.53 42.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.918 0.39 . . . . 0.0 110.808 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.649 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 36.9 Cg_exo -52.91 141.57 55.43 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.646 2.231 . . . . 0.0 111.926 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.554 ' HB2' ' C ' ' A' ' 91' ' ' LEU . . . -67.82 146.07 54.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.908 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.643 ' C ' ' CD1' ' A' ' 89' ' ' LEU . . . 98.36 3.13 57.67 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.52 ' N ' HD11 ' A' ' 89' ' ' LEU . 71.2 mt -119.57 131.61 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.732 0.301 . . . . 0.0 110.616 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.648 ' CD2' ' NH2' ' A' ' 108' ' ' ARG . 98.9 m-85 -62.09 146.05 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.201 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 105' ' ' PHE . 22.7 p-80 -160.42 156.44 26.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 0.0 111.247 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.643 ' NE ' ' O ' ' A' ' 85' ' ' TYR . 41.0 ttt180 -141.74 128.21 20.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.065 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.715 ' CG ' ' NH1' ' A' ' 96' ' ' ARG . 68.9 t80 -107.09 124.04 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.836 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.706 ' OG1' ' CZ ' ' A' ' 104' ' ' TYR . 16.5 p -138.06 154.36 49.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.646 ' CG1' ' O ' ' A' ' 136' ' ' THR . 17.2 m -165.05 25.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.198 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.655 ' OD2' ' N ' ' A' ' 139' ' ' GLU . 51.2 p30 -65.0 -24.64 67.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.618 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.655 ' N ' ' OD2' ' A' ' 138' ' ' ASP . 60.2 mp0 -55.17 -34.48 63.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.77 0.319 . . . . 0.0 111.175 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.52 ' HG2' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -100.46 -28.18 13.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.581 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 58.18 27.38 15.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.616 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -173.15 96.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.437 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.485 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 42.4 m -136.17 139.05 42.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.954 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.555 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 71.2 tttt -117.24 116.03 26.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.603 ' HB2' ' CD1' ' A' ' 98' ' ' ILE . . . -141.69 154.62 45.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.014 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.685 ' SD ' ' CD1' ' A' ' 99' ' ' LEU . 6.5 mtp -96.16 146.8 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.223 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.639 ' HB3' ' CE1' ' A' ' 149' ' ' PHE . 21.3 mmt85 -120.08 136.55 54.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.535 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 148' ' ' LEU . 5.8 mp -118.6 119.38 34.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.527 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.639 ' CE1' ' HB3' ' A' ' 147' ' ' ARG . 96.7 m-85 -129.98 159.38 36.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.563 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.555 ' CG1' ' HD2' ' A' ' 61' ' ' TYR . 15.7 m -112.23 131.59 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.28 -162.08 41.79 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' A' ' 152' ' ' GLU . 0.1 OUTLIER -68.35 144.07 96.22 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.829 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.526 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 31.4 Cg_exo -55.46 96.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.891 2.394 . . . . 0.0 112.172 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.4 -39.33 83.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.254 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.481 ' CE3' ' O ' ' A' ' 155' ' ' TRP . 9.0 t90 -55.1 -33.22 62.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.789 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.526 ' OG1' ' HB2' ' A' ' 153' ' ' PRO . 42.4 m -45.64 -43.88 12.79 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.32 101.01 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.345 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -142.0 158.45 43.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.698 ' OD1' ' CZ ' ' A' ' 165' ' ' PHE . 20.3 m120 -91.09 139.8 30.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.08 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.668 ' CB ' ' CD ' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -43.26 -74.0 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.533 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.668 ' CD ' ' CB ' ' A' ' 160' ' ' ARG . 49.4 Cg_endo -72.47 130.59 16.31 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.41 2.074 . . . . 0.0 111.884 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.624 ' CB ' ' O ' ' A' ' 89' ' ' LEU . . . -66.07 -33.08 74.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 0.0 110.505 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.509 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 23.4 t70 -65.64 -18.91 65.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.539 ' HB2' ' HG2' ' A' ' 161' ' ' PRO . 12.1 t60 -47.6 -35.06 8.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.588 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.698 ' CZ ' ' OD1' ' A' ' 159' ' ' ASN . 91.8 m-85 -86.24 133.08 33.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.46 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.652 ' O ' ' CB ' ' A' ' 170' ' ' GLN . 97.4 mt-10 -60.0 -45.31 93.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.81 -46.84 62.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.402 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 165' ' ' PHE . 92.9 mtt180 -85.45 -9.85 56.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.564 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 165' ' ' PHE . . . -106.19 -52.44 0.78 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.652 ' CB ' ' O ' ' A' ' 166' ' ' GLU . 63.4 tt0 -55.97 -37.6 69.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.361 . . . . 0.0 110.532 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.518 ' HA ' ' CD2' ' A' ' 174' ' ' PHE . 7.9 t80 -58.42 -37.78 76.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.109 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.68 -38.06 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.604 ' O ' ' OE1' ' A' ' 177' ' ' GLN . 56.2 mttp -55.99 -35.15 66.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.682 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.57 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 96.3 m-85 -58.2 -36.75 73.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.433 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.538 ' O ' ' HB ' ' A' ' 178' ' ' THR . 60.9 mt -61.33 -35.44 77.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.828 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.16 96.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.695 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.604 ' OE1' ' O ' ' A' ' 173' ' ' LYS . 8.2 mp0 -64.35 -32.65 74.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.555 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 175' ' ' LEU . 10.7 m . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.574 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 ttm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 2' ' ' VAL . 14.2 p -127.74 143.78 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.624 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.481 ' N ' HG22 ' A' ' 2' ' ' VAL . 50.4 tt0 -80.68 134.96 35.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.324 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.634 ' C ' HG11 ' A' ' 26' ' ' VAL . . . -148.54 137.74 21.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.657 ' CZ3' ' HB3' ' A' ' 25' ' ' PRO . 3.5 t-105 -137.87 154.12 49.5 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.681 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.694 ' CE2' ' OD2' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -105.7 110.52 22.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.398 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.652 ' HE2' ' CE1' ' A' ' 18' ' ' HIS . 88.8 mtp -94.33 0.54 55.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.694 ' OD2' ' CE2' ' A' ' 6' ' ' TYR . 52.1 p-10 -56.95 -33.95 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 110.685 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.666 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 59.9 t0 -98.69 -48.6 4.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.488 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.658 ' CB ' ' C ' ' A' ' 18' ' ' HIS . . . -71.48 149.29 93.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.185 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.82 144.79 78.64 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.885 2.39 . . . . 0.0 112.029 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.585 ' HA2' ' CE ' ' A' ' 7' ' ' MET . . . -58.72 -24.71 57.67 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' O ' ' CE1' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -45.0 111.97 1.41 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 110.488 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -59.29 -30.87 94.0 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.991 2.461 . . . . 0.0 112.166 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -54.27 -38.95 66.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.517 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.2 156.75 73.92 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.481 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.603 ' HB2' ' CG ' ' A' ' 19' ' ' ARG . 47.7 Cg_endo -73.6 -5.12 16.56 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.841 2.361 . . . . 0.0 111.442 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.658 ' C ' ' CB ' ' A' ' 10' ' ' ALA . 73.3 m-70 68.81 31.4 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.611 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.637 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -126.0 95.63 39.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.677 ' O ' ' C ' ' A' ' 22' ' ' PRO . 60.5 Cg_endo -78.09 120.27 4.93 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.749 2.299 . . . . 0.0 111.368 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.578 ' OD2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -61.59 118.48 38.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.328 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.677 ' C ' ' O ' ' A' ' 20' ' ' PRO . 4.4 Cg_exo -77.04 125.71 12.3 Favored 'Cis proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.37 -1.512 . . . . 0.0 111.43 -1.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.76 166.09 46.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.551 ' NH2' ' HD2' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -153.17 117.41 2.82 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 121.11 0.481 . . . . 0.0 111.04 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.657 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 74.3 Cg_endo -77.42 165.67 27.09 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 123.119 2.546 . . . . 0.0 111.239 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.634 HG11 ' C ' ' A' ' 4' ' ' ALA . 10.5 p -126.95 159.3 37.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.286 0.565 . . . . 0.0 110.884 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.604 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -128.62 172.03 19.52 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.574 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 22.8 tp -53.66 -36.62 62.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.656 0.265 . . . . 0.0 110.774 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -55.08 -41.34 71.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.789 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.601 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 99.4 mm-40 -64.12 -40.94 97.27 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.521 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.604 ' CD2' HD11 ' A' ' 115' ' ' ILE . 25.5 mt -72.61 -32.11 65.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.447 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.598 ' NH1' HD22 ' A' ' 37' ' ' LEU . 19.1 mmm180 -54.7 -41.77 70.66 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -70.99 -27.21 63.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.585 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.598 HD21 ' CG1' ' A' ' 107' ' ' VAL . 13.1 tp -66.47 -9.97 39.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.752 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.637 ' O ' ' CG ' ' A' ' 128' ' ' PRO . . . 95.44 13.29 52.04 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.4 t -97.78 134.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.072 0.463 . . . . 0.0 110.545 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.645 HD12 ' CE2' ' A' ' 39' ' ' TRP . 3.1 tm? -103.95 128.71 51.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.951 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.502 ' N ' HD13 ' A' ' 37' ' ' LEU . 73.8 t80 -116.07 125.26 52.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 0.0 110.893 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.724 ' CE3' ' CE ' ' A' ' 124' ' ' MET . 1.5 m-90 -110.62 134.87 52.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.132 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.59 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 1.7 ptpt -99.37 105.3 17.25 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.772 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.653 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 43.7 mt -140.2 160.61 39.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.963 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 45' ' ' LYS . 58.5 t0 -119.79 139.28 52.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 46' ' ' TYR . . . -55.07 -43.68 74.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.122 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -66.84 -33.69 76.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.784 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.62 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 45.7 mttp -87.26 -6.0 58.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.355 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.723 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -76.72 -58.5 3.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.905 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.723 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 84.3 tt0 -70.68 -38.14 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 9.8 p-10 -74.1 -16.91 61.0 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.871 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.65 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 2.9 t0 -130.2 83.94 61.54 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.057 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 53' ' ' GLU . 77.7 Cg_exo -42.95 -8.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 123.36 2.707 . . . . 0.0 112.557 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 49' ' ' ASP . 84.2 tt0 -42.69 -34.58 0.93 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 52' ' ' LEU . 2.3 tm? -54.63 -41.03 69.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' OE2' ' HD3' ' A' ' 56' ' ' ARG . 46.7 tp10 -61.06 -34.83 75.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.981 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 25.1 mttm -58.49 -41.79 86.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.407 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -61.93 -33.75 59.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.658 ' NH2' ' O ' ' A' ' 62' ' ' SER . 60.2 ttt180 -54.98 -42.81 72.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.699 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -67.23 -39.14 86.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.543 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -63.59 -38.53 91.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.262 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.692 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 37.9 mmt180 -92.86 -2.18 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 110.527 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 62.33 51.08 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.15 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.692 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 57.3 m-85 -100.27 112.26 24.58 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.159 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.658 ' O ' ' NH2' ' A' ' 56' ' ' ARG . 61.2 m -83.85 -15.72 47.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.849 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.699 ' CZ2' ' OD2' ' A' ' 65' ' ' ASP . 48.2 t90 -130.65 128.02 40.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.731 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.629 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 16.7 ptm -153.56 133.2 12.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.545 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.699 ' OD2' ' CZ2' ' A' ' 63' ' ' TRP . 97.2 m-20 -145.85 172.04 13.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.527 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -111.19 123.13 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.048 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 74' ' ' LEU . 19.8 tt -133.0 148.36 31.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.629 ' OG1' ' O ' ' A' ' 143' ' ' THR . 5.1 t -127.04 148.02 50.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.186 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.706 ' CD1' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -83.02 107.95 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 74' ' ' LEU . 12.8 t -170.11 113.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.082 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.569 ' HB3' ' CB ' ' A' ' 77' ' ' TYR . 7.4 pttm -59.87 -30.97 69.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.386 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -61.79 -40.29 94.7 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.639 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -109.66 -41.19 4.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 111.174 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.617 ' CD1' ' CD1' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -113.3 90.68 17.41 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.771 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.622 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 5.6 Cg_endo -51.18 166.84 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.581 2.187 . . . . 0.0 110.587 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.622 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 61.3 t-20 86.1 22.13 0.08 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.362 . . . . 0.0 110.593 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.631 ' CE2' HG23 ' A' ' 81' ' ' ILE . 15.2 t80 -59.82 -40.36 88.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.577 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 59.4 mp0 -59.3 -56.04 27.21 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.531 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.654 ' O ' ' CG ' ' A' ' 83' ' ' MET . 96.9 mt-10 -73.59 -30.56 63.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.49 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 8.3 tptt -56.85 -55.53 33.22 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.569 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.644 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -71.6 -44.71 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.759 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 20.5 mttt -57.33 -35.99 70.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.73 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -57.84 -45.05 86.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.145 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.513 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 97.6 m-85 -77.61 -27.52 51.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.566 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.644 ' CE2' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -54.09 -47.32 71.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.555 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -87.56 132.62 33.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.775 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' HG2' ' HB2' ' A' ' 134' ' ' ARG . 98.0 mt-10 -61.77 135.72 57.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.137 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -136.0 155.92 49.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.685 ' CD1' ' N ' ' A' ' 131' ' ' ILE . 43.9 tp -121.45 164.24 17.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.293 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.637 ' CE1' ' HE1' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -168.03 142.83 3.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.237 0.541 . . . . 0.0 110.515 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.685 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.5 OUTLIER -65.78 -19.54 65.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.096 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.634 ' C ' ' CB ' ' A' ' 129' ' ' ALA . 58.4 t0 -107.79 148.36 29.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.226 0.536 . . . . 0.0 111.36 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.62 ' OD2' ' O ' ' A' ' 127' ' ' LEU . 61.2 t0 -84.48 128.29 34.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.651 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.613 ' OE2' ' CB ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -100.95 139.49 36.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.707 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.611 HG12 ' CG2' ' A' ' 126' ' ' THR . 67.8 mt -115.19 132.34 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.446 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -133.33 146.02 50.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.399 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.671 ' CD1' ' HB2' ' A' ' 124' ' ' MET . 1.2 t80 -127.72 127.53 43.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.97 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.678 ' CG2' ' O ' ' A' ' 101' ' ' GLY . 1.5 mp -93.91 99.09 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 111.0 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.568 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 19.0 mt -74.82 -34.44 62.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.482 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.549 ' HA ' ' HG3' ' A' ' 121' ' ' LYS . 58.6 t0 -146.8 -31.79 0.33 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.226 -0.59 . . . . 0.0 112.062 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.678 ' O ' ' CG2' ' A' ' 98' ' ' ILE . . . -56.57 161.83 7.06 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.592 ' HB2' ' CD ' ' A' ' 140' ' ' LYS . 66.8 m -145.95 148.7 33.06 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.184 -0.508 . . . . 0.0 109.888 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.513 ' HA3' HG12 ' A' ' 137' ' ' VAL . . . 170.92 -168.07 41.21 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.687 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.608 ' CE2' ' HD2' ' A' ' 118' ' ' PHE . 94.6 m-85 -113.91 133.22 55.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.748 0.308 . . . . 0.0 110.502 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.64 ' CD2' HG23 ' A' ' 107' ' ' VAL . 65.5 t80 -106.7 124.96 50.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.289 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.548 ' OD2' ' CE3' ' A' ' 114' ' ' TRP . 61.2 t0 -91.14 121.34 32.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.64 HG23 ' CD2' ' A' ' 105' ' ' PHE . 28.7 t -121.87 138.61 51.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.589 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.641 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 29.2 ttp180 -113.55 137.99 50.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.525 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 56.8 t0 -97.74 156.72 16.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.704 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.561 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 0.8 OUTLIER -61.49 -24.07 66.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.557 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.657 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 86.0 tt0 -77.41 11.33 2.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.319 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 111' ' ' GLU . 84.2 m-20 64.85 43.88 3.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.966 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.657 ' NE2' ' OE1' ' A' ' 111' ' ' GLU . 51.9 mt-30 -124.32 149.89 46.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.422 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.641 ' CZ3' ' HB2' ' A' ' 108' ' ' ARG . 95.1 m95 -111.71 136.15 51.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' A' ' 31' ' ' LEU . 64.3 mt -118.61 133.99 63.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.579 ' O ' HD13 ' A' ' 117' ' ' ILE . 69.6 ttt180 -90.68 111.2 22.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.579 HD13 ' O ' ' A' ' 116' ' ' ARG . 16.9 mm -115.9 134.58 58.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.937 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.608 ' HD2' ' CE2' ' A' ' 104' ' ' TYR . 83.6 t80 -101.07 132.37 46.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.549 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . 21.8 mmt -95.33 117.63 30.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.39 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.596 ' O ' ' CG ' ' A' ' 123' ' ' ASP . 84.4 tt0 -108.96 150.43 27.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.177 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 18.0 tttp -51.25 128.96 23.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.254 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 41' ' ' LEU . . . 94.31 -3.38 69.21 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.604 ' O ' ' OD1' ' A' ' 123' ' ' ASP . 41.8 p-10 -95.64 119.18 33.7 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.633 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.724 ' CE ' ' CE3' ' A' ' 39' ' ' TRP . 52.8 ttp -111.52 127.15 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.228 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.06 148.15 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.991 0.424 . . . . 0.0 111.605 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.611 ' CG2' HG12 ' A' ' 95' ' ' ILE . 93.9 m -113.81 135.49 53.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.282 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.711 ' CD1' ' CG ' ' A' ' 133' ' ' HIS . 0.2 OUTLIER -112.61 110.2 52.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.637 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 33.2 Cg_exo -55.97 142.16 85.33 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.942 2.428 . . . . 0.0 112.013 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.66 ' CB ' ' C ' ' A' ' 91' ' ' LEU . . . -71.61 149.19 45.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.653 ' C ' ' CD1' ' A' ' 89' ' ' LEU . . . 101.38 -1.58 53.77 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.685 ' N ' ' CD1' ' A' ' 89' ' ' LEU . 69.4 mt -120.57 132.72 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.781 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.645 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 95.6 m-85 -78.29 143.96 36.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.265 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.711 ' CG ' ' CD1' ' A' ' 127' ' ' LEU . 9.0 p-80 -158.03 157.6 33.23 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.162 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.618 ' CD ' ' O ' ' A' ' 85' ' ' TYR . 21.8 ttp180 -131.56 130.66 42.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.599 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.711 ' CE1' ' CG1' ' A' ' 137' ' ' VAL . 81.3 t80 -113.76 131.21 56.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.741 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.655 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 17.6 p -127.7 153.64 46.26 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.711 ' CG1' ' CE1' ' A' ' 135' ' ' PHE . 6.0 m -165.55 18.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.212 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.665 ' OD1' ' N ' ' A' ' 139' ' ' GLU . 51.7 p30 -63.79 -25.41 68.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.627 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.665 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 49.6 mt-10 -56.28 -38.73 71.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.592 ' CD ' ' HB2' ' A' ' 102' ' ' SER . 59.7 mtpt -96.69 -7.44 34.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.616 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.0 t30 47.48 11.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.747 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 140' ' ' LYS . 45.8 t80 -150.02 120.54 7.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.466 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.629 ' O ' ' OG1' ' A' ' 68' ' ' THR . 44.1 m -134.79 132.74 39.06 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.61 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.564 ' H ' ' CA ' ' A' ' 101' ' ' GLY . 31.0 tttt -126.8 108.7 11.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 97' ' ' TYR . . . -141.97 152.21 43.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.0 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 56.7 ttp -101.27 137.39 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.801 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.593 ' NH2' HG23 ' A' ' 67' ' ' ILE . 81.6 mtm-85 -123.35 146.6 47.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 111.158 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.592 ' N ' HD11 ' A' ' 148' ' ' LEU . 5.1 mp -115.37 134.39 55.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.41 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' TRP . 2.3 m-85 -152.72 161.78 42.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.756 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.29 140.22 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.402 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.23 -166.25 40.18 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 5.3 pm0 -65.73 149.61 97.21 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.473 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.642 ' O ' ' CG2' ' A' ' 156' ' ' THR . 35.2 Cg_exo -53.15 125.75 19.36 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.721 2.28 . . . . 0.0 112.035 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.522 ' CG1' ' N ' ' A' ' 155' ' ' TRP . 5.6 p -92.41 -43.95 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.514 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.73 ' CZ2' ' CB ' ' A' ' 83' ' ' MET . 3.3 t90 -57.44 -36.47 71.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.619 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.642 ' CG2' ' O ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -36.92 -53.84 0.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.467 ' H ' HG21 ' A' ' 156' ' ' THR . . . -147.07 101.75 3.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.304 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -134.51 158.71 43.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.407 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.733 ' ND2' ' CZ ' ' A' ' 165' ' ' PHE . 81.5 m-20 -91.47 137.21 32.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.098 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.592 ' CG ' ' HD3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -46.1 -64.53 0.91 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.572 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.592 ' HD3' ' CG ' ' A' ' 160' ' ' ARG . 52.1 Cg_endo -76.3 133.77 15.03 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.531 2.154 . . . . 0.0 112.263 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.62 ' HB1' ' N ' ' A' ' 90' ' ' HIS . . . -65.37 -30.73 71.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.655 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.494 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 48.1 p30 -91.68 13.49 17.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.585 ' HD1' ' ND2' ' A' ' 159' ' ' ASN . 6.3 t-160 -52.23 -37.96 56.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.295 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.733 ' CZ ' ' ND2' ' A' ' 159' ' ' ASN . 97.4 m-85 -86.22 134.0 33.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.316 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -59.71 -45.83 90.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.856 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.63 ' O ' ' CD1' ' A' ' 171' ' ' TYR . . . -71.39 -46.75 59.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.389 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.553 ' O ' HG22 ' A' ' 172' ' ' VAL . 70.2 ttt180 -85.96 -4.07 59.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.591 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 165' ' ' PHE . . . -107.18 -57.67 0.59 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.485 ' HA ' HE21 ' A' ' 170' ' ' GLN . 0.8 OUTLIER -56.38 -37.87 70.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 0.0 110.564 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.63 ' CD1' ' O ' ' A' ' 167' ' ' ALA . 13.8 m-30 -63.49 -32.33 73.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 168' ' ' ARG . 71.4 t -60.7 -39.79 82.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.615 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.57 -34.85 71.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.627 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -56.61 -41.58 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.522 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.673 ' CD2' ' N ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -60.92 -35.33 76.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.571 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.74 -32.78 73.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.562 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.75 -32.64 74.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.519 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.5 m . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.585 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.3 ttm . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.599 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 14.7 p -128.18 142.43 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.579 ' OE1' ' CD2' ' A' ' 118' ' ' PHE . 49.6 tt0 -100.18 114.7 28.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.878 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.678 ' CB ' ' CG1' ' A' ' 26' ' ' VAL . . . -164.3 171.82 14.35 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.568 ' O ' ' CG2' ' A' ' 115' ' ' ILE . 0.1 OUTLIER -121.24 142.15 50.19 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.659 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.653 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 22.8 t80 -104.42 68.58 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.463 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.58 ' HB2' ' O ' ' A' ' 114' ' ' TRP . 87.8 mtp -55.71 -26.53 45.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.753 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.658 ' OD2' ' N ' ' A' ' 114' ' ' TRP . 86.0 m-20 -53.93 -34.59 60.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.583 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.627 ' CG ' ' CE2' ' A' ' 6' ' ' TYR . 92.3 m-20 -104.42 5.35 34.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.494 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.6 ' CB ' ' HB3' ' A' ' 18' ' ' HIS . . . -75.27 148.54 83.82 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.933 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.649 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 28.1 Cg_exo -57.65 142.09 95.64 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.698 2.265 . . . . 0.0 111.518 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.55 29.89 0.59 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 11' ' ' PRO . 10.2 m-20 -114.71 97.81 47.99 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.962 0.41 . . . . 0.0 110.59 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.565 ' HA ' ' CE1' ' A' ' 18' ' ' HIS . 20.4 Cg_exo -61.89 -12.74 27.16 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.938 2.425 . . . . 0.0 111.97 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.6 ttt-85 -56.61 -38.38 71.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.03 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.544 ' C ' ' H ' ' A' ' 18' ' ' HIS . 22.1 mt-30 -107.96 168.44 7.89 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.046 0.45 . . . . 0.0 111.242 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.618 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 25.4 Cg_exo -59.5 2.29 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.185 2.59 . . . . 0.0 111.884 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.649 ' CD2' ' O ' ' A' ' 11' ' ' PRO . 17.5 m80 74.8 29.67 1.04 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.173 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.615 ' NE ' ' HB2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -121.88 96.2 47.13 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.467 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.636 ' O ' ' C ' ' A' ' 22' ' ' PRO . 36.2 Cg_endo -68.88 125.41 12.57 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.557 2.171 . . . . 0.0 111.18 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.41 118.53 44.85 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.809 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.636 ' C ' ' O ' ' A' ' 20' ' ' PRO . 1.6 Cg_endo -81.71 143.67 57.91 Favored 'Cis proline' 0 C--N 1.309 -1.537 0 C-N-CA 123.615 -1.41 . . . . 0.0 111.966 -0.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.56 161.06 43.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -133.58 117.54 14.29 Favored Pre-proline 0 C--N 1.332 -0.183 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.131 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.38 157.31 61.58 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 123.058 2.506 . . . . 0.0 111.467 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.678 ' CG1' ' CB ' ' A' ' 4' ' ' ALA . 1.7 p -57.37 142.61 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.761 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 30' ' ' GLN . . . -82.89 100.41 2.2 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.599 ' HB2' ' CG1' ' A' ' 2' ' ' VAL . 21.4 tp -47.15 -43.12 20.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.725 0.298 . . . . 0.0 110.317 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.8 -35.34 80.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.021 0.439 . . . . 0.0 109.946 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.595 ' O ' HD12 ' A' ' 34' ' ' LEU . 93.5 mt-30 -61.38 -41.73 97.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.097 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 10.3 mt -69.49 -34.41 74.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.43 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -42.12 65.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 33' ' ' ARG . 19.9 ttp180 -64.8 -31.21 72.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.018 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 34' ' ' LEU . 10.3 mp -65.3 -18.13 65.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.026 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.88 23.13 11.03 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 HG11 ' CE2' ' A' ' 38' ' ' TYR . 92.3 t -99.28 132.24 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 0.0 110.742 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 55.3 mt -108.75 141.21 41.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.633 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.54 ' OH ' HD13 ' A' ' 31' ' ' LEU . 54.0 m-85 -118.01 123.55 45.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.623 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.536 ' HZ3' ' OG1' ' A' ' 126' ' ' THR . 2.3 m-90 -121.23 132.3 54.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.179 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -105.84 104.98 14.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.062 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.634 ' C ' ' OH ' ' A' ' 97' ' ' TYR . 1.3 mp -140.58 153.34 46.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.95 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 46' ' ' TYR . 85.9 m-20 -102.92 133.07 48.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.531 ' O ' ' HD1' ' A' ' 46' ' ' TYR . . . -49.52 -43.98 45.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.69 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.683 ' OD2' ' N ' ' A' ' 45' ' ' LYS . 56.6 p30 -65.79 -31.6 72.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.673 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.683 ' N ' ' OD2' ' A' ' 44' ' ' ASP . 12.0 ttmm -85.38 -19.39 31.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.268 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.721 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -61.56 -56.48 19.47 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.822 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.721 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 84.9 tt0 -72.01 -40.86 68.18 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.584 -0.446 . . . . 0.0 109.984 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.618 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 17.8 m120 -66.77 -22.92 66.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.806 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.659 ' O ' ' N ' ' A' ' 51' ' ' GLU . 23.4 t0 -124.32 84.64 56.09 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.305 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 53' ' ' GLU . 75.0 Cg_exo -41.05 -8.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.59 2.86 . . . . 0.0 112.584 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 49' ' ' ASP . 12.4 tm-20 -41.87 -32.53 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -54.28 -41.03 68.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 50' ' ' PRO . 96.9 mt-10 -60.97 -35.89 77.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.266 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -59.64 -44.73 93.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.949 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.0 mt -62.01 -32.82 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.664 ' HG3' ' CZ ' ' A' ' 61' ' ' TYR . 27.2 ttt180 -55.74 -42.02 74.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.702 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -61.42 -41.46 97.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.779 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -67.48 -44.79 77.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.536 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.593 ' NH2' ' HB ' ' A' ' 95' ' ' ILE . 46.7 mtp85 -76.38 -19.48 58.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.534 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 56' ' ' ARG . 14.5 t-20 60.34 44.5 12.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.706 ' O ' ' CD2' ' A' ' 61' ' ' TYR . 4.2 p90 -112.0 126.15 54.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.094 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.555 ' C ' HH21 ' A' ' 56' ' ' ARG . 51.8 p -94.51 0.2 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.311 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.772 ' CE3' ' CE2' ' A' ' 149' ' ' PHE . 49.1 t90 -123.35 133.39 54.13 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.72 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.643 ' CB ' ' CD2' ' A' ' 148' ' ' LEU . 8.6 ptm -154.49 145.37 22.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.256 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.564 ' HB3' ' CH2' ' A' ' 63' ' ' TRP . 49.9 t0 -159.27 162.9 36.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 0.0 110.83 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 65.7 mt -114.06 127.96 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.497 HG12 ' N ' ' A' ' 68' ' ' THR . 5.3 tt -130.69 154.37 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 111.496 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.533 ' OG1' ' HG2' ' A' ' 144' ' ' LYS . 42.0 m -117.02 142.14 47.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.331 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.615 ' C ' ' SG ' ' A' ' 70' ' ' CYS . 2.2 mt -104.22 125.71 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.147 0.499 . . . . 0.0 111.168 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.615 ' SG ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -171.12 128.27 0.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.459 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -57.32 -46.03 83.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.889 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -67.72 -40.83 84.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.848 0.356 . . . . 0.0 111.033 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 70' ' ' CYS . 30.5 tttt -69.51 -41.22 76.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.034 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.619 ' O ' ' O ' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -133.47 87.41 37.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.777 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 74' ' ' LEU . 72.3 Cg_exo -41.01 176.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.22 1.947 . . . . 0.0 110.418 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.645 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 59.5 t-20 69.94 36.48 1.98 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.322 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.641 ' CE2' HG13 ' A' ' 81' ' ' ILE . 24.2 t80 -65.33 -51.45 60.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.567 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.647 ' O ' ' CD ' ' A' ' 82' ' ' LYS . 97.0 mt-10 -69.35 -46.97 65.74 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.643 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 98.7 mt-10 -65.17 -42.26 93.88 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.443 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.646 ' HE3' ' CE2' ' A' ' 155' ' ' TRP . 14.4 tptt -71.71 -45.73 60.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.15 0.5 . . . . 0.0 109.933 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.673 ' O ' ' CB ' ' A' ' 85' ' ' TYR . 14.1 mm -61.56 -58.13 8.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.799 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.647 ' CD ' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -54.21 -32.64 56.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.488 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 76.8 mmm -59.47 -61.15 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.254 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 81' ' ' ILE . 46.0 p90 -86.96 -16.31 36.21 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.695 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.673 ' CB ' ' O ' ' A' ' 81' ' ' ILE . 19.9 t80 -61.92 -46.26 90.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.14 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -65.47 142.49 58.14 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.231 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.6 139.47 31.7 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.149 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -164.79 170.36 15.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.032 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.638 ' O ' ' CB ' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -133.08 171.83 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.529 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.628 ' HE1' ' CD2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -170.41 154.68 4.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.673 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.582 HD11 ' CG1' ' A' ' 172' ' ' VAL . 0.3 OUTLIER -74.55 5.05 5.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.916 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.567 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 49.7 p30 -108.98 152.2 25.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.474 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.607 ' O ' ' OD2' ' A' ' 93' ' ' ASP . 50.1 p30 -81.76 146.96 29.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.653 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.567 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 7.3 mm-40 -105.88 116.07 31.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.826 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.646 ' CD1' ' OG1' ' A' ' 126' ' ' THR . 6.3 tp -127.78 119.95 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.353 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.537 ' NH2' HG23 ' A' ' 143' ' ' THR . 63.4 ttt180 -134.65 137.41 43.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.478 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.661 ' CD1' ' HB2' ' A' ' 124' ' ' MET . 1.6 t80 -114.61 129.02 56.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.179 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.659 ' CG2' ' O ' ' A' ' 101' ' ' GLY . 20.0 mm -86.08 99.87 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.423 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.644 HD23 ' CD2' ' A' ' 97' ' ' TYR . 1.7 mt -82.81 -43.87 16.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.893 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.625 ' OD2' ' O ' ' A' ' 99' ' ' LEU . 91.3 m-20 -144.88 -21.08 0.51 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.896 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.659 ' O ' ' CG2' ' A' ' 98' ' ' ILE . . . -82.8 -176.7 51.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.507 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 49.0 m -151.23 158.05 43.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.547 ' C ' ' CD2' ' A' ' 104' ' ' TYR . . . 176.45 178.37 46.17 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.287 -0.958 . . . . 0.0 111.694 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.765 ' CE2' ' CD1' ' A' ' 118' ' ' PHE . 2.8 m-85 -124.32 140.4 52.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.613 0.244 . . . . 0.0 110.384 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.771 ' CD1' ' SD ' ' A' ' 119' ' ' MET . 18.5 m-30 -109.09 128.92 55.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 110.723 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.699 ' OD1' ' CE3' ' A' ' 114' ' ' TRP . 23.8 t70 -93.6 121.32 34.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.472 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.564 ' CG1' HD12 ' A' ' 117' ' ' ILE . 13.0 p -131.85 145.92 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.626 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.643 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 20.8 ttp180 -116.81 143.2 45.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 110.749 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.462 ' C ' ' OD2' ' A' ' 109' ' ' ASP . 49.3 p30 -101.55 174.41 5.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.423 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 112' ' ' ASP . 87.3 mttt -56.98 -31.66 65.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.046 0.451 . . . . 0.0 110.337 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 112' ' ' ASP . 84.5 tt0 -59.81 -9.14 2.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.105 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 111' ' ' GLU . 85.2 m-20 69.33 38.36 1.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.473 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.642 ' CB ' ' CG ' ' A' ' 8' ' ' ASP . 95.5 mm-40 -120.62 154.39 35.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.87 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.699 ' CE3' ' OD1' ' A' ' 106' ' ' ASP . 98.6 m95 -104.25 137.23 42.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.17 0.51 . . . . 0.0 111.387 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.568 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 72.3 mt -119.07 134.19 63.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.981 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.557 ' NH2' ' HD1' ' A' ' 104' ' ' TYR . 13.5 tpt180 -90.49 124.67 35.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.587 HG23 ' CE ' ' A' ' 119' ' ' MET . 21.9 mt -113.33 134.18 56.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.878 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.765 ' CD1' ' CE2' ' A' ' 104' ' ' TYR . 65.1 t80 -101.48 129.87 47.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.953 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.771 ' SD ' ' CD1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -115.13 123.9 50.13 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.446 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 123' ' ' ASP . 12.7 pt-20 -102.75 169.99 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.568 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.589 ' HA ' ' CG2' ' A' ' 98' ' ' ILE . 18.3 ptpt -64.79 123.7 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.953 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 95.93 -1.94 63.66 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.568 ' O ' HG12 ' A' ' 98' ' ' ILE . 60.2 t0 -93.89 119.96 33.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 0.0 111.007 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.661 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . 21.7 ttt -108.52 132.4 53.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.304 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 14.8 p -135.65 146.53 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 110.83 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.646 ' OG1' ' CD1' ' A' ' 95' ' ' ILE . 42.1 m -119.72 139.37 52.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.336 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.566 ' CD2' ' HB2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -114.71 143.36 29.86 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.005 0.431 . . . . 0.0 110.841 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.566 ' HG3' ' O ' ' A' ' 34' ' ' LEU . 32.4 Cg_endo -66.65 154.39 74.59 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.053 2.502 . . . . 0.0 112.238 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 92' ' ' ASP . . . -94.14 138.95 31.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.586 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.604 ' O ' ' NE2' ' A' ' 170' ' ' GLN . . . 96.62 -0.18 61.11 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.517 HD13 ' HG2' ' A' ' 128' ' ' PRO . 70.6 mt -116.82 142.38 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.684 0.278 . . . . 0.0 110.277 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.633 ' CG ' HD23 ' A' ' 89' ' ' LEU . 99.7 m-85 -52.2 131.94 33.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.419 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.628 ' CD2' ' HE1' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -156.09 134.57 11.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.449 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.571 ' HG3' ' O ' ' A' ' 85' ' ' TYR . 23.3 ttp180 -139.81 136.81 34.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.871 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.66 ' CD2' ' CD2' ' A' ' 105' ' ' PHE . 21.6 m-30 -112.68 134.07 54.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.351 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.555 ' C ' HG12 ' A' ' 137' ' ' VAL . 56.9 m -126.6 136.28 52.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.926 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.555 HG12 ' C ' ' A' ' 136' ' ' THR . 1.3 m -147.83 6.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.189 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.621 ' O ' ' OD1' ' A' ' 141' ' ' ASN . 22.2 t70 -55.65 -38.23 69.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.398 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.48 -42.6 96.63 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.227 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 142' ' ' TYR . 10.6 mmtm -66.59 -33.23 75.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.725 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.621 ' OD1' ' O ' ' A' ' 138' ' ' ASP . 87.5 m-20 68.32 -10.99 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.616 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.539 ' H ' ' C ' ' A' ' 140' ' ' LYS . 49.4 t80 -151.55 117.38 5.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.367 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.537 HG23 ' NH2' ' A' ' 96' ' ' ARG . 46.4 m -136.22 127.25 27.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.874 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.533 ' HG2' ' OG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -117.54 103.1 9.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.614 ' CB ' ' O ' ' A' ' 97' ' ' TYR . . . -141.82 154.58 45.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.589 ' SD ' ' HE3' ' A' ' 64' ' ' MET . 0.1 OUTLIER -97.48 143.14 28.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.618 ' NH2' ' CD2' ' A' ' 149' ' ' PHE . 67.5 ttp85 -115.61 140.69 48.94 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.819 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.646 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 48.2 mt -118.57 134.26 55.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.721 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.772 ' CE2' ' CE3' ' A' ' 63' ' ' TRP . 6.3 p90 -149.8 160.46 43.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.374 . . . . 0.0 110.597 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.5 ' CG2' ' HA ' ' A' ' 61' ' ' TYR . 31.1 t -115.87 130.69 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.1 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.433 ' O ' ' CE1' ' A' ' 149' ' ' PHE . . . 80.08 -164.17 47.84 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 152' ' ' GLU . 2.4 pt-20 -73.11 126.45 90.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.452 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.569 ' HG3' ' CZ ' ' A' ' 149' ' ' PHE . 25.1 Cg_exo -58.94 124.23 15.25 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.79 2.327 . . . . 0.0 112.295 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.4 -34.13 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.447 . . . . 0.0 109.973 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.701 ' CE3' ' O ' ' A' ' 155' ' ' TRP . 1.7 t-105 -58.94 -29.95 67.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.759 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 153' ' ' PRO . 38.3 m -44.49 -46.31 9.66 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.291 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.93 100.89 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.453 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.69 ' CD1' ' C ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -157.0 166.64 32.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.709 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.594 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 86.7 m-20 -91.08 156.62 17.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.994 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.597 ' CB ' ' HD3' ' A' ' 161' ' ' PRO . 0.3 OUTLIER -36.73 -61.73 0.61 Allowed Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.178 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.597 ' HD3' ' CB ' ' A' ' 160' ' ' ARG . 74.1 Cg_endo -81.38 98.54 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.856 2.37 . . . . 0.0 111.697 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.638 ' CB ' ' O ' ' A' ' 89' ' ' LEU . . . -63.32 -33.73 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.78 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.564 ' OD1' ' HB2' ' A' ' 89' ' ' LEU . 88.5 m-20 -77.87 -5.23 50.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.553 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.511 ' HB2' ' HG2' ' A' ' 161' ' ' PRO . 28.5 t-80 -56.61 -32.55 65.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.626 ' O ' ' N ' ' A' ' 169' ' ' GLY . 97.6 m-85 -85.29 133.65 34.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.006 0.431 . . . . 0.0 110.982 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.14 -45.05 83.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.594 ' O ' ' CG2' ' A' ' 172' ' ' VAL . . . -70.22 -45.74 65.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.324 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.466 ' HB2' ' HB2' ' A' ' 165' ' ' PHE . 94.5 mtt-85 -87.74 -1.91 58.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.434 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 165' ' ' PHE . . . -86.7 176.07 47.56 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.604 ' NE2' ' O ' ' A' ' 130' ' ' GLY . 94.7 mt-30 -61.37 -31.46 71.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -58.93 -28.06 65.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.599 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.594 ' CG2' ' O ' ' A' ' 167' ' ' ALA . 5.1 p -54.84 -34.58 31.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.416 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.572 ' CE ' HD13 ' A' ' 91' ' ' LEU . 47.2 mttt -58.22 -35.1 71.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.509 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.34 -41.19 75.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.686 ' CD2' ' N ' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -61.28 -35.07 76.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.505 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.02 72.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.603 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -63.83 -32.95 74.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.518 HG21 ' O ' ' A' ' 175' ' ' LEU . 1.7 t . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.584 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.7 mtm . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 14.6 p -127.96 140.47 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.541 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.432 ' N ' HG23 ' A' ' 2' ' ' VAL . 97.8 mm-40 -102.72 115.77 31.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.63 ' CB ' HG11 ' A' ' 26' ' ' VAL . . . -163.88 155.96 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.758 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.639 ' CZ3' ' HB3' ' A' ' 25' ' ' PRO . 0.9 OUTLIER -128.24 141.22 51.52 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.191 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.682 ' CE1' ' CD1' ' A' ' 115' ' ' ILE . 2.1 t80 -96.13 -6.01 39.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.11 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.591 ' HG3' ' CD ' ' A' ' 20' ' ' PRO . 85.4 mmm -94.15 13.03 24.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.265 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.93 -33.77 57.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.911 0.386 . . . . 0.0 110.919 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.661 ' OD1' ' N ' ' A' ' 10' ' ' ALA . 53.6 p30 -57.89 -29.52 65.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.103 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.661 ' N ' ' OD1' ' A' ' 9' ' ' ASP . . . -57.87 130.31 82.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 110.397 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.644 ' O ' ' NE2' ' A' ' 18' ' ' HIS . 19.3 Cg_endo -61.33 134.68 53.29 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.695 2.263 . . . . 0.0 112.164 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.81 -177.61 34.49 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.421 ' OD2' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -74.39 135.05 76.02 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 0.0 110.324 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.17 -25.84 79.57 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.617 2.211 . . . . 0.0 111.995 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.471 ' HA ' HH11 ' A' ' 15' ' ' ARG . 7.7 mmm180 -57.73 -34.78 69.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.832 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.421 ' NE2' ' OD2' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -100.2 155.17 36.72 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.033 0.444 . . . . 0.0 110.693 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.585 ' HG2' ' CG ' ' A' ' 19' ' ' ARG . 46.9 Cg_endo -85.8 -3.55 9.02 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 123.247 2.632 . . . . 0.0 112.112 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.644 ' NE2' ' O ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER 47.28 44.97 16.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.028 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.585 ' CG ' ' HG2' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -61.81 107.42 1.13 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.854 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.68 ' O ' ' N ' ' A' ' 23' ' ' GLY . 35.1 Cg_endo -68.0 159.45 52.93 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.864 2.376 . . . . 0.0 111.62 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 107.39 55.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.697 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 20' ' ' PRO . 63.2 Cg_endo -78.11 150.02 88.1 Favored 'Cis proline' 0 C--N 1.309 -1.55 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.355 -0.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -95.85 173.49 30.73 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -152.91 117.65 2.89 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 111.08 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.639 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 55.7 Cg_endo -74.11 152.8 45.98 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.158 2.572 . . . . 0.0 111.756 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.63 HG11 ' CB ' ' A' ' 4' ' ' ALA . 1.3 p -58.66 144.75 11.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 30' ' ' GLN . . . -94.69 104.56 3.16 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.556 ' HB2' ' CG1' ' A' ' 2' ' ' VAL . 8.4 tt -45.27 -44.29 11.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.73 -34.55 77.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 27' ' ' GLY . 50.3 tt0 -61.89 -40.85 96.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.264 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.576 HD13 ' CG2' ' A' ' 26' ' ' VAL . 9.0 mp -63.39 -39.41 94.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.636 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 54.2 ttt85 -57.23 -44.05 83.43 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.521 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -75.17 -30.51 60.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.627 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 30.8 tp -68.73 -7.24 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.127 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.572 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . 102.65 -0.3 49.25 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 32' ' ' ARG . 93.1 t -101.8 126.56 55.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.362 . . . . 0.0 110.557 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.567 ' CD2' ' HG3' ' A' ' 32' ' ' ARG . 79.8 mt -111.53 147.56 35.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.612 ' CD2' ' HE2' ' A' ' 40' ' ' LYS . 32.8 t80 -114.22 124.28 51.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.142 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.683 ' CZ3' ' OG1' ' A' ' 126' ' ' THR . 1.5 m0 -113.1 138.63 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.757 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.612 ' HE2' ' CD2' ' A' ' 38' ' ' TYR . 61.8 mmtt -98.65 105.92 18.12 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.656 ' O ' ' CA ' ' A' ' 122' ' ' GLY . 31.8 mt -138.27 139.11 39.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.207 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 46' ' ' TYR . 87.6 m-20 -108.46 128.72 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 99' ' ' LEU . . . -50.36 -42.8 53.77 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.956 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.14 -33.69 76.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.573 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 49' ' ' ASP . 2.2 mtpt -88.07 -17.53 30.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.001 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.687 ' CZ ' ' CD2' ' A' ' 97' ' ' TYR . 0.1 OUTLIER -58.55 -49.1 78.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.764 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -82.8 -44.18 15.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.057 0.456 . . . . 0.0 109.927 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -66.78 -23.38 66.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.612 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 45' ' ' LYS . 1.9 t0 -127.18 84.34 63.7 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.572 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.7 Cg_endo -49.47 -8.69 0.1 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 123.083 2.522 . . . . 0.0 111.288 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.535 ' H ' ' C ' ' A' ' 49' ' ' ASP . 84.5 tt0 -43.81 -35.96 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.47 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.686 ' C ' ' CD2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -59.17 -33.31 70.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.651 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 1.5 tp10 -64.74 -35.82 82.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.925 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -58.64 -40.18 82.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.069 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.89 -44.47 90.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.667 ' NE ' ' O ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -66.62 -36.47 82.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.439 179.332 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.633 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 70.3 ttp85 -62.52 -42.78 99.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.297 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.18 -35.62 80.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.614 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -85.03 0.33 51.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.429 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.49 42.3 14.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.181 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.667 ' O ' ' NE ' ' A' ' 56' ' ' ARG . 19.3 m-85 -80.22 122.67 27.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.971 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.26 -31.74 12.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.203 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.708 ' CH2' ' CG ' ' A' ' 65' ' ' ASP . 37.7 t90 -113.07 121.47 44.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 111.3 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.655 ' SD ' HD23 ' A' ' 148' ' ' LEU . 83.4 mmm -146.61 139.48 25.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.523 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.708 ' CG ' ' CH2' ' A' ' 63' ' ' TRP . 21.1 p30 -163.13 165.04 25.04 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.841 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.572 ' CG1' ' HE2' ' A' ' 146' ' ' MET . 65.8 mt -115.17 131.8 66.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.267 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.673 ' CG2' ' NH1' ' A' ' 147' ' ' ARG . 10.7 tp -129.15 158.87 41.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.403 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.584 ' CA ' ' HG3' ' A' ' 144' ' ' LYS . 5.5 t -123.55 153.15 41.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.533 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.653 ' N ' ' O ' ' A' ' 143' ' ' THR . 0.3 OUTLIER -104.09 103.48 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.433 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 72' ' ' ASP . 20.9 t -172.06 110.18 0.26 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.522 ' HB3' ' CB ' ' A' ' 77' ' ' TYR . 0.8 OUTLIER -58.65 -35.32 72.36 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.295 -179.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 90.3 m-20 -59.19 -39.42 82.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.444 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -97.36 -41.29 8.31 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.313 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -123.95 85.69 54.05 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.99 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.588 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 2.7 Cg_exo -40.74 172.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.451 2.1 . . . . 0.0 110.316 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.631 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 62.6 t-20 72.4 29.53 2.13 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.358 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.704 ' C ' ' CD2' ' A' ' 77' ' ' TYR . 1.6 t80 -64.23 -45.83 86.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.574 ' O ' HG13 ' A' ' 81' ' ' ILE . 20.1 pt-20 -71.44 -47.52 55.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.631 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 98.2 mt-10 -66.78 -40.12 88.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.386 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.537 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 57.4 tttp -67.99 -47.75 67.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.557 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.732 ' CD1' ' CE1' ' A' ' 85' ' ' TYR . 2.7 pp -67.4 -42.41 87.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.568 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.538 ' N ' ' CD1' ' A' ' 81' ' ' ILE . 55.4 tttp -55.87 -39.57 71.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.132 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.579 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 61.8 mtt -59.78 -44.25 94.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.94 0.4 . . . . 0.0 110.695 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.672 ' CE2' ' CZ2' ' A' ' 155' ' ' TRP . 95.5 m-85 -73.51 -33.57 64.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.615 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.732 ' CE1' ' CD1' ' A' ' 81' ' ' ILE . 11.4 m-30 -60.04 -45.66 92.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.542 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 83' ' ' MET . 20.4 pt-20 -64.66 129.74 40.95 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.329 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.633 ' OE2' ' CH2' ' A' ' 114' ' ' TRP . 96.1 mt-10 -63.61 137.9 58.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.552 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.666 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.5 OUTLIER -150.91 171.94 16.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.452 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.717 ' CD2' ' CE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.81 -179.91 5.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.273 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.648 ' O ' ' CB ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -170.71 146.48 2.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 179.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.584 ' CD2' ' HD2' ' A' ' 173' ' ' LYS . 6.3 mp -65.82 -24.77 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.329 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.576 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 48.6 p30 -108.22 150.54 27.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 111.261 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.618 ' OD1' ' O ' ' A' ' 127' ' ' LEU . 49.2 t0 -84.32 128.9 34.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.967 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.631 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -107.93 140.38 41.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.87 0.367 . . . . 0.0 110.667 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.643 HD13 ' CE1' ' A' ' 61' ' ' TYR . 15.3 pt -113.75 133.2 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.478 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.728 ' NH1' ' CZ ' ' A' ' 105' ' ' PHE . 42.3 ttm180 -123.27 138.89 54.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.382 . . . . 0.0 110.686 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.687 ' CD2' ' CZ ' ' A' ' 46' ' ' TYR . 17.5 t80 -118.49 129.84 55.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.474 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.594 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 11.4 mm -91.14 94.22 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.169 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.586 ' CD1' ' CB ' ' A' ' 43' ' ' ALA . 12.8 tp -80.15 -33.21 38.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.524 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.684 ' CG ' ' N ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -66.53 -68.64 0.36 Allowed 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.633 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.684 ' N ' ' CG ' ' A' ' 100' ' ' ASP . . . 157.86 -28.11 0.47 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.517 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.644 ' O ' ' CG2' ' A' ' 143' ' ' THR . 97.1 p -113.64 141.72 46.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.681 0.741 . . . . 0.0 111.237 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.527 ' HA2' ' CZ ' ' A' ' 135' ' ' PHE . . . -173.75 125.41 1.12 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.564 ' OH ' ' HG3' ' A' ' 116' ' ' ARG . 81.1 t80 -115.89 131.29 56.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.727 0.298 . . . . 0.0 110.815 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.728 ' CZ ' ' NH1' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -137.73 157.01 47.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.707 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.567 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 49.5 p30 -144.88 151.27 38.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.358 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.61 141.96 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.967 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.64 ' HB2' ' CH2' ' A' ' 114' ' ' TRP . 38.2 ttt180 -106.4 137.35 44.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.406 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 56.7 t0 -103.35 156.56 17.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.552 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 26.6 mttp -59.28 -30.74 68.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.058 0.456 . . . . 0.0 110.328 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.631 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 96.0 mt-10 -68.99 -0.63 5.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.214 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.648 ' C ' ' OD2' ' A' ' 112' ' ' ASP . 0.0 OUTLIER 76.62 32.09 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.52 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.631 ' NE2' ' OE1' ' A' ' 111' ' ' GLU . 54.8 mt-30 -110.19 146.0 36.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.046 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.64 ' CH2' ' HB2' ' A' ' 108' ' ' ARG . 82.7 m95 -113.66 139.54 48.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.969 0.414 . . . . 0.0 111.175 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.682 ' CD1' ' CE1' ' A' ' 6' ' ' TYR . 60.5 mt -114.14 125.19 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.224 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 71.6 ttp85 -93.3 114.1 26.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.24 128.3 73.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.602 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.48 ' CE2' ' OE2' ' A' ' 139' ' ' GLU . 67.8 t80 -103.33 131.04 50.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.267 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.605 ' SD ' ' HD1' ' A' ' 105' ' ' PHE . 88.4 mtp -100.11 127.57 46.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.627 ' OE2' ' OD2' ' A' ' 123' ' ' ASP . 3.6 mp0 -110.76 159.65 17.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 0.0 110.76 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.619 ' CA ' ' HA2' ' A' ' 101' ' ' GLY . 8.0 pttm -45.67 121.2 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.143 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.656 ' CA ' ' O ' ' A' ' 41' ' ' LEU . . . 89.25 6.56 71.09 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.774 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.627 ' OD2' ' OE2' ' A' ' 120' ' ' GLU . 87.4 m-20 -92.18 119.46 31.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.705 ' SD ' ' O ' ' A' ' 96' ' ' ARG . 1.2 tpt -113.88 129.78 56.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.182 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 37' ' ' LEU . 12.6 p -134.28 144.68 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.836 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.683 ' OG1' ' CZ3' ' A' ' 39' ' ' TRP . 82.8 m -105.51 132.7 51.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.043 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.618 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -102.49 122.68 45.52 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.9 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 35' ' ' GLY . 20.7 Cg_endo -63.89 144.51 88.48 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.954 2.436 . . . . 0.0 112.107 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.648 ' CB ' ' O ' ' A' ' 90' ' ' HIS . . . -75.9 142.33 42.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.058 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.12 11.3 61.48 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.514 HD11 ' HG2' ' A' ' 128' ' ' PRO . 1.2 mt -115.47 148.78 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.766 0.317 . . . . 0.0 110.716 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.717 ' CE2' ' CD2' ' A' ' 89' ' ' LEU . 7.8 m-30 -94.75 131.31 40.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.179 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.624 ' HE1' ' CE1' ' A' ' 90' ' ' HIS . 20.0 p-80 -154.64 167.74 29.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.58 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.562 ' HG2' ' OD1' ' A' ' 106' ' ' ASP . 16.1 ptp180 -149.41 150.78 32.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.632 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.69 ' O ' ' CD2' ' A' ' 85' ' ' TYR . 68.8 t80 -114.42 132.41 56.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 104' ' ' TYR . 46.5 m -125.54 137.11 53.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.023 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.559 HG13 ' CB ' ' A' ' 143' ' ' THR . 15.3 m -117.77 12.0 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.594 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.459 ' H ' HG22 ' A' ' 136' ' ' THR . 56.3 t0 -57.61 -23.19 49.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.151 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 84.4 tt0 -44.71 -34.77 2.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.289 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 19.6 mtpt -159.95 4.28 0.08 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.6 m120 58.71 33.27 22.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.902 0.382 . . . . 0.0 110.555 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.473 ' O ' ' OG ' ' A' ' 102' ' ' SER . 62.3 t80 -151.99 97.65 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.178 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.653 ' O ' ' N ' ' A' ' 69' ' ' ILE . 53.3 m -135.25 130.76 35.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.386 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.617 ' HB3' ' CB ' ' A' ' 100' ' ' ASP . 29.3 tttt -130.43 117.16 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.594 ' HB1' ' CD1' ' A' ' 98' ' ' ILE . . . -141.51 156.88 45.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.635 ' SD ' ' HE1' ' A' ' 64' ' ' MET . 44.2 ttm -92.19 135.17 34.21 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.673 ' NH1' ' CG2' ' A' ' 67' ' ' ILE . 50.2 mtm-85 -111.27 149.23 31.34 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.084 0.469 . . . . 0.0 111.256 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.655 HD23 ' SD ' ' A' ' 64' ' ' MET . 1.8 tm? -119.92 119.32 33.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.862 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.611 ' HD1' ' CZ3' ' A' ' 63' ' ' TRP . 98.1 m-85 -129.8 153.55 48.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.984 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.48 129.86 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.074 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.32 -159.43 38.99 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.47 148.37 98.1 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 110.633 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.424 ' HB2' ' CG2' ' A' ' 156' ' ' THR . 38.0 Cg_endo -69.51 95.25 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.884 2.39 . . . . 0.0 112.294 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 155' ' ' TRP . 16.5 m -76.32 -27.41 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.688 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.672 ' CZ2' ' CE2' ' A' ' 84' ' ' PHE . 43.6 t90 -56.3 -34.05 66.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.424 ' CG2' ' HB2' ' A' ' 153' ' ' PRO . 53.7 p -46.32 -43.83 16.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.56 100.55 3.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.25 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.654 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -151.12 159.99 44.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.67 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.704 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . 41.9 t-20 -91.23 161.07 15.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.98 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.574 ' HG2' ' CD ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -32.7 -60.16 0.38 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.381 . . . . 0.0 110.547 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 160' ' ' ARG . 37.5 Cg_endo -69.42 137.47 36.53 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.838 2.358 . . . . 0.0 112.317 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.696 ' O ' ' CZ ' ' A' ' 165' ' ' PHE . . . -66.72 -29.29 69.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.48 ' OD1' ' C ' ' A' ' 163' ' ' ASP . 48.5 p30 -85.84 14.24 6.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.704 ' CD2' ' CB ' ' A' ' 159' ' ' ASN . 54.0 t-80 -54.26 -39.25 66.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.029 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.696 ' CZ ' ' O ' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -87.36 126.71 35.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 110.814 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 171' ' ' TYR . 73.8 mm-40 -65.83 -45.89 80.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.461 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 171' ' ' TYR . . . -71.27 -46.62 60.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.918 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.589 ' C ' ' CD2' ' A' ' 165' ' ' PHE . 74.4 mtt85 -89.4 7.01 38.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.812 0.339 . . . . 0.0 110.706 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.559 ' N ' ' HD2' ' A' ' 165' ' ' PHE . . . -108.57 -114.9 3.8 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -58.4 -35.3 71.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.752 0.311 . . . . 0.0 110.668 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.527 ' HB3' ' O ' ' A' ' 167' ' ' ALA . 71.6 t80 -55.4 -39.11 69.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.414 ' CG2' ' HA ' ' A' ' 168' ' ' ARG . 73.2 t -58.26 -38.98 71.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.602 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.584 ' HD2' ' CD2' ' A' ' 91' ' ' LEU . 60.5 mtpt -57.75 -34.89 70.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.678 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -56.72 -41.33 77.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.499 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.0 tp -57.26 -37.68 72.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.632 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.34 72.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.655 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -63.59 -33.06 74.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.527 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.6 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 10.5 p -127.83 141.58 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.53 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.567 ' OE1' ' HA ' ' A' ' 3' ' ' GLN . 13.2 mm-40 -94.25 114.58 26.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.497 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.674 ' CB ' ' CG1' ' A' ' 26' ' ' VAL . . . -163.55 162.7 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.891 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.524 ' HE3' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -126.95 148.21 50.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.064 0.459 . . . . 0.0 111.685 -178.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.697 ' CZ ' ' OD2' ' A' ' 8' ' ' ASP . 1.2 t80 -108.71 77.29 1.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.238 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.411 ' H ' ' HG2' ' A' ' 7' ' ' MET . 17.1 ptm -72.47 5.72 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.566 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.697 ' OD2' ' CZ ' ' A' ' 6' ' ' TYR . 89.7 m-20 -54.34 -34.36 60.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.206 0.527 . . . . 0.0 110.037 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -107.09 5.81 28.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.303 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 18' ' ' HIS . . . -105.99 153.96 39.82 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.806 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 13' ' ' ASP . 32.5 Cg_endo -66.86 141.04 57.42 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.811 2.341 . . . . 0.0 112.171 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.44 33.28 0.69 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.591 ' OD2' ' N ' ' A' ' 15' ' ' ARG . 2.3 t0 -100.1 110.21 58.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 110.532 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.64 -33.24 86.52 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.749 2.299 . . . . 0.0 112.297 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.591 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 26.8 mmt180 -53.98 -34.76 60.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.583 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 63.7 mt-30 -100.06 139.28 20.62 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.258 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.605 ' HB2' ' CG ' ' A' ' 19' ' ' ARG . 23.6 Cg_exo -60.27 -6.77 5.66 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 122.827 2.351 . . . . 0.0 111.325 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.58 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 62.0 m-70 71.71 39.03 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.121 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.605 ' CG ' ' HB2' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -89.48 100.56 2.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.253 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.629 ' O ' ' C ' ' A' ' 22' ' ' PRO . 16.1 Cg_endo -60.91 153.68 61.7 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.608 2.205 . . . . 0.0 111.73 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -105.55 112.31 64.71 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.622 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' C ' ' O ' ' A' ' 20' ' ' PRO . 37.8 Cg_endo -73.33 156.76 99.5 Favored 'Cis proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.144 -1.607 . . . . 0.0 112.348 -0.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' A' ' 20' ' ' PRO . . . -68.57 143.64 40.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.496 ' HG3' ' HG2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -152.71 121.05 3.18 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.222 0.534 . . . . 0.0 111.225 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.73 156.32 63.74 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.161 2.574 . . . . 0.0 111.327 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.674 ' CG1' ' CB ' ' A' ' 4' ' ' ALA . 1.2 p -57.33 144.7 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.54 103.02 2.92 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.6 ' HB2' ' CG1' ' A' ' 2' ' ' VAL . 9.2 tt -48.64 -40.34 27.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.809 0.337 . . . . 0.0 110.348 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -59.37 -36.98 76.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.168 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.575 ' OE1' ' HA ' ' A' ' 30' ' ' GLN . 15.1 mm-40 -61.33 -43.59 98.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.693 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.577 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 18.2 mt -71.77 -34.54 69.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.22 -43.11 70.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.286 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.536 ' CG ' HH11 ' A' ' 33' ' ' ARG . 2.6 ttt-85 -65.29 -31.05 71.99 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.577 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 28.2 tp -65.13 -18.55 65.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.888 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' A' ' 128' ' ' PRO . . . 102.83 17.24 19.44 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.51 128.97 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.263 0.554 . . . . 0.0 110.979 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 126' ' ' THR . 35.5 mt -123.89 143.0 50.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.15 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 124' ' ' MET . 30.6 p90 -144.46 150.97 38.52 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.871 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.635 ' CZ3' ' HE2' ' A' ' 124' ' ' MET . 24.3 m-90 -123.13 141.21 52.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.575 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 4.1 ttpm? -99.37 104.42 16.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.898 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.651 ' CB ' ' OH ' ' A' ' 97' ' ' TYR . 1.1 mt -141.32 150.83 43.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.288 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.639 ' OD1' ' NZ ' ' A' ' 45' ' ' LYS . 84.4 m-20 -102.23 132.54 48.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB3' ' CA ' ' A' ' 99' ' ' LEU . . . -47.09 -44.1 20.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.16 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -62.57 -33.22 74.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.738 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.639 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 18.0 mttp -86.6 -8.18 57.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.319 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.692 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -71.42 -56.09 6.63 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.692 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 48.8 tp10 -76.09 -42.23 47.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.555 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.482 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -66.85 -23.51 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.633 ' CB ' ' O ' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -124.02 85.29 54.51 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.829 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.1 Cg_endo -44.06 -9.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.395 2.73 . . . . 0.0 112.008 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.615 ' HG3' ' NZ ' ' A' ' 54' ' ' LYS . 83.7 tt0 -42.9 -35.55 1.24 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.458 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.602 ' C ' ' CD1' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -57.31 -38.23 73.71 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' N ' HD12 ' A' ' 52' ' ' LEU . 84.0 tt0 -59.51 -34.35 72.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.709 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.615 ' NZ ' ' HG3' ' A' ' 51' ' ' GLU . 7.8 ttpm? -57.28 -45.44 84.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.768 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.2 mt -62.19 -39.87 85.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.629 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 64' ' ' MET . 69.4 ttt180 -60.84 -44.29 97.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.336 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -64.29 -42.06 96.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.537 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -62.95 -41.07 99.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.643 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.729 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 38.5 mmt180 -82.97 -12.02 57.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.019 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 65.4 50.12 1.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.866 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.729 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 25.9 m-85 -99.48 115.53 29.53 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.117 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.536 ' C ' HH21 ' A' ' 56' ' ' ARG . 59.9 p -88.04 -16.9 32.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.218 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.669 ' CH2' ' HB2' ' A' ' 65' ' ' ASP . 1.6 t-105 -114.07 110.6 20.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.002 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 56' ' ' ARG . 25.0 ttt -146.15 138.23 25.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.35 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.669 ' HB2' ' CH2' ' A' ' 63' ' ' TRP . 21.9 t70 -159.98 179.21 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.583 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.525 ' HA ' ' HG2' ' A' ' 146' ' ' MET . 52.8 mt -106.85 126.2 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.486 HG22 HD13 ' A' ' 67' ' ' ILE . 1.8 mm -117.15 135.6 57.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.337 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.516 ' OG1' ' HG3' ' A' ' 144' ' ' LYS . 47.6 m -125.43 141.18 52.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.656 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 142' ' ' TYR . 45.8 mt -109.74 122.03 63.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.199 0.524 . . . . 0.0 111.128 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.663 ' O ' ' N ' ' A' ' 74' ' ' LEU . 1.1 t -164.63 118.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.612 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -57.4 -42.79 82.94 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.093 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -62.94 -40.3 97.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.738 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -105.2 1.65 28.42 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.427 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.663 ' N ' ' O ' ' A' ' 70' ' ' CYS . 0.7 OUTLIER -130.25 83.08 64.04 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.838 0.351 . . . . 0.0 111.227 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.588 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 14.1 Cg_endo -59.23 161.37 16.68 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.194 1.929 . . . . 0.0 109.607 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.649 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 56.7 t-20 70.86 38.03 1.23 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.169 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.647 ' CZ ' HG13 ' A' ' 81' ' ' ILE . 7.4 t80 -64.97 -48.03 75.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.602 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.592 ' CG ' ' HE3' ' A' ' 82' ' ' LYS . 84.1 tt0 -61.89 -56.74 16.18 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.636 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 97.8 mt-10 -64.92 -41.5 95.51 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.214 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.68 ' O ' ' CD2' ' A' ' 84' ' ' PHE . 26.3 tttp -67.08 -37.97 84.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.173 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.707 ' CD1' ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -71.3 -54.41 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.119 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.647 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 98.3 mttt -50.1 -30.1 10.37 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.424 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.646 ' HE3' ' CH2' ' A' ' 155' ' ' TRP . 74.0 mtm -74.46 -58.77 3.08 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.738 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 18.3 p90 -87.29 -49.75 7.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.692 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.738 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -52.72 -47.12 67.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.039 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.722 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 84.6 tt0 -55.64 141.62 37.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 110.813 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -57.44 136.02 56.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.645 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -157.46 -172.25 3.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.657 ' O ' ' CB ' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -145.33 178.97 7.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.416 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.661 ' CE1' ' CE1' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -170.7 140.71 1.73 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.044 0.449 . . . . 0.0 110.676 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.494 HD11 ' HA ' ' A' ' 170' ' ' GLN . 66.3 mt -80.67 2.33 26.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.421 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -108.89 153.36 23.64 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.551 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -61.33 134.95 57.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.412 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.564 ' O ' HG21 ' A' ' 126' ' ' THR . 31.0 tt0 -108.32 116.99 32.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.748 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.605 HG12 ' CG2' ' A' ' 126' ' ' THR . 10.1 mt -129.24 129.84 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.4 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.435 ' CZ ' ' CZ ' ' A' ' 105' ' ' PHE . 14.0 ptm180 -139.72 148.41 42.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.015 0.435 . . . . 0.0 110.721 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.651 ' OH ' ' CB ' ' A' ' 41' ' ' LEU . 2.2 t80 -122.75 138.71 54.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.593 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.641 ' O ' ' N ' ' A' ' 122' ' ' GLY . 12.5 mm -104.1 114.55 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.143 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.589 HD13 ' CG ' ' A' ' 146' ' ' MET . 17.3 mt -84.22 -43.61 14.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.159 0.504 . . . . 0.0 109.971 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.47 162.41 38.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.33 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.55 173.93 45.85 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.703 ' OG ' ' CZ ' ' A' ' 118' ' ' PHE . 33.3 t -123.2 141.2 52.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.814 0.34 . . . . 0.0 110.492 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.92 150.04 20.04 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.72 ' CE1' ' CE1' ' A' ' 118' ' ' PHE . 88.8 m-85 -116.82 127.36 54.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.478 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.665 ' CE2' ' CD1' ' A' ' 135' ' ' PHE . 98.6 m-85 -123.77 149.22 45.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.002 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.602 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 53.8 p30 -133.35 144.48 49.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.462 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.61 146.38 31.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.701 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.646 ' HB2' ' CH2' ' A' ' 114' ' ' TRP . 76.2 ttt180 -113.06 125.67 54.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.008 0.432 . . . . 0.0 110.737 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.76 156.69 22.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.408 ' C ' ' H ' ' A' ' 112' ' ' ASP . 39.5 ttpt -56.23 -32.67 64.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 110.417 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 85.1 tt0 -66.35 -2.52 4.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.217 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 111' ' ' GLU . 59.8 t0 76.17 40.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.31 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.59 ' HB3' ' CG ' ' A' ' 8' ' ' ASP . 93.9 mt-30 -113.8 144.3 43.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.183 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.646 ' CH2' ' HB2' ' A' ' 108' ' ' ARG . 87.1 m95 -111.2 130.65 55.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.014 0.435 . . . . 0.0 111.182 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.598 HG12 ' CE2' ' A' ' 6' ' ' TYR . 64.9 mt -117.95 133.96 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.524 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.562 ' C ' HD13 ' A' ' 117' ' ' ILE . 59.4 ttp180 -91.94 116.7 29.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.595 HG21 ' CE ' ' A' ' 119' ' ' MET . 11.9 mm -112.0 127.23 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.422 . . . . 0.0 110.539 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 104' ' ' TYR . 80.1 t80 -106.32 133.13 51.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.917 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.623 ' HG3' ' CE1' ' A' ' 105' ' ' PHE . 16.2 mmt -107.0 126.28 52.12 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.443 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 84.8 tt0 -108.35 148.51 29.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.703 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -44.68 138.03 3.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.123 0.487 . . . . 0.0 111.072 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 79.12 1.04 84.83 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.567 ' O ' HG12 ' A' ' 98' ' ' ILE . 57.2 t0 -94.92 119.7 33.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.867 0.365 . . . . 0.0 111.266 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.635 ' HE2' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -97.32 136.49 37.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.663 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.484 HG21 ' N ' ' A' ' 126' ' ' THR . 12.8 p -137.32 143.72 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.303 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.605 ' CG2' HG12 ' A' ' 95' ' ' ILE . 95.9 m -122.54 131.54 53.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.006 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.414 HD23 ' HB ' ' A' ' 131' ' ' ILE . 0.4 OUTLIER -112.9 120.05 41.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.904 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.583 ' O ' HD11 ' A' ' 131' ' ' ILE . 38.9 Cg_exo -57.11 155.47 28.74 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.806 2.338 . . . . 0.0 111.877 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.6 147.43 29.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 131' ' ' ILE . . . 94.88 9.25 58.62 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.583 HD11 ' O ' ' A' ' 128' ' ' PRO . 3.4 mp -114.55 151.26 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.478 ' HE2' HD23 ' A' ' 89' ' ' LEU . 51.6 m-85 -101.26 135.76 42.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.225 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.661 ' CE1' ' CE1' ' A' ' 90' ' ' HIS . 13.4 p-80 -148.0 158.63 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.123 0.487 . . . . 0.0 111.188 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.552 ' NH1' ' OG1' ' A' ' 136' ' ' THR . 74.0 ttp85 -134.02 132.68 40.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.0 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.665 ' CD1' ' CE2' ' A' ' 105' ' ' PHE . 17.1 t80 -106.38 131.03 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.896 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.552 ' OG1' ' NH1' ' A' ' 134' ' ' ARG . 41.5 m -126.39 131.09 51.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.975 0.417 . . . . 0.0 110.913 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 141' ' ' ASN . 15.0 m -126.9 13.68 3.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.213 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.567 ' HA ' ' OD1' ' A' ' 141' ' ' ASN . 91.6 m-20 -63.32 -23.08 67.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.47 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.644 ' HG3' ' CE2' ' A' ' 104' ' ' TYR . 75.2 mm-40 -56.57 -35.53 68.29 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.286 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.502 ' HG3' ' H ' ' A' ' 142' ' ' TYR . 0.8 OUTLIER -140.66 -22.89 0.8 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.525 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 137' ' ' VAL . 87.0 m-20 59.12 38.5 23.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.715 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.515 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 65.9 t80 -157.71 97.0 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.442 HG21 ' N ' ' A' ' 144' ' ' LYS . 39.6 m -133.44 143.17 48.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.0 110.907 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.516 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 66.7 tttt -126.41 109.83 12.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.746 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.598 ' HB2' ' CD1' ' A' ' 98' ' ' ILE . . . -141.88 154.4 45.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.184 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.589 ' CG ' HD13 ' A' ' 99' ' ' LEU . 69.8 mtm -94.74 146.68 24.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.184 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.543 ' HB3' ' CE2' ' A' ' 149' ' ' PHE . 19.4 mmm-85 -113.91 140.43 48.38 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.378 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 148' ' ' LEU . 5.1 mp -113.85 115.35 27.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.532 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.569 ' HB2' ' CD1' ' A' ' 63' ' ' TRP . 94.5 m-85 -135.25 156.19 49.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.614 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.54 ' O ' ' CG2' ' A' ' 150' ' ' VAL . 1.3 p -127.7 74.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.945 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.62 -173.0 43.26 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.541 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 71.3 tt0 -73.1 143.4 83.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.901 0.382 . . . . 0.0 110.672 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 152' ' ' GLU . 36.6 Cg_exo -57.53 71.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.867 2.378 . . . . 0.0 112.11 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 152' ' ' GLU . 8.6 p -61.63 -32.78 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.152 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.655 ' HA ' ' CD1' ' A' ' 158' ' ' TYR . 5.2 t90 -54.88 -29.29 55.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.786 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 42.7 m -45.61 -43.11 11.98 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.654 ' O ' ' CZ ' ' A' ' 165' ' ' PHE . . . -147.33 100.89 3.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.366 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.655 ' CD1' ' HA ' ' A' ' 155' ' ' TRP . 21.6 p90 -151.91 164.8 36.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.659 ' HB2' ' CG ' ' A' ' 164' ' ' HIS . 85.7 m-20 -89.4 160.59 16.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.119 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.618 ' CB ' ' HD3' ' A' ' 161' ' ' PRO . 2.1 mpp_? -32.99 -57.02 0.53 Allowed Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.426 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.618 ' HD3' ' CB ' ' A' ' 160' ' ' ARG . 18.2 Cg_exo -65.34 132.35 31.17 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.757 2.305 . . . . 0.0 111.79 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.657 ' CB ' ' O ' ' A' ' 89' ' ' LEU . . . -67.41 -29.61 69.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.838 0.351 . . . . 0.0 110.609 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.489 ' OD1' ' C ' ' A' ' 163' ' ' ASP . 48.1 p30 -92.01 7.26 43.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.451 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.659 ' CG ' ' HB2' ' A' ' 159' ' ' ASN . 2.1 t-80 -64.77 -32.92 74.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.757 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.654 ' CZ ' ' O ' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -77.19 132.13 38.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.405 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -59.54 -45.17 92.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.002 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 172' ' ' VAL . . . -70.69 -46.06 63.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.276 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.534 ' CA ' ' HE ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -86.77 3.61 44.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.884 0.373 . . . . 0.0 110.61 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 165' ' ' PHE . . . -80.35 -168.71 38.71 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.494 ' HA ' HD11 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -42.44 -21.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 110.508 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 169' ' ' GLY . 72.1 t80 -51.85 -38.51 56.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.225 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 167' ' ' ALA . 8.0 m -67.84 -26.12 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.585 ' C ' ' HD2' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -60.59 -29.69 69.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.664 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.509 ' N ' ' HG3' ' A' ' 173' ' ' LYS . 69.5 t80 -57.01 -41.96 79.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.561 ' C ' HD21 ' A' ' 175' ' ' LEU . 9.6 tt -57.72 -37.72 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.45 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.679 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.68 -32.72 74.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.549 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.558 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.584 ' CB ' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -126.5 124.69 65.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.719 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.655 ' OE1' ' CD2' ' A' ' 118' ' ' PHE . 63.4 tt0 -104.35 113.72 27.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.062 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.623 ' HB1' ' CB ' ' A' ' 26' ' ' VAL . . . -164.4 157.76 17.79 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.485 ' CZ3' ' HB3' ' A' ' 25' ' ' PRO . 1.4 t-105 -133.22 148.91 52.03 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.686 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.659 ' CE2' ' HA ' ' A' ' 26' ' ' VAL . 14.8 m-85 -98.8 87.87 3.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.785 ' SD ' ' CH2' ' A' ' 114' ' ' TRP . 86.1 mtp -86.89 3.09 46.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.351 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.592 ' CB ' ' HB2' ' A' ' 113' ' ' GLN . 14.5 p-10 -58.78 -33.85 70.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.547 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.558 ' OD2' ' HD3' ' A' ' 24' ' ' ARG . 89.8 m-20 -68.55 -67.11 0.49 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.592 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.44 103.08 44.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -66.08 141.39 63.59 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.689 2.259 . . . . 0.0 111.763 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.46 -177.48 40.06 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 1.2 p-10 -71.87 147.94 91.84 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.879 0.371 . . . . 0.0 110.536 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.646 ' O ' ' NH1' ' A' ' 116' ' ' ARG . 19.4 Cg_endo -60.88 -28.21 86.01 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.736 2.291 . . . . 0.0 112.13 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -54.78 -39.65 68.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.658 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -108.16 155.69 39.72 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.409 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.598 ' HG2' ' CG ' ' A' ' 19' ' ' ARG . 57.4 Cg_endo -87.53 -6.85 6.85 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.1 2.533 . . . . 0.0 111.876 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 45.56 45.62 10.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.598 ' CG ' ' HG2' ' A' ' 17' ' ' PRO . 5.9 mtt180 -61.57 112.26 5.74 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.869 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.8 Cg_exo -56.84 161.06 10.93 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.862 2.375 . . . . 0.0 111.71 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -124.3 97.44 40.03 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.496 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.568 ' O ' ' HB2' ' A' ' 20' ' ' PRO . 11.4 Cg_exo -67.32 153.98 85.5 Favored 'Cis proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.484 -0.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -90.8 179.81 43.03 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HD3' ' OD2' ' A' ' 9' ' ' ASP . 5.6 ptm180 -152.86 117.52 2.89 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 111.144 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.485 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 73.1 Cg_endo -81.83 158.56 18.58 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.331 2.687 . . . . 0.0 111.745 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.659 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 1.4 p -57.99 147.31 6.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.159 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.14 108.93 3.66 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.584 HD12 ' CB ' ' A' ' 2' ' ' VAL . 26.2 tp -47.25 -41.26 18.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.847 0.356 . . . . 0.0 110.269 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -70.16 -31.52 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.248 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.564 ' HG2' ' OH ' ' A' ' 6' ' ' TYR . 66.3 tp60 -62.93 -46.51 87.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.426 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 9.3 mt -69.44 -34.22 74.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.532 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -52.54 -43.68 65.33 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -66.54 -32.01 73.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.831 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 35.5 tp -64.5 -25.72 68.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.924 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.585 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . 110.04 23.63 6.05 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.606 HG11 ' CZ ' ' A' ' 38' ' ' TYR . 24.4 t -100.76 128.68 52.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.269 0.557 . . . . 0.0 111.138 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.648 ' HB3' ' CH2' ' A' ' 39' ' ' TRP . 3.0 mt -125.59 141.55 51.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.128 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.663 ' CD1' ' N ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -126.84 134.11 50.6 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.853 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.686 ' NE1' ' CG2' ' A' ' 55' ' ' ILE . 1.2 m95 -101.2 128.46 47.3 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -97.84 105.64 17.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.619 ' O ' ' OH ' ' A' ' 97' ' ' TYR . 3.1 mp -139.66 147.34 40.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.696 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.671 ' O ' ' N ' ' A' ' 45' ' ' LYS . 84.1 m-20 -97.72 123.81 41.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 46' ' ' TYR . . . -41.88 -44.64 3.45 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.583 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -62.8 -33.91 76.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.048 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 42' ' ' ASP . 66.9 mttm -85.26 -14.8 45.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.318 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.791 ' CZ ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -55.92 -49.09 74.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -83.14 -41.65 18.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.094 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.514 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 2.8 m120 -67.11 -22.85 65.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.737 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 45' ' ' LYS . 3.1 t0 -127.12 84.65 62.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.961 0.41 . . . . 0.0 111.524 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.0 Cg_endo -48.7 -8.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 123.23 2.62 . . . . 0.0 111.448 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.58 ' CD ' ' HD2' ' A' ' 54' ' ' LYS . 45.6 tp10 -42.59 -33.54 0.72 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.717 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.723 ' CD2' ' CE2' ' A' ' 46' ' ' TYR . 24.6 tp -55.32 -41.08 71.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.007 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 50' ' ' PRO . 75.3 mm-40 -63.16 -34.18 77.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.306 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.58 ' HD2' ' CD ' ' A' ' 51' ' ' GLU . 37.8 mttm -59.06 -41.82 88.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.527 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.686 ' CG2' ' NE1' ' A' ' 39' ' ' TRP . 87.6 mt -62.82 -36.26 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.598 ' NH2' ' HA ' ' A' ' 63' ' ' TRP . 72.1 ttt180 -58.09 -41.54 83.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.234 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.48 HH11 ' HA ' ' A' ' 54' ' ' LYS . 77.4 mtt85 -61.82 -36.01 79.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.446 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -60.28 -39.08 85.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.656 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HG2' ' CZ ' ' A' ' 61' ' ' TYR . 8.8 tpt180 -99.99 -11.16 20.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 110.296 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' ARG . 30.5 t-20 58.08 51.58 8.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.531 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.671 ' CE2' HG13 ' A' ' 95' ' ' ILE . 58.9 m-85 -70.05 124.24 23.59 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.228 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.487 ' C ' HH21 ' A' ' 56' ' ' ARG . 24.2 m -60.8 -36.9 80.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.809 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.692 ' CD1' ' O ' ' A' ' 63' ' ' TRP . 0.0 OUTLIER -138.26 149.93 46.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.379 . . . . 0.0 110.854 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.731 ' SD ' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -145.47 117.57 8.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.321 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.659 ' OD2' ' CZ3' ' A' ' 63' ' ' TRP . 90.1 m-20 -143.03 169.62 17.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.838 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.624 ' HB ' ' CG ' ' A' ' 146' ' ' MET . 14.5 tt -121.49 144.44 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.93 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 68' ' ' THR . 9.8 tp -133.91 157.38 41.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.852 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.48 ' O ' ' CD1' ' A' ' 74' ' ' LEU . 54.3 m -117.06 138.41 51.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.017 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 142' ' ' TYR . 1.1 mp -90.52 96.47 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.335 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.644 ' O ' ' N ' ' A' ' 74' ' ' LEU . 45.8 t -154.53 128.04 8.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.945 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -57.72 -41.5 81.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.953 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.96 -40.17 96.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.437 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.58 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 40.7 tptt -100.12 -6.77 25.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 111.204 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 70' ' ' CYS . 0.2 OUTLIER -126.45 76.63 73.45 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.393 . . . . 0.0 111.163 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.531 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 10.8 Cg_endo -56.42 152.5 39.44 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.365 2.043 . . . . 0.0 110.061 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.604 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 39.3 t-20 74.65 39.13 0.45 Allowed 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.209 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.64 ' CZ ' HG13 ' A' ' 81' ' ' ILE . 58.1 t80 -59.66 -40.7 88.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.509 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.639 ' O ' ' CB ' ' A' ' 82' ' ' LYS . 97.0 mt-10 -60.13 -56.89 16.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.708 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.604 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 75.6 mm-40 -71.87 -38.21 70.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.589 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 84' ' ' PHE . 10.2 tptp -64.64 -56.58 12.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.165 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.726 ' CG2' ' CE1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -71.71 -35.66 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.117 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.639 ' CB ' ' O ' ' A' ' 78' ' ' GLU . 26.1 tptt -59.48 -41.45 89.82 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.74 ' SD ' ' CH2' ' A' ' 155' ' ' TRP . 59.1 mtt -60.02 -42.15 93.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.537 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 80' ' ' LYS . 80.0 m-85 -69.24 -36.74 77.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.658 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.726 ' CE1' ' CG2' ' A' ' 81' ' ' ILE . 15.0 m-30 -61.0 -45.19 95.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.589 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.75 138.08 58.13 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.87 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -90.74 121.16 32.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.733 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.719 ' ND1' ' CE1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -141.63 173.92 11.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.04 0.448 . . . . 0.0 111.178 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.649 HD12 ' CE1' ' A' ' 132' ' ' TYR . 3.5 mp -130.38 159.89 35.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.109 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.557 ' O ' ' HB2' ' A' ' 129' ' ' ALA . 4.0 p80 -170.81 153.38 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.095 0.474 . . . . 0.0 110.838 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.663 ' CD1' ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -67.78 16.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.823 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 90' ' ' HIS . 59.0 t0 -108.53 148.32 30.44 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.616 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.637 ' OD2' ' NH2' ' A' ' 59' ' ' ARG . 83.1 m-20 -83.93 142.34 30.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.514 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.612 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 16.2 mm-40 -99.35 118.25 35.57 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.697 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.674 ' CD1' ' CG2' ' A' ' 126' ' ' THR . 32.9 mm -122.2 119.41 58.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.309 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.641 ' HD2' ' CE2' ' A' ' 105' ' ' PHE . 38.8 mtt85 -139.18 138.27 36.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.31 0.576 . . . . 0.0 111.452 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.791 ' CD2' ' CZ ' ' A' ' 46' ' ' TYR . 25.8 t80 -125.82 129.92 50.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 120' ' ' GLU . 14.0 mm -89.02 93.31 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.52 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.595 HD21 ' CD1' ' A' ' 66' ' ' ILE . 10.4 tp -72.65 -38.93 67.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.202 0.525 . . . . 0.0 109.651 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . 54.7 t0 -155.2 154.43 32.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.211 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 100' ' ' ASP . . . 82.14 -166.49 46.35 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 50.2 m -121.01 147.33 45.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.304 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -132.21 149.09 19.35 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.648 ' CE2' ' HG3' ' A' ' 116' ' ' ARG . 81.2 t80 -125.81 131.3 52.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.344 . . . . 0.0 110.615 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.641 ' CE2' ' HD2' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -122.08 146.25 47.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 133' ' ' HIS . 23.2 t70 -124.67 128.33 48.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.416 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.14 144.4 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.505 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 114' ' ' TRP . 21.3 ttp180 -122.77 130.67 53.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.652 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 110' ' ' LYS . 57.8 t0 -85.73 156.23 20.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.695 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.571 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -60.79 -25.53 66.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.893 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.543 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 96.2 mt-10 -63.77 2.89 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.877 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 111' ' ' GLU . 54.3 t0 76.51 41.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 110.327 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.592 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 13.4 pt20 -143.37 165.83 26.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.857 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.785 ' CH2' ' SD ' ' A' ' 7' ' ' MET . 25.1 p-90 -133.69 149.84 51.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.025 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.56 ' CD1' ' HE1' ' A' ' 6' ' ' TYR . 68.7 mt -117.7 136.63 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.186 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.648 ' HG3' ' CE2' ' A' ' 104' ' ' TYR . 56.9 ttt180 -90.25 120.35 31.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.528 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 105' ' ' PHE . 27.4 pt -120.8 128.67 76.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.655 ' CD2' ' OE1' ' A' ' 3' ' ' GLN . 71.2 t80 -109.79 136.71 48.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.614 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.466 ' SD ' ' HB ' ' A' ' 125' ' ' VAL . 16.0 mmt -106.37 133.44 51.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.724 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.556 ' O ' ' HB ' ' A' ' 98' ' ' ILE . 94.6 mt-10 -107.51 168.36 9.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.431 ' HA ' HG22 ' A' ' 98' ' ' ILE . 36.1 ttpt -64.82 127.5 31.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.691 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.585 ' HA2' ' OH ' ' A' ' 97' ' ' TYR . . . 94.4 -15.42 63.3 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -95.98 121.46 37.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.701 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.615 ' HG3' ' CA ' ' A' ' 97' ' ' TYR . 18.1 ttt -102.64 150.2 23.67 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.466 ' HB ' ' SD ' ' A' ' 119' ' ' MET . 12.7 p -134.91 141.26 43.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.257 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.674 ' CG2' ' CD1' ' A' ' 95' ' ' ILE . 87.9 m -125.31 132.35 52.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.052 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.424 ' CD1' ' CE1' ' A' ' 105' ' ' PHE . 4.1 mt -121.18 127.42 26.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.888 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.59 ' HG2' ' CD1' ' A' ' 131' ' ' ILE . 12.8 Cg_endo -59.36 141.44 97.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.797 2.331 . . . . 0.0 111.902 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 90' ' ' HIS . . . -69.76 148.94 48.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.104 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.89 3.58 56.98 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.59 ' CD1' ' HG2' ' A' ' 128' ' ' PRO . 70.4 mt -116.25 137.15 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.305 . . . . 0.0 110.635 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.649 ' CE1' HD12 ' A' ' 89' ' ' LEU . 88.8 m-85 -58.4 128.3 36.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.145 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.564 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 45.0 p-80 -146.15 146.51 30.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.97 0.414 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.619 ' NE ' ' O ' ' A' ' 85' ' ' TYR . 77.9 ttt180 -135.7 134.34 39.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.111 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.573 ' HD2' ' CE2' ' A' ' 105' ' ' PHE . 70.5 t80 -106.7 124.72 50.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.757 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.641 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 18.5 p -130.81 155.45 46.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.592 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.641 ' CG1' ' O ' ' A' ' 136' ' ' THR . 34.7 m -164.96 17.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.271 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.641 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 48.1 p30 -70.8 -15.09 62.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 75.7 mm-40 -59.25 -39.45 82.88 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.33 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.509 ' HD3' ' HB2' ' A' ' 102' ' ' SER . 9.5 mtpm? -110.25 -19.33 13.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 138' ' ' ASP . 10.6 m120 59.6 30.47 20.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.347 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 66.3 t80 -172.94 96.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.196 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 56.9 m -136.16 134.4 38.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.13 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 5.8 ttmt -117.88 114.89 23.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.915 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 97' ' ' TYR . . . -142.07 155.21 45.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.067 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.653 ' SD ' ' HE2' ' A' ' 46' ' ' TYR . 5.9 mtt -93.64 145.82 24.28 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.016 0.436 . . . . 0.0 110.679 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -129.89 138.89 51.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.738 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.731 ' CD2' ' SD ' ' A' ' 64' ' ' MET . 41.0 mt -110.98 132.49 54.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.78 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.669 ' CE1' ' O ' ' A' ' 152' ' ' GLU . 62.4 t80 -132.97 152.93 51.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 110.878 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.56 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 11.7 t -116.02 129.66 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.763 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.5 -162.35 37.9 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.669 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 1.8 mm-40 -69.08 155.36 93.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.927 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.406 ' HB2' HG23 ' A' ' 156' ' ' THR . 27.8 Cg_endo -65.02 78.8 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.909 2.406 . . . . 0.0 112.184 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.57 HG11 ' CE2' ' A' ' 149' ' ' PHE . 7.0 p -60.61 -30.39 46.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.74 ' CH2' ' SD ' ' A' ' 83' ' ' MET . 43.3 t90 -52.5 -35.92 54.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.96 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 153' ' ' PRO . 47.6 p -48.9 -43.42 39.21 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.61 101.19 3.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.963 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.719 ' CE1' ' ND1' ' A' ' 88' ' ' HIS . 18.9 p90 -136.18 155.62 49.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.717 ' ND2' ' CZ ' ' A' ' 165' ' ' PHE . 89.8 m-20 -92.07 137.85 32.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.356 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.612 ' CB ' ' HD3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -50.41 -57.79 11.91 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.699 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.612 ' HD3' ' CB ' ' A' ' 160' ' ' ARG . 14.6 Cg_exo -64.02 131.97 32.68 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.529 2.153 . . . . 0.0 111.929 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.568 ' HB1' ' C ' ' A' ' 89' ' ' LEU . . . -68.61 -31.69 71.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.509 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.562 ' OD2' ' HG2' ' A' ' 170' ' ' GLN . 89.8 m-20 -98.28 13.44 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.715 ' CD2' ' ND2' ' A' ' 159' ' ' ASN . 61.0 t60 -54.03 -38.35 65.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.567 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.717 ' CZ ' ' ND2' ' A' ' 159' ' ' ASN . 97.4 m-85 -86.68 127.32 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.477 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.56 ' O ' HG23 ' A' ' 172' ' ' VAL . 11.8 tm-20 -61.6 -46.43 89.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.007 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.59 -45.85 61.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.58 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -85.0 0.33 51.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.706 -179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 165' ' ' PHE . . . -64.89 147.39 50.98 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.562 ' HG2' ' OD2' ' A' ' 163' ' ' ASP . 99.7 mm-40 -58.79 -32.14 69.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.704 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -55.15 -39.67 69.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.633 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 166' ' ' GLU . 73.7 t -59.23 -39.74 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.578 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.433 ' HE2' HE22 ' A' ' 170' ' ' GLN . 9.8 mttp -58.28 -34.63 70.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.575 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -56.5 -41.49 76.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.646 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.3 tp -57.37 -37.78 73.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.527 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.11 72.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.586 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -63.78 -33.05 74.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.551 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.5 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' A' ' 28' ' ' LEU . 11.7 p . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.593 0.235 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.575 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 11.7 mm-40 -100.22 116.27 31.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.443 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 1.084 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -164.41 157.53 17.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.792 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.705 ' O ' HG23 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -124.89 145.38 49.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.011 0.434 . . . . 0.0 111.67 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.558 ' CE2' HD11 ' A' ' 115' ' ' ILE . 1.4 t80 -96.07 76.03 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.711 ' SD ' ' ND1' ' A' ' 18' ' ' HIS . 73.7 mtm . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.732 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.711 ' ND1' ' SD ' ' A' ' 7' ' ' MET . 65.4 m170 . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.996 0.427 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.672 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -91.17 102.14 5.1 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.302 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.68 ' O ' ' N ' ' A' ' 23' ' ' GLY . 12.3 Cg_endo -58.74 161.15 15.71 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.77 2.314 . . . . 0.0 111.687 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.599 ' OD1' ' C ' ' A' ' 21' ' ' ASP . 13.5 t0 -119.37 101.68 48.88 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.575 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.536 ' C ' ' O ' ' A' ' 20' ' ' PRO . 12.9 Cg_exo -66.9 158.04 81.88 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.516 -1.452 . . . . 0.0 112.375 -0.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -82.94 152.21 29.67 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.594 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -152.68 119.85 3.09 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.296 0.569 . . . . 0.0 111.315 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 56.2 Cg_endo -74.75 157.44 43.81 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 123.028 2.485 . . . . 0.0 111.294 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.084 HG11 ' HB3' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -57.23 147.64 5.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.912 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 30' ' ' GLN . . . -97.89 102.24 2.64 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.752 ' C ' HD23 ' A' ' 28' ' ' LEU . 7.4 tt -46.06 -47.78 17.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.834 0.35 . . . . 0.0 110.358 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.52 -34.39 78.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.174 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 93.7 mt-30 -62.33 -40.98 98.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.678 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.588 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 6.6 mt -69.8 -38.68 76.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.345 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -55.98 -41.09 74.28 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.319 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -63.32 -32.33 73.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.588 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 26.2 tp -64.91 -23.9 67.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.938 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.649 ' O ' ' CG ' ' A' ' 128' ' ' PRO . . . 112.31 18.26 7.75 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 t -96.21 129.55 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 0.0 111.054 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.825 HD13 ' NH2' ' A' ' 59' ' ' ARG . 30.9 mt -120.48 141.06 50.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.131 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.689 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -139.78 139.45 36.44 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.836 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.999 ' NE1' HG21 ' A' ' 55' ' ' ILE . 1.9 m95 -109.53 133.65 52.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.497 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' C ' HD12 ' A' ' 41' ' ' LEU . 11.7 mtmt -105.99 102.74 12.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.809 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.629 ' O ' ' OH ' ' A' ' 97' ' ' TYR . 5.1 mp -142.76 156.49 45.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.247 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 45' ' ' LYS . 87.7 m-20 -90.32 122.29 33.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.529 ' HA ' HD22 ' A' ' 99' ' ' LEU . . . -42.01 -43.25 3.11 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.166 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.522 ' OD2' ' HB3' ' A' ' 42' ' ' ASP . 5.5 p-10 -66.88 -32.8 74.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.688 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.648 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 70.4 mttt -85.04 -11.59 55.01 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.2 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.722 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -71.86 -56.7 5.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.639 -0.424 . . . . 0.0 109.925 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.722 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 83.9 tt0 -67.04 -36.81 82.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.44 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.593 ' CG ' ' HA ' ' A' ' 45' ' ' LYS . 17.6 p-10 -78.67 -11.74 59.99 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.497 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' ' O ' ' A' ' 45' ' ' LYS . 10.2 t0 -130.94 83.26 61.66 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.82 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.1 Cg_endo -46.4 -8.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 123.535 2.824 . . . . 0.0 112.049 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 49' ' ' ASP . 96.9 mt-10 -46.05 -34.46 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.397 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.087 HD13 ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -59.06 -32.4 69.74 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 1.087 ' N ' HD13 ' A' ' 52' ' ' LEU . 84.8 tt0 -64.06 -35.26 80.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.685 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -59.18 -40.62 86.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.699 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.999 HG21 ' NE1' ' A' ' 39' ' ' TRP . 84.3 mt -59.85 -37.24 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.505 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.713 ' HG2' HD23 ' A' ' 148' ' ' LEU . 70.5 mtp180 -59.43 -40.83 88.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.603 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.97 -41.14 86.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.07 -32.54 74.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.694 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.825 ' NH2' HD13 ' A' ' 37' ' ' LEU . 39.0 mmt180 -99.41 7.42 45.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.218 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.793 ' ND2' ' O ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER 59.91 46.39 11.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.75 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.723 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 22.7 m-85 -105.49 113.03 26.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.279 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.664 ' C ' ' NH2' ' A' ' 56' ' ' ARG . 1.4 t -99.73 -21.45 15.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.248 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.57 ' HB3' ' O ' ' A' ' 149' ' ' PHE . 70.5 t90 -109.42 127.88 54.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.837 0.351 . . . . 0.0 111.041 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 56' ' ' ARG . 8.8 ptm -143.14 147.58 35.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.321 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 66' ' ' ILE . 46.3 t0 -159.47 166.76 30.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.433 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.534 ' HA ' ' HG2' ' A' ' 146' ' ' MET . 59.2 mt -108.39 122.25 62.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.522 HD12 ' HG3' ' A' ' 147' ' ' ARG . 72.6 mt -119.42 138.46 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.372 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.553 ' OG1' ' HG3' ' A' ' 144' ' ' LYS . 36.1 m -119.41 142.48 48.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.617 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.674 ' C ' ' SG ' ' A' ' 70' ' ' CYS . 64.2 mt -105.76 125.7 61.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.0 111.028 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.674 ' SG ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -169.1 135.4 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.657 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -57.96 -45.67 86.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.983 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.675 ' OD1' ' N ' ' A' ' 73' ' ' LYS . 55.6 p30 -77.21 -33.17 56.28 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.675 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 80.3 tttt -98.29 -3.66 36.76 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.459 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.031 HD21 ' HD3' ' A' ' 80' ' ' LYS . 1.1 tp -125.58 73.46 68.75 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.124 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.579 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 48.2 Cg_exo -49.97 154.14 5.55 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 121.892 1.728 . . . . 0.0 109.611 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.642 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 63.5 t-20 70.18 32.54 2.89 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.34 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.674 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 27.4 t80 -62.38 -45.7 91.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.434 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 49.0 tp10 -54.82 -54.18 45.6 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.642 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 97.7 mt-10 -76.34 -45.13 33.57 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.398 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 1.031 ' HD3' HD21 ' A' ' 74' ' ' LEU . 23.2 tttp -60.45 -49.52 77.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.281 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.907 HD13 ' CE2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -70.46 -37.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.391 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.607 ' CD ' ' HA ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -70.8 -37.22 73.28 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.617 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.611 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 87.0 mtp -56.68 -48.73 76.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.663 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.907 ' CE2' HD13 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -87.19 -14.85 40.01 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.653 179.535 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.825 ' CZ ' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -56.54 -46.32 80.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.97 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -75.93 146.42 39.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.959 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.567 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -80.51 135.51 36.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.292 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.442 ' CD2' ' C ' ' A' ' 88' ' ' HIS . 2.5 p-80 -144.87 170.67 15.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.007 0.432 . . . . 0.0 110.979 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.149 HD11 ' C ' ' A' ' 130' ' ' GLY . 28.3 tp -124.55 153.32 42.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.576 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.569 ' CE1' ' HE1' ' A' ' 133' ' ' HIS . 1.7 p80 -170.81 165.85 7.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.992 0.425 . . . . 0.0 110.897 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.54 ' C ' ' HB1' ' A' ' 129' ' ' ALA . 49.0 mt -85.09 16.24 3.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.585 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.71 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 88.2 m-20 -107.65 149.29 28.26 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.369 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.605 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 49.2 p30 -83.88 164.95 19.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.427 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.605 ' OE2' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -125.71 114.83 19.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.918 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.72 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 2.7 mp -120.41 116.32 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.149 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.715 ' NH1' ' CG ' ' A' ' 135' ' ' PHE . 68.1 mtt180 -131.62 138.37 48.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.011 0.434 . . . . 0.0 110.77 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.668 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.3 t80 -127.42 128.71 46.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.384 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.866 HG12 ' HE2' ' A' ' 119' ' ' MET . 23.8 mm -96.69 95.64 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.311 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.212 HD11 ' SD ' ' A' ' 146' ' ' MET . 16.9 mt -71.49 -35.62 70.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.0 109.851 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . 20.2 t70 -157.44 162.81 38.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.339 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 143' ' ' THR . . . 90.86 175.68 44.11 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.541 ' OG ' ' HZ ' ' A' ' 118' ' ' PHE . 41.1 t -129.37 142.98 50.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.716 0.293 . . . . 0.0 110.696 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.632 ' HA3' HG12 ' A' ' 137' ' ' VAL . . . -173.23 179.24 44.78 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.7 ' CZ ' ' OG1' ' A' ' 136' ' ' THR . 50.3 p90 -140.13 150.13 43.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.925 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 133' ' ' HIS . 3.7 t80 -110.52 141.43 43.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.993 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.564 ' HB3' ' H ' ' A' ' 134' ' ' ARG . 60.2 t0 -94.5 124.22 38.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.571 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 117' ' ' ILE . 21.8 m -128.1 154.55 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.602 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.648 ' NH2' ' CD2' ' A' ' 132' ' ' TYR . 24.0 ttp180 -123.71 143.1 50.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 55.4 t0 -99.51 156.8 16.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.466 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.533 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -60.54 -25.06 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.086 0.469 . . . . 0.0 110.48 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 46.5 tp10 -76.16 11.1 1.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.043 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 110' ' ' LYS . 83.7 m-20 62.81 42.84 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.367 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.492 ' OE1' ' CE1' ' A' ' 6' ' ' TYR . 82.3 mt-30 -120.46 149.19 42.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.092 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.642 ' CZ2' ' HD3' ' A' ' 108' ' ' ARG . 94.2 m95 -111.44 133.06 54.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.982 0.42 . . . . 0.0 111.134 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 5' ' ' TRP . 69.1 mt -121.05 134.94 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.509 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 116' ' ' ARG . 8.1 ptm180 -91.08 114.37 26.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.787 HD11 HG21 ' A' ' 107' ' ' VAL . 45.0 mt -108.38 129.63 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.678 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.541 ' HZ ' ' OG ' ' A' ' 102' ' ' SER . 74.1 t80 -94.72 128.83 41.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.913 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.866 ' HE2' HG12 ' A' ' 98' ' ' ILE . 89.0 mtp -100.43 122.55 43.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.354 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.552 ' HG2' ' N ' ' A' ' 121' ' ' LYS . 84.7 tt0 -111.61 160.2 17.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.566 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -55.48 133.39 50.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 41' ' ' LEU . . . 88.92 -12.91 64.46 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -95.22 123.46 38.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.879 0.371 . . . . 0.0 111.306 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.688 ' CE ' ' CD1' ' A' ' 39' ' ' TRP . 5.1 ttp -107.11 151.38 25.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.609 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.43 143.31 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.302 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 41.2 m -126.38 133.22 51.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.046 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.598 ' CD2' ' CG ' ' A' ' 133' ' ' HIS . 7.6 tp -115.59 113.53 42.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.918 0.39 . . . . 0.0 110.808 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.649 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 36.9 Cg_exo -52.91 141.57 55.43 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.646 2.231 . . . . 0.0 111.926 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.71 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -67.82 146.07 54.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.908 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 1.149 ' C ' HD11 ' A' ' 89' ' ' LEU . . . 98.36 3.13 57.67 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.609 ' N ' HD11 ' A' ' 89' ' ' LEU . 71.2 mt -119.57 131.61 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.732 0.301 . . . . 0.0 110.616 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.667 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 98.9 m-85 -62.09 146.05 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.201 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.655 ' HB2' ' CZ ' ' A' ' 105' ' ' PHE . 22.7 p-80 -160.42 156.44 26.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 0.0 111.247 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.643 ' NE ' ' O ' ' A' ' 85' ' ' TYR . 41.0 ttt180 -141.74 128.21 20.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.065 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.715 ' CG ' ' NH1' ' A' ' 96' ' ' ARG . 68.9 t80 -107.09 124.04 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.836 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.7 ' OG1' ' CZ ' ' A' ' 104' ' ' TYR . 16.5 p -138.06 154.36 49.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.646 ' CG1' ' O ' ' A' ' 136' ' ' THR . 17.2 m -165.05 25.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.198 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.655 ' OD2' ' N ' ' A' ' 139' ' ' GLU . 51.2 p30 -65.0 -24.64 67.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.618 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.655 ' N ' ' OD2' ' A' ' 138' ' ' ASP . 60.2 mp0 -55.17 -34.48 63.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.77 0.319 . . . . 0.0 111.175 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -100.46 -28.18 13.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.581 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 58.18 27.38 15.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.616 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -173.15 96.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.437 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.505 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 42.4 m -136.17 139.05 42.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.954 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.553 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 71.2 tttt -117.24 116.03 26.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.69 154.62 45.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.014 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' MET . . . . . 1.212 ' SD ' HD11 ' A' ' 99' ' ' LEU . 6.5 mtp -96.16 146.8 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.223 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.66 ' HB3' ' CE1' ' A' ' 149' ' ' PHE . 21.3 mmt85 -120.08 136.55 54.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.535 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.727 ' N ' HD12 ' A' ' 148' ' ' LEU . 5.8 mp -118.6 119.38 34.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.527 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 147' ' ' ARG . 96.7 m-85 -129.98 159.38 36.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.563 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.555 ' CG1' ' HD2' ' A' ' 61' ' ' TYR . 15.7 m -112.23 131.59 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.28 -162.08 41.79 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' A' ' 152' ' ' GLU . 0.1 OUTLIER -68.35 144.07 96.22 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.829 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.549 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 31.4 Cg_exo -55.46 96.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.891 2.394 . . . . 0.0 112.172 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.4 -39.33 83.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.254 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.481 ' O ' ' CE3' ' A' ' 155' ' ' TRP . 9.0 t90 -55.1 -33.22 62.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.789 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 153' ' ' PRO . 42.4 m -45.64 -43.88 12.79 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.32 101.01 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.345 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -142.0 158.45 43.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.08 179.6 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.529 ' HA ' ' CD2' ' A' ' 174' ' ' PHE . 7.9 t80 . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.936 0.398 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.68 -38.06 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.604 ' O ' ' OE1' ' A' ' 177' ' ' GLN . 56.2 mttp -55.99 -35.15 66.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.682 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.584 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 96.3 m-85 -58.2 -36.75 73.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.433 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 178' ' ' THR . 60.9 mt -61.33 -35.44 77.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.828 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.515 ' HB3' ' NE2' ' A' ' 177' ' ' GLN . . . -61.37 -41.16 96.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.695 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.604 ' OE1' ' O ' ' A' ' 173' ' ' LYS . 8.2 mp0 -64.35 -32.65 74.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.555 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 175' ' ' LEU . 10.7 m . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.574 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.735 0.302 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -80.68 134.96 35.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.324 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.685 ' CB ' HG13 ' A' ' 26' ' ' VAL . . . -148.54 137.74 21.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.818 ' CA ' HG12 ' A' ' 26' ' ' VAL . 3.5 t-105 -137.87 154.12 49.5 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.681 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.55 ' HD2' ' NH2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.7 110.52 22.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.398 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 116' ' ' ARG . 88.8 mtp . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CD2' HH11 ' A' ' 116' ' ' ARG . 73.3 m-70 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.658 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -126.0 95.63 39.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.677 ' O ' ' C ' ' A' ' 22' ' ' PRO . 60.5 Cg_endo -78.09 120.27 4.93 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.749 2.299 . . . . 0.0 111.368 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.578 ' OD2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -61.59 118.48 38.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.328 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.677 ' C ' ' O ' ' A' ' 20' ' ' PRO . 4.4 Cg_exo -77.04 125.71 12.3 Favored 'Cis proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.37 -1.512 . . . . 0.0 111.43 -1.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.76 166.09 46.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.55 ' NH2' ' HD2' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -153.17 117.41 2.82 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 121.11 0.481 . . . . 0.0 111.04 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.688 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 74.3 Cg_endo -77.42 165.67 27.09 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 123.119 2.546 . . . . 0.0 111.239 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.818 HG12 ' CA ' ' A' ' 5' ' ' TRP . 10.5 p -126.95 159.3 37.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.286 0.565 . . . . 0.0 110.884 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.581 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -128.62 172.03 19.52 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.791 HD11 ' HB2' ' A' ' 38' ' ' TYR . 22.8 tp -53.66 -36.62 62.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.656 0.265 . . . . 0.0 110.774 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -55.08 -41.34 71.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.789 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.618 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 99.4 mm-40 -64.12 -40.94 97.27 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.521 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.866 HD21 HD13 ' A' ' 115' ' ' ILE . 25.5 mt -72.61 -32.11 65.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.447 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 19.1 mmm180 -54.7 -41.77 70.66 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -70.99 -27.21 63.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.585 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.648 HD21 ' CG1' ' A' ' 107' ' ' VAL . 13.1 tp -66.47 -9.97 39.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.752 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.637 ' O ' ' CG ' ' A' ' 128' ' ' PRO . . . 95.44 13.29 52.04 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.4 t -97.78 134.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.072 0.463 . . . . 0.0 110.545 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.655 HD11 ' CE2' ' A' ' 39' ' ' TRP . 3.1 tm? -103.95 128.71 51.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.951 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.791 ' HB2' HD11 ' A' ' 28' ' ' LEU . 73.8 t80 -116.07 125.26 52.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 0.0 110.893 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.831 ' CE3' ' HE2' ' A' ' 124' ' ' MET . 1.5 m-90 -110.62 134.87 52.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.132 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 1.7 ptpt -99.37 105.3 17.25 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.772 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 43.7 mt -140.2 160.61 39.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.963 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 45' ' ' LYS . 58.5 t0 -119.79 139.28 52.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 46' ' ' TYR . . . -55.07 -43.68 74.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.122 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -66.84 -33.69 76.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.784 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.62 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 45.7 mttp -87.26 -6.0 58.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.355 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.723 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -76.72 -58.5 3.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.905 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.723 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 84.3 tt0 -70.68 -38.14 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 9.8 p-10 -74.1 -16.91 61.0 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.871 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.65 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 2.9 t0 -130.2 83.94 61.54 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.057 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 53' ' ' GLU . 77.7 Cg_exo -42.95 -8.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 123.36 2.707 . . . . 0.0 112.557 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 49' ' ' ASP . 84.2 tt0 -42.69 -34.58 0.93 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.809 HD13 ' C ' ' A' ' 52' ' ' LEU . 2.3 tm? -54.63 -41.03 69.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.562 ' OE2' ' HD3' ' A' ' 56' ' ' ARG . 46.7 tp10 -61.06 -34.83 75.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.981 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 25.1 mttm -58.49 -41.79 86.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.407 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -61.93 -33.75 59.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.658 ' NH2' ' O ' ' A' ' 62' ' ' SER . 60.2 ttt180 -54.98 -42.81 72.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.699 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -67.23 -39.14 86.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.543 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -63.59 -38.53 91.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.262 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.692 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 37.9 mmt180 -92.86 -2.18 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 110.527 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 62.33 51.08 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.15 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 1.061 ' CE1' HD12 ' A' ' 95' ' ' ILE . 57.3 m-85 -100.27 112.26 24.58 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.159 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.658 ' O ' ' NH2' ' A' ' 56' ' ' ARG . 61.2 m -83.85 -15.72 47.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.849 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.699 ' CZ2' ' OD2' ' A' ' 65' ' ' ASP . 48.2 t90 -130.65 128.02 40.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.731 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.629 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 16.7 ptm -153.56 133.2 12.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.545 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.699 ' OD2' ' CZ2' ' A' ' 63' ' ' TRP . 97.2 m-20 -145.85 172.04 13.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.527 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.516 HD11 ' OH ' ' A' ' 46' ' ' TYR . 62.7 mt -111.19 123.13 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.048 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.974 HD11 ' CD1' ' A' ' 74' ' ' LEU . 19.8 tt -133.0 148.36 31.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.627 ' OG1' ' O ' ' A' ' 143' ' ' THR . 5.1 t -127.04 148.02 50.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.186 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.711 ' N ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -83.02 107.95 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 74' ' ' LEU . 12.8 t -170.11 113.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.082 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HB3' ' CB ' ' A' ' 77' ' ' TYR . 7.4 pttm -59.87 -30.97 69.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.386 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -61.79 -40.29 94.7 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.639 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -109.66 -41.19 4.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 111.174 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.974 ' CD1' HD11 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -113.3 90.68 17.41 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.771 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.631 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 5.6 Cg_endo -51.18 166.84 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.581 2.187 . . . . 0.0 110.587 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.631 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 61.3 t-20 86.1 22.13 0.08 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.362 . . . . 0.0 110.593 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.841 ' O ' HG23 ' A' ' 81' ' ' ILE . 15.2 t80 -59.82 -40.36 88.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 59.4 mp0 -59.3 -56.04 27.21 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.531 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.654 ' O ' ' CG ' ' A' ' 83' ' ' MET . 96.9 mt-10 -73.59 -30.56 63.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.49 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 8.3 tptt -56.85 -55.53 33.22 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.569 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.841 HG23 ' O ' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -71.6 -44.71 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.759 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 20.5 mttt -57.33 -35.99 70.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.73 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -57.84 -45.05 86.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.145 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 97.6 m-85 -77.61 -27.52 51.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.566 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.806 ' HE2' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -54.09 -47.32 71.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.555 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -87.56 132.62 33.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.775 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.556 ' HG2' ' HB2' ' A' ' 134' ' ' ARG . 98.0 mt-10 -61.77 135.72 57.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.137 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -136.0 155.92 49.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.092 HD11 ' C ' ' A' ' 130' ' ' GLY . 43.9 tp -121.45 164.24 17.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.293 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.932 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 0.1 OUTLIER -168.03 142.83 3.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.237 0.541 . . . . 0.0 110.515 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.768 HD11 HG22 ' A' ' 172' ' ' VAL . 0.5 OUTLIER -65.78 -19.54 65.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.096 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 1.137 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 58.4 t0 -107.79 148.36 29.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.226 0.536 . . . . 0.0 111.36 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.62 ' OD2' ' O ' ' A' ' 127' ' ' LEU . 61.2 t0 -84.48 128.29 34.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.651 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.613 ' OE2' ' CB ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -100.95 139.49 36.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.707 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.061 HD12 ' CE1' ' A' ' 61' ' ' TYR . 67.8 mt -115.19 132.34 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.446 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -133.33 146.02 50.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.399 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 41' ' ' LEU . 1.2 t80 -127.72 127.53 43.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.97 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.87 ' N ' HD12 ' A' ' 98' ' ' ILE . 1.5 mp -93.91 99.09 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 111.0 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.588 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 19.0 mt -74.82 -34.44 62.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.482 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.573 ' HA ' ' HG3' ' A' ' 121' ' ' LYS . 58.6 t0 -146.8 -31.79 0.33 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.226 -0.59 . . . . 0.0 112.062 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.678 ' O ' ' CG2' ' A' ' 98' ' ' ILE . . . -56.57 161.83 7.06 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.609 ' HB2' ' CD ' ' A' ' 140' ' ' LYS . 66.8 m -145.95 148.7 33.06 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.184 -0.508 . . . . 0.0 109.888 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.532 ' HA3' HG12 ' A' ' 137' ' ' VAL . . . 170.92 -168.07 41.21 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.687 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.61 ' CE2' ' HD2' ' A' ' 118' ' ' PHE . 94.6 m-85 -113.91 133.22 55.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.748 0.308 . . . . 0.0 110.502 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.944 ' HZ ' HD12 ' A' ' 127' ' ' LEU . 65.5 t80 -106.7 124.96 50.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.289 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.582 ' HB3' ' H ' ' A' ' 134' ' ' ARG . 61.2 t0 -91.14 121.34 32.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.816 HG22 ' CE2' ' A' ' 105' ' ' PHE . 28.7 t -121.87 138.61 51.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.589 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.643 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 29.2 ttp180 -113.55 137.99 50.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.525 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 56.8 t0 -97.74 156.72 16.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.704 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.561 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 0.8 OUTLIER -61.49 -24.07 66.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.557 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 86.0 tt0 -77.41 11.33 2.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.319 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 111' ' ' GLU . 84.2 m-20 64.85 43.88 3.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.966 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.507 ' OE1' ' OE1' ' A' ' 111' ' ' GLU . 42.0 mt-30 -124.32 149.89 46.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.422 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.643 ' CZ3' ' HB2' ' A' ' 108' ' ' ARG . 95.1 m95 -111.71 136.15 51.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.866 HD13 HD21 ' A' ' 31' ' ' LEU . 64.3 mt -118.61 133.99 63.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.622 ' O ' HD13 ' A' ' 117' ' ' ILE . 69.6 ttt180 -90.68 111.2 22.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.645 HD11 HG22 ' A' ' 115' ' ' ILE . 16.9 mm -115.9 134.58 58.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.937 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.61 ' HD2' ' CE2' ' A' ' 104' ' ' TYR . 83.6 t80 -101.07 132.37 46.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.55 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . 21.8 mmt -95.33 117.63 30.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.39 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.596 ' O ' ' CG ' ' A' ' 123' ' ' ASP . 84.4 tt0 -108.96 150.43 27.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.177 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 18.0 tttp -51.25 128.96 23.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.254 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 41' ' ' LEU . . . 94.31 -3.38 69.21 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.604 ' OD1' ' O ' ' A' ' 123' ' ' ASP . 41.8 p-10 -95.64 119.18 33.7 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.633 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.831 ' HE2' ' CE3' ' A' ' 39' ' ' TRP . 52.8 ttp -111.52 127.15 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.228 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.06 148.15 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.991 0.424 . . . . 0.0 111.605 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.744 HG23 HG12 ' A' ' 95' ' ' ILE . 93.9 m -113.81 135.49 53.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.282 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.944 HD12 ' HZ ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -112.61 110.2 52.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.746 ' HD2' HD23 ' A' ' 127' ' ' LEU . 33.2 Cg_exo -55.97 142.16 85.33 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.942 2.428 . . . . 0.0 112.013 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 1.137 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -71.61 149.19 45.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 1.092 ' C ' HD11 ' A' ' 89' ' ' LEU . . . 101.38 -1.58 53.77 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.802 ' N ' HD11 ' A' ' 89' ' ' LEU . 69.4 mt -120.57 132.72 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.781 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.668 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 95.6 m-85 -78.29 143.96 36.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.265 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.711 ' CG ' ' CD1' ' A' ' 127' ' ' LEU . 9.0 p-80 -158.03 157.6 33.23 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.162 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.618 ' CD ' ' O ' ' A' ' 85' ' ' TYR . 21.8 ttp180 -131.56 130.66 42.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.599 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.711 ' CE1' ' CG1' ' A' ' 137' ' ' VAL . 81.3 t80 -113.76 131.21 56.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.741 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.655 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 17.6 p -127.7 153.64 46.26 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.711 ' CG1' ' CE1' ' A' ' 135' ' ' PHE . 6.0 m -165.55 18.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.212 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.665 ' OD1' ' N ' ' A' ' 139' ' ' GLU . 51.7 p30 -63.79 -25.41 68.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.627 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.665 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 49.6 mt-10 -56.28 -38.73 71.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.609 ' CD ' ' HB2' ' A' ' 102' ' ' SER . 59.7 mtpt -96.69 -7.44 34.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.616 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.0 t30 47.48 11.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.747 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 140' ' ' LYS . 45.8 t80 -150.02 120.54 7.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.466 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.627 ' O ' ' OG1' ' A' ' 68' ' ' THR . 44.1 m -134.79 132.74 39.06 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.61 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.588 ' H ' ' CA ' ' A' ' 101' ' ' GLY . 31.0 tttt -126.8 108.7 11.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.97 152.21 43.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.0 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.588 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 56.7 ttp -101.27 137.39 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.801 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.715 ' NH2' HG21 ' A' ' 67' ' ' ILE . 81.6 mtm-85 -123.35 146.6 47.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 111.158 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 148' ' ' LEU . 5.1 mp -115.37 134.39 55.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.41 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' TRP . 2.3 m-85 -152.72 161.78 42.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.756 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.29 140.22 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.402 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.23 -166.25 40.18 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 5.3 pm0 -65.73 149.61 97.21 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.473 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.642 ' O ' ' CG2' ' A' ' 156' ' ' THR . 35.2 Cg_exo -53.15 125.75 19.36 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.721 2.28 . . . . 0.0 112.035 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 155' ' ' TRP . 5.6 p -92.41 -43.95 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.514 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.73 ' CZ2' ' CB ' ' A' ' 83' ' ' MET . 3.3 t90 -57.44 -36.47 71.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.619 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.642 ' CG2' ' O ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -36.92 -53.84 0.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.471 ' H ' HG23 ' A' ' 156' ' ' THR . . . -147.07 101.75 3.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.304 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -134.51 158.71 43.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.407 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.098 179.635 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.434 ' N ' ' CD2' ' A' ' 171' ' ' TYR . 13.8 m-30 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.772 0.32 . . . . 0.0 110.569 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.768 HG22 HD11 ' A' ' 91' ' ' LEU . 71.4 t -60.7 -39.79 82.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.615 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.57 -34.85 71.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.627 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -56.61 -41.58 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.522 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.673 ' N ' ' CD2' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -60.92 -35.33 76.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.571 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.74 -32.78 73.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.562 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.75 -32.64 74.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.519 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.5 m . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.585 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 14.7 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.758 0.313 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.719 ' NE2' ' CD2' ' A' ' 118' ' ' PHE . 15.4 tt0 -100.18 114.7 28.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.878 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 1.161 ' HB3' ' CG1' ' A' ' 26' ' ' VAL . . . -164.3 171.82 14.35 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.758 ' O ' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -121.24 142.15 50.19 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.659 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.581 ' CE1' ' OE1' ' A' ' 30' ' ' GLN . 22.8 t80 -104.42 68.58 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.463 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.591 ' HB2' ' O ' ' A' ' 114' ' ' TRP . 87.8 mtp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.753 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.5 m80 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.615 0.245 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.565 ' CD ' ' HZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -121.88 96.2 47.13 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.467 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.636 ' O ' ' C ' ' A' ' 22' ' ' PRO . 36.2 Cg_endo -68.88 125.41 12.57 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.557 2.171 . . . . 0.0 111.18 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -63.41 118.53 44.85 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.809 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.636 ' C ' ' O ' ' A' ' 20' ' ' PRO . 1.6 Cg_endo -81.71 143.67 57.91 Favored 'Cis proline' 0 C--N 1.309 -1.537 0 C-N-CA 123.615 -1.41 . . . . 0.0 111.966 -0.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.56 161.06 43.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -133.58 117.54 14.29 Favored Pre-proline 0 C--N 1.332 -0.183 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.131 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.38 157.31 61.58 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 123.058 2.506 . . . . 0.0 111.467 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.161 ' CG1' ' HB3' ' A' ' 4' ' ' ALA . 1.7 p -57.37 142.61 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.761 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 30' ' ' GLN . . . -82.89 100.41 2.2 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.601 ' HB2' ' CG1' ' A' ' 2' ' ' VAL . 21.4 tp -47.15 -43.12 20.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.725 0.298 . . . . 0.0 110.317 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.8 -35.34 80.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.021 0.439 . . . . 0.0 109.946 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.784 ' O ' HD13 ' A' ' 34' ' ' LEU . 93.5 mt-30 -61.38 -41.73 97.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.097 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 34' ' ' LEU . 10.3 mt -69.49 -34.41 74.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.43 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -42.12 65.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 33' ' ' ARG . 19.9 ttp180 -64.8 -31.21 72.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.018 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 30' ' ' GLN . 10.3 mp -65.3 -18.13 65.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.026 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.88 23.13 11.03 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.28 132.24 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 0.0 110.742 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 55.3 mt -108.75 141.21 41.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.633 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -118.01 123.55 45.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.623 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.859 ' HZ3' ' HG1' ' A' ' 126' ' ' THR . 2.3 m-90 -121.23 132.3 54.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.179 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -105.84 104.98 14.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.062 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.634 ' C ' ' OH ' ' A' ' 97' ' ' TYR . 1.3 mp -140.58 153.34 46.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.95 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 46' ' ' TYR . 85.9 m-20 -102.92 133.07 48.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.532 ' O ' ' HD1' ' A' ' 46' ' ' TYR . . . -49.52 -43.98 45.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.69 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.683 ' OD2' ' N ' ' A' ' 45' ' ' LYS . 56.6 p30 -65.79 -31.6 72.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.673 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.683 ' N ' ' OD2' ' A' ' 44' ' ' ASP . 12.0 ttmm -85.38 -19.39 31.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.268 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.721 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -61.56 -56.48 19.47 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.822 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.721 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 84.9 tt0 -72.01 -40.86 68.18 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.584 -0.446 . . . . 0.0 109.984 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.618 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 17.8 m120 -66.77 -22.92 66.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.806 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.659 ' O ' ' N ' ' A' ' 51' ' ' GLU . 23.4 t0 -124.32 84.64 56.09 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.305 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 53' ' ' GLU . 75.0 Cg_exo -41.05 -8.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.59 2.86 . . . . 0.0 112.584 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 49' ' ' ASP . 12.4 tm-20 -41.87 -32.53 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -54.28 -41.03 68.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 96.9 mt-10 -60.97 -35.89 77.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.266 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -59.64 -44.73 93.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.949 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.0 mt -62.01 -32.82 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.654 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . 27.2 ttt180 -55.74 -42.02 74.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.702 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -61.42 -41.46 97.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.779 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -67.48 -44.79 77.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.536 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.642 HH12 HG21 ' A' ' 126' ' ' THR . 46.7 mtp85 -76.38 -19.48 58.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.534 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 56' ' ' ARG . 14.5 t-20 60.34 44.5 12.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.932 ' HA ' HG22 ' A' ' 150' ' ' VAL . 4.2 p90 -112.0 126.15 54.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.094 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.572 ' C ' HH21 ' A' ' 56' ' ' ARG . 51.8 p -94.51 0.2 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.311 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.772 ' CE3' ' CE2' ' A' ' 149' ' ' PHE . 49.1 t90 -123.35 133.39 54.13 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.72 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.659 ' HB3' HD22 ' A' ' 148' ' ' LEU . 8.6 ptm -154.49 145.37 22.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.256 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.589 ' HB3' ' CH2' ' A' ' 63' ' ' TRP . 49.9 t0 -159.27 162.9 36.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 0.0 110.83 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.504 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 65.7 mt -114.06 127.96 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.505 HG12 ' N ' ' A' ' 68' ' ' THR . 5.3 tt -130.69 154.37 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 111.496 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.626 HG23 ' HG2' ' A' ' 144' ' ' LYS . 42.0 m -117.02 142.14 47.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.331 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.615 ' C ' ' SG ' ' A' ' 70' ' ' CYS . 2.2 mt -104.22 125.71 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.147 0.499 . . . . 0.0 111.168 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.615 ' SG ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -171.12 128.27 0.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.459 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -57.32 -46.03 83.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.889 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -67.72 -40.83 84.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.848 0.356 . . . . 0.0 111.033 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 70' ' ' CYS . 30.5 tttt -69.51 -41.22 76.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.034 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.741 HD23 ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -133.47 87.41 37.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.777 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 74' ' ' LEU . 72.3 Cg_exo -41.01 176.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.22 1.947 . . . . 0.0 110.418 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.662 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 59.5 t-20 69.94 36.48 1.98 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.322 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.649 ' CE2' HG13 ' A' ' 81' ' ' ILE . 24.2 t80 -65.33 -51.45 60.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.567 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.647 ' O ' ' CD ' ' A' ' 82' ' ' LYS . 97.0 mt-10 -69.35 -46.97 65.74 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.662 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 98.7 mt-10 -65.17 -42.26 93.88 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.443 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.657 ' HE3' ' CE2' ' A' ' 155' ' ' TRP . 14.4 tptt -71.71 -45.73 60.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.15 0.5 . . . . 0.0 109.933 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.916 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 14.1 mm -61.56 -58.13 8.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.799 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.647 ' CD ' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -54.21 -32.64 56.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.488 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.63 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 76.8 mmm -59.47 -61.15 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.254 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.916 ' CZ ' HD13 ' A' ' 81' ' ' ILE . 46.0 p90 -86.96 -16.31 36.21 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.695 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.673 ' CB ' ' O ' ' A' ' 81' ' ' ILE . 19.9 t80 -61.92 -46.26 90.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.14 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -65.47 142.49 58.14 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.231 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.6 139.47 31.7 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.149 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -164.79 170.36 15.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.032 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -133.08 171.83 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.529 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.631 ' HE1' ' CD2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -170.41 154.68 4.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.673 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.563 HD11 ' HG3' ' A' ' 173' ' ' LYS . 0.3 OUTLIER -74.55 5.05 5.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.916 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 49.7 p30 -108.98 152.2 25.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.474 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.607 ' OD2' ' O ' ' A' ' 93' ' ' ASP . 50.1 p30 -81.76 146.96 29.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.653 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.556 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 7.3 mm-40 -105.88 116.07 31.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.826 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.016 HD13 ' OG1' ' A' ' 126' ' ' THR . 6.3 tp -127.78 119.95 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.353 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.53 ' HE ' ' HB3' ' A' ' 145' ' ' ALA . 63.4 ttt180 -134.65 137.41 43.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.478 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.933 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.6 t80 -114.61 129.02 56.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.179 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.711 HG22 ' HA ' ' A' ' 121' ' ' LYS . 20.0 mm -86.08 99.87 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.423 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 97' ' ' TYR . 1.7 mt -82.81 -43.87 16.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.893 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.625 ' OD2' ' O ' ' A' ' 99' ' ' LEU . 91.3 m-20 -144.88 -21.08 0.51 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.896 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.659 ' O ' ' CG2' ' A' ' 98' ' ' ILE . . . -82.8 -176.7 51.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.525 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 49.0 m -151.23 158.05 43.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.547 ' C ' ' CD2' ' A' ' 104' ' ' TYR . . . 176.45 178.37 46.17 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.287 -0.958 . . . . 0.0 111.694 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.765 ' CE2' ' CD1' ' A' ' 118' ' ' PHE . 2.8 m-85 -124.32 140.4 52.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.613 0.244 . . . . 0.0 110.384 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.771 ' CD1' ' SD ' ' A' ' 119' ' ' MET . 18.5 m-30 -109.09 128.92 55.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 110.723 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.699 ' OD1' ' CE3' ' A' ' 114' ' ' TRP . 23.8 t70 -93.6 121.32 34.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.472 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.542 ' CG1' HD11 ' A' ' 117' ' ' ILE . 13.0 p -131.85 145.92 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.626 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.657 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 20.8 ttp180 -116.81 143.2 45.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 110.749 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD2' ' C ' ' A' ' 109' ' ' ASP . 49.3 p30 -101.55 174.41 5.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.423 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.98 -31.66 65.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.046 0.451 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 112' ' ' ASP . 84.5 tt0 -59.81 -9.14 2.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.105 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 111' ' ' GLU . 85.2 m-20 69.33 38.36 1.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.473 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.591 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 95.5 mm-40 -120.62 154.39 35.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.87 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.699 ' CE3' ' OD1' ' A' ' 106' ' ' ASP . 98.6 m95 -104.25 137.23 42.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.17 0.51 . . . . 0.0 111.387 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.758 HG23 ' O ' ' A' ' 5' ' ' TRP . 72.3 mt -119.07 134.19 63.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.981 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.556 ' NH2' ' HD1' ' A' ' 104' ' ' TYR . 13.5 tpt180 -90.49 124.67 35.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.917 HG22 ' HE3' ' A' ' 119' ' ' MET . 21.9 mt -113.33 134.18 56.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.878 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.765 ' CD1' ' CE2' ' A' ' 104' ' ' TYR . 65.1 t80 -101.48 129.87 47.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.953 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.917 ' HE3' HG22 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -115.13 123.9 50.13 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.446 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 123' ' ' ASP . 12.7 pt-20 -102.75 169.99 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.568 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.711 ' HA ' HG22 ' A' ' 98' ' ' ILE . 18.3 ptpt -64.79 123.7 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.953 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 95.93 -1.94 63.66 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.577 ' O ' HG12 ' A' ' 98' ' ' ILE . 60.2 t0 -93.89 119.96 33.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 0.0 111.007 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.66 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . 21.7 ttt -108.52 132.4 53.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.304 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 14.8 p -135.65 146.53 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 110.83 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . 1.016 ' OG1' HD13 ' A' ' 95' ' ' ILE . 42.1 m -119.72 139.37 52.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.336 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.933 HD22 ' HB2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -114.71 143.36 29.86 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.005 0.431 . . . . 0.0 110.841 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.599 ' CG ' HD12 ' A' ' 131' ' ' ILE . 32.4 Cg_endo -66.65 154.39 74.59 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.053 2.502 . . . . 0.0 112.238 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.524 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -94.14 138.95 31.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.586 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.62 -0.18 61.11 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.599 HD12 ' CG ' ' A' ' 128' ' ' PRO . 70.6 mt -116.82 142.38 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.684 0.278 . . . . 0.0 110.277 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.699 ' CD2' HD21 ' A' ' 89' ' ' LEU . 99.7 m-85 -52.2 131.94 33.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.419 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.933 ' HB2' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -156.09 134.57 11.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.449 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 85' ' ' TYR . 23.3 ttp180 -139.81 136.81 34.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.871 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.66 ' CD2' ' CD2' ' A' ' 105' ' ' PHE . 21.6 m-30 -112.68 134.07 54.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.351 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 56.9 m -126.6 136.28 52.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.926 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.3 m -147.83 6.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.189 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.621 ' O ' ' OD1' ' A' ' 141' ' ' ASN . 22.2 t70 -55.65 -38.23 69.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.398 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.48 -42.6 96.63 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.227 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 102' ' ' SER . 10.6 mmtm -66.59 -33.23 75.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.725 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.621 ' OD1' ' O ' ' A' ' 138' ' ' ASP . 87.5 m-20 68.32 -10.99 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.616 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.49 ' H ' ' C ' ' A' ' 140' ' ' LYS . 49.4 t80 -151.55 117.38 5.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.367 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.569 HG23 ' HA3' ' A' ' 101' ' ' GLY . 46.4 m -136.22 127.25 27.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.874 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.626 ' HG2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -117.54 103.1 9.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.933 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.82 154.58 45.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.596 ' SD ' ' HE3' ' A' ' 64' ' ' MET . 0.1 OUTLIER -97.48 143.14 28.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.618 ' NH2' ' CD2' ' A' ' 149' ' ' PHE . 67.5 ttp85 -115.61 140.69 48.94 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.819 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.835 HD13 ' CE1' ' A' ' 61' ' ' TYR . 48.2 mt -118.57 134.26 55.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.721 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.772 ' CE2' ' CE3' ' A' ' 63' ' ' TRP . 6.3 p90 -149.8 160.46 43.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.374 . . . . 0.0 110.597 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.932 HG22 ' HA ' ' A' ' 61' ' ' TYR . 31.1 t -115.87 130.69 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.1 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.433 ' O ' ' CE1' ' A' ' 149' ' ' PHE . . . 80.08 -164.17 47.84 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 153' ' ' PRO . 2.4 pt-20 -73.11 126.45 90.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.452 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 149' ' ' PHE . 25.1 Cg_exo -58.94 124.23 15.25 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.79 2.327 . . . . 0.0 112.295 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.4 -34.13 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.447 . . . . 0.0 109.973 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' ' CE3' ' A' ' 155' ' ' TRP . 1.7 t-105 -58.94 -29.95 67.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.759 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.567 ' OG1' ' HB2' ' A' ' 153' ' ' PRO . 38.3 m -44.49 -46.31 9.66 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.291 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.93 100.89 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.453 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.69 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -157.0 166.64 32.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.709 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.594 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 86.7 m-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.994 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.782 0.325 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.1 p -54.84 -34.58 31.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.416 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.563 ' HG3' HD11 ' A' ' 91' ' ' LEU . 47.2 mttt -58.22 -35.1 71.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.509 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.34 -41.19 75.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.754 ' O ' HG22 ' A' ' 178' ' ' THR . 0.2 OUTLIER -61.28 -35.07 76.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.505 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.02 72.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.603 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -63.83 -32.95 74.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.754 HG22 ' O ' ' A' ' 175' ' ' LEU . 1.7 t . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.584 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.856 ' HB ' HD12 ' A' ' 28' ' ' LEU . 14.6 p . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.801 0.334 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -102.72 115.77 31.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 1.111 ' HB3' ' CG1' ' A' ' 26' ' ' VAL . . . -163.88 155.96 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.758 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.637 ' CZ3' ' HB3' ' A' ' 25' ' ' PRO . 0.9 OUTLIER -128.24 141.22 51.52 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.191 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.931 ' CE1' HD11 ' A' ' 115' ' ' ILE . 2.1 t80 -96.13 -6.01 39.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.11 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.597 ' CE ' ' HG3' ' A' ' 20' ' ' PRO . 85.4 mmm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.265 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.553 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.146 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.423 ' HA ' ' HE1' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -61.81 107.42 1.13 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.854 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.68 ' O ' ' N ' ' A' ' 23' ' ' GLY . 35.1 Cg_endo -68.0 159.45 52.93 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.864 2.376 . . . . 0.0 111.62 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -112.27 107.39 55.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.697 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 21' ' ' ASP . 63.2 Cg_endo -78.11 150.02 88.1 Favored 'Cis proline' 0 C--N 1.309 -1.55 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.355 -0.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -95.85 173.49 30.73 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -152.91 117.65 2.89 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 111.08 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.637 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 55.7 Cg_endo -74.11 152.8 45.98 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.158 2.572 . . . . 0.0 111.756 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.111 ' CG1' ' HB3' ' A' ' 4' ' ' ALA . 1.3 p -58.66 144.75 11.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 30' ' ' GLN . . . -94.69 104.56 3.16 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.856 HD12 ' HB ' ' A' ' 2' ' ' VAL . 8.4 tt -45.27 -44.29 11.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.73 -34.55 77.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 27' ' ' GLY . 50.3 tt0 -61.89 -40.85 96.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.264 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.796 HD11 ' CG2' ' A' ' 26' ' ' VAL . 9.0 mp -63.39 -39.41 94.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.636 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.754 ' NH1' HD22 ' A' ' 37' ' ' LEU . 54.2 ttt85 -57.23 -44.05 83.43 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.521 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -75.17 -30.51 60.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.627 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 34' ' ' LEU . 30.8 tp -68.73 -7.24 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.127 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.561 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . 102.65 -0.3 49.25 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 32' ' ' ARG . 93.1 t -101.8 126.56 55.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.362 . . . . 0.0 110.557 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.754 HD22 ' NH1' ' A' ' 32' ' ' ARG . 79.8 mt -111.53 147.56 35.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.605 ' CD2' ' HE2' ' A' ' 40' ' ' LYS . 32.8 t80 -114.22 124.28 51.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.142 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.683 ' CZ3' ' OG1' ' A' ' 126' ' ' THR . 1.5 m0 -113.1 138.63 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.757 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.605 ' HE2' ' CD2' ' A' ' 38' ' ' TYR . 61.8 mmtt -98.65 105.92 18.12 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.888 HD13 ' HE1' ' A' ' 46' ' ' TYR . 31.8 mt -138.27 139.11 39.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.207 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 46' ' ' TYR . 87.6 m-20 -108.46 128.72 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 99' ' ' LEU . . . -50.36 -42.8 53.77 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.956 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.14 -33.69 76.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.573 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 49' ' ' ASP . 2.2 mtpt -88.07 -17.53 30.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.001 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.888 ' HE1' HD13 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -58.55 -49.1 78.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.764 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -82.8 -44.18 15.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.057 0.456 . . . . 0.0 109.927 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -66.78 -23.38 66.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.612 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 45' ' ' LYS . 1.9 t0 -127.18 84.34 63.7 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.567 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.7 Cg_endo -49.47 -8.69 0.1 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 123.083 2.522 . . . . 0.0 111.288 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 49' ' ' ASP . 84.5 tt0 -43.81 -35.96 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.47 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.052 HD13 ' H ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -59.17 -33.31 70.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.374 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 1.052 ' H ' HD13 ' A' ' 52' ' ' LEU . 1.5 tp10 -64.74 -35.82 82.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.925 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -58.64 -40.18 82.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.069 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.89 -44.47 90.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.667 ' NE ' ' O ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -66.62 -36.47 82.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.439 179.332 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.625 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 70.3 ttp85 -62.52 -42.78 99.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.297 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.18 -35.62 80.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.614 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -85.03 0.33 51.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.429 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 60.49 42.3 14.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.181 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.68 ' CZ ' ' HB3' ' A' ' 59' ' ' ARG . 19.3 m-85 -80.22 122.67 27.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.971 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.26 -31.74 12.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.203 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.708 ' CH2' ' CG ' ' A' ' 65' ' ' ASP . 37.7 t90 -113.07 121.47 44.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 111.3 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.816 ' SD ' HD23 ' A' ' 148' ' ' LEU . 83.4 mmm -146.61 139.48 25.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.523 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.708 ' CG ' ' CH2' ' A' ' 63' ' ' TRP . 21.1 p30 -163.13 165.04 25.04 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.841 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.759 HD13 HD22 ' A' ' 99' ' ' LEU . 65.8 mt -115.17 131.8 66.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.267 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.673 ' CG2' ' NH1' ' A' ' 147' ' ' ARG . 10.7 tp -129.15 158.87 41.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.403 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 144' ' ' LYS . 5.5 t -123.55 153.15 41.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.533 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.733 HG21 HG21 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -104.09 103.48 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.433 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 72' ' ' ASP . 20.9 t -172.06 110.18 0.26 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 77' ' ' TYR . 0.8 OUTLIER -58.65 -35.32 72.36 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.295 -179.299 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 90.3 m-20 -59.19 -39.42 82.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.444 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -97.36 -41.29 8.31 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.313 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -123.95 85.69 54.05 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.99 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.591 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 2.7 Cg_exo -40.74 172.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.451 2.1 . . . . 0.0 110.316 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.643 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 62.6 t-20 72.4 29.53 2.13 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.358 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.918 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.6 t80 -64.23 -45.83 86.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.58 ' O ' HG13 ' A' ' 81' ' ' ILE . 20.1 pt-20 -71.44 -47.52 55.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.643 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 98.2 mt-10 -66.78 -40.12 88.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.386 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.538 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 57.4 tttp -67.99 -47.75 67.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.557 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.092 HD13 ' CE1' ' A' ' 85' ' ' TYR . 2.7 pp -67.4 -42.41 87.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.568 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.81 ' N ' HD12 ' A' ' 81' ' ' ILE . 55.4 tttp -55.87 -39.57 71.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.132 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.593 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 61.8 mtt -59.78 -44.25 94.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.94 0.4 . . . . 0.0 110.695 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.672 ' CE2' ' CZ2' ' A' ' 155' ' ' TRP . 95.5 m-85 -73.51 -33.57 64.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.615 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 1.092 ' CE1' HD13 ' A' ' 81' ' ' ILE . 11.4 m-30 -60.04 -45.66 92.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.542 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 83' ' ' MET . 20.4 pt-20 -64.66 129.74 40.95 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.329 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.633 ' OE2' ' CH2' ' A' ' 114' ' ' TRP . 96.1 mt-10 -63.61 137.9 58.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.552 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.666 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.5 OUTLIER -150.91 171.94 16.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.452 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.171 HD22 ' CE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.81 -179.91 5.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.273 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.939 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -170.71 146.48 2.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 179.628 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 91' ' ' LEU . 6.3 mp -65.82 -24.77 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.329 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.581 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 48.6 p30 -108.22 150.54 27.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 111.261 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.747 ' OD2' HG22 ' A' ' 126' ' ' THR . 49.2 t0 -84.32 128.9 34.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.967 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.631 ' OE2' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -107.93 140.38 41.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.87 0.367 . . . . 0.0 110.667 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.826 HD12 ' HE3' ' A' ' 124' ' ' MET . 15.3 pt -113.75 133.2 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.478 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.728 ' NH1' ' CZ ' ' A' ' 105' ' ' PHE . 42.3 ttm180 -123.27 138.89 54.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.382 . . . . 0.0 110.686 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.687 ' CD2' ' CZ ' ' A' ' 46' ' ' TYR . 17.5 t80 -118.49 129.84 55.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.474 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.825 HG12 ' HE2' ' A' ' 119' ' ' MET . 11.4 mm -91.14 94.22 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.169 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.759 HD22 HD13 ' A' ' 66' ' ' ILE . 12.8 tp -80.15 -33.21 38.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.524 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.684 ' CG ' ' N ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -66.53 -68.64 0.36 Allowed 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.633 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.684 ' N ' ' CG ' ' A' ' 100' ' ' ASP . . . 157.86 -28.11 0.47 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.517 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 1.122 ' O ' HG23 ' A' ' 143' ' ' THR . 97.1 p -113.64 141.72 46.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.681 0.741 . . . . 0.0 111.237 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.546 ' HA2' ' CZ ' ' A' ' 135' ' ' PHE . . . -173.75 125.41 1.12 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.561 ' OH ' ' HG3' ' A' ' 116' ' ' ARG . 81.1 t80 -115.89 131.29 56.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.727 0.298 . . . . 0.0 110.815 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.728 ' CZ ' ' NH1' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -137.73 157.01 47.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.707 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.572 ' OD1' ' HG2' ' A' ' 134' ' ' ARG . 49.5 p30 -144.88 151.27 38.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.358 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.61 141.96 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.967 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.651 ' HB2' ' CH2' ' A' ' 114' ' ' TRP . 38.2 ttt180 -106.4 137.35 44.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.406 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 56.7 t0 -103.35 156.56 17.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.552 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 26.6 mttp -59.28 -30.74 68.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.058 0.456 . . . . 0.0 110.328 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.626 ' O ' ' OD2' ' A' ' 112' ' ' ASP . 96.0 mt-10 -68.99 -0.63 5.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.214 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.648 ' OD2' ' C ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER 76.62 32.09 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.52 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.484 ' OE1' ' OE1' ' A' ' 111' ' ' GLU . 41.5 mt-30 -110.19 146.0 36.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.046 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.651 ' CH2' ' HB2' ' A' ' 108' ' ' ARG . 82.7 m95 -113.66 139.54 48.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.969 0.414 . . . . 0.0 111.175 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.931 HD11 ' CE1' ' A' ' 6' ' ' TYR . 60.5 mt -114.14 125.19 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.224 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 71.6 ttp85 -93.3 114.1 26.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.24 128.3 73.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.602 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.48 ' CE2' ' OE2' ' A' ' 139' ' ' GLU . 67.8 t80 -103.33 131.04 50.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.267 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.825 ' HE2' HG12 ' A' ' 98' ' ' ILE . 88.4 mtp -100.11 127.57 46.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.627 ' OE2' ' OD2' ' A' ' 123' ' ' ASP . 3.6 mp0 -110.76 159.65 17.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 0.0 110.76 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.629 ' CA ' ' HA2' ' A' ' 101' ' ' GLY . 8.0 pttm -45.67 121.2 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.143 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.656 ' CA ' ' O ' ' A' ' 41' ' ' LEU . . . 89.25 6.56 71.09 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.774 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.627 ' OD2' ' OE2' ' A' ' 120' ' ' GLU . 87.4 m-20 -92.18 119.46 31.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.826 ' HE3' HD12 ' A' ' 95' ' ' ILE . 1.2 tpt -113.88 129.78 56.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.182 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 37' ' ' LEU . 12.6 p -134.28 144.68 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.836 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.747 HG22 ' OD2' ' A' ' 93' ' ' ASP . 82.8 m -105.51 132.7 51.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.043 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.625 HD22 ' CE1' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -102.49 122.68 45.52 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.9 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.61 ' HG2' HD12 ' A' ' 131' ' ' ILE . 20.7 Cg_endo -63.89 144.51 88.48 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.954 2.436 . . . . 0.0 112.107 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.939 ' HB1' ' O ' ' A' ' 90' ' ' HIS . . . -75.9 142.33 42.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.058 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.12 11.3 61.48 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 128' ' ' PRO . 1.2 mt -115.47 148.78 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.766 0.317 . . . . 0.0 110.716 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 1.171 ' CE2' HD22 ' A' ' 89' ' ' LEU . 7.8 m-30 -94.75 131.31 40.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.179 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.63 ' HE1' ' CE1' ' A' ' 90' ' ' HIS . 20.0 p-80 -154.64 167.74 29.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.58 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.572 ' HG2' ' OD1' ' A' ' 106' ' ' ASP . 16.1 ptp180 -149.41 150.78 32.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.632 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.69 ' O ' ' CD2' ' A' ' 85' ' ' TYR . 68.8 t80 -114.42 132.41 56.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 138' ' ' ASP . 46.5 m -125.54 137.11 53.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.023 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.759 HG22 ' OH ' ' A' ' 85' ' ' TYR . 15.3 m -117.77 12.0 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.594 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.657 ' H ' HG22 ' A' ' 136' ' ' THR . 56.3 t0 -57.61 -23.19 49.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.151 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.592 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 84.4 tt0 -44.71 -34.77 2.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.289 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 19.6 mtpt -159.95 4.28 0.08 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 58.71 33.27 22.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.902 0.382 . . . . 0.0 110.555 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.473 ' O ' ' OG ' ' A' ' 102' ' ' SER . 62.3 t80 -151.99 97.65 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.178 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 1.122 HG23 ' O ' ' A' ' 102' ' ' SER . 53.3 m -135.25 130.76 35.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.386 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.639 ' HB3' ' CB ' ' A' ' 100' ' ' ASP . 29.3 tttt -130.43 117.16 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.656 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.51 156.88 45.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.704 ' SD ' ' HE3' ' A' ' 64' ' ' MET . 44.2 ttm -92.19 135.17 34.21 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.673 ' NH1' ' CG2' ' A' ' 67' ' ' ILE . 50.2 mtm-85 -111.27 149.23 31.34 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.084 0.469 . . . . 0.0 111.256 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.946 HD13 ' C ' ' A' ' 148' ' ' LEU . 1.8 tm? -119.92 119.32 33.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.862 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.658 ' N ' HD22 ' A' ' 148' ' ' LEU . 98.1 m-85 -129.8 153.55 48.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.984 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.48 129.86 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.074 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.32 -159.43 38.99 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.47 148.37 98.1 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 110.633 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.69 ' HB2' HG23 ' A' ' 156' ' ' THR . 38.0 Cg_endo -69.51 95.25 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.884 2.39 . . . . 0.0 112.294 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.32 -27.41 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.688 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.672 ' CZ2' ' CE2' ' A' ' 84' ' ' PHE . 43.6 t90 -56.3 -34.05 66.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.69 HG23 ' HB2' ' A' ' 153' ' ' PRO . 53.7 p -46.32 -43.83 16.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.56 100.55 3.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.25 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CD2' ' O ' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -151.12 159.99 44.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.67 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.98 179.166 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.6 t80 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.824 0.345 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 73.2 t -58.26 -38.98 71.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.602 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.589 ' HD2' ' CD2' ' A' ' 91' ' ' LEU . 60.5 mtpt -57.75 -34.89 70.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.678 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -56.72 -41.33 77.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.499 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.0 tp -57.26 -37.68 72.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.632 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.34 72.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.655 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -63.59 -33.06 74.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.527 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.019 ' HB ' HD12 ' A' ' 28' ' ' LEU . 10.5 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.733 0.301 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.567 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 13.2 mm-40 -94.25 114.58 26.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.497 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 1.158 ' HB3' ' CG1' ' A' ' 26' ' ' VAL . . . -163.55 162.7 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.891 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.519 ' HE3' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -126.95 148.21 50.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.064 0.459 . . . . 0.0 111.685 -178.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.599 ' CE2' HG12 ' A' ' 115' ' ' ILE . 1.2 t80 -108.71 77.29 1.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.238 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.1 ptm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.566 -178.49 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 35.3 m80 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.91 0.386 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.493 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -89.48 100.56 2.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.253 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.629 ' O ' ' C ' ' A' ' 22' ' ' PRO . 16.1 Cg_endo -60.91 153.68 61.7 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.608 2.205 . . . . 0.0 111.73 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -105.55 112.31 64.71 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.622 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.629 ' C ' ' O ' ' A' ' 20' ' ' PRO . 37.8 Cg_endo -73.33 156.76 99.5 Favored 'Cis proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.144 -1.607 . . . . 0.0 112.348 -0.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 20' ' ' PRO . . . -68.57 143.64 40.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HG3' ' HG2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -152.71 121.05 3.18 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.222 0.534 . . . . 0.0 111.225 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.73 156.32 63.74 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.161 2.574 . . . . 0.0 111.327 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.158 ' CG1' ' HB3' ' A' ' 4' ' ' ALA . 1.2 p -57.33 144.7 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.54 103.02 2.92 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.019 HD12 ' HB ' ' A' ' 2' ' ' VAL . 9.2 tt -48.64 -40.34 27.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.809 0.337 . . . . 0.0 110.348 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -59.37 -36.98 76.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.168 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.574 ' OE1' ' HA ' ' A' ' 30' ' ' GLN . 15.1 mm-40 -61.33 -43.59 98.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.693 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.59 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 18.2 mt -71.77 -34.54 69.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.22 -43.11 70.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.286 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.544 ' CG ' HH11 ' A' ' 33' ' ' ARG . 2.6 ttt-85 -65.29 -31.05 71.99 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.59 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 28.2 tp -65.13 -18.55 65.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.888 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.553 ' O ' ' HG3' ' A' ' 128' ' ' PRO . . . 102.83 17.24 19.44 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.51 128.97 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.263 0.554 . . . . 0.0 110.979 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 126' ' ' THR . 35.5 mt -123.89 143.0 50.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.15 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.814 ' CE1' HD11 ' A' ' 28' ' ' LEU . 30.6 p90 -144.46 150.97 38.52 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.871 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.6 ' HB2' ' CB ' ' A' ' 124' ' ' MET . 24.3 m-90 -123.13 141.21 52.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.575 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.442 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 4.1 ttpm? -99.37 104.42 16.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.898 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.666 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 1.1 mt -141.32 150.83 43.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.288 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.639 ' OD1' ' NZ ' ' A' ' 45' ' ' LYS . 84.4 m-20 -102.23 132.54 48.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.545 ' HB2' ' CA ' ' A' ' 99' ' ' LEU . . . -47.09 -44.1 20.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.16 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -62.57 -33.22 74.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.738 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.639 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 18.0 mttp -86.6 -8.18 57.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.319 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.692 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -71.42 -56.09 6.63 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.692 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 48.8 tp10 -76.09 -42.23 47.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.555 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.482 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -66.85 -23.51 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.633 ' CB ' ' O ' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -124.02 85.29 54.51 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.829 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.1 Cg_endo -44.06 -9.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.395 2.73 . . . . 0.0 112.008 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.644 ' HG3' ' NZ ' ' A' ' 54' ' ' LYS . 83.7 tt0 -42.9 -35.55 1.24 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.458 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.877 HD13 ' C ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -57.31 -38.23 73.71 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.662 ' N ' HD13 ' A' ' 52' ' ' LEU . 84.0 tt0 -59.51 -34.35 72.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.709 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.644 ' NZ ' ' HG3' ' A' ' 51' ' ' GLU . 7.8 ttpm? -57.28 -45.44 84.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.768 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.2 mt -62.19 -39.87 85.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.629 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 64' ' ' MET . 69.4 ttt180 -60.84 -44.29 97.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.336 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -64.29 -42.06 96.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.537 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -62.95 -41.07 99.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.643 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.729 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 38.5 mmt180 -82.97 -12.02 57.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.019 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 65.4 50.12 1.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.866 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.729 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 25.9 m-85 -99.48 115.53 29.53 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.117 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.549 ' C ' HH21 ' A' ' 56' ' ' ARG . 59.9 p -88.04 -16.9 32.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.218 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.694 ' CH2' ' HB2' ' A' ' 65' ' ' ASP . 1.6 t-105 -114.07 110.6 20.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.002 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.646 ' CE ' HD11 ' A' ' 52' ' ' LEU . 25.0 ttt -146.15 138.23 25.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.35 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.694 ' HB2' ' CH2' ' A' ' 63' ' ' TRP . 21.9 t70 -159.98 179.21 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.583 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.544 ' HA ' ' HG2' ' A' ' 146' ' ' MET . 52.8 mt -106.85 126.2 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 mm -117.15 135.6 57.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.337 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.517 ' OG1' ' HG3' ' A' ' 144' ' ' LYS . 47.6 m -125.43 141.18 52.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.656 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 142' ' ' TYR . 45.8 mt -109.74 122.03 63.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.199 0.524 . . . . 0.0 111.128 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.663 ' O ' ' N ' ' A' ' 74' ' ' LEU . 1.1 t -164.63 118.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.612 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -57.4 -42.79 82.94 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.093 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -62.94 -40.3 97.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.738 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -105.2 1.65 28.42 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.427 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.961 HD21 ' HD3' ' A' ' 80' ' ' LYS . 0.7 OUTLIER -130.25 83.08 64.04 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.838 0.351 . . . . 0.0 111.227 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.593 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 14.1 Cg_endo -59.23 161.37 16.68 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.194 1.929 . . . . 0.0 109.607 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 56.7 t-20 70.86 38.03 1.23 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.169 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.66 ' CZ ' HG13 ' A' ' 81' ' ' ILE . 7.4 t80 -64.97 -48.03 75.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.602 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' CG ' ' HE3' ' A' ' 82' ' ' LYS . 84.1 tt0 -61.89 -56.74 16.18 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.655 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 97.8 mt-10 -64.92 -41.5 95.51 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.214 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.961 ' HD3' HD21 ' A' ' 74' ' ' LEU . 26.3 tttp -67.08 -37.97 84.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.173 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.856 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -71.3 -54.41 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.119 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.647 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 98.3 mttt -50.1 -30.1 10.37 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.424 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.646 ' HE3' ' HA ' ' A' ' 80' ' ' LYS . 74.0 mtm -74.46 -58.77 3.08 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.856 ' CZ ' HD13 ' A' ' 81' ' ' ILE . 18.3 p90 -87.29 -49.75 7.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.692 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.771 ' CB ' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -52.72 -47.12 67.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.039 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.722 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 84.6 tt0 -55.64 141.62 37.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 110.813 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -57.44 136.02 56.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.645 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -157.46 -172.25 3.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.786 HD22 ' CE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -145.33 178.97 7.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.416 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.661 ' CE1' ' CE1' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -170.7 140.71 1.73 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.044 0.449 . . . . 0.0 110.676 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.3 mt -80.67 2.33 26.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.421 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -108.89 153.36 23.64 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.551 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -61.33 134.95 57.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.412 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -108.32 116.99 32.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.748 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.856 HG12 HG23 ' A' ' 126' ' ' THR . 10.1 mt -129.24 129.84 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.4 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.435 ' CZ ' ' CZ ' ' A' ' 105' ' ' PHE . 14.0 ptm180 -139.72 148.41 42.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.015 0.435 . . . . 0.0 110.721 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.666 ' CZ ' ' HB2' ' A' ' 41' ' ' LEU . 2.2 t80 -122.75 138.71 54.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.593 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 122' ' ' GLY . 12.5 mm -104.1 114.55 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.143 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.723 HD21 ' CE ' ' A' ' 146' ' ' MET . 17.3 mt -84.22 -43.61 14.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.159 0.504 . . . . 0.0 109.971 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.47 162.41 38.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.33 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.55 173.93 45.85 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.682 ' OG ' ' CZ ' ' A' ' 118' ' ' PHE . 33.3 t -123.2 141.2 52.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.814 0.34 . . . . 0.0 110.492 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.92 150.04 20.04 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.72 ' CE1' ' CE1' ' A' ' 118' ' ' PHE . 88.8 m-85 -116.82 127.36 54.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.478 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.665 ' CE2' ' CD1' ' A' ' 135' ' ' PHE . 98.6 m-85 -123.77 149.22 45.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.002 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.602 ' OD2' ' O ' ' A' ' 106' ' ' ASP . 53.8 p30 -133.35 144.48 49.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.462 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.61 146.38 31.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.701 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.66 ' HB2' ' CH2' ' A' ' 114' ' ' TRP . 76.2 ttt180 -113.06 125.67 54.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.008 0.432 . . . . 0.0 110.737 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.76 156.69 22.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -56.23 -32.67 64.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 110.417 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.541 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 85.1 tt0 -66.35 -2.52 4.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.217 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 111' ' ' GLU . 59.8 t0 76.17 40.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.31 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.497 ' NE2' ' CD ' ' A' ' 111' ' ' GLU . 93.9 mt-30 -113.8 144.3 43.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.183 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.66 ' CH2' ' HB2' ' A' ' 108' ' ' ARG . 87.1 m95 -111.2 130.65 55.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.014 0.435 . . . . 0.0 111.182 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.611 HG22 HD11 ' A' ' 117' ' ' ILE . 64.9 mt -117.95 133.96 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.524 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.564 ' C ' HD13 ' A' ' 117' ' ' ILE . 59.4 ttp180 -91.94 116.7 29.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 115' ' ' ILE . 11.9 mm -112.0 127.23 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.422 . . . . 0.0 110.539 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 104' ' ' TYR . 80.1 t80 -106.32 133.13 51.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.917 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.643 ' HG3' ' CE1' ' A' ' 105' ' ' PHE . 16.2 mmt -107.0 126.28 52.12 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.443 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 84.8 tt0 -108.35 148.51 29.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.703 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -44.68 138.03 3.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.123 0.487 . . . . 0.0 111.072 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 79.12 1.04 84.83 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 98' ' ' ILE . 57.2 t0 -94.92 119.7 33.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.867 0.365 . . . . 0.0 111.266 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.644 ' HG3' ' CB ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -97.32 136.49 37.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.663 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.32 143.72 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.303 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.856 HG23 HG12 ' A' ' 95' ' ' ILE . 95.9 m -122.54 131.54 53.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.006 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.9 120.05 41.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.553 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 38.9 Cg_exo -57.11 155.47 28.74 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.806 2.338 . . . . 0.0 111.877 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.6 147.43 29.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 131' ' ' ILE . . . 94.88 9.25 58.62 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.76 HD12 ' N ' ' A' ' 131' ' ' ILE . 3.4 mp -114.55 151.26 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.786 ' CE2' HD22 ' A' ' 89' ' ' LEU . 51.6 m-85 -101.26 135.76 42.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.225 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.661 ' CE1' ' CE1' ' A' ' 90' ' ' HIS . 13.4 p-80 -148.0 158.63 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.123 0.487 . . . . 0.0 111.188 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.566 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 74.0 ttp85 -134.02 132.68 40.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.0 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.665 ' CD1' ' CE2' ' A' ' 105' ' ' PHE . 17.1 t80 -106.38 131.03 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.896 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.552 ' OG1' ' NH1' ' A' ' 134' ' ' ARG . 41.5 m -126.39 131.09 51.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.975 0.417 . . . . 0.0 110.913 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 141' ' ' ASN . 15.0 m -126.9 13.68 3.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.213 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.59 ' HA ' ' OD1' ' A' ' 141' ' ' ASN . 91.6 m-20 -63.32 -23.08 67.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.47 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.658 ' HG3' ' CE2' ' A' ' 104' ' ' TYR . 75.2 mm-40 -56.57 -35.53 68.29 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.286 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.583 ' HG3' ' H ' ' A' ' 142' ' ' TYR . 0.8 OUTLIER -140.66 -22.89 0.8 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.525 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 137' ' ' VAL . 87.0 m-20 59.12 38.5 23.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.715 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.606 ' HD2' ' HG ' ' A' ' 70' ' ' CYS . 65.9 t80 -157.71 97.0 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.6 m -133.44 143.17 48.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.0 110.907 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.517 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 66.7 tttt -126.41 109.83 12.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.746 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.88 154.4 45.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.184 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.723 ' CE ' HD21 ' A' ' 99' ' ' LEU . 69.8 mtm -94.74 146.68 24.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.184 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.574 ' HB3' ' CE2' ' A' ' 149' ' ' PHE . 19.4 mmm-85 -113.91 140.43 48.38 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.378 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 148' ' ' LEU . 5.1 mp -113.85 115.35 27.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.532 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.586 ' HB2' ' CD1' ' A' ' 63' ' ' TRP . 94.5 m-85 -135.25 156.19 49.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.614 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 150' ' ' VAL . 1.3 p -127.7 74.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.945 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.62 -173.0 43.26 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.556 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 71.3 tt0 -73.1 143.4 83.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.901 0.382 . . . . 0.0 110.672 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.556 ' HD2' ' CG ' ' A' ' 152' ' ' GLU . 36.6 Cg_exo -57.53 71.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.867 2.378 . . . . 0.0 112.11 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 152' ' ' GLU . 8.6 p -61.63 -32.78 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.152 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.658 ' HA ' ' CD1' ' A' ' 158' ' ' TYR . 5.2 t90 -54.88 -29.29 55.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.786 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 42.7 m -45.61 -43.11 11.98 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.33 100.89 3.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.366 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.658 ' CD1' ' HA ' ' A' ' 155' ' ' TRP . 21.6 p90 -151.91 164.8 36.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.608 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 85.7 m-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.119 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.1 t80 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.938 0.399 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.0 m -67.84 -26.12 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.798 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.584 ' HD2' ' C ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -60.59 -29.69 69.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.664 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.49 ' N ' ' HG3' ' A' ' 173' ' ' LYS . 69.5 t80 -57.01 -41.96 79.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 175' ' ' LEU . 9.6 tt -57.72 -37.72 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.45 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.679 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.68 -32.72 74.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.549 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.558 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.843 ' HB ' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.747 0.308 . . . . 0.0 110.719 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.655 ' OE1' ' CD2' ' A' ' 118' ' ' PHE . 63.4 tt0 -104.35 113.72 27.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.062 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 1.04 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -164.4 157.76 17.79 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.499 ' O ' HG23 ' A' ' 115' ' ' ILE . 1.4 t-105 -133.22 148.91 52.03 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.686 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.669 ' CE2' ' HA ' ' A' ' 26' ' ' VAL . 14.8 m-85 -98.8 87.87 3.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.785 ' SD ' ' CH2' ' A' ' 114' ' ' TRP . 86.1 mtp . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.351 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.472 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 5.9 mtt180 -61.57 112.26 5.74 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.869 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.8 Cg_exo -56.84 161.06 10.93 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.862 2.375 . . . . 0.0 111.71 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -124.3 97.44 40.03 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.496 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' A' ' 20' ' ' PRO . 11.4 Cg_exo -67.32 153.98 85.5 Favored 'Cis proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.484 -0.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -90.8 179.81 43.03 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -152.86 117.52 2.89 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 111.144 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.495 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 73.1 Cg_endo -81.83 158.56 18.58 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.331 2.687 . . . . 0.0 111.745 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.04 HG11 ' HB3' ' A' ' 4' ' ' ALA . 1.4 p -57.99 147.31 6.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.159 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.14 108.93 3.66 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.843 HD13 ' HB ' ' A' ' 2' ' ' VAL . 26.2 tp -47.25 -41.26 18.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.847 0.356 . . . . 0.0 110.269 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -70.16 -31.52 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.248 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.575 ' HG2' ' OH ' ' A' ' 6' ' ' TYR . 66.3 tp60 -62.93 -46.51 87.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.426 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.435 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 9.3 mt -69.44 -34.22 74.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.532 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -52.54 -43.68 65.33 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -66.54 -32.01 73.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.831 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 35.5 tp -64.5 -25.72 68.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.924 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.598 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . 110.04 23.63 6.05 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.792 HG12 ' CZ ' ' A' ' 38' ' ' TYR . 24.4 t -100.76 128.68 52.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.269 0.557 . . . . 0.0 111.138 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.672 ' HB3' ' CH2' ' A' ' 39' ' ' TRP . 3.0 mt -125.59 141.55 51.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.128 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.792 ' CZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -126.84 134.11 50.6 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.853 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 1.032 ' NE1' HG21 ' A' ' 55' ' ' ILE . 1.2 m95 -101.2 128.46 47.3 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -97.84 105.64 17.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.798 HD11 ' HB3' ' A' ' 39' ' ' TRP . 3.1 mp -139.66 147.34 40.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.696 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.671 ' O ' ' N ' ' A' ' 45' ' ' LYS . 84.1 m-20 -97.72 123.81 41.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 46' ' ' TYR . . . -41.88 -44.64 3.45 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.583 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -62.8 -33.91 76.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.048 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 42' ' ' ASP . 66.9 mttm -85.26 -14.8 45.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.318 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.958 ' CE2' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.92 -49.09 74.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -83.14 -41.65 18.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.094 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.525 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 39.9 m-20 -67.11 -22.85 65.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.737 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 45' ' ' LYS . 3.1 t0 -127.12 84.65 62.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.961 0.41 . . . . 0.0 111.524 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.0 Cg_endo -48.7 -8.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 123.23 2.62 . . . . 0.0 111.448 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.59 ' CD ' ' HD2' ' A' ' 54' ' ' LYS . 45.6 tp10 -42.59 -33.54 0.72 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.717 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.958 HD22 ' CE2' ' A' ' 46' ' ' TYR . 24.6 tp -55.32 -41.08 71.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.007 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 50' ' ' PRO . 75.3 mm-40 -63.16 -34.18 77.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.306 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.59 ' HD2' ' CD ' ' A' ' 51' ' ' GLU . 37.8 mttm -59.06 -41.82 88.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.527 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.032 HG21 ' NE1' ' A' ' 39' ' ' TRP . 87.6 mt -62.82 -36.26 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.618 ' NH2' ' HA ' ' A' ' 63' ' ' TRP . 72.1 ttt180 -58.09 -41.54 83.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.234 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.494 HH11 ' HA ' ' A' ' 54' ' ' LYS . 77.4 mtt85 -61.82 -36.01 79.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.446 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -60.28 -39.08 85.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.656 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.666 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 8.8 tpt180 -99.99 -11.16 20.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 110.296 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' ARG . 30.5 t-20 58.08 51.58 8.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.531 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.842 ' CD1' HD13 ' A' ' 148' ' ' LEU . 58.9 m-85 -70.05 124.24 23.59 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.228 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.504 ' C ' HH21 ' A' ' 56' ' ' ARG . 24.2 m -60.8 -36.9 80.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.809 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.692 ' O ' ' CD1' ' A' ' 63' ' ' TRP . 0.0 OUTLIER -138.26 149.93 46.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.379 . . . . 0.0 110.854 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.911 ' SD ' HD21 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -145.47 117.57 8.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.321 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.659 ' OD2' ' CZ3' ' A' ' 63' ' ' TRP . 90.1 m-20 -143.03 169.62 17.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.838 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.977 ' CD1' HD22 ' A' ' 99' ' ' LEU . 14.5 tt -121.49 144.44 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.93 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 68' ' ' THR . 9.8 tp -133.91 157.38 41.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.852 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.868 ' O ' HD13 ' A' ' 74' ' ' LEU . 54.3 m -117.06 138.41 51.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.017 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 69' ' ' ILE . 1.1 mp -90.52 96.47 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.335 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.644 ' O ' ' N ' ' A' ' 74' ' ' LEU . 45.8 t -154.53 128.04 8.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.945 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -57.72 -41.5 81.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.953 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.96 -40.17 96.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.437 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.572 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 40.7 tptt -100.12 -6.77 25.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 111.204 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.868 HD13 ' O ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -126.45 76.63 73.45 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.393 . . . . 0.0 111.163 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.537 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 10.8 Cg_endo -56.42 152.5 39.44 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.365 2.043 . . . . 0.0 110.061 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 39.3 t-20 74.65 39.13 0.45 Allowed 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.209 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.655 ' CZ ' HG13 ' A' ' 81' ' ' ILE . 58.1 t80 -59.66 -40.7 88.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.509 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.639 ' O ' ' CB ' ' A' ' 82' ' ' LYS . 97.0 mt-10 -60.13 -56.89 16.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.708 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.609 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 75.6 mm-40 -71.87 -38.21 70.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.589 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.609 ' HZ2' ' HE1' ' A' ' 84' ' ' PHE . 10.2 tptp -64.64 -56.58 12.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.165 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.014 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -71.71 -35.66 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.117 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.639 ' CB ' ' O ' ' A' ' 78' ' ' GLU . 26.1 tptt -59.48 -41.45 89.82 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.74 ' SD ' ' CH2' ' A' ' 155' ' ' TRP . 59.1 mtt -60.02 -42.15 93.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.537 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.609 ' HE1' ' HZ2' ' A' ' 80' ' ' LYS . 80.0 m-85 -69.24 -36.74 77.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.658 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 1.014 ' CE2' HD12 ' A' ' 81' ' ' ILE . 15.0 m-30 -61.0 -45.19 95.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.589 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.75 138.08 58.13 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.87 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.619 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -90.74 121.16 32.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.733 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.719 ' ND1' ' CE1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -141.63 173.92 11.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.04 0.448 . . . . 0.0 111.178 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.08 HD11 ' CD1' ' A' ' 132' ' ' TYR . 3.5 mp -130.38 159.89 35.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.109 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.587 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 4.0 p80 -170.81 153.38 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.095 0.474 . . . . 0.0 110.838 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.046 HD22 ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -67.78 16.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.823 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.759 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 59.0 t0 -108.53 148.32 30.44 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.616 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.637 ' OD2' ' NH2' ' A' ' 59' ' ' ARG . 83.1 m-20 -83.93 142.34 30.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.514 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 16.2 mm-40 -99.35 118.25 35.57 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.697 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.05 ' CD1' HG23 ' A' ' 126' ' ' THR . 32.9 mm -122.2 119.41 58.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.309 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.666 ' HD2' ' CE2' ' A' ' 105' ' ' PHE . 38.8 mtt85 -139.18 138.27 36.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.31 0.576 . . . . 0.0 111.452 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.791 ' CD2' ' CZ ' ' A' ' 46' ' ' TYR . 25.8 t80 -125.82 129.92 50.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 120' ' ' GLU . 14.0 mm -89.02 93.31 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.52 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.977 HD22 ' CD1' ' A' ' 66' ' ' ILE . 10.4 tp -72.65 -38.93 67.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.202 0.525 . . . . 0.0 109.651 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . 54.7 t0 -155.2 154.43 32.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.211 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 100' ' ' ASP . . . 82.14 -166.49 46.35 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 50.2 m -121.01 147.33 45.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.304 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -132.21 149.09 19.35 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.668 ' CE2' ' HG3' ' A' ' 116' ' ' ARG . 81.2 t80 -125.81 131.3 52.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.344 . . . . 0.0 110.615 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.796 ' HB3' HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -122.08 146.25 47.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 133' ' ' HIS . 23.2 t70 -124.67 128.33 48.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.416 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.14 144.4 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.505 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 114' ' ' TRP . 21.3 ttp180 -122.77 130.67 53.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.652 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 110' ' ' LYS . 57.8 t0 -85.73 156.23 20.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.695 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.571 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -60.79 -25.53 66.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.893 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 96.2 mt-10 -63.77 2.89 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.877 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 111' ' ' GLU . 54.3 t0 76.51 41.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 110.327 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 20.3 pt20 -143.37 165.83 26.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.857 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.785 ' CH2' ' SD ' ' A' ' 7' ' ' MET . 25.1 p-90 -133.69 149.84 51.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.025 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.572 HD13 ' HE1' ' A' ' 6' ' ' TYR . 68.7 mt -117.7 136.63 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.186 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.668 ' HG3' ' CE2' ' A' ' 104' ' ' TYR . 56.9 ttt180 -90.25 120.35 31.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.528 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.796 HD11 ' HB3' ' A' ' 105' ' ' PHE . 27.4 pt -120.8 128.67 76.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.655 ' CD2' ' OE1' ' A' ' 3' ' ' GLN . 71.2 t80 -109.79 136.71 48.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.614 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.47 ' SD ' ' HB ' ' A' ' 125' ' ' VAL . 16.0 mmt -106.37 133.44 51.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.724 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' O ' ' HB ' ' A' ' 98' ' ' ILE . 94.6 mt-10 -107.51 168.36 9.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -64.82 127.5 31.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.691 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.594 ' HA2' ' OH ' ' A' ' 97' ' ' TYR . . . 94.4 -15.42 63.3 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -95.98 121.46 37.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.701 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.711 ' CE ' HG22 ' A' ' 95' ' ' ILE . 18.1 ttt -102.64 150.2 23.67 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.47 ' HB ' ' SD ' ' A' ' 119' ' ' MET . 12.7 p -134.91 141.26 43.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.257 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . 1.05 HG23 ' CD1' ' A' ' 95' ' ' ILE . 87.9 m -125.31 132.35 52.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.052 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.523 HD23 HG22 ' A' ' 36' ' ' VAL . 4.1 mt -121.18 127.42 26.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.888 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.756 ' HG2' HD12 ' A' ' 131' ' ' ILE . 12.8 Cg_endo -59.36 141.44 97.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.797 2.331 . . . . 0.0 111.902 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.759 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -69.76 148.94 48.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.104 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.89 3.58 56.98 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.756 HD12 ' HG2' ' A' ' 128' ' ' PRO . 70.4 mt -116.25 137.15 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.305 . . . . 0.0 110.635 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 1.08 ' CD1' HD11 ' A' ' 89' ' ' LEU . 88.8 m-85 -58.4 128.3 36.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.145 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 45.0 p-80 -146.15 146.51 30.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.97 0.414 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.619 ' NE ' ' O ' ' A' ' 85' ' ' TYR . 77.9 ttt180 -135.7 134.34 39.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.111 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.574 ' HD2' ' CE2' ' A' ' 105' ' ' PHE . 70.5 t80 -106.7 124.72 50.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.757 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.691 ' O ' HG13 ' A' ' 137' ' ' VAL . 18.5 p -130.81 155.45 46.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.592 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 136' ' ' THR . 34.7 m -164.96 17.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.271 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 139' ' ' GLU . 48.1 p30 -70.8 -15.09 62.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 75.7 mm-40 -59.25 -39.45 82.88 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.33 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.521 ' HD3' ' HB2' ' A' ' 102' ' ' SER . 9.5 mtpm? -110.25 -19.33 13.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 138' ' ' ASP . 77.6 m-20 59.6 30.47 20.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.347 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 66.3 t80 -172.94 96.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.196 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.543 ' H ' ' HB ' ' A' ' 69' ' ' ILE . 56.9 m -136.16 134.4 38.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.13 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 5.8 ttmt -117.88 114.89 23.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.915 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.713 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -142.07 155.21 45.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.067 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.653 ' SD ' ' HE2' ' A' ' 46' ' ' TYR . 5.9 mtt -93.64 145.82 24.28 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.016 0.436 . . . . 0.0 110.679 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -129.89 138.89 51.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.738 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.911 HD21 ' SD ' ' A' ' 64' ' ' MET . 41.0 mt -110.98 132.49 54.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.78 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.669 ' CE1' ' O ' ' A' ' 152' ' ' GLU . 62.4 t80 -132.97 152.93 51.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 110.878 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.56 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 11.7 t -116.02 129.66 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.763 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.5 -162.35 37.9 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.669 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 1.8 mm-40 -69.08 155.36 93.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.927 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 156' ' ' THR . 27.8 Cg_endo -65.02 78.8 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.909 2.406 . . . . 0.0 112.184 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.498 HG12 ' CE2' ' A' ' 149' ' ' PHE . 7.0 p -60.61 -30.39 46.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.74 ' CH2' ' SD ' ' A' ' 83' ' ' MET . 43.3 t90 -52.5 -35.92 54.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.96 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.605 HG23 ' HB2' ' A' ' 153' ' ' PRO . 47.6 p -48.9 -43.42 39.21 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.61 101.19 3.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.963 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.719 ' CE1' ' ND1' ' A' ' 88' ' ' HIS . 18.9 p90 -136.18 155.62 49.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.356 179.448 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.0 t80 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.71 0.291 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.23 -39.74 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.578 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -58.28 -34.63 70.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.575 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -56.5 -41.49 76.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.646 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.3 tp -57.37 -37.78 73.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.527 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.11 72.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.586 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -63.78 -33.05 74.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.551 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.5 -179.952 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' A' ' 28' ' ' LEU . 11.7 p -127.9 140.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.541 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.575 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 11.7 mm-40 -100.22 116.27 31.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.443 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.084 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -164.41 157.53 17.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.792 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.705 ' O ' HG23 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -124.89 145.38 49.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.011 0.434 . . . . 0.0 111.67 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.558 ' CE2' HD11 ' A' ' 115' ' ' ILE . 1.4 t80 -96.07 76.03 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.794 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . 73.7 mtm -61.12 -2.44 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.732 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.628 ' OD1' ' CD ' ' A' ' 113' ' ' GLN . 54.3 t0 -53.1 -34.41 56.5 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.987 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.402 ' CB ' ' HB3' ' A' ' 20' ' ' PRO . 91.2 m-20 -113.03 8.28 18.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.406 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.794 ' HB3' ' HA ' ' A' ' 7' ' ' MET . . . -106.08 156.95 35.91 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.873 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 36.5 Cg_endo -68.26 142.06 53.98 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.834 2.356 . . . . 0.0 112.287 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.38 -30.51 64.84 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.51 ' O ' ' NE2' ' A' ' 18' ' ' HIS . 1.7 m-20 -49.41 115.41 4.84 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.95 0.405 . . . . 0.0 110.512 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 13' ' ' ASP . 27.9 Cg_endo -64.86 -34.67 48.11 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.911 2.407 . . . . 0.0 112.368 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -56.14 -36.05 67.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.571 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.521 ' CD ' ' HD2' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -71.54 157.42 89.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.378 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.589 ' HB2' ' CG ' ' A' ' 19' ' ' ARG . 51.2 Cg_endo -75.76 -5.2 16.19 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.624 2.216 . . . . 0.0 111.381 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.723 ' HA ' ' HB1' ' A' ' 10' ' ' ALA . 65.4 m170 62.6 35.56 14.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.118 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.672 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -91.17 102.14 5.1 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.302 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.68 ' O ' ' N ' ' A' ' 23' ' ' GLY . 12.3 Cg_endo -58.74 161.15 15.71 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.77 2.314 . . . . 0.0 111.687 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.599 ' OD1' ' C ' ' A' ' 21' ' ' ASP . 13.5 t0 -119.37 101.68 48.88 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.575 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.536 ' C ' ' O ' ' A' ' 20' ' ' PRO . 12.9 Cg_exo -66.9 158.04 81.88 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.516 -1.452 . . . . 0.0 112.375 -0.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -82.94 152.21 29.67 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.594 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -152.68 119.85 3.09 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.296 0.569 . . . . 0.0 111.315 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 56.2 Cg_endo -74.75 157.44 43.81 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 123.028 2.485 . . . . 0.0 111.294 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.084 HG11 ' HB3' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -57.23 147.64 5.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.912 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 30' ' ' GLN . . . -97.89 102.24 2.64 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.752 ' C ' HD23 ' A' ' 28' ' ' LEU . 7.4 tt -46.06 -47.78 17.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.834 0.35 . . . . 0.0 110.358 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.52 -34.39 78.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.174 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 93.7 mt-30 -62.33 -40.98 98.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.678 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.588 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 6.6 mt -69.8 -38.68 76.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.345 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -55.98 -41.09 74.28 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.319 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -63.32 -32.33 73.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.588 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 26.2 tp -64.91 -23.9 67.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.938 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.649 ' O ' ' CG ' ' A' ' 128' ' ' PRO . . . 112.31 18.26 7.75 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 t -96.21 129.55 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 0.0 111.054 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.825 HD13 ' NH2' ' A' ' 59' ' ' ARG . 30.9 mt -120.48 141.06 50.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.131 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.689 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -139.78 139.45 36.44 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.836 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.999 ' NE1' HG21 ' A' ' 55' ' ' ILE . 1.9 m95 -109.53 133.65 52.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.497 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' C ' HD12 ' A' ' 41' ' ' LEU . 11.7 mtmt -105.99 102.74 12.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.809 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.629 ' O ' ' OH ' ' A' ' 97' ' ' TYR . 5.1 mp -142.76 156.49 45.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.247 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 45' ' ' LYS . 87.7 m-20 -90.32 122.29 33.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.529 ' HA ' HD22 ' A' ' 99' ' ' LEU . . . -42.01 -43.25 3.11 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.166 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.522 ' OD2' ' HB3' ' A' ' 42' ' ' ASP . 5.5 p-10 -66.88 -32.8 74.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.688 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.648 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 70.4 mttt -85.04 -11.59 55.01 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.2 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.722 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -71.86 -56.7 5.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.639 -0.424 . . . . 0.0 109.925 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.722 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 83.9 tt0 -67.04 -36.81 82.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.44 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.593 ' CG ' ' HA ' ' A' ' 45' ' ' LYS . 17.6 p-10 -78.67 -11.74 59.99 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.497 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' ' O ' ' A' ' 45' ' ' LYS . 10.2 t0 -130.94 83.26 61.66 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.82 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.1 Cg_endo -46.4 -8.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 123.535 2.824 . . . . 0.0 112.049 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 49' ' ' ASP . 96.9 mt-10 -46.05 -34.46 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.397 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.087 HD13 ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -59.06 -32.4 69.74 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 1.087 ' N ' HD13 ' A' ' 52' ' ' LEU . 84.8 tt0 -64.06 -35.26 80.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.685 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -59.18 -40.62 86.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.699 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.999 HG21 ' NE1' ' A' ' 39' ' ' TRP . 84.3 mt -59.85 -37.24 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.505 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.713 ' HG2' HD23 ' A' ' 148' ' ' LEU . 70.5 mtp180 -59.43 -40.83 88.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.603 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.97 -41.14 86.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.07 -32.54 74.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.694 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.825 ' NH2' HD13 ' A' ' 37' ' ' LEU . 39.0 mmt180 -99.41 7.42 45.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.218 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.793 ' ND2' ' O ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER 59.91 46.39 11.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.75 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.723 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 22.7 m-85 -105.49 113.03 26.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.279 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.664 ' C ' ' NH2' ' A' ' 56' ' ' ARG . 1.4 t -99.73 -21.45 15.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.248 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.57 ' HB3' ' O ' ' A' ' 149' ' ' PHE . 70.5 t90 -109.42 127.88 54.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.837 0.351 . . . . 0.0 111.041 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 56' ' ' ARG . 8.8 ptm -143.14 147.58 35.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.321 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 66' ' ' ILE . 46.3 t0 -159.47 166.76 30.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.433 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.534 ' HA ' ' HG2' ' A' ' 146' ' ' MET . 59.2 mt -108.39 122.25 62.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.522 HD12 ' HG3' ' A' ' 147' ' ' ARG . 72.6 mt -119.42 138.46 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.372 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.553 ' OG1' ' HG3' ' A' ' 144' ' ' LYS . 36.1 m -119.41 142.48 48.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.617 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.674 ' C ' ' SG ' ' A' ' 70' ' ' CYS . 64.2 mt -105.76 125.7 61.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.0 111.028 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.674 ' SG ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -169.1 135.4 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.657 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -57.96 -45.67 86.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.983 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.675 ' OD1' ' N ' ' A' ' 73' ' ' LYS . 55.6 p30 -77.21 -33.17 56.28 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.675 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 80.3 tttt -98.29 -3.66 36.76 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.459 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.031 HD21 ' HD3' ' A' ' 80' ' ' LYS . 1.1 tp -125.58 73.46 68.75 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.124 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.579 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 48.2 Cg_exo -49.97 154.14 5.55 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 121.892 1.728 . . . . 0.0 109.611 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.642 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 63.5 t-20 70.18 32.54 2.89 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.34 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.674 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 27.4 t80 -62.38 -45.7 91.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.434 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 49.0 tp10 -54.82 -54.18 45.6 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.642 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 97.7 mt-10 -76.34 -45.13 33.57 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.398 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 1.031 ' HD3' HD21 ' A' ' 74' ' ' LEU . 23.2 tttp -60.45 -49.52 77.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.281 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.907 HD13 ' CE2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -70.46 -37.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.391 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.607 ' CD ' ' HA ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -70.8 -37.22 73.28 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.617 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.611 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 87.0 mtp -56.68 -48.73 76.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.663 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.907 ' CE2' HD13 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -87.19 -14.85 40.01 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.653 179.535 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.825 ' CZ ' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -56.54 -46.32 80.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.97 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' OE2' ' NE ' ' A' ' 160' ' ' ARG . 92.5 mt-10 -75.93 146.42 39.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.959 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.567 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -80.51 135.51 36.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.292 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.442 ' CD2' ' C ' ' A' ' 88' ' ' HIS . 2.5 p-80 -144.87 170.67 15.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.007 0.432 . . . . 0.0 110.979 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.149 HD11 ' C ' ' A' ' 130' ' ' GLY . 28.3 tp -124.55 153.32 42.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.576 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.612 ' HA ' ' CB ' ' A' ' 162' ' ' ALA . 1.7 p80 -170.81 165.85 7.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.992 0.425 . . . . 0.0 110.897 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.54 ' C ' ' HB1' ' A' ' 129' ' ' ALA . 49.0 mt -85.09 16.24 3.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.585 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.71 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 88.2 m-20 -107.65 149.29 28.26 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.369 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.605 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 49.2 p30 -83.88 164.95 19.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.427 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.605 ' OE2' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -125.71 114.83 19.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.918 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.72 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 2.7 mp -120.41 116.32 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.149 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.715 ' NH1' ' CG ' ' A' ' 135' ' ' PHE . 68.1 mtt180 -131.62 138.37 48.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.011 0.434 . . . . 0.0 110.77 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.668 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.3 t80 -127.42 128.71 46.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.384 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.866 HG12 ' HE2' ' A' ' 119' ' ' MET . 23.8 mm -96.69 95.64 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.311 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.212 HD11 ' SD ' ' A' ' 146' ' ' MET . 16.9 mt -71.49 -35.62 70.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.0 109.851 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . 20.2 t70 -157.44 162.81 38.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.339 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 143' ' ' THR . . . 90.86 175.68 44.11 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.541 ' OG ' ' HZ ' ' A' ' 118' ' ' PHE . 41.1 t -129.37 142.98 50.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.716 0.293 . . . . 0.0 110.696 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.632 ' HA3' HG12 ' A' ' 137' ' ' VAL . . . -173.23 179.24 44.78 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.7 ' CZ ' ' OG1' ' A' ' 136' ' ' THR . 50.3 p90 -140.13 150.13 43.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.925 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 133' ' ' HIS . 3.7 t80 -110.52 141.43 43.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.993 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.564 ' HB3' ' H ' ' A' ' 134' ' ' ARG . 60.2 t0 -94.5 124.22 38.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.571 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 117' ' ' ILE . 21.8 m -128.1 154.55 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.602 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.648 ' NH2' ' CD2' ' A' ' 132' ' ' TYR . 24.0 ttp180 -123.71 143.1 50.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 55.4 t0 -99.51 156.8 16.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.466 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.533 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -60.54 -25.06 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.086 0.469 . . . . 0.0 110.48 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 46.5 tp10 -76.16 11.1 1.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.043 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 110' ' ' LYS . 83.7 m-20 62.81 42.84 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.367 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.628 ' CD ' ' OD1' ' A' ' 8' ' ' ASP . 82.3 mt-30 -120.46 149.19 42.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.092 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.642 ' CZ2' ' HD3' ' A' ' 108' ' ' ARG . 94.2 m95 -111.44 133.06 54.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.982 0.42 . . . . 0.0 111.134 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 5' ' ' TRP . 69.1 mt -121.05 134.94 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.509 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 116' ' ' ARG . 8.1 ptm180 -91.08 114.37 26.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.787 HD11 HG21 ' A' ' 107' ' ' VAL . 45.0 mt -108.38 129.63 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.678 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.541 ' HZ ' ' OG ' ' A' ' 102' ' ' SER . 74.1 t80 -94.72 128.83 41.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.913 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.866 ' HE2' HG12 ' A' ' 98' ' ' ILE . 89.0 mtp -100.43 122.55 43.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.354 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.552 ' HG2' ' N ' ' A' ' 121' ' ' LYS . 84.7 tt0 -111.61 160.2 17.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.566 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -55.48 133.39 50.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 41' ' ' LEU . . . 88.92 -12.91 64.46 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -95.22 123.46 38.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.879 0.371 . . . . 0.0 111.306 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.688 ' CE ' ' CD1' ' A' ' 39' ' ' TRP . 5.1 ttp -107.11 151.38 25.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.609 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.43 143.31 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.302 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 41.2 m -126.38 133.22 51.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.046 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.598 ' CD2' ' CG ' ' A' ' 133' ' ' HIS . 7.6 tp -115.59 113.53 42.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.918 0.39 . . . . 0.0 110.808 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.649 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 36.9 Cg_exo -52.91 141.57 55.43 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.646 2.231 . . . . 0.0 111.926 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.71 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -67.82 146.07 54.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.908 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 1.149 ' C ' HD11 ' A' ' 89' ' ' LEU . . . 98.36 3.13 57.67 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.609 ' N ' HD11 ' A' ' 89' ' ' LEU . 71.2 mt -119.57 131.61 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.732 0.301 . . . . 0.0 110.616 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.667 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 98.9 m-85 -62.09 146.05 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.201 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.655 ' HB2' ' CZ ' ' A' ' 105' ' ' PHE . 22.7 p-80 -160.42 156.44 26.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 0.0 111.247 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.643 ' NE ' ' O ' ' A' ' 85' ' ' TYR . 41.0 ttt180 -141.74 128.21 20.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.065 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.715 ' CG ' ' NH1' ' A' ' 96' ' ' ARG . 68.9 t80 -107.09 124.04 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.836 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.7 ' OG1' ' CZ ' ' A' ' 104' ' ' TYR . 16.5 p -138.06 154.36 49.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.646 ' CG1' ' O ' ' A' ' 136' ' ' THR . 17.2 m -165.05 25.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.198 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.655 ' OD2' ' N ' ' A' ' 139' ' ' GLU . 51.2 p30 -65.0 -24.64 67.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.618 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.655 ' N ' ' OD2' ' A' ' 138' ' ' ASP . 60.2 mp0 -55.17 -34.48 63.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.77 0.319 . . . . 0.0 111.175 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -100.46 -28.18 13.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.581 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 58.18 27.38 15.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.616 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -173.15 96.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.437 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.505 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 42.4 m -136.17 139.05 42.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.954 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.553 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 71.2 tttt -117.24 116.03 26.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.69 154.62 45.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.014 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' MET . . . . . 1.212 ' SD ' HD11 ' A' ' 99' ' ' LEU . 6.5 mtp -96.16 146.8 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.223 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.66 ' HB3' ' CE1' ' A' ' 149' ' ' PHE . 21.3 mmt85 -120.08 136.55 54.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.535 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.727 ' N ' HD12 ' A' ' 148' ' ' LEU . 5.8 mp -118.6 119.38 34.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.527 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 147' ' ' ARG . 96.7 m-85 -129.98 159.38 36.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.563 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.555 ' CG1' ' HD2' ' A' ' 61' ' ' TYR . 15.7 m -112.23 131.59 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.28 -162.08 41.79 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' A' ' 152' ' ' GLU . 0.1 OUTLIER -68.35 144.07 96.22 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.829 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.549 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 31.4 Cg_exo -55.46 96.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.891 2.394 . . . . 0.0 112.172 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.4 -39.33 83.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.254 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.481 ' O ' ' CE3' ' A' ' 155' ' ' TRP . 9.0 t90 -55.1 -33.22 62.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.789 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 153' ' ' PRO . 42.4 m -45.64 -43.88 12.79 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.32 101.01 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.345 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -142.0 158.45 43.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.698 ' OD1' ' CZ ' ' A' ' 165' ' ' PHE . 20.3 m120 -91.09 139.8 30.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.08 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.668 ' CB ' ' CD ' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -43.26 -74.0 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.533 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.668 ' CD ' ' CB ' ' A' ' 160' ' ' ARG . 49.4 Cg_endo -72.47 130.59 16.31 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.41 2.074 . . . . 0.0 111.884 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.952 ' HB2' ' O ' ' A' ' 89' ' ' LEU . . . -66.07 -33.08 74.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 0.0 110.505 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.538 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 23.4 t70 -65.64 -18.91 65.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.526 ' HB2' ' HG2' ' A' ' 161' ' ' PRO . 12.1 t60 -47.6 -35.06 8.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.588 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.698 ' CZ ' ' OD1' ' A' ' 159' ' ' ASN . 91.8 m-85 -86.24 133.08 33.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.46 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.652 ' O ' ' CB ' ' A' ' 170' ' ' GLN . 97.4 mt-10 -60.0 -45.31 93.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.81 -46.84 62.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.402 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.507 ' HB2' ' HB2' ' A' ' 165' ' ' PHE . 92.9 mtt180 -85.45 -9.85 56.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.564 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 165' ' ' PHE . . . -106.19 -52.44 0.78 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.652 ' CB ' ' O ' ' A' ' 166' ' ' GLU . 63.4 tt0 -55.97 -37.6 69.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.361 . . . . 0.0 110.532 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.529 ' HA ' ' CD2' ' A' ' 174' ' ' PHE . 7.9 t80 -58.42 -37.78 76.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.109 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.68 -38.06 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.604 ' O ' ' OE1' ' A' ' 177' ' ' GLN . 56.2 mttp -55.99 -35.15 66.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.682 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.584 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 96.3 m-85 -58.2 -36.75 73.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.433 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 178' ' ' THR . 60.9 mt -61.33 -35.44 77.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.828 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.515 ' HB3' ' NE2' ' A' ' 177' ' ' GLN . . . -61.37 -41.16 96.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.695 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.604 ' OE1' ' O ' ' A' ' 173' ' ' LYS . 8.2 mp0 -64.35 -32.65 74.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.555 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 175' ' ' LEU . 10.7 m . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.574 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 ttm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p -127.74 143.78 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.624 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -80.68 134.96 35.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.324 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.685 ' CB ' HG13 ' A' ' 26' ' ' VAL . . . -148.54 137.74 21.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.818 ' CA ' HG12 ' A' ' 26' ' ' VAL . 3.5 t-105 -137.87 154.12 49.5 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.681 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.694 ' CE2' ' OD2' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -105.7 110.52 22.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.398 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.767 ' HE2' ' HA2' ' A' ' 12' ' ' GLY . 88.8 mtp -94.33 0.54 55.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.694 ' OD2' ' CE2' ' A' ' 6' ' ' TYR . 52.1 p-10 -56.95 -33.95 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 110.685 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.666 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 59.9 t0 -98.69 -48.6 4.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.488 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.953 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . . . -71.48 149.29 93.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.185 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.82 144.79 78.64 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.885 2.39 . . . . 0.0 112.029 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.767 ' HA2' ' HE2' ' A' ' 7' ' ' MET . . . -58.72 -24.71 57.67 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' O ' ' CE1' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -45.0 111.97 1.41 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 110.488 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -59.29 -30.87 94.0 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.991 2.461 . . . . 0.0 112.166 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -54.27 -38.95 66.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.517 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.2 156.75 73.92 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.481 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.597 ' HB2' ' CD ' ' A' ' 19' ' ' ARG . 47.7 Cg_endo -73.6 -5.12 16.56 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.841 2.361 . . . . 0.0 111.442 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.857 ' HA ' ' HB1' ' A' ' 10' ' ' ALA . 73.3 m-70 68.81 31.4 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.611 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.658 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -126.0 95.63 39.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.953 ' HD3' ' HB2' ' A' ' 10' ' ' ALA . 60.5 Cg_endo -78.09 120.27 4.93 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.749 2.299 . . . . 0.0 111.368 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.578 ' OD2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -61.59 118.48 38.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.328 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.677 ' C ' ' O ' ' A' ' 20' ' ' PRO . 4.4 Cg_exo -77.04 125.71 12.3 Favored 'Cis proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.37 -1.512 . . . . 0.0 111.43 -1.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.76 166.09 46.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.55 ' NH2' ' HD2' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -153.17 117.41 2.82 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 121.11 0.481 . . . . 0.0 111.04 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.688 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 74.3 Cg_endo -77.42 165.67 27.09 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 123.119 2.546 . . . . 0.0 111.239 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.818 HG12 ' CA ' ' A' ' 5' ' ' TRP . 10.5 p -126.95 159.3 37.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.286 0.565 . . . . 0.0 110.884 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.581 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -128.62 172.03 19.52 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.791 HD11 ' HB2' ' A' ' 38' ' ' TYR . 22.8 tp -53.66 -36.62 62.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.656 0.265 . . . . 0.0 110.774 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -55.08 -41.34 71.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.789 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.618 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 99.4 mm-40 -64.12 -40.94 97.27 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.521 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.866 HD21 HD13 ' A' ' 115' ' ' ILE . 25.5 mt -72.61 -32.11 65.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.447 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 19.1 mmm180 -54.7 -41.77 70.66 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -70.99 -27.21 63.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.585 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.648 HD21 ' CG1' ' A' ' 107' ' ' VAL . 13.1 tp -66.47 -9.97 39.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.752 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.637 ' O ' ' CG ' ' A' ' 128' ' ' PRO . . . 95.44 13.29 52.04 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.4 t -97.78 134.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.072 0.463 . . . . 0.0 110.545 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.655 HD11 ' CE2' ' A' ' 39' ' ' TRP . 3.1 tm? -103.95 128.71 51.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.951 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.791 ' HB2' HD11 ' A' ' 28' ' ' LEU . 73.8 t80 -116.07 125.26 52.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 0.0 110.893 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.831 ' CE3' ' HE2' ' A' ' 124' ' ' MET . 1.5 m-90 -110.62 134.87 52.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.132 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 1.7 ptpt -99.37 105.3 17.25 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.772 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 43.7 mt -140.2 160.61 39.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.963 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 45' ' ' LYS . 58.5 t0 -119.79 139.28 52.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 46' ' ' TYR . . . -55.07 -43.68 74.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.122 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -66.84 -33.69 76.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.784 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.62 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 45.7 mttp -87.26 -6.0 58.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.355 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.723 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -76.72 -58.5 3.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.905 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.723 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 84.3 tt0 -70.68 -38.14 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 9.8 p-10 -74.1 -16.91 61.0 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.871 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.65 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 2.9 t0 -130.2 83.94 61.54 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.057 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 53' ' ' GLU . 77.7 Cg_exo -42.95 -8.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 123.36 2.707 . . . . 0.0 112.557 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 49' ' ' ASP . 84.2 tt0 -42.69 -34.58 0.93 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.809 HD13 ' C ' ' A' ' 52' ' ' LEU . 2.3 tm? -54.63 -41.03 69.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.562 ' OE2' ' HD3' ' A' ' 56' ' ' ARG . 46.7 tp10 -61.06 -34.83 75.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.981 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 25.1 mttm -58.49 -41.79 86.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.407 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -61.93 -33.75 59.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.658 ' NH2' ' O ' ' A' ' 62' ' ' SER . 60.2 ttt180 -54.98 -42.81 72.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.699 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -67.23 -39.14 86.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.543 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -63.59 -38.53 91.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.262 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.692 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 37.9 mmt180 -92.86 -2.18 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 110.527 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 62.33 51.08 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.15 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 1.061 ' CE1' HD12 ' A' ' 95' ' ' ILE . 57.3 m-85 -100.27 112.26 24.58 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.159 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.658 ' O ' ' NH2' ' A' ' 56' ' ' ARG . 61.2 m -83.85 -15.72 47.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.849 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.699 ' CZ2' ' OD2' ' A' ' 65' ' ' ASP . 48.2 t90 -130.65 128.02 40.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.731 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.629 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 16.7 ptm -153.56 133.2 12.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.545 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.699 ' OD2' ' CZ2' ' A' ' 63' ' ' TRP . 97.2 m-20 -145.85 172.04 13.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.527 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.516 HD11 ' OH ' ' A' ' 46' ' ' TYR . 62.7 mt -111.19 123.13 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.048 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.974 HD11 ' CD1' ' A' ' 74' ' ' LEU . 19.8 tt -133.0 148.36 31.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.627 ' OG1' ' O ' ' A' ' 143' ' ' THR . 5.1 t -127.04 148.02 50.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.186 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.711 ' N ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -83.02 107.95 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 74' ' ' LEU . 12.8 t -170.11 113.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.082 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HB3' ' CB ' ' A' ' 77' ' ' TYR . 7.4 pttm -59.87 -30.97 69.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.386 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -61.79 -40.29 94.7 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.639 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -109.66 -41.19 4.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 111.174 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.974 ' CD1' HD11 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -113.3 90.68 17.41 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.771 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.631 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 5.6 Cg_endo -51.18 166.84 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.581 2.187 . . . . 0.0 110.587 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.631 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 61.3 t-20 86.1 22.13 0.08 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.362 . . . . 0.0 110.593 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.841 ' O ' HG23 ' A' ' 81' ' ' ILE . 15.2 t80 -59.82 -40.36 88.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 59.4 mp0 -59.3 -56.04 27.21 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.531 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.654 ' O ' ' CG ' ' A' ' 83' ' ' MET . 96.9 mt-10 -73.59 -30.56 63.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.49 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 8.3 tptt -56.85 -55.53 33.22 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.569 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.841 HG23 ' O ' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -71.6 -44.71 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.759 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 20.5 mttt -57.33 -35.99 70.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.73 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -57.84 -45.05 86.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.145 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 97.6 m-85 -77.61 -27.52 51.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.566 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.806 ' HE2' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -54.09 -47.32 71.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.555 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -87.56 132.62 33.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.775 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.556 ' HG2' ' HB2' ' A' ' 134' ' ' ARG . 98.0 mt-10 -61.77 135.72 57.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.137 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -136.0 155.92 49.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.092 HD11 ' C ' ' A' ' 130' ' ' GLY . 43.9 tp -121.45 164.24 17.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.293 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.932 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 0.1 OUTLIER -168.03 142.83 3.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.237 0.541 . . . . 0.0 110.515 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.768 HD11 HG22 ' A' ' 172' ' ' VAL . 0.5 OUTLIER -65.78 -19.54 65.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.096 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 1.137 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 58.4 t0 -107.79 148.36 29.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.226 0.536 . . . . 0.0 111.36 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.62 ' OD2' ' O ' ' A' ' 127' ' ' LEU . 61.2 t0 -84.48 128.29 34.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.651 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.613 ' OE2' ' CB ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -100.95 139.49 36.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.707 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.061 HD12 ' CE1' ' A' ' 61' ' ' TYR . 67.8 mt -115.19 132.34 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.446 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -133.33 146.02 50.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.399 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 41' ' ' LEU . 1.2 t80 -127.72 127.53 43.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.97 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.87 ' N ' HD12 ' A' ' 98' ' ' ILE . 1.5 mp -93.91 99.09 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 111.0 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.588 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 19.0 mt -74.82 -34.44 62.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.482 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.573 ' HA ' ' HG3' ' A' ' 121' ' ' LYS . 58.6 t0 -146.8 -31.79 0.33 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.226 -0.59 . . . . 0.0 112.062 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.678 ' O ' ' CG2' ' A' ' 98' ' ' ILE . . . -56.57 161.83 7.06 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.609 ' HB2' ' CD ' ' A' ' 140' ' ' LYS . 66.8 m -145.95 148.7 33.06 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.184 -0.508 . . . . 0.0 109.888 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.532 ' HA3' HG12 ' A' ' 137' ' ' VAL . . . 170.92 -168.07 41.21 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.687 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.61 ' CE2' ' HD2' ' A' ' 118' ' ' PHE . 94.6 m-85 -113.91 133.22 55.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.748 0.308 . . . . 0.0 110.502 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.944 ' HZ ' HD12 ' A' ' 127' ' ' LEU . 65.5 t80 -106.7 124.96 50.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.289 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.582 ' HB3' ' H ' ' A' ' 134' ' ' ARG . 61.2 t0 -91.14 121.34 32.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.816 HG22 ' CE2' ' A' ' 105' ' ' PHE . 28.7 t -121.87 138.61 51.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.589 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.643 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 29.2 ttp180 -113.55 137.99 50.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.525 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 56.8 t0 -97.74 156.72 16.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.704 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.561 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 0.8 OUTLIER -61.49 -24.07 66.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.557 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.657 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 86.0 tt0 -77.41 11.33 2.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.319 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 111' ' ' GLU . 84.2 m-20 64.85 43.88 3.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.966 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.657 ' NE2' ' OE1' ' A' ' 111' ' ' GLU . 51.9 mt-30 -124.32 149.89 46.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.422 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.643 ' CZ3' ' HB2' ' A' ' 108' ' ' ARG . 95.1 m95 -111.71 136.15 51.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.866 HD13 HD21 ' A' ' 31' ' ' LEU . 64.3 mt -118.61 133.99 63.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.622 ' O ' HD13 ' A' ' 117' ' ' ILE . 69.6 ttt180 -90.68 111.2 22.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.645 HD11 HG22 ' A' ' 115' ' ' ILE . 16.9 mm -115.9 134.58 58.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.937 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.61 ' HD2' ' CE2' ' A' ' 104' ' ' TYR . 83.6 t80 -101.07 132.37 46.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.55 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . 21.8 mmt -95.33 117.63 30.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.39 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.596 ' O ' ' CG ' ' A' ' 123' ' ' ASP . 84.4 tt0 -108.96 150.43 27.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.177 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 18.0 tttp -51.25 128.96 23.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.254 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 41' ' ' LEU . . . 94.31 -3.38 69.21 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.604 ' OD1' ' O ' ' A' ' 123' ' ' ASP . 41.8 p-10 -95.64 119.18 33.7 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.633 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.831 ' HE2' ' CE3' ' A' ' 39' ' ' TRP . 52.8 ttp -111.52 127.15 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.228 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.06 148.15 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.991 0.424 . . . . 0.0 111.605 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.744 HG23 HG12 ' A' ' 95' ' ' ILE . 93.9 m -113.81 135.49 53.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.282 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.944 HD12 ' HZ ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -112.61 110.2 52.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.746 ' HD2' HD23 ' A' ' 127' ' ' LEU . 33.2 Cg_exo -55.97 142.16 85.33 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.942 2.428 . . . . 0.0 112.013 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 1.137 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -71.61 149.19 45.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 1.092 ' C ' HD11 ' A' ' 89' ' ' LEU . . . 101.38 -1.58 53.77 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.802 ' N ' HD11 ' A' ' 89' ' ' LEU . 69.4 mt -120.57 132.72 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.781 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.668 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 95.6 m-85 -78.29 143.96 36.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.265 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.711 ' CG ' ' CD1' ' A' ' 127' ' ' LEU . 9.0 p-80 -158.03 157.6 33.23 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.162 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.618 ' CD ' ' O ' ' A' ' 85' ' ' TYR . 21.8 ttp180 -131.56 130.66 42.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.599 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.711 ' CE1' ' CG1' ' A' ' 137' ' ' VAL . 81.3 t80 -113.76 131.21 56.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.741 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.655 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 17.6 p -127.7 153.64 46.26 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.711 ' CG1' ' CE1' ' A' ' 135' ' ' PHE . 6.0 m -165.55 18.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.212 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.665 ' OD1' ' N ' ' A' ' 139' ' ' GLU . 51.7 p30 -63.79 -25.41 68.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.627 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.665 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 49.6 mt-10 -56.28 -38.73 71.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.609 ' CD ' ' HB2' ' A' ' 102' ' ' SER . 59.7 mtpt -96.69 -7.44 34.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.616 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.0 t30 47.48 11.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.747 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 140' ' ' LYS . 45.8 t80 -150.02 120.54 7.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.466 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.627 ' O ' ' OG1' ' A' ' 68' ' ' THR . 44.1 m -134.79 132.74 39.06 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.61 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.588 ' H ' ' CA ' ' A' ' 101' ' ' GLY . 31.0 tttt -126.8 108.7 11.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.97 152.21 43.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.0 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.588 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 56.7 ttp -101.27 137.39 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.801 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.715 ' NH2' HG21 ' A' ' 67' ' ' ILE . 81.6 mtm-85 -123.35 146.6 47.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 111.158 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 148' ' ' LEU . 5.1 mp -115.37 134.39 55.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.41 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' TRP . 2.3 m-85 -152.72 161.78 42.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.756 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.29 140.22 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.402 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.23 -166.25 40.18 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 5.3 pm0 -65.73 149.61 97.21 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.473 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.642 ' O ' ' CG2' ' A' ' 156' ' ' THR . 35.2 Cg_exo -53.15 125.75 19.36 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.721 2.28 . . . . 0.0 112.035 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 155' ' ' TRP . 5.6 p -92.41 -43.95 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.514 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.73 ' CZ2' ' CB ' ' A' ' 83' ' ' MET . 3.3 t90 -57.44 -36.47 71.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.619 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.642 ' CG2' ' O ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -36.92 -53.84 0.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.471 ' H ' HG23 ' A' ' 156' ' ' THR . . . -147.07 101.75 3.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.304 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -134.51 158.71 43.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.407 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.733 ' ND2' ' CZ ' ' A' ' 165' ' ' PHE . 81.5 m-20 -91.47 137.21 32.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.098 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.621 ' CG ' ' HD3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -46.1 -64.53 0.91 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.572 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.621 ' HD3' ' CG ' ' A' ' 160' ' ' ARG . 52.1 Cg_endo -76.3 133.77 15.03 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.531 2.154 . . . . 0.0 112.263 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.681 ' HB2' ' C ' ' A' ' 89' ' ' LEU . . . -65.37 -30.73 71.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.655 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.517 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 48.1 p30 -91.68 13.49 17.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.506 ' HB2' ' HG2' ' A' ' 161' ' ' PRO . 6.3 t-160 -52.23 -37.96 56.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.295 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.733 ' CZ ' ' ND2' ' A' ' 159' ' ' ASN . 97.4 m-85 -86.22 134.0 33.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.316 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -59.71 -45.83 90.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.856 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.63 ' O ' ' CD1' ' A' ' 171' ' ' TYR . . . -71.39 -46.75 59.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.389 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 70.2 ttt180 -85.96 -4.07 59.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.591 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 165' ' ' PHE . . . -107.18 -57.67 0.59 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -56.38 -37.87 70.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 0.0 110.564 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.63 ' CD1' ' O ' ' A' ' 167' ' ' ALA . 13.8 m-30 -63.49 -32.33 73.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.768 HG22 HD11 ' A' ' 91' ' ' LEU . 71.4 t -60.7 -39.79 82.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.615 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.57 -34.85 71.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.627 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -56.61 -41.58 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.522 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.673 ' N ' ' CD2' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -60.92 -35.33 76.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.571 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.74 -32.78 73.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.562 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.75 -32.64 74.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.519 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.5 m . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.585 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.3 ttm . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 14.7 p -128.18 142.43 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.719 ' NE2' ' CD2' ' A' ' 118' ' ' PHE . 15.4 tt0 -100.18 114.7 28.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.878 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.161 ' HB3' ' CG1' ' A' ' 26' ' ' VAL . . . -164.3 171.82 14.35 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.758 ' O ' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -121.24 142.15 50.19 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.659 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.674 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 22.8 t80 -104.42 68.58 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.463 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.591 ' HB2' ' O ' ' A' ' 114' ' ' TRP . 87.8 mtp -55.71 -26.53 45.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.753 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.674 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 86.0 m-20 -53.93 -34.59 60.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.583 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.627 ' CG ' ' CE2' ' A' ' 6' ' ' TYR . 92.3 m-20 -104.42 5.35 34.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.494 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.762 ' HB1' ' HB3' ' A' ' 18' ' ' HIS . . . -75.27 148.54 83.82 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.933 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.55 ' HD3' ' HD3' ' A' ' 20' ' ' PRO . 28.1 Cg_exo -57.65 142.09 95.64 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.698 2.265 . . . . 0.0 111.518 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.55 29.89 0.59 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 11' ' ' PRO . 10.2 m-20 -114.71 97.81 47.99 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.962 0.41 . . . . 0.0 110.59 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -61.89 -12.74 27.16 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.938 2.425 . . . . 0.0 111.97 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.6 ttt-85 -56.61 -38.38 71.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.03 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.508 ' C ' ' H ' ' A' ' 18' ' ' HIS . 22.1 mt-30 -107.96 168.44 7.89 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.046 0.45 . . . . 0.0 111.242 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.643 ' HB2' ' NE ' ' A' ' 19' ' ' ARG . 25.4 Cg_exo -59.5 2.29 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.185 2.59 . . . . 0.0 111.884 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.762 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 34.6 m-70 74.8 29.67 1.04 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.173 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.643 ' NE ' ' HB2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -121.88 96.2 47.13 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.467 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.636 ' O ' ' C ' ' A' ' 22' ' ' PRO . 36.2 Cg_endo -68.88 125.41 12.57 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.557 2.171 . . . . 0.0 111.18 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -63.41 118.53 44.85 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.809 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.636 ' C ' ' O ' ' A' ' 20' ' ' PRO . 1.6 Cg_endo -81.71 143.67 57.91 Favored 'Cis proline' 0 C--N 1.309 -1.537 0 C-N-CA 123.615 -1.41 . . . . 0.0 111.966 -0.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.56 161.06 43.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -133.58 117.54 14.29 Favored Pre-proline 0 C--N 1.332 -0.183 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.131 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.38 157.31 61.58 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 123.058 2.506 . . . . 0.0 111.467 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.161 ' CG1' ' HB3' ' A' ' 4' ' ' ALA . 1.7 p -57.37 142.61 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.761 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 30' ' ' GLN . . . -82.89 100.41 2.2 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.601 ' HB2' ' CG1' ' A' ' 2' ' ' VAL . 21.4 tp -47.15 -43.12 20.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.725 0.298 . . . . 0.0 110.317 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.8 -35.34 80.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.021 0.439 . . . . 0.0 109.946 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.784 ' O ' HD13 ' A' ' 34' ' ' LEU . 93.5 mt-30 -61.38 -41.73 97.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.097 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 34' ' ' LEU . 10.3 mt -69.49 -34.41 74.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.43 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -42.12 65.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 33' ' ' ARG . 19.9 ttp180 -64.8 -31.21 72.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.018 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 30' ' ' GLN . 10.3 mp -65.3 -18.13 65.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.026 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.88 23.13 11.03 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.28 132.24 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 0.0 110.742 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 55.3 mt -108.75 141.21 41.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.633 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -118.01 123.55 45.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.623 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.859 ' HZ3' ' HG1' ' A' ' 126' ' ' THR . 2.3 m-90 -121.23 132.3 54.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.179 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -105.84 104.98 14.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.062 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.634 ' C ' ' OH ' ' A' ' 97' ' ' TYR . 1.3 mp -140.58 153.34 46.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.95 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 46' ' ' TYR . 85.9 m-20 -102.92 133.07 48.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.532 ' O ' ' HD1' ' A' ' 46' ' ' TYR . . . -49.52 -43.98 45.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.69 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.683 ' OD2' ' N ' ' A' ' 45' ' ' LYS . 56.6 p30 -65.79 -31.6 72.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.673 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.683 ' N ' ' OD2' ' A' ' 44' ' ' ASP . 12.0 ttmm -85.38 -19.39 31.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.268 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.721 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -61.56 -56.48 19.47 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.822 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.721 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 84.9 tt0 -72.01 -40.86 68.18 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.584 -0.446 . . . . 0.0 109.984 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.618 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 17.8 m120 -66.77 -22.92 66.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.806 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.659 ' O ' ' N ' ' A' ' 51' ' ' GLU . 23.4 t0 -124.32 84.64 56.09 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.305 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 53' ' ' GLU . 75.0 Cg_exo -41.05 -8.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.59 2.86 . . . . 0.0 112.584 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 49' ' ' ASP . 12.4 tm-20 -41.87 -32.53 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -54.28 -41.03 68.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 96.9 mt-10 -60.97 -35.89 77.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.266 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -59.64 -44.73 93.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.949 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.0 mt -62.01 -32.82 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.654 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . 27.2 ttt180 -55.74 -42.02 74.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.702 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -61.42 -41.46 97.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.779 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -67.48 -44.79 77.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.536 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.642 HH12 HG21 ' A' ' 126' ' ' THR . 46.7 mtp85 -76.38 -19.48 58.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.534 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 56' ' ' ARG . 14.5 t-20 60.34 44.5 12.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.932 ' HA ' HG22 ' A' ' 150' ' ' VAL . 4.2 p90 -112.0 126.15 54.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.094 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.572 ' C ' HH21 ' A' ' 56' ' ' ARG . 51.8 p -94.51 0.2 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.311 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.772 ' CE3' ' CE2' ' A' ' 149' ' ' PHE . 49.1 t90 -123.35 133.39 54.13 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.72 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.659 ' HB3' HD22 ' A' ' 148' ' ' LEU . 8.6 ptm -154.49 145.37 22.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.256 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.589 ' HB3' ' CH2' ' A' ' 63' ' ' TRP . 49.9 t0 -159.27 162.9 36.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 0.0 110.83 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.504 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 65.7 mt -114.06 127.96 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.505 HG12 ' N ' ' A' ' 68' ' ' THR . 5.3 tt -130.69 154.37 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 111.496 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.626 HG23 ' HG2' ' A' ' 144' ' ' LYS . 42.0 m -117.02 142.14 47.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.331 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.615 ' C ' ' SG ' ' A' ' 70' ' ' CYS . 2.2 mt -104.22 125.71 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.147 0.499 . . . . 0.0 111.168 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.615 ' SG ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -171.12 128.27 0.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.459 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -57.32 -46.03 83.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.889 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -67.72 -40.83 84.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.848 0.356 . . . . 0.0 111.033 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 70' ' ' CYS . 30.5 tttt -69.51 -41.22 76.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.034 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.741 HD23 ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -133.47 87.41 37.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.777 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 74' ' ' LEU . 72.3 Cg_exo -41.01 176.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.22 1.947 . . . . 0.0 110.418 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.662 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 59.5 t-20 69.94 36.48 1.98 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.322 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.649 ' CE2' HG13 ' A' ' 81' ' ' ILE . 24.2 t80 -65.33 -51.45 60.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.567 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.647 ' O ' ' CD ' ' A' ' 82' ' ' LYS . 97.0 mt-10 -69.35 -46.97 65.74 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.662 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 98.7 mt-10 -65.17 -42.26 93.88 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.443 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.657 ' HE3' ' CE2' ' A' ' 155' ' ' TRP . 14.4 tptt -71.71 -45.73 60.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.15 0.5 . . . . 0.0 109.933 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.916 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 14.1 mm -61.56 -58.13 8.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.799 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.647 ' CD ' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -54.21 -32.64 56.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.488 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.63 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 76.8 mmm -59.47 -61.15 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.254 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.916 ' CZ ' HD13 ' A' ' 81' ' ' ILE . 46.0 p90 -86.96 -16.31 36.21 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.695 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.673 ' CB ' ' O ' ' A' ' 81' ' ' ILE . 19.9 t80 -61.92 -46.26 90.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.14 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -65.47 142.49 58.14 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.231 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.6 139.47 31.7 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.149 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -164.79 170.36 15.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.032 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.134 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -133.08 171.83 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.529 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.631 ' HE1' ' CD2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -170.41 154.68 4.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.673 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.563 HD11 ' HG3' ' A' ' 173' ' ' LYS . 0.3 OUTLIER -74.55 5.05 5.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.916 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 49.7 p30 -108.98 152.2 25.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.474 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.607 ' OD2' ' O ' ' A' ' 93' ' ' ASP . 50.1 p30 -81.76 146.96 29.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.653 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.556 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 7.3 mm-40 -105.88 116.07 31.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.826 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.016 HD13 ' OG1' ' A' ' 126' ' ' THR . 6.3 tp -127.78 119.95 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.353 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.53 ' HE ' ' HB3' ' A' ' 145' ' ' ALA . 63.4 ttt180 -134.65 137.41 43.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.478 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.933 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.6 t80 -114.61 129.02 56.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.179 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.711 HG22 ' HA ' ' A' ' 121' ' ' LYS . 20.0 mm -86.08 99.87 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.423 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 97' ' ' TYR . 1.7 mt -82.81 -43.87 16.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.893 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.625 ' OD2' ' O ' ' A' ' 99' ' ' LEU . 91.3 m-20 -144.88 -21.08 0.51 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.896 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.659 ' O ' ' CG2' ' A' ' 98' ' ' ILE . . . -82.8 -176.7 51.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.525 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 49.0 m -151.23 158.05 43.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.547 ' C ' ' CD2' ' A' ' 104' ' ' TYR . . . 176.45 178.37 46.17 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.287 -0.958 . . . . 0.0 111.694 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.765 ' CE2' ' CD1' ' A' ' 118' ' ' PHE . 2.8 m-85 -124.32 140.4 52.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.613 0.244 . . . . 0.0 110.384 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.771 ' CD1' ' SD ' ' A' ' 119' ' ' MET . 18.5 m-30 -109.09 128.92 55.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 110.723 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.699 ' OD1' ' CE3' ' A' ' 114' ' ' TRP . 23.8 t70 -93.6 121.32 34.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.472 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.542 ' CG1' HD11 ' A' ' 117' ' ' ILE . 13.0 p -131.85 145.92 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.626 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.657 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 20.8 ttp180 -116.81 143.2 45.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 110.749 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD2' ' C ' ' A' ' 109' ' ' ASP . 49.3 p30 -101.55 174.41 5.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.423 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.98 -31.66 65.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.046 0.451 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 112' ' ' ASP . 84.5 tt0 -59.81 -9.14 2.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.105 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 111' ' ' GLU . 85.2 m-20 69.33 38.36 1.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.473 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.642 ' CB ' ' CG ' ' A' ' 8' ' ' ASP . 95.5 mm-40 -120.62 154.39 35.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.87 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.699 ' CE3' ' OD1' ' A' ' 106' ' ' ASP . 98.6 m95 -104.25 137.23 42.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.17 0.51 . . . . 0.0 111.387 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.758 HG23 ' O ' ' A' ' 5' ' ' TRP . 72.3 mt -119.07 134.19 63.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.981 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.556 ' NH2' ' HD1' ' A' ' 104' ' ' TYR . 13.5 tpt180 -90.49 124.67 35.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.917 HG22 ' HE3' ' A' ' 119' ' ' MET . 21.9 mt -113.33 134.18 56.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.878 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.765 ' CD1' ' CE2' ' A' ' 104' ' ' TYR . 65.1 t80 -101.48 129.87 47.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.953 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.917 ' HE3' HG22 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -115.13 123.9 50.13 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.446 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 123' ' ' ASP . 12.7 pt-20 -102.75 169.99 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.568 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.711 ' HA ' HG22 ' A' ' 98' ' ' ILE . 18.3 ptpt -64.79 123.7 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.953 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 95.93 -1.94 63.66 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.577 ' O ' HG12 ' A' ' 98' ' ' ILE . 60.2 t0 -93.89 119.96 33.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 0.0 111.007 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.66 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . 21.7 ttt -108.52 132.4 53.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.304 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 14.8 p -135.65 146.53 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 110.83 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . 1.016 ' OG1' HD13 ' A' ' 95' ' ' ILE . 42.1 m -119.72 139.37 52.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.336 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.933 HD22 ' HB2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -114.71 143.36 29.86 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.005 0.431 . . . . 0.0 110.841 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.599 ' CG ' HD12 ' A' ' 131' ' ' ILE . 32.4 Cg_endo -66.65 154.39 74.59 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.053 2.502 . . . . 0.0 112.238 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.524 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -94.14 138.95 31.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.586 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.604 ' O ' ' NE2' ' A' ' 170' ' ' GLN . . . 96.62 -0.18 61.11 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.599 HD12 ' CG ' ' A' ' 128' ' ' PRO . 70.6 mt -116.82 142.38 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.684 0.278 . . . . 0.0 110.277 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.699 ' CD2' HD21 ' A' ' 89' ' ' LEU . 99.7 m-85 -52.2 131.94 33.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.419 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.933 ' HB2' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -156.09 134.57 11.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.449 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 85' ' ' TYR . 23.3 ttp180 -139.81 136.81 34.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.871 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.66 ' CD2' ' CD2' ' A' ' 105' ' ' PHE . 21.6 m-30 -112.68 134.07 54.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.351 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 56.9 m -126.6 136.28 52.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.926 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.3 m -147.83 6.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.189 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.621 ' O ' ' OD1' ' A' ' 141' ' ' ASN . 22.2 t70 -55.65 -38.23 69.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.398 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.48 -42.6 96.63 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.227 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 102' ' ' SER . 10.6 mmtm -66.59 -33.23 75.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.725 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.621 ' OD1' ' O ' ' A' ' 138' ' ' ASP . 87.5 m-20 68.32 -10.99 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.616 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.49 ' H ' ' C ' ' A' ' 140' ' ' LYS . 49.4 t80 -151.55 117.38 5.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.367 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.569 HG23 ' HA3' ' A' ' 101' ' ' GLY . 46.4 m -136.22 127.25 27.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.874 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.626 ' HG2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -117.54 103.1 9.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.933 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.82 154.58 45.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.596 ' SD ' ' HE3' ' A' ' 64' ' ' MET . 0.1 OUTLIER -97.48 143.14 28.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.618 ' NH2' ' CD2' ' A' ' 149' ' ' PHE . 67.5 ttp85 -115.61 140.69 48.94 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.819 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.835 HD13 ' CE1' ' A' ' 61' ' ' TYR . 48.2 mt -118.57 134.26 55.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.721 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.772 ' CE2' ' CE3' ' A' ' 63' ' ' TRP . 6.3 p90 -149.8 160.46 43.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.374 . . . . 0.0 110.597 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.932 HG22 ' HA ' ' A' ' 61' ' ' TYR . 31.1 t -115.87 130.69 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.1 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.433 ' O ' ' CE1' ' A' ' 149' ' ' PHE . . . 80.08 -164.17 47.84 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 153' ' ' PRO . 2.4 pt-20 -73.11 126.45 90.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.452 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 149' ' ' PHE . 25.1 Cg_exo -58.94 124.23 15.25 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.79 2.327 . . . . 0.0 112.295 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.4 -34.13 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.447 . . . . 0.0 109.973 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' ' CE3' ' A' ' 155' ' ' TRP . 1.7 t-105 -58.94 -29.95 67.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.759 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.567 ' OG1' ' HB2' ' A' ' 153' ' ' PRO . 38.3 m -44.49 -46.31 9.66 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.291 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.93 100.89 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.453 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.69 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -157.0 166.64 32.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.709 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.594 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 86.7 m-20 -91.08 156.62 17.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.994 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.606 ' CB ' ' HD3' ' A' ' 161' ' ' PRO . 0.3 OUTLIER -36.73 -61.73 0.61 Allowed Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.178 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.606 ' HD3' ' CB ' ' A' ' 160' ' ' ARG . 74.1 Cg_endo -81.38 98.54 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.856 2.37 . . . . 0.0 111.697 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 1.134 ' HB3' ' O ' ' A' ' 89' ' ' LEU . . . -63.32 -33.73 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.78 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.588 ' OD1' ' HB2' ' A' ' 89' ' ' LEU . 88.5 m-20 -77.87 -5.23 50.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.553 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.531 ' HB2' ' HG2' ' A' ' 161' ' ' PRO . 28.5 t-80 -56.61 -32.55 65.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.626 ' O ' ' N ' ' A' ' 169' ' ' GLY . 97.6 m-85 -85.29 133.65 34.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.006 0.431 . . . . 0.0 110.982 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.14 -45.05 83.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.594 ' O ' ' CG2' ' A' ' 172' ' ' VAL . . . -70.22 -45.74 65.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.324 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.481 ' HB2' ' HB2' ' A' ' 165' ' ' PHE . 94.5 mtt-85 -87.74 -1.91 58.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.434 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.663 ' O ' HG12 ' A' ' 172' ' ' VAL . . . -86.7 176.07 47.56 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.604 ' NE2' ' O ' ' A' ' 130' ' ' GLY . 94.7 mt-30 -61.37 -31.46 71.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -58.93 -28.06 65.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.599 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 169' ' ' GLY . 5.1 p -54.84 -34.58 31.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.416 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.563 ' HG3' HD11 ' A' ' 91' ' ' LEU . 47.2 mttt -58.22 -35.1 71.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.509 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.34 -41.19 75.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.754 ' O ' HG22 ' A' ' 178' ' ' THR . 0.2 OUTLIER -61.28 -35.07 76.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.505 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.02 72.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.603 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -63.83 -32.95 74.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.754 HG22 ' O ' ' A' ' 175' ' ' LEU . 1.7 t . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.584 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.7 mtm . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.856 ' HB ' HD12 ' A' ' 28' ' ' LEU . 14.6 p -127.96 140.47 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.541 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -102.72 115.77 31.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.111 ' HB3' ' CG1' ' A' ' 26' ' ' VAL . . . -163.88 155.96 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.758 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.637 ' CZ3' ' HB3' ' A' ' 25' ' ' PRO . 0.9 OUTLIER -128.24 141.22 51.52 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.191 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.931 ' CE1' HD11 ' A' ' 115' ' ' ILE . 2.1 t80 -96.13 -6.01 39.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.11 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.597 ' CE ' ' HG3' ' A' ' 20' ' ' PRO . 85.4 mmm -94.15 13.03 24.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.265 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.93 -33.77 57.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.911 0.386 . . . . 0.0 110.919 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.661 ' OD1' ' N ' ' A' ' 10' ' ' ALA . 53.6 p30 -57.89 -29.52 65.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.103 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.661 ' N ' ' OD1' ' A' ' 9' ' ' ASP . . . -57.87 130.31 82.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 110.397 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.644 ' O ' ' NE2' ' A' ' 18' ' ' HIS . 19.3 Cg_endo -61.33 134.68 53.29 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.695 2.263 . . . . 0.0 112.164 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.81 -177.61 34.49 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.39 135.05 76.02 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 0.0 110.324 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.17 -25.84 79.57 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.617 2.211 . . . . 0.0 111.995 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.483 HH11 ' HA ' ' A' ' 15' ' ' ARG . 7.7 mmm180 -57.73 -34.78 69.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.832 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -100.2 155.17 36.72 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.033 0.444 . . . . 0.0 110.693 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.59 ' HG2' ' CG ' ' A' ' 19' ' ' ARG . 46.9 Cg_endo -85.8 -3.55 9.02 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 123.247 2.632 . . . . 0.0 112.112 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.644 ' NE2' ' O ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER 47.28 44.97 16.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.028 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.59 ' CG ' ' HG2' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -61.81 107.42 1.13 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.854 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.68 ' O ' ' N ' ' A' ' 23' ' ' GLY . 35.1 Cg_endo -68.0 159.45 52.93 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.864 2.376 . . . . 0.0 111.62 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -112.27 107.39 55.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.697 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 21' ' ' ASP . 63.2 Cg_endo -78.11 150.02 88.1 Favored 'Cis proline' 0 C--N 1.309 -1.55 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.355 -0.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -95.85 173.49 30.73 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -152.91 117.65 2.89 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 111.08 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.637 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 55.7 Cg_endo -74.11 152.8 45.98 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.158 2.572 . . . . 0.0 111.756 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.111 ' CG1' ' HB3' ' A' ' 4' ' ' ALA . 1.3 p -58.66 144.75 11.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 30' ' ' GLN . . . -94.69 104.56 3.16 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.856 HD12 ' HB ' ' A' ' 2' ' ' VAL . 8.4 tt -45.27 -44.29 11.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.73 -34.55 77.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 27' ' ' GLY . 50.3 tt0 -61.89 -40.85 96.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.264 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.796 HD11 ' CG2' ' A' ' 26' ' ' VAL . 9.0 mp -63.39 -39.41 94.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.636 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.754 ' NH1' HD22 ' A' ' 37' ' ' LEU . 54.2 ttt85 -57.23 -44.05 83.43 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.521 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -75.17 -30.51 60.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.627 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 34' ' ' LEU . 30.8 tp -68.73 -7.24 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.127 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.561 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . 102.65 -0.3 49.25 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 32' ' ' ARG . 93.1 t -101.8 126.56 55.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.362 . . . . 0.0 110.557 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.754 HD22 ' NH1' ' A' ' 32' ' ' ARG . 79.8 mt -111.53 147.56 35.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.605 ' CD2' ' HE2' ' A' ' 40' ' ' LYS . 32.8 t80 -114.22 124.28 51.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.142 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.683 ' CZ3' ' OG1' ' A' ' 126' ' ' THR . 1.5 m0 -113.1 138.63 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.757 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.605 ' HE2' ' CD2' ' A' ' 38' ' ' TYR . 61.8 mmtt -98.65 105.92 18.12 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.888 HD13 ' HE1' ' A' ' 46' ' ' TYR . 31.8 mt -138.27 139.11 39.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.207 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 46' ' ' TYR . 87.6 m-20 -108.46 128.72 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 99' ' ' LEU . . . -50.36 -42.8 53.77 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.956 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.14 -33.69 76.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.573 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 49' ' ' ASP . 2.2 mtpt -88.07 -17.53 30.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.001 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.888 ' HE1' HD13 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -58.55 -49.1 78.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.764 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -82.8 -44.18 15.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.057 0.456 . . . . 0.0 109.927 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -66.78 -23.38 66.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.612 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 45' ' ' LYS . 1.9 t0 -127.18 84.34 63.7 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.567 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.7 Cg_endo -49.47 -8.69 0.1 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 123.083 2.522 . . . . 0.0 111.288 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 49' ' ' ASP . 84.5 tt0 -43.81 -35.96 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.47 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.052 HD13 ' H ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -59.17 -33.31 70.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.374 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 1.052 ' H ' HD13 ' A' ' 52' ' ' LEU . 1.5 tp10 -64.74 -35.82 82.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.925 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -58.64 -40.18 82.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.069 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.89 -44.47 90.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.667 ' NE ' ' O ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -66.62 -36.47 82.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.439 179.332 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.625 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 70.3 ttp85 -62.52 -42.78 99.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.297 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.18 -35.62 80.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.614 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -85.03 0.33 51.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.429 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 60.49 42.3 14.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.181 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.68 ' CZ ' ' HB3' ' A' ' 59' ' ' ARG . 19.3 m-85 -80.22 122.67 27.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.971 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.26 -31.74 12.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.203 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.708 ' CH2' ' CG ' ' A' ' 65' ' ' ASP . 37.7 t90 -113.07 121.47 44.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 111.3 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.816 ' SD ' HD23 ' A' ' 148' ' ' LEU . 83.4 mmm -146.61 139.48 25.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.523 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.708 ' CG ' ' CH2' ' A' ' 63' ' ' TRP . 21.1 p30 -163.13 165.04 25.04 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.841 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.759 HD13 HD22 ' A' ' 99' ' ' LEU . 65.8 mt -115.17 131.8 66.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.267 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.673 ' CG2' ' NH1' ' A' ' 147' ' ' ARG . 10.7 tp -129.15 158.87 41.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.403 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 144' ' ' LYS . 5.5 t -123.55 153.15 41.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.533 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.733 HG21 HG21 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -104.09 103.48 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.433 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 72' ' ' ASP . 20.9 t -172.06 110.18 0.26 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 77' ' ' TYR . 0.8 OUTLIER -58.65 -35.32 72.36 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.295 -179.299 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 90.3 m-20 -59.19 -39.42 82.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.444 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -97.36 -41.29 8.31 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.313 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -123.95 85.69 54.05 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.99 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.591 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 2.7 Cg_exo -40.74 172.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.451 2.1 . . . . 0.0 110.316 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.643 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 62.6 t-20 72.4 29.53 2.13 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.358 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.918 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.6 t80 -64.23 -45.83 86.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.58 ' O ' HG13 ' A' ' 81' ' ' ILE . 20.1 pt-20 -71.44 -47.52 55.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.643 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 98.2 mt-10 -66.78 -40.12 88.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.386 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.538 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 57.4 tttp -67.99 -47.75 67.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.557 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.092 HD13 ' CE1' ' A' ' 85' ' ' TYR . 2.7 pp -67.4 -42.41 87.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.568 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.81 ' N ' HD12 ' A' ' 81' ' ' ILE . 55.4 tttp -55.87 -39.57 71.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.132 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.593 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 61.8 mtt -59.78 -44.25 94.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.94 0.4 . . . . 0.0 110.695 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.672 ' CE2' ' CZ2' ' A' ' 155' ' ' TRP . 95.5 m-85 -73.51 -33.57 64.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.615 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 1.092 ' CE1' HD13 ' A' ' 81' ' ' ILE . 11.4 m-30 -60.04 -45.66 92.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.542 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 83' ' ' MET . 20.4 pt-20 -64.66 129.74 40.95 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.329 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.633 ' OE2' ' CH2' ' A' ' 114' ' ' TRP . 96.1 mt-10 -63.61 137.9 58.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.552 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.666 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.5 OUTLIER -150.91 171.94 16.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.452 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.171 HD22 ' CE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.81 -179.91 5.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.273 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.939 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -170.71 146.48 2.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 179.628 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 91' ' ' LEU . 6.3 mp -65.82 -24.77 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.329 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.581 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 48.6 p30 -108.22 150.54 27.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 111.261 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.747 ' OD2' HG22 ' A' ' 126' ' ' THR . 49.2 t0 -84.32 128.9 34.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.967 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.631 ' OE2' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -107.93 140.38 41.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.87 0.367 . . . . 0.0 110.667 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.826 HD12 ' HE3' ' A' ' 124' ' ' MET . 15.3 pt -113.75 133.2 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.478 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.728 ' NH1' ' CZ ' ' A' ' 105' ' ' PHE . 42.3 ttm180 -123.27 138.89 54.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.382 . . . . 0.0 110.686 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.687 ' CD2' ' CZ ' ' A' ' 46' ' ' TYR . 17.5 t80 -118.49 129.84 55.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.474 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.825 HG12 ' HE2' ' A' ' 119' ' ' MET . 11.4 mm -91.14 94.22 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.169 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.759 HD22 HD13 ' A' ' 66' ' ' ILE . 12.8 tp -80.15 -33.21 38.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.524 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.684 ' CG ' ' N ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -66.53 -68.64 0.36 Allowed 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.633 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.684 ' N ' ' CG ' ' A' ' 100' ' ' ASP . . . 157.86 -28.11 0.47 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.517 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 1.122 ' O ' HG23 ' A' ' 143' ' ' THR . 97.1 p -113.64 141.72 46.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.681 0.741 . . . . 0.0 111.237 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.546 ' HA2' ' CZ ' ' A' ' 135' ' ' PHE . . . -173.75 125.41 1.12 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.561 ' OH ' ' HG3' ' A' ' 116' ' ' ARG . 81.1 t80 -115.89 131.29 56.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.727 0.298 . . . . 0.0 110.815 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.728 ' CZ ' ' NH1' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -137.73 157.01 47.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.707 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.572 ' OD1' ' HG2' ' A' ' 134' ' ' ARG . 49.5 p30 -144.88 151.27 38.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.358 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.61 141.96 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.967 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.651 ' HB2' ' CH2' ' A' ' 114' ' ' TRP . 38.2 ttt180 -106.4 137.35 44.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.406 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 56.7 t0 -103.35 156.56 17.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.552 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 26.6 mttp -59.28 -30.74 68.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.058 0.456 . . . . 0.0 110.328 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.626 ' O ' ' OD2' ' A' ' 112' ' ' ASP . 96.0 mt-10 -68.99 -0.63 5.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.214 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.648 ' OD2' ' C ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER 76.62 32.09 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.52 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.484 ' OE1' ' OE1' ' A' ' 111' ' ' GLU . 41.5 mt-30 -110.19 146.0 36.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.046 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.651 ' CH2' ' HB2' ' A' ' 108' ' ' ARG . 82.7 m95 -113.66 139.54 48.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.969 0.414 . . . . 0.0 111.175 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.931 HD11 ' CE1' ' A' ' 6' ' ' TYR . 60.5 mt -114.14 125.19 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.224 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 71.6 ttp85 -93.3 114.1 26.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.24 128.3 73.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.602 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.48 ' CE2' ' OE2' ' A' ' 139' ' ' GLU . 67.8 t80 -103.33 131.04 50.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.267 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.825 ' HE2' HG12 ' A' ' 98' ' ' ILE . 88.4 mtp -100.11 127.57 46.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.627 ' OE2' ' OD2' ' A' ' 123' ' ' ASP . 3.6 mp0 -110.76 159.65 17.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 0.0 110.76 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.629 ' CA ' ' HA2' ' A' ' 101' ' ' GLY . 8.0 pttm -45.67 121.2 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.143 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.656 ' CA ' ' O ' ' A' ' 41' ' ' LEU . . . 89.25 6.56 71.09 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.774 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.627 ' OD2' ' OE2' ' A' ' 120' ' ' GLU . 87.4 m-20 -92.18 119.46 31.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.826 ' HE3' HD12 ' A' ' 95' ' ' ILE . 1.2 tpt -113.88 129.78 56.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.182 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 37' ' ' LEU . 12.6 p -134.28 144.68 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.836 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.747 HG22 ' OD2' ' A' ' 93' ' ' ASP . 82.8 m -105.51 132.7 51.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.043 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.625 HD22 ' CE1' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -102.49 122.68 45.52 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.9 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.61 ' HG2' HD12 ' A' ' 131' ' ' ILE . 20.7 Cg_endo -63.89 144.51 88.48 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.954 2.436 . . . . 0.0 112.107 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.939 ' HB1' ' O ' ' A' ' 90' ' ' HIS . . . -75.9 142.33 42.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.058 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.12 11.3 61.48 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 128' ' ' PRO . 1.2 mt -115.47 148.78 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.766 0.317 . . . . 0.0 110.716 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 1.171 ' CE2' HD22 ' A' ' 89' ' ' LEU . 7.8 m-30 -94.75 131.31 40.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.179 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.63 ' HE1' ' CE1' ' A' ' 90' ' ' HIS . 20.0 p-80 -154.64 167.74 29.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.58 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.572 ' HG2' ' OD1' ' A' ' 106' ' ' ASP . 16.1 ptp180 -149.41 150.78 32.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.632 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.69 ' O ' ' CD2' ' A' ' 85' ' ' TYR . 68.8 t80 -114.42 132.41 56.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 138' ' ' ASP . 46.5 m -125.54 137.11 53.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.023 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.759 HG22 ' OH ' ' A' ' 85' ' ' TYR . 15.3 m -117.77 12.0 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.594 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.657 ' H ' HG22 ' A' ' 136' ' ' THR . 56.3 t0 -57.61 -23.19 49.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.151 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.592 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 84.4 tt0 -44.71 -34.77 2.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.289 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 19.6 mtpt -159.95 4.28 0.08 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 58.71 33.27 22.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.902 0.382 . . . . 0.0 110.555 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.473 ' O ' ' OG ' ' A' ' 102' ' ' SER . 62.3 t80 -151.99 97.65 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.178 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 1.122 HG23 ' O ' ' A' ' 102' ' ' SER . 53.3 m -135.25 130.76 35.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.386 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.639 ' HB3' ' CB ' ' A' ' 100' ' ' ASP . 29.3 tttt -130.43 117.16 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.656 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.51 156.88 45.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.704 ' SD ' ' HE3' ' A' ' 64' ' ' MET . 44.2 ttm -92.19 135.17 34.21 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.673 ' NH1' ' CG2' ' A' ' 67' ' ' ILE . 50.2 mtm-85 -111.27 149.23 31.34 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.084 0.469 . . . . 0.0 111.256 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.946 HD13 ' C ' ' A' ' 148' ' ' LEU . 1.8 tm? -119.92 119.32 33.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.862 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.658 ' N ' HD22 ' A' ' 148' ' ' LEU . 98.1 m-85 -129.8 153.55 48.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.984 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.48 129.86 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.074 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.32 -159.43 38.99 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.47 148.37 98.1 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 110.633 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.69 ' HB2' HG23 ' A' ' 156' ' ' THR . 38.0 Cg_endo -69.51 95.25 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.884 2.39 . . . . 0.0 112.294 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.32 -27.41 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.688 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.672 ' CZ2' ' CE2' ' A' ' 84' ' ' PHE . 43.6 t90 -56.3 -34.05 66.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.69 HG23 ' HB2' ' A' ' 153' ' ' PRO . 53.7 p -46.32 -43.83 16.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.56 100.55 3.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.25 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CD2' ' O ' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -151.12 159.99 44.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.67 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.668 ' HB3' ' CG ' ' A' ' 164' ' ' HIS . 41.9 t-20 -91.23 161.07 15.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.98 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.59 ' HG2' ' CD ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -32.7 -60.16 0.38 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.381 . . . . 0.0 110.547 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 160' ' ' ARG . 37.5 Cg_endo -69.42 137.47 36.53 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.838 2.358 . . . . 0.0 112.317 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.959 ' HB2' ' O ' ' A' ' 89' ' ' LEU . . . -66.72 -29.29 69.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.48 ' C ' ' OD1' ' A' ' 163' ' ' ASP . 48.5 p30 -85.84 14.24 6.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.668 ' CG ' ' HB3' ' A' ' 159' ' ' ASN . 83.1 t60 -54.26 -39.25 66.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.029 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.696 ' CZ ' ' O ' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -87.36 126.71 35.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 110.814 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 171' ' ' TYR . 73.8 mm-40 -65.83 -45.89 80.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.461 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 171' ' ' TYR . . . -71.27 -46.62 60.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.918 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.589 ' C ' ' CD2' ' A' ' 165' ' ' PHE . 74.4 mtt85 -89.4 7.01 38.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.812 0.339 . . . . 0.0 110.706 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.559 ' N ' ' HD2' ' A' ' 165' ' ' PHE . . . -108.57 -114.9 3.8 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -58.4 -35.3 71.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.752 0.311 . . . . 0.0 110.668 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.53 ' HB3' ' O ' ' A' ' 167' ' ' ALA . 71.6 t80 -55.4 -39.11 69.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' A' ' 168' ' ' ARG . 73.2 t -58.26 -38.98 71.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.602 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.589 ' HD2' ' CD2' ' A' ' 91' ' ' LEU . 60.5 mtpt -57.75 -34.89 70.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.678 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -56.72 -41.33 77.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.499 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.0 tp -57.26 -37.68 72.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.632 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.34 72.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.655 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -63.59 -33.06 74.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.527 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.019 ' HB ' HD12 ' A' ' 28' ' ' LEU . 10.5 p -127.83 141.58 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.53 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.567 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 13.2 mm-40 -94.25 114.58 26.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.497 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.158 ' HB3' ' CG1' ' A' ' 26' ' ' VAL . . . -163.55 162.7 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.891 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.519 ' HE3' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -126.95 148.21 50.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.064 0.459 . . . . 0.0 111.685 -178.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.697 ' CZ ' ' OD2' ' A' ' 8' ' ' ASP . 1.2 t80 -108.71 77.29 1.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.238 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.55 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . 17.1 ptm -72.47 5.72 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.566 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.697 ' OD2' ' CZ ' ' A' ' 6' ' ' TYR . 89.7 m-20 -54.34 -34.36 60.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.206 0.527 . . . . 0.0 110.037 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -107.09 5.81 28.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.303 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 7' ' ' MET . . . -105.99 153.96 39.82 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.806 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.495 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 32.5 Cg_endo -66.86 141.04 57.42 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.811 2.341 . . . . 0.0 112.171 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.44 33.28 0.69 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.591 ' OD2' ' N ' ' A' ' 15' ' ' ARG . 2.3 t0 -100.1 110.21 58.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 110.532 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.64 -33.24 86.52 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.749 2.299 . . . . 0.0 112.297 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.591 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 26.8 mmt180 -53.98 -34.76 60.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.583 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 63.7 mt-30 -100.06 139.28 20.62 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.258 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.606 ' HB2' ' CG ' ' A' ' 19' ' ' ARG . 23.6 Cg_exo -60.27 -6.77 5.66 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 122.827 2.351 . . . . 0.0 111.325 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 62.0 m-70 71.71 39.03 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.121 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.606 ' CG ' ' HB2' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -89.48 100.56 2.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.253 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.629 ' O ' ' C ' ' A' ' 22' ' ' PRO . 16.1 Cg_endo -60.91 153.68 61.7 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.608 2.205 . . . . 0.0 111.73 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -105.55 112.31 64.71 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.622 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' C ' ' O ' ' A' ' 20' ' ' PRO . 37.8 Cg_endo -73.33 156.76 99.5 Favored 'Cis proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.144 -1.607 . . . . 0.0 112.348 -0.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 20' ' ' PRO . . . -68.57 143.64 40.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HG3' ' HG2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -152.71 121.05 3.18 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.222 0.534 . . . . 0.0 111.225 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.73 156.32 63.74 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.161 2.574 . . . . 0.0 111.327 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.158 ' CG1' ' HB3' ' A' ' 4' ' ' ALA . 1.2 p -57.33 144.7 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.54 103.02 2.92 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.019 HD12 ' HB ' ' A' ' 2' ' ' VAL . 9.2 tt -48.64 -40.34 27.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.809 0.337 . . . . 0.0 110.348 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -59.37 -36.98 76.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.168 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.574 ' OE1' ' HA ' ' A' ' 30' ' ' GLN . 15.1 mm-40 -61.33 -43.59 98.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.693 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.59 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 18.2 mt -71.77 -34.54 69.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.22 -43.11 70.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.286 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.544 ' CG ' HH11 ' A' ' 33' ' ' ARG . 2.6 ttt-85 -65.29 -31.05 71.99 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.59 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 28.2 tp -65.13 -18.55 65.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.888 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.553 ' O ' ' HG3' ' A' ' 128' ' ' PRO . . . 102.83 17.24 19.44 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.51 128.97 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.263 0.554 . . . . 0.0 110.979 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 126' ' ' THR . 35.5 mt -123.89 143.0 50.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.15 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.814 ' CE1' HD11 ' A' ' 28' ' ' LEU . 30.6 p90 -144.46 150.97 38.52 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.871 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.6 ' HB2' ' CB ' ' A' ' 124' ' ' MET . 24.3 m-90 -123.13 141.21 52.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.575 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.442 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 4.1 ttpm? -99.37 104.42 16.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.898 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.666 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 1.1 mt -141.32 150.83 43.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.288 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.639 ' OD1' ' NZ ' ' A' ' 45' ' ' LYS . 84.4 m-20 -102.23 132.54 48.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.545 ' HB2' ' CA ' ' A' ' 99' ' ' LEU . . . -47.09 -44.1 20.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.16 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -62.57 -33.22 74.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.738 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.639 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 18.0 mttp -86.6 -8.18 57.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.319 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.692 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -71.42 -56.09 6.63 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.692 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 48.8 tp10 -76.09 -42.23 47.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.555 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.482 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -66.85 -23.51 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.633 ' CB ' ' O ' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -124.02 85.29 54.51 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.829 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.1 Cg_endo -44.06 -9.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.395 2.73 . . . . 0.0 112.008 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.644 ' HG3' ' NZ ' ' A' ' 54' ' ' LYS . 83.7 tt0 -42.9 -35.55 1.24 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.458 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.877 HD13 ' C ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -57.31 -38.23 73.71 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.662 ' N ' HD13 ' A' ' 52' ' ' LEU . 84.0 tt0 -59.51 -34.35 72.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.709 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.644 ' NZ ' ' HG3' ' A' ' 51' ' ' GLU . 7.8 ttpm? -57.28 -45.44 84.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.768 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.2 mt -62.19 -39.87 85.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.629 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 64' ' ' MET . 69.4 ttt180 -60.84 -44.29 97.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.336 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -64.29 -42.06 96.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.537 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -62.95 -41.07 99.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.643 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.729 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 38.5 mmt180 -82.97 -12.02 57.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.019 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 65.4 50.12 1.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.866 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.729 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 25.9 m-85 -99.48 115.53 29.53 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.117 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.549 ' C ' HH21 ' A' ' 56' ' ' ARG . 59.9 p -88.04 -16.9 32.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.218 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.694 ' CH2' ' HB2' ' A' ' 65' ' ' ASP . 1.6 t-105 -114.07 110.6 20.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.002 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.646 ' CE ' HD11 ' A' ' 52' ' ' LEU . 25.0 ttt -146.15 138.23 25.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.35 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.694 ' HB2' ' CH2' ' A' ' 63' ' ' TRP . 21.9 t70 -159.98 179.21 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.583 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.544 ' HA ' ' HG2' ' A' ' 146' ' ' MET . 52.8 mt -106.85 126.2 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 mm -117.15 135.6 57.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.337 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.517 ' OG1' ' HG3' ' A' ' 144' ' ' LYS . 47.6 m -125.43 141.18 52.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.656 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 142' ' ' TYR . 45.8 mt -109.74 122.03 63.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.199 0.524 . . . . 0.0 111.128 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.663 ' O ' ' N ' ' A' ' 74' ' ' LEU . 1.1 t -164.63 118.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.612 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -57.4 -42.79 82.94 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.093 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -62.94 -40.3 97.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.738 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -105.2 1.65 28.42 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.427 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.961 HD21 ' HD3' ' A' ' 80' ' ' LYS . 0.7 OUTLIER -130.25 83.08 64.04 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.838 0.351 . . . . 0.0 111.227 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.593 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 14.1 Cg_endo -59.23 161.37 16.68 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.194 1.929 . . . . 0.0 109.607 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 56.7 t-20 70.86 38.03 1.23 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.169 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.66 ' CZ ' HG13 ' A' ' 81' ' ' ILE . 7.4 t80 -64.97 -48.03 75.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.602 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' CG ' ' HE3' ' A' ' 82' ' ' LYS . 84.1 tt0 -61.89 -56.74 16.18 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.655 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 97.8 mt-10 -64.92 -41.5 95.51 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.214 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.961 ' HD3' HD21 ' A' ' 74' ' ' LEU . 26.3 tttp -67.08 -37.97 84.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.173 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.856 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -71.3 -54.41 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.119 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.647 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 98.3 mttt -50.1 -30.1 10.37 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.424 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.646 ' HE3' ' HA ' ' A' ' 80' ' ' LYS . 74.0 mtm -74.46 -58.77 3.08 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.856 ' CZ ' HD13 ' A' ' 81' ' ' ILE . 18.3 p90 -87.29 -49.75 7.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.692 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.771 ' CB ' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -52.72 -47.12 67.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.039 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.722 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 84.6 tt0 -55.64 141.62 37.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 110.813 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -57.44 136.02 56.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.645 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -157.46 -172.25 3.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.818 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -145.33 178.97 7.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.416 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.661 ' CE1' ' CE1' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -170.7 140.71 1.73 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.044 0.449 . . . . 0.0 110.676 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.3 mt -80.67 2.33 26.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.421 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -108.89 153.36 23.64 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.551 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -61.33 134.95 57.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.412 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -108.32 116.99 32.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.748 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.856 HG12 HG23 ' A' ' 126' ' ' THR . 10.1 mt -129.24 129.84 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.4 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.435 ' CZ ' ' CZ ' ' A' ' 105' ' ' PHE . 14.0 ptm180 -139.72 148.41 42.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.015 0.435 . . . . 0.0 110.721 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.666 ' CZ ' ' HB2' ' A' ' 41' ' ' LEU . 2.2 t80 -122.75 138.71 54.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.593 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 122' ' ' GLY . 12.5 mm -104.1 114.55 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.143 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.723 HD21 ' CE ' ' A' ' 146' ' ' MET . 17.3 mt -84.22 -43.61 14.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.159 0.504 . . . . 0.0 109.971 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.47 162.41 38.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.33 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.55 173.93 45.85 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.682 ' OG ' ' CZ ' ' A' ' 118' ' ' PHE . 33.3 t -123.2 141.2 52.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.814 0.34 . . . . 0.0 110.492 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.92 150.04 20.04 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.72 ' CE1' ' CE1' ' A' ' 118' ' ' PHE . 88.8 m-85 -116.82 127.36 54.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.478 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.665 ' CE2' ' CD1' ' A' ' 135' ' ' PHE . 98.6 m-85 -123.77 149.22 45.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.002 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.602 ' OD2' ' O ' ' A' ' 106' ' ' ASP . 53.8 p30 -133.35 144.48 49.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.462 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.61 146.38 31.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.701 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.66 ' HB2' ' CH2' ' A' ' 114' ' ' TRP . 76.2 ttt180 -113.06 125.67 54.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.008 0.432 . . . . 0.0 110.737 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.76 156.69 22.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -56.23 -32.67 64.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 110.417 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.541 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 85.1 tt0 -66.35 -2.52 4.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.217 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 111' ' ' GLU . 59.8 t0 76.17 40.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.31 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.601 ' HB3' ' CG ' ' A' ' 8' ' ' ASP . 93.9 mt-30 -113.8 144.3 43.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.183 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.66 ' CH2' ' HB2' ' A' ' 108' ' ' ARG . 87.1 m95 -111.2 130.65 55.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.014 0.435 . . . . 0.0 111.182 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.611 HG22 HD11 ' A' ' 117' ' ' ILE . 64.9 mt -117.95 133.96 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.524 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.564 ' C ' HD13 ' A' ' 117' ' ' ILE . 59.4 ttp180 -91.94 116.7 29.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 115' ' ' ILE . 11.9 mm -112.0 127.23 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.422 . . . . 0.0 110.539 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 104' ' ' TYR . 80.1 t80 -106.32 133.13 51.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.917 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.643 ' HG3' ' CE1' ' A' ' 105' ' ' PHE . 16.2 mmt -107.0 126.28 52.12 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.443 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 84.8 tt0 -108.35 148.51 29.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.703 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -44.68 138.03 3.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.123 0.487 . . . . 0.0 111.072 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 79.12 1.04 84.83 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 98' ' ' ILE . 57.2 t0 -94.92 119.7 33.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.867 0.365 . . . . 0.0 111.266 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.644 ' HG3' ' CB ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -97.32 136.49 37.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.663 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.32 143.72 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.303 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.856 HG23 HG12 ' A' ' 95' ' ' ILE . 95.9 m -122.54 131.54 53.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.006 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.9 120.05 41.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.553 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 38.9 Cg_exo -57.11 155.47 28.74 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.806 2.338 . . . . 0.0 111.877 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.6 147.43 29.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 131' ' ' ILE . . . 94.88 9.25 58.62 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.76 HD12 ' N ' ' A' ' 131' ' ' ILE . 3.4 mp -114.55 151.26 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.786 ' CE2' HD22 ' A' ' 89' ' ' LEU . 51.6 m-85 -101.26 135.76 42.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.225 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.661 ' CE1' ' CE1' ' A' ' 90' ' ' HIS . 13.4 p-80 -148.0 158.63 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.123 0.487 . . . . 0.0 111.188 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.566 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 74.0 ttp85 -134.02 132.68 40.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.0 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.665 ' CD1' ' CE2' ' A' ' 105' ' ' PHE . 17.1 t80 -106.38 131.03 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.896 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.552 ' OG1' ' NH1' ' A' ' 134' ' ' ARG . 41.5 m -126.39 131.09 51.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.975 0.417 . . . . 0.0 110.913 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 141' ' ' ASN . 15.0 m -126.9 13.68 3.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.213 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.59 ' HA ' ' OD1' ' A' ' 141' ' ' ASN . 91.6 m-20 -63.32 -23.08 67.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.47 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.658 ' HG3' ' CE2' ' A' ' 104' ' ' TYR . 75.2 mm-40 -56.57 -35.53 68.29 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.286 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.583 ' HG3' ' H ' ' A' ' 142' ' ' TYR . 0.8 OUTLIER -140.66 -22.89 0.8 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.525 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 137' ' ' VAL . 87.0 m-20 59.12 38.5 23.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.715 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.606 ' HD2' ' HG ' ' A' ' 70' ' ' CYS . 65.9 t80 -157.71 97.0 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.6 m -133.44 143.17 48.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.0 110.907 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.517 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 66.7 tttt -126.41 109.83 12.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.746 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.88 154.4 45.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.184 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.723 ' CE ' HD21 ' A' ' 99' ' ' LEU . 69.8 mtm -94.74 146.68 24.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.184 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.574 ' HB3' ' CE2' ' A' ' 149' ' ' PHE . 19.4 mmm-85 -113.91 140.43 48.38 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.378 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 148' ' ' LEU . 5.1 mp -113.85 115.35 27.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.532 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.586 ' HB2' ' CD1' ' A' ' 63' ' ' TRP . 94.5 m-85 -135.25 156.19 49.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.614 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 150' ' ' VAL . 1.3 p -127.7 74.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.945 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.62 -173.0 43.26 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.556 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 71.3 tt0 -73.1 143.4 83.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.901 0.382 . . . . 0.0 110.672 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.556 ' HD2' ' CG ' ' A' ' 152' ' ' GLU . 36.6 Cg_exo -57.53 71.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.867 2.378 . . . . 0.0 112.11 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.548 HG11 ' HG2' ' A' ' 168' ' ' ARG . 8.6 p -61.63 -32.78 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.152 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.658 ' HA ' ' CD1' ' A' ' 158' ' ' TYR . 5.2 t90 -54.88 -29.29 55.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.786 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 42.7 m -45.61 -43.11 11.98 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.654 ' O ' ' CZ ' ' A' ' 165' ' ' PHE . . . -147.33 100.89 3.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.366 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.658 ' CD1' ' HA ' ' A' ' 155' ' ' TRP . 21.6 p90 -151.91 164.8 36.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.681 ' HB2' ' CG ' ' A' ' 164' ' ' HIS . 10.6 m120 -89.4 160.59 16.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.119 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.613 ' CB ' ' HD3' ' A' ' 161' ' ' PRO . 2.1 mpp_? -32.99 -57.02 0.53 Allowed Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.426 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 160' ' ' ARG . 18.2 Cg_exo -65.34 132.35 31.17 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.757 2.305 . . . . 0.0 111.79 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 89' ' ' LEU . . . -67.41 -29.61 69.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.838 0.351 . . . . 0.0 110.609 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.489 ' C ' ' OD1' ' A' ' 163' ' ' ASP . 48.1 p30 -92.01 7.26 43.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.451 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.681 ' CG ' ' HB2' ' A' ' 159' ' ' ASN . 1.8 t-160 -64.77 -32.92 74.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.757 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.654 ' CZ ' ' O ' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -77.19 132.13 38.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.405 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -59.54 -45.17 92.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.002 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.407 ' O ' ' CG1' ' A' ' 172' ' ' VAL . . . -70.69 -46.06 63.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.276 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.557 ' HE ' ' CA ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -86.77 3.61 44.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.884 0.373 . . . . 0.0 110.61 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.553 ' O ' HG22 ' A' ' 172' ' ' VAL . . . -80.35 -168.71 38.71 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -42.44 -21.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 110.508 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 169' ' ' GLY . 72.1 t80 -51.85 -38.51 56.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.225 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 169' ' ' GLY . 8.0 m -67.84 -26.12 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.584 ' HD2' ' C ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -60.59 -29.69 69.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.664 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.49 ' N ' ' HG3' ' A' ' 173' ' ' LYS . 69.5 t80 -57.01 -41.96 79.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 175' ' ' LEU . 9.6 tt -57.72 -37.72 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.45 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.679 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.68 -32.72 74.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.549 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.558 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.843 ' HB ' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -126.5 124.69 65.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.719 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.655 ' OE1' ' CD2' ' A' ' 118' ' ' PHE . 63.4 tt0 -104.35 113.72 27.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.062 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 1.04 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -164.4 157.76 17.79 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.499 ' O ' HG23 ' A' ' 115' ' ' ILE . 1.4 t-105 -133.22 148.91 52.03 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.686 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.669 ' CE2' ' HA ' ' A' ' 26' ' ' VAL . 14.8 m-85 -98.8 87.87 3.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.785 ' SD ' ' CH2' ' A' ' 114' ' ' TRP . 86.1 mtp -86.89 3.09 46.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.351 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.611 ' CB ' ' HB2' ' A' ' 113' ' ' GLN . 14.5 p-10 -58.78 -33.85 70.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.547 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.567 ' OD2' ' HD3' ' A' ' 24' ' ' ARG . 89.8 m-20 -68.55 -67.11 0.49 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.592 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.44 103.08 44.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -66.08 141.39 63.59 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.689 2.259 . . . . 0.0 111.763 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.46 -177.48 40.06 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -71.87 147.94 91.84 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.879 0.371 . . . . 0.0 110.536 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.646 ' O ' ' NH1' ' A' ' 116' ' ' ARG . 19.4 Cg_endo -60.88 -28.21 86.01 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.736 2.291 . . . . 0.0 112.13 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -54.78 -39.65 68.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.658 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -108.16 155.69 39.72 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.409 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.603 ' HG2' ' CG ' ' A' ' 19' ' ' ARG . 57.4 Cg_endo -87.53 -6.85 6.85 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.1 2.533 . . . . 0.0 111.876 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 45.56 45.62 10.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.603 ' CG ' ' HG2' ' A' ' 17' ' ' PRO . 5.9 mtt180 -61.57 112.26 5.74 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.869 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.8 Cg_exo -56.84 161.06 10.93 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.862 2.375 . . . . 0.0 111.71 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -124.3 97.44 40.03 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.496 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' A' ' 20' ' ' PRO . 11.4 Cg_exo -67.32 153.98 85.5 Favored 'Cis proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.484 -0.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -90.8 179.81 43.03 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.567 ' HD3' ' OD2' ' A' ' 9' ' ' ASP . 5.6 ptm180 -152.86 117.52 2.89 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 111.144 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 73.1 Cg_endo -81.83 158.56 18.58 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.331 2.687 . . . . 0.0 111.745 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.04 HG11 ' HB3' ' A' ' 4' ' ' ALA . 1.4 p -57.99 147.31 6.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.159 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.14 108.93 3.66 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.843 HD13 ' HB ' ' A' ' 2' ' ' VAL . 26.2 tp -47.25 -41.26 18.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.847 0.356 . . . . 0.0 110.269 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -70.16 -31.52 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.248 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.575 ' HG2' ' OH ' ' A' ' 6' ' ' TYR . 66.3 tp60 -62.93 -46.51 87.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.426 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.435 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 9.3 mt -69.44 -34.22 74.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.532 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -52.54 -43.68 65.33 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -66.54 -32.01 73.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.831 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 35.5 tp -64.5 -25.72 68.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.924 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.598 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . 110.04 23.63 6.05 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.792 HG12 ' CZ ' ' A' ' 38' ' ' TYR . 24.4 t -100.76 128.68 52.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.269 0.557 . . . . 0.0 111.138 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.672 ' HB3' ' CH2' ' A' ' 39' ' ' TRP . 3.0 mt -125.59 141.55 51.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.128 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.792 ' CZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -126.84 134.11 50.6 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.853 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 1.032 ' NE1' HG21 ' A' ' 55' ' ' ILE . 1.2 m95 -101.2 128.46 47.3 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -97.84 105.64 17.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.798 HD11 ' HB3' ' A' ' 39' ' ' TRP . 3.1 mp -139.66 147.34 40.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.696 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.671 ' O ' ' N ' ' A' ' 45' ' ' LYS . 84.1 m-20 -97.72 123.81 41.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 46' ' ' TYR . . . -41.88 -44.64 3.45 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.583 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -62.8 -33.91 76.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.048 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 42' ' ' ASP . 66.9 mttm -85.26 -14.8 45.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.318 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.958 ' CE2' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.92 -49.09 74.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -83.14 -41.65 18.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.094 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.525 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 39.9 m-20 -67.11 -22.85 65.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.737 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 45' ' ' LYS . 3.1 t0 -127.12 84.65 62.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.961 0.41 . . . . 0.0 111.524 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.0 Cg_endo -48.7 -8.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 123.23 2.62 . . . . 0.0 111.448 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.59 ' CD ' ' HD2' ' A' ' 54' ' ' LYS . 45.6 tp10 -42.59 -33.54 0.72 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.717 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.958 HD22 ' CE2' ' A' ' 46' ' ' TYR . 24.6 tp -55.32 -41.08 71.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.007 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 50' ' ' PRO . 75.3 mm-40 -63.16 -34.18 77.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.306 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.59 ' HD2' ' CD ' ' A' ' 51' ' ' GLU . 37.8 mttm -59.06 -41.82 88.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.527 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.032 HG21 ' NE1' ' A' ' 39' ' ' TRP . 87.6 mt -62.82 -36.26 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.618 ' NH2' ' HA ' ' A' ' 63' ' ' TRP . 72.1 ttt180 -58.09 -41.54 83.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.234 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.494 HH11 ' HA ' ' A' ' 54' ' ' LYS . 77.4 mtt85 -61.82 -36.01 79.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.446 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -60.28 -39.08 85.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.656 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.666 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 8.8 tpt180 -99.99 -11.16 20.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 110.296 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' ARG . 30.5 t-20 58.08 51.58 8.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.531 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.842 ' CD1' HD13 ' A' ' 148' ' ' LEU . 58.9 m-85 -70.05 124.24 23.59 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.228 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.504 ' C ' HH21 ' A' ' 56' ' ' ARG . 24.2 m -60.8 -36.9 80.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.809 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.692 ' O ' ' CD1' ' A' ' 63' ' ' TRP . 0.0 OUTLIER -138.26 149.93 46.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.379 . . . . 0.0 110.854 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.911 ' SD ' HD21 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -145.47 117.57 8.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.321 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.659 ' OD2' ' CZ3' ' A' ' 63' ' ' TRP . 90.1 m-20 -143.03 169.62 17.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.838 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.977 ' CD1' HD22 ' A' ' 99' ' ' LEU . 14.5 tt -121.49 144.44 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.93 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 68' ' ' THR . 9.8 tp -133.91 157.38 41.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.852 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.868 ' O ' HD13 ' A' ' 74' ' ' LEU . 54.3 m -117.06 138.41 51.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.017 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 69' ' ' ILE . 1.1 mp -90.52 96.47 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.335 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.644 ' O ' ' N ' ' A' ' 74' ' ' LEU . 45.8 t -154.53 128.04 8.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.945 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -57.72 -41.5 81.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.953 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.96 -40.17 96.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.437 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.572 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 40.7 tptt -100.12 -6.77 25.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 111.204 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.868 HD13 ' O ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -126.45 76.63 73.45 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.393 . . . . 0.0 111.163 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.537 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 10.8 Cg_endo -56.42 152.5 39.44 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.365 2.043 . . . . 0.0 110.061 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 39.3 t-20 74.65 39.13 0.45 Allowed 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.209 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.655 ' CZ ' HG13 ' A' ' 81' ' ' ILE . 58.1 t80 -59.66 -40.7 88.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.509 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.639 ' O ' ' CB ' ' A' ' 82' ' ' LYS . 97.0 mt-10 -60.13 -56.89 16.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.708 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.609 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 75.6 mm-40 -71.87 -38.21 70.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.589 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.609 ' HZ2' ' HE1' ' A' ' 84' ' ' PHE . 10.2 tptp -64.64 -56.58 12.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.165 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.014 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -71.71 -35.66 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.117 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.639 ' CB ' ' O ' ' A' ' 78' ' ' GLU . 26.1 tptt -59.48 -41.45 89.82 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.74 ' SD ' ' CH2' ' A' ' 155' ' ' TRP . 59.1 mtt -60.02 -42.15 93.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.537 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.609 ' HE1' ' HZ2' ' A' ' 80' ' ' LYS . 80.0 m-85 -69.24 -36.74 77.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.658 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 1.014 ' CE2' HD12 ' A' ' 81' ' ' ILE . 15.0 m-30 -61.0 -45.19 95.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.589 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.75 138.08 58.13 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.87 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.619 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -90.74 121.16 32.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.733 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.719 ' ND1' ' CE1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -141.63 173.92 11.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.04 0.448 . . . . 0.0 111.178 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.08 HD11 ' CD1' ' A' ' 132' ' ' TYR . 3.5 mp -130.38 159.89 35.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.109 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.587 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 4.0 p80 -170.81 153.38 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.095 0.474 . . . . 0.0 110.838 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.046 HD22 ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -67.78 16.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.823 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.759 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 59.0 t0 -108.53 148.32 30.44 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.616 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.637 ' OD2' ' NH2' ' A' ' 59' ' ' ARG . 83.1 m-20 -83.93 142.34 30.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.514 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 16.2 mm-40 -99.35 118.25 35.57 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.697 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.05 ' CD1' HG23 ' A' ' 126' ' ' THR . 32.9 mm -122.2 119.41 58.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.309 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.666 ' HD2' ' CE2' ' A' ' 105' ' ' PHE . 38.8 mtt85 -139.18 138.27 36.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.31 0.576 . . . . 0.0 111.452 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.791 ' CD2' ' CZ ' ' A' ' 46' ' ' TYR . 25.8 t80 -125.82 129.92 50.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 120' ' ' GLU . 14.0 mm -89.02 93.31 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.52 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.977 HD22 ' CD1' ' A' ' 66' ' ' ILE . 10.4 tp -72.65 -38.93 67.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.202 0.525 . . . . 0.0 109.651 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . 54.7 t0 -155.2 154.43 32.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.211 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 100' ' ' ASP . . . 82.14 -166.49 46.35 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 50.2 m -121.01 147.33 45.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.304 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -132.21 149.09 19.35 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.668 ' CE2' ' HG3' ' A' ' 116' ' ' ARG . 81.2 t80 -125.81 131.3 52.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.344 . . . . 0.0 110.615 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.796 ' HB3' HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -122.08 146.25 47.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 133' ' ' HIS . 23.2 t70 -124.67 128.33 48.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.416 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.14 144.4 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.505 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 114' ' ' TRP . 21.3 ttp180 -122.77 130.67 53.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.652 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 110' ' ' LYS . 57.8 t0 -85.73 156.23 20.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.695 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.571 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -60.79 -25.53 66.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.893 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.543 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 96.2 mt-10 -63.77 2.89 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.877 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 111' ' ' GLU . 54.3 t0 76.51 41.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 110.327 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.611 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 13.4 pt20 -143.37 165.83 26.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.857 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.785 ' CH2' ' SD ' ' A' ' 7' ' ' MET . 25.1 p-90 -133.69 149.84 51.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.025 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.572 HD13 ' HE1' ' A' ' 6' ' ' TYR . 68.7 mt -117.7 136.63 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.186 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.668 ' HG3' ' CE2' ' A' ' 104' ' ' TYR . 56.9 ttt180 -90.25 120.35 31.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.528 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.796 HD11 ' HB3' ' A' ' 105' ' ' PHE . 27.4 pt -120.8 128.67 76.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.655 ' CD2' ' OE1' ' A' ' 3' ' ' GLN . 71.2 t80 -109.79 136.71 48.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.614 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.47 ' SD ' ' HB ' ' A' ' 125' ' ' VAL . 16.0 mmt -106.37 133.44 51.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.724 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' O ' ' HB ' ' A' ' 98' ' ' ILE . 94.6 mt-10 -107.51 168.36 9.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -64.82 127.5 31.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.691 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.594 ' HA2' ' OH ' ' A' ' 97' ' ' TYR . . . 94.4 -15.42 63.3 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -95.98 121.46 37.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.701 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.711 ' CE ' HG22 ' A' ' 95' ' ' ILE . 18.1 ttt -102.64 150.2 23.67 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.47 ' HB ' ' SD ' ' A' ' 119' ' ' MET . 12.7 p -134.91 141.26 43.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.257 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . 1.05 HG23 ' CD1' ' A' ' 95' ' ' ILE . 87.9 m -125.31 132.35 52.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.052 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.523 HD23 HG22 ' A' ' 36' ' ' VAL . 4.1 mt -121.18 127.42 26.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.888 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.756 ' HG2' HD12 ' A' ' 131' ' ' ILE . 12.8 Cg_endo -59.36 141.44 97.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.797 2.331 . . . . 0.0 111.902 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.759 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -69.76 148.94 48.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.104 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.89 3.58 56.98 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.756 HD12 ' HG2' ' A' ' 128' ' ' PRO . 70.4 mt -116.25 137.15 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.305 . . . . 0.0 110.635 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 1.08 ' CD1' HD11 ' A' ' 89' ' ' LEU . 88.8 m-85 -58.4 128.3 36.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.145 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 45.0 p-80 -146.15 146.51 30.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.97 0.414 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.619 ' NE ' ' O ' ' A' ' 85' ' ' TYR . 77.9 ttt180 -135.7 134.34 39.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.111 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.574 ' HD2' ' CE2' ' A' ' 105' ' ' PHE . 70.5 t80 -106.7 124.72 50.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.757 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.691 ' O ' HG13 ' A' ' 137' ' ' VAL . 18.5 p -130.81 155.45 46.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.592 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 136' ' ' THR . 34.7 m -164.96 17.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.271 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 139' ' ' GLU . 48.1 p30 -70.8 -15.09 62.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 75.7 mm-40 -59.25 -39.45 82.88 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.33 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.521 ' HD3' ' HB2' ' A' ' 102' ' ' SER . 9.5 mtpm? -110.25 -19.33 13.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 138' ' ' ASP . 77.6 m-20 59.6 30.47 20.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.347 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 66.3 t80 -172.94 96.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.196 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.543 ' H ' ' HB ' ' A' ' 69' ' ' ILE . 56.9 m -136.16 134.4 38.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.13 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 5.8 ttmt -117.88 114.89 23.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.915 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.713 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -142.07 155.21 45.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.067 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.653 ' SD ' ' HE2' ' A' ' 46' ' ' TYR . 5.9 mtt -93.64 145.82 24.28 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.016 0.436 . . . . 0.0 110.679 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -129.89 138.89 51.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.738 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.911 HD21 ' SD ' ' A' ' 64' ' ' MET . 41.0 mt -110.98 132.49 54.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.78 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.669 ' CE1' ' O ' ' A' ' 152' ' ' GLU . 62.4 t80 -132.97 152.93 51.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 110.878 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.56 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 11.7 t -116.02 129.66 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.763 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.5 -162.35 37.9 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.669 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 1.8 mm-40 -69.08 155.36 93.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.927 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 156' ' ' THR . 27.8 Cg_endo -65.02 78.8 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.909 2.406 . . . . 0.0 112.184 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.498 HG12 ' CE2' ' A' ' 149' ' ' PHE . 7.0 p -60.61 -30.39 46.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.74 ' CH2' ' SD ' ' A' ' 83' ' ' MET . 43.3 t90 -52.5 -35.92 54.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.96 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.605 HG23 ' HB2' ' A' ' 153' ' ' PRO . 47.6 p -48.9 -43.42 39.21 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.61 101.19 3.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.963 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.719 ' CE1' ' ND1' ' A' ' 88' ' ' HIS . 18.9 p90 -136.18 155.62 49.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.567 ' OD1' ' CZ ' ' A' ' 165' ' ' PHE . 11.0 m120 -92.07 137.85 32.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.356 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.611 ' CB ' ' HD3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -50.41 -57.79 11.91 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.699 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 160' ' ' ARG . 14.6 Cg_exo -64.02 131.97 32.68 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.529 2.153 . . . . 0.0 111.929 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.57 ' HB2' ' C ' ' A' ' 89' ' ' LEU . . . -68.61 -31.69 71.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.509 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.577 ' OD2' ' HG2' ' A' ' 170' ' ' GLN . 89.8 m-20 -98.28 13.44 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 161' ' ' PRO . 56.8 t-80 -54.03 -38.35 65.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.567 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.567 ' CZ ' ' OD1' ' A' ' 159' ' ' ASN . 97.4 m-85 -86.68 127.32 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.477 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 11.8 tm-20 -61.6 -46.43 89.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.007 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.59 -45.85 61.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.58 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.593 ' CZ ' ' HA ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -85.0 0.33 51.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.706 -179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 165' ' ' PHE . . . -64.89 147.39 50.98 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.577 ' HG2' ' OD2' ' A' ' 163' ' ' ASP . 30.3 mm100 -58.79 -32.14 69.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.704 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -55.15 -39.67 69.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.633 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 166' ' ' GLU . 73.7 t -59.23 -39.74 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.578 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.412 ' HD2' ' NE2' ' A' ' 170' ' ' GLN . 9.8 mttp -58.28 -34.63 70.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.575 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -56.5 -41.49 76.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.646 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.3 tp -57.37 -37.78 73.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.527 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.11 72.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.586 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -63.78 -33.05 74.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.551 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.5 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' A' ' 28' ' ' LEU . 11.7 p . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.593 0.235 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.575 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 11.7 mm-40 -100.22 116.27 31.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.443 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 1.084 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -164.41 157.53 17.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.792 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.705 ' O ' HG23 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -124.89 145.38 49.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.011 0.434 . . . . 0.0 111.67 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.671 ' OH ' ' NE2' ' A' ' 113' ' ' GLN . 1.4 t80 -96.07 76.03 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.711 ' SD ' ' ND1' ' A' ' 18' ' ' HIS . 73.7 mtm . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.732 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.711 ' ND1' ' SD ' ' A' ' 7' ' ' MET . 65.4 m170 . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.996 0.427 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.672 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -91.17 102.14 5.1 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.302 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.68 ' O ' ' N ' ' A' ' 23' ' ' GLY . 12.3 Cg_endo -58.74 161.15 15.71 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.77 2.314 . . . . 0.0 111.687 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.599 ' OD1' ' C ' ' A' ' 21' ' ' ASP . 13.5 t0 -119.37 101.68 48.88 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.575 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.536 ' C ' ' O ' ' A' ' 20' ' ' PRO . 12.9 Cg_exo -66.9 158.04 81.88 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.516 -1.452 . . . . 0.0 112.375 -0.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -82.94 152.21 29.67 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.594 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -152.68 119.85 3.09 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.296 0.569 . . . . 0.0 111.315 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 56.2 Cg_endo -74.75 157.44 43.81 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 123.028 2.485 . . . . 0.0 111.294 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.084 HG11 ' HB3' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -57.23 147.64 5.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.912 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 30' ' ' GLN . . . -97.89 102.24 2.64 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.752 ' C ' HD23 ' A' ' 28' ' ' LEU . 7.4 tt -46.06 -47.78 17.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.834 0.35 . . . . 0.0 110.358 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.52 -34.39 78.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.174 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 93.7 mt-30 -62.33 -40.98 98.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.678 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.588 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 6.6 mt -69.8 -38.68 76.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.345 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -55.98 -41.09 74.28 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.319 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -63.32 -32.33 73.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.588 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 26.2 tp -64.91 -23.9 67.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.938 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.649 ' O ' ' CG ' ' A' ' 128' ' ' PRO . . . 112.31 18.26 7.75 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 t -96.21 129.55 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 0.0 111.054 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.825 HD13 ' NH2' ' A' ' 59' ' ' ARG . 30.9 mt -120.48 141.06 50.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.131 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.689 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -139.78 139.45 36.44 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.836 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.999 ' NE1' HG21 ' A' ' 55' ' ' ILE . 1.9 m95 -109.53 133.65 52.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.497 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' C ' HD12 ' A' ' 41' ' ' LEU . 11.7 mtmt -105.99 102.74 12.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.809 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.629 ' O ' ' OH ' ' A' ' 97' ' ' TYR . 5.1 mp -142.76 156.49 45.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.247 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 45' ' ' LYS . 87.7 m-20 -90.32 122.29 33.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.529 ' HA ' HD22 ' A' ' 99' ' ' LEU . . . -42.01 -43.25 3.11 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.166 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.522 ' OD2' ' HB3' ' A' ' 42' ' ' ASP . 5.5 p-10 -66.88 -32.8 74.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.688 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.648 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 70.4 mttt -85.04 -11.59 55.01 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.2 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.722 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -71.86 -56.7 5.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.639 -0.424 . . . . 0.0 109.925 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.722 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 83.9 tt0 -67.04 -36.81 82.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.44 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.593 ' CG ' ' HA ' ' A' ' 45' ' ' LYS . 17.6 p-10 -78.67 -11.74 59.99 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.497 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' ' O ' ' A' ' 45' ' ' LYS . 10.2 t0 -130.94 83.26 61.66 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.82 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.1 Cg_endo -46.4 -8.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 123.535 2.824 . . . . 0.0 112.049 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 49' ' ' ASP . 96.9 mt-10 -46.05 -34.46 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.397 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.087 HD13 ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -59.06 -32.4 69.74 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 1.087 ' N ' HD13 ' A' ' 52' ' ' LEU . 84.8 tt0 -64.06 -35.26 80.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.685 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -59.18 -40.62 86.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.699 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.999 HG21 ' NE1' ' A' ' 39' ' ' TRP . 84.3 mt -59.85 -37.24 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.505 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.713 ' HG2' HD23 ' A' ' 148' ' ' LEU . 70.5 mtp180 -59.43 -40.83 88.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.603 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.97 -41.14 86.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.07 -32.54 74.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.694 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.825 ' NH2' HD13 ' A' ' 37' ' ' LEU . 39.0 mmt180 -99.41 7.42 45.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.218 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.682 ' O ' ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER 59.91 46.39 11.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.75 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.723 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 22.7 m-85 -105.49 113.03 26.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.279 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.664 ' C ' ' NH2' ' A' ' 56' ' ' ARG . 1.4 t -99.73 -21.45 15.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.248 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.57 ' HB3' ' O ' ' A' ' 149' ' ' PHE . 70.5 t90 -109.42 127.88 54.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.837 0.351 . . . . 0.0 111.041 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 56' ' ' ARG . 8.8 ptm -143.14 147.58 35.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.321 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 66' ' ' ILE . 46.3 t0 -159.47 166.76 30.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.433 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.534 ' HA ' ' HG2' ' A' ' 146' ' ' MET . 59.2 mt -108.39 122.25 62.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.522 HD12 ' HG3' ' A' ' 147' ' ' ARG . 72.6 mt -119.42 138.46 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.372 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.553 ' OG1' ' HG3' ' A' ' 144' ' ' LYS . 36.1 m -119.41 142.48 48.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.617 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.674 ' C ' ' SG ' ' A' ' 70' ' ' CYS . 64.2 mt -105.76 125.7 61.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.0 111.028 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.674 ' SG ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -169.1 135.4 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.657 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -57.96 -45.67 86.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.983 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.675 ' OD1' ' N ' ' A' ' 73' ' ' LYS . 55.6 p30 -77.21 -33.17 56.28 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.675 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 80.3 tttt -98.29 -3.66 36.76 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.459 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.031 HD21 ' HD3' ' A' ' 80' ' ' LYS . 1.1 tp -125.58 73.46 68.75 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.124 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.579 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 48.2 Cg_exo -49.97 154.14 5.55 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 121.892 1.728 . . . . 0.0 109.611 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.642 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 63.5 t-20 70.18 32.54 2.89 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.34 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.674 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 27.4 t80 -62.38 -45.7 91.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.434 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 49.0 tp10 -54.82 -54.18 45.6 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.642 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 97.7 mt-10 -76.34 -45.13 33.57 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.398 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 1.031 ' HD3' HD21 ' A' ' 74' ' ' LEU . 23.2 tttp -60.45 -49.52 77.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.281 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.907 HD13 ' CE2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -70.46 -37.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.391 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.607 ' CD ' ' HA ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -70.8 -37.22 73.28 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.617 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.611 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 87.0 mtp -56.68 -48.73 76.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.663 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.907 ' CE2' HD13 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -87.19 -14.85 40.01 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.653 179.535 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.825 ' CZ ' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -56.54 -46.32 80.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.97 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -75.93 146.42 39.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.959 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.567 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -80.51 135.51 36.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.292 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.442 ' CD2' ' C ' ' A' ' 88' ' ' HIS . 2.5 p-80 -144.87 170.67 15.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.007 0.432 . . . . 0.0 110.979 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.149 HD11 ' C ' ' A' ' 130' ' ' GLY . 28.3 tp -124.55 153.32 42.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.576 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.569 ' CE1' ' HE1' ' A' ' 133' ' ' HIS . 1.7 p80 -170.81 165.85 7.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.992 0.425 . . . . 0.0 110.897 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.54 ' C ' ' HB1' ' A' ' 129' ' ' ALA . 49.0 mt -85.09 16.24 3.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.585 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.71 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 88.2 m-20 -107.65 149.29 28.26 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.369 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.605 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 49.2 p30 -83.88 164.95 19.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.427 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.605 ' OE2' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -125.71 114.83 19.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.918 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.72 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 2.7 mp -120.41 116.32 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.149 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.715 ' NH1' ' CG ' ' A' ' 135' ' ' PHE . 68.1 mtt180 -131.62 138.37 48.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.011 0.434 . . . . 0.0 110.77 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.668 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.3 t80 -127.42 128.71 46.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.384 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.866 HG12 ' HE2' ' A' ' 119' ' ' MET . 23.8 mm -96.69 95.64 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.311 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.212 HD11 ' SD ' ' A' ' 146' ' ' MET . 16.9 mt -71.49 -35.62 70.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.0 109.851 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . 20.2 t70 -157.44 162.81 38.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.339 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 143' ' ' THR . . . 90.86 175.68 44.11 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.541 ' OG ' ' HZ ' ' A' ' 118' ' ' PHE . 41.1 t -129.37 142.98 50.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.716 0.293 . . . . 0.0 110.696 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.632 ' HA3' HG12 ' A' ' 137' ' ' VAL . . . -173.23 179.24 44.78 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.7 ' CZ ' ' OG1' ' A' ' 136' ' ' THR . 50.3 p90 -140.13 150.13 43.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.925 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 133' ' ' HIS . 3.7 t80 -110.52 141.43 43.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.993 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.564 ' HB3' ' H ' ' A' ' 134' ' ' ARG . 60.2 t0 -94.5 124.22 38.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.571 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 117' ' ' ILE . 21.8 m -128.1 154.55 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.602 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.648 ' NH2' ' CD2' ' A' ' 132' ' ' TYR . 24.0 ttp180 -123.71 143.1 50.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 55.4 t0 -99.51 156.8 16.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.466 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.533 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -60.54 -25.06 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.086 0.469 . . . . 0.0 110.48 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 46.5 tp10 -76.16 11.1 1.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.043 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 110' ' ' LYS . 83.7 m-20 62.81 42.84 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.367 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.671 ' NE2' ' OH ' ' A' ' 6' ' ' TYR . 25.3 mt-30 -120.46 149.19 42.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.092 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.642 ' CZ2' ' HD3' ' A' ' 108' ' ' ARG . 94.2 m95 -111.44 133.06 54.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.982 0.42 . . . . 0.0 111.134 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 5' ' ' TRP . 69.1 mt -121.05 134.94 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.509 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 116' ' ' ARG . 8.1 ptm180 -91.08 114.37 26.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.787 HD11 HG21 ' A' ' 107' ' ' VAL . 45.0 mt -108.38 129.63 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.678 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.541 ' HZ ' ' OG ' ' A' ' 102' ' ' SER . 74.1 t80 -94.72 128.83 41.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.913 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.866 ' HE2' HG12 ' A' ' 98' ' ' ILE . 89.0 mtp -100.43 122.55 43.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.354 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.552 ' HG2' ' N ' ' A' ' 121' ' ' LYS . 84.7 tt0 -111.61 160.2 17.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.566 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -55.48 133.39 50.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 41' ' ' LEU . . . 88.92 -12.91 64.46 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -95.22 123.46 38.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.879 0.371 . . . . 0.0 111.306 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.688 ' CE ' ' CD1' ' A' ' 39' ' ' TRP . 5.1 ttp -107.11 151.38 25.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.609 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.43 143.31 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.302 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 41.2 m -126.38 133.22 51.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.046 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.598 ' CD2' ' CG ' ' A' ' 133' ' ' HIS . 7.6 tp -115.59 113.53 42.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.918 0.39 . . . . 0.0 110.808 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.649 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 36.9 Cg_exo -52.91 141.57 55.43 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.646 2.231 . . . . 0.0 111.926 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.71 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -67.82 146.07 54.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.908 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 1.149 ' C ' HD11 ' A' ' 89' ' ' LEU . . . 98.36 3.13 57.67 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.609 ' N ' HD11 ' A' ' 89' ' ' LEU . 71.2 mt -119.57 131.61 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.732 0.301 . . . . 0.0 110.616 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.667 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 98.9 m-85 -62.09 146.05 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.201 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.655 ' HB2' ' CZ ' ' A' ' 105' ' ' PHE . 22.7 p-80 -160.42 156.44 26.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 0.0 111.247 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.643 ' NE ' ' O ' ' A' ' 85' ' ' TYR . 41.0 ttt180 -141.74 128.21 20.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.065 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.715 ' CG ' ' NH1' ' A' ' 96' ' ' ARG . 68.9 t80 -107.09 124.04 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.836 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.7 ' OG1' ' CZ ' ' A' ' 104' ' ' TYR . 16.5 p -138.06 154.36 49.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.646 ' CG1' ' O ' ' A' ' 136' ' ' THR . 17.2 m -165.05 25.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.198 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.655 ' OD2' ' N ' ' A' ' 139' ' ' GLU . 51.2 p30 -65.0 -24.64 67.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.618 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.655 ' N ' ' OD2' ' A' ' 138' ' ' ASP . 60.2 mp0 -55.17 -34.48 63.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.77 0.319 . . . . 0.0 111.175 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -100.46 -28.18 13.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.581 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 58.18 27.38 15.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.616 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -173.15 96.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.437 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.505 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 42.4 m -136.17 139.05 42.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.954 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.553 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 71.2 tttt -117.24 116.03 26.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.69 154.62 45.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.014 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 1.212 ' SD ' HD11 ' A' ' 99' ' ' LEU . 6.5 mtp -96.16 146.8 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.223 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.66 ' HB3' ' CE1' ' A' ' 149' ' ' PHE . 21.3 mmt85 -120.08 136.55 54.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.535 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.727 ' N ' HD12 ' A' ' 148' ' ' LEU . 5.8 mp -118.6 119.38 34.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.527 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 147' ' ' ARG . 96.7 m-85 -129.98 159.38 36.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.563 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.555 ' CG1' ' HD2' ' A' ' 61' ' ' TYR . 15.7 m -112.23 131.59 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.28 -162.08 41.79 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' A' ' 152' ' ' GLU . 0.1 OUTLIER -68.35 144.07 96.22 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.829 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.549 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 31.4 Cg_exo -55.46 96.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.891 2.394 . . . . 0.0 112.172 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.4 -39.33 83.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.254 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.481 ' O ' ' CE3' ' A' ' 155' ' ' TRP . 9.0 t90 -55.1 -33.22 62.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.789 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 153' ' ' PRO . 42.4 m -45.64 -43.88 12.79 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.32 101.01 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.345 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -142.0 158.45 43.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 20.3 m120 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.08 179.6 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.529 ' HA ' ' CD2' ' A' ' 174' ' ' PHE . 7.9 t80 . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.936 0.398 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.68 -38.06 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.604 ' O ' ' OE1' ' A' ' 177' ' ' GLN . 56.2 mttp -55.99 -35.15 66.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.682 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.584 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 96.3 m-85 -58.2 -36.75 73.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.433 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 178' ' ' THR . 60.9 mt -61.33 -35.44 77.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.828 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.515 ' HB3' ' NE2' ' A' ' 177' ' ' GLN . . . -61.37 -41.16 96.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.695 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.604 ' OE1' ' O ' ' A' ' 173' ' ' LYS . 8.2 mp0 -64.35 -32.65 74.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.555 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 175' ' ' LEU . 10.7 m . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.574 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.735 0.302 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -80.68 134.96 35.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.324 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.685 ' CB ' HG13 ' A' ' 26' ' ' VAL . . . -148.54 137.74 21.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.818 ' CA ' HG12 ' A' ' 26' ' ' VAL . 3.5 t-105 -137.87 154.12 49.5 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.681 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.55 ' HD2' ' NH2' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.7 110.52 22.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.398 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 116' ' ' ARG . 88.8 mtp . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CD2' HH11 ' A' ' 116' ' ' ARG . 73.3 m-70 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.808 0.337 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.658 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -126.0 95.63 39.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.677 ' O ' ' C ' ' A' ' 22' ' ' PRO . 60.5 Cg_endo -78.09 120.27 4.93 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.749 2.299 . . . . 0.0 111.368 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.578 ' OD2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -61.59 118.48 38.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.328 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.677 ' C ' ' O ' ' A' ' 20' ' ' PRO . 4.4 Cg_exo -77.04 125.71 12.3 Favored 'Cis proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.37 -1.512 . . . . 0.0 111.43 -1.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.76 166.09 46.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.55 ' NH2' ' HD2' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -153.17 117.41 2.82 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 121.11 0.481 . . . . 0.0 111.04 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.688 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 74.3 Cg_endo -77.42 165.67 27.09 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 123.119 2.546 . . . . 0.0 111.239 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.818 HG12 ' CA ' ' A' ' 5' ' ' TRP . 10.5 p -126.95 159.3 37.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.286 0.565 . . . . 0.0 110.884 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.581 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -128.62 172.03 19.52 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.791 HD11 ' HB2' ' A' ' 38' ' ' TYR . 22.8 tp -53.66 -36.62 62.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.656 0.265 . . . . 0.0 110.774 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -55.08 -41.34 71.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.789 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.618 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 99.4 mm-40 -64.12 -40.94 97.27 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.521 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.866 HD21 HD13 ' A' ' 115' ' ' ILE . 25.5 mt -72.61 -32.11 65.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.447 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 19.1 mmm180 -54.7 -41.77 70.66 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -70.99 -27.21 63.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.585 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.648 HD21 ' CG1' ' A' ' 107' ' ' VAL . 13.1 tp -66.47 -9.97 39.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.752 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.637 ' O ' ' CG ' ' A' ' 128' ' ' PRO . . . 95.44 13.29 52.04 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.4 t -97.78 134.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.072 0.463 . . . . 0.0 110.545 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.655 HD11 ' CE2' ' A' ' 39' ' ' TRP . 3.1 tm? -103.95 128.71 51.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.951 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.791 ' HB2' HD11 ' A' ' 28' ' ' LEU . 73.8 t80 -116.07 125.26 52.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 0.0 110.893 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.831 ' CE3' ' HE2' ' A' ' 124' ' ' MET . 1.5 m-90 -110.62 134.87 52.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.132 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 1.7 ptpt -99.37 105.3 17.25 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.772 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 43.7 mt -140.2 160.61 39.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.963 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 45' ' ' LYS . 58.5 t0 -119.79 139.28 52.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 46' ' ' TYR . . . -55.07 -43.68 74.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.122 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -66.84 -33.69 76.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.784 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.62 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 45.7 mttp -87.26 -6.0 58.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.355 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.723 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -76.72 -58.5 3.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.905 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.723 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 84.3 tt0 -70.68 -38.14 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 9.8 p-10 -74.1 -16.91 61.0 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.871 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.65 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 2.9 t0 -130.2 83.94 61.54 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.057 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 53' ' ' GLU . 77.7 Cg_exo -42.95 -8.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 123.36 2.707 . . . . 0.0 112.557 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 49' ' ' ASP . 84.2 tt0 -42.69 -34.58 0.93 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.809 HD13 ' C ' ' A' ' 52' ' ' LEU . 2.3 tm? -54.63 -41.03 69.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.562 ' OE2' ' HD3' ' A' ' 56' ' ' ARG . 46.7 tp10 -61.06 -34.83 75.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.981 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 25.1 mttm -58.49 -41.79 86.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.407 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -61.93 -33.75 59.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.658 ' NH2' ' O ' ' A' ' 62' ' ' SER . 60.2 ttt180 -54.98 -42.81 72.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.699 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -67.23 -39.14 86.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.543 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -63.59 -38.53 91.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.262 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.692 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 37.9 mmt180 -92.86 -2.18 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 110.527 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 62.33 51.08 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.15 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 1.061 ' CE1' HD12 ' A' ' 95' ' ' ILE . 57.3 m-85 -100.27 112.26 24.58 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.159 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.658 ' O ' ' NH2' ' A' ' 56' ' ' ARG . 61.2 m -83.85 -15.72 47.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.849 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.699 ' CZ2' ' OD2' ' A' ' 65' ' ' ASP . 48.2 t90 -130.65 128.02 40.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.731 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.629 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 16.7 ptm -153.56 133.2 12.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.545 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.699 ' OD2' ' CZ2' ' A' ' 63' ' ' TRP . 97.2 m-20 -145.85 172.04 13.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.527 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.516 HD11 ' OH ' ' A' ' 46' ' ' TYR . 62.7 mt -111.19 123.13 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.048 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.974 HD11 ' CD1' ' A' ' 74' ' ' LEU . 19.8 tt -133.0 148.36 31.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.627 ' OG1' ' O ' ' A' ' 143' ' ' THR . 5.1 t -127.04 148.02 50.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.186 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.711 ' N ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -83.02 107.95 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 74' ' ' LEU . 12.8 t -170.11 113.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.082 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HB3' ' CB ' ' A' ' 77' ' ' TYR . 7.4 pttm -59.87 -30.97 69.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.386 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -61.79 -40.29 94.7 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.639 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -109.66 -41.19 4.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 111.174 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.974 ' CD1' HD11 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -113.3 90.68 17.41 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.771 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.631 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 5.6 Cg_endo -51.18 166.84 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.581 2.187 . . . . 0.0 110.587 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.631 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 61.3 t-20 86.1 22.13 0.08 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.362 . . . . 0.0 110.593 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.841 ' O ' HG23 ' A' ' 81' ' ' ILE . 15.2 t80 -59.82 -40.36 88.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 59.4 mp0 -59.3 -56.04 27.21 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.531 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.654 ' O ' ' CG ' ' A' ' 83' ' ' MET . 96.9 mt-10 -73.59 -30.56 63.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.49 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 8.3 tptt -56.85 -55.53 33.22 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.569 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.841 HG23 ' O ' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -71.6 -44.71 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.759 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 20.5 mttt -57.33 -35.99 70.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.73 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -57.84 -45.05 86.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.145 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 97.6 m-85 -77.61 -27.52 51.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.566 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.806 ' HE2' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -54.09 -47.32 71.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.555 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -87.56 132.62 33.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.775 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.556 ' HG2' ' HB2' ' A' ' 134' ' ' ARG . 98.0 mt-10 -61.77 135.72 57.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.137 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -136.0 155.92 49.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.092 HD11 ' C ' ' A' ' 130' ' ' GLY . 43.9 tp -121.45 164.24 17.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.293 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.932 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 0.1 OUTLIER -168.03 142.83 3.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.237 0.541 . . . . 0.0 110.515 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.768 HD11 HG22 ' A' ' 172' ' ' VAL . 0.5 OUTLIER -65.78 -19.54 65.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.096 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 1.137 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 58.4 t0 -107.79 148.36 29.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.226 0.536 . . . . 0.0 111.36 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.62 ' OD2' ' O ' ' A' ' 127' ' ' LEU . 61.2 t0 -84.48 128.29 34.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.651 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.613 ' OE2' ' CB ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -100.95 139.49 36.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.707 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.061 HD12 ' CE1' ' A' ' 61' ' ' TYR . 67.8 mt -115.19 132.34 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.446 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -133.33 146.02 50.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.399 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 41' ' ' LEU . 1.2 t80 -127.72 127.53 43.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.97 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.87 ' N ' HD12 ' A' ' 98' ' ' ILE . 1.5 mp -93.91 99.09 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 111.0 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.588 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 19.0 mt -74.82 -34.44 62.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.482 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.573 ' HA ' ' HG3' ' A' ' 121' ' ' LYS . 58.6 t0 -146.8 -31.79 0.33 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.226 -0.59 . . . . 0.0 112.062 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.678 ' O ' ' CG2' ' A' ' 98' ' ' ILE . . . -56.57 161.83 7.06 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.609 ' HB2' ' CD ' ' A' ' 140' ' ' LYS . 66.8 m -145.95 148.7 33.06 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.184 -0.508 . . . . 0.0 109.888 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.532 ' HA3' HG12 ' A' ' 137' ' ' VAL . . . 170.92 -168.07 41.21 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.687 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.61 ' CE2' ' HD2' ' A' ' 118' ' ' PHE . 94.6 m-85 -113.91 133.22 55.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.748 0.308 . . . . 0.0 110.502 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.944 ' HZ ' HD12 ' A' ' 127' ' ' LEU . 65.5 t80 -106.7 124.96 50.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.289 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.582 ' HB3' ' H ' ' A' ' 134' ' ' ARG . 61.2 t0 -91.14 121.34 32.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.816 HG22 ' CE2' ' A' ' 105' ' ' PHE . 28.7 t -121.87 138.61 51.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.589 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.643 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 29.2 ttp180 -113.55 137.99 50.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.525 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 56.8 t0 -97.74 156.72 16.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.704 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.561 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 0.8 OUTLIER -61.49 -24.07 66.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.557 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.657 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 86.0 tt0 -77.41 11.33 2.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.319 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 111' ' ' GLU . 84.2 m-20 64.85 43.88 3.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.966 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.657 ' NE2' ' OE1' ' A' ' 111' ' ' GLU . 51.9 mt-30 -124.32 149.89 46.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.422 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.643 ' CZ3' ' HB2' ' A' ' 108' ' ' ARG . 95.1 m95 -111.71 136.15 51.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.866 HD13 HD21 ' A' ' 31' ' ' LEU . 64.3 mt -118.61 133.99 63.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.622 ' O ' HD13 ' A' ' 117' ' ' ILE . 69.6 ttt180 -90.68 111.2 22.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.645 HD11 HG22 ' A' ' 115' ' ' ILE . 16.9 mm -115.9 134.58 58.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.937 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.61 ' HD2' ' CE2' ' A' ' 104' ' ' TYR . 83.6 t80 -101.07 132.37 46.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.55 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . 21.8 mmt -95.33 117.63 30.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.39 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.596 ' O ' ' CG ' ' A' ' 123' ' ' ASP . 84.4 tt0 -108.96 150.43 27.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.177 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 18.0 tttp -51.25 128.96 23.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.254 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 41' ' ' LEU . . . 94.31 -3.38 69.21 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.604 ' OD1' ' O ' ' A' ' 123' ' ' ASP . 41.8 p-10 -95.64 119.18 33.7 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.633 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.831 ' HE2' ' CE3' ' A' ' 39' ' ' TRP . 52.8 ttp -111.52 127.15 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.228 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.06 148.15 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.991 0.424 . . . . 0.0 111.605 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.744 HG23 HG12 ' A' ' 95' ' ' ILE . 93.9 m -113.81 135.49 53.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.282 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.944 HD12 ' HZ ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -112.61 110.2 52.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.746 ' HD2' HD23 ' A' ' 127' ' ' LEU . 33.2 Cg_exo -55.97 142.16 85.33 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.942 2.428 . . . . 0.0 112.013 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 1.137 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -71.61 149.19 45.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 1.092 ' C ' HD11 ' A' ' 89' ' ' LEU . . . 101.38 -1.58 53.77 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.802 ' N ' HD11 ' A' ' 89' ' ' LEU . 69.4 mt -120.57 132.72 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.781 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.668 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 95.6 m-85 -78.29 143.96 36.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.265 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.711 ' CG ' ' CD1' ' A' ' 127' ' ' LEU . 9.0 p-80 -158.03 157.6 33.23 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.162 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.618 ' CD ' ' O ' ' A' ' 85' ' ' TYR . 21.8 ttp180 -131.56 130.66 42.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.599 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.711 ' CE1' ' CG1' ' A' ' 137' ' ' VAL . 81.3 t80 -113.76 131.21 56.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.741 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.655 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 17.6 p -127.7 153.64 46.26 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.711 ' CG1' ' CE1' ' A' ' 135' ' ' PHE . 6.0 m -165.55 18.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.212 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.665 ' OD1' ' N ' ' A' ' 139' ' ' GLU . 51.7 p30 -63.79 -25.41 68.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.627 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.665 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 49.6 mt-10 -56.28 -38.73 71.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.609 ' CD ' ' HB2' ' A' ' 102' ' ' SER . 59.7 mtpt -96.69 -7.44 34.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.616 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.0 t30 47.48 11.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.747 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 140' ' ' LYS . 45.8 t80 -150.02 120.54 7.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.466 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.627 ' O ' ' OG1' ' A' ' 68' ' ' THR . 44.1 m -134.79 132.74 39.06 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.61 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.588 ' H ' ' CA ' ' A' ' 101' ' ' GLY . 31.0 tttt -126.8 108.7 11.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.97 152.21 43.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.0 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.588 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 56.7 ttp -101.27 137.39 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.801 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.715 ' NH2' HG21 ' A' ' 67' ' ' ILE . 81.6 mtm-85 -123.35 146.6 47.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 111.158 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 148' ' ' LEU . 5.1 mp -115.37 134.39 55.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.41 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' TRP . 2.3 m-85 -152.72 161.78 42.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.756 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.29 140.22 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.402 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.23 -166.25 40.18 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 5.3 pm0 -65.73 149.61 97.21 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.473 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.642 ' O ' ' CG2' ' A' ' 156' ' ' THR . 35.2 Cg_exo -53.15 125.75 19.36 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.721 2.28 . . . . 0.0 112.035 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 155' ' ' TRP . 5.6 p -92.41 -43.95 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.514 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.73 ' CZ2' ' CB ' ' A' ' 83' ' ' MET . 3.3 t90 -57.44 -36.47 71.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.619 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.642 ' CG2' ' O ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -36.92 -53.84 0.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.471 ' H ' HG23 ' A' ' 156' ' ' THR . . . -147.07 101.75 3.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.304 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -134.51 158.71 43.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.407 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.098 179.635 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.434 ' N ' ' CD2' ' A' ' 171' ' ' TYR . 13.8 m-30 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.772 0.32 . . . . 0.0 110.569 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.768 HG22 HD11 ' A' ' 91' ' ' LEU . 71.4 t -60.7 -39.79 82.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.615 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.57 -34.85 71.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.627 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -56.61 -41.58 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.522 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.673 ' N ' ' CD2' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -60.92 -35.33 76.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.571 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.74 -32.78 73.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.562 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.75 -32.64 74.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.519 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.5 m . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.585 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 14.7 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.758 0.313 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.579 ' OE1' ' CD2' ' A' ' 118' ' ' PHE . 49.6 tt0 -100.18 114.7 28.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.878 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 1.161 ' HB3' ' CG1' ' A' ' 26' ' ' VAL . . . -164.3 171.82 14.35 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.758 ' O ' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -121.24 142.15 50.19 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.659 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.581 ' CE1' ' OE1' ' A' ' 30' ' ' GLN . 22.8 t80 -104.42 68.58 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.463 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.591 ' HB2' ' O ' ' A' ' 114' ' ' TRP . 87.8 mtp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.753 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 17.5 m80 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.615 0.245 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.565 ' CD ' ' HZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -121.88 96.2 47.13 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.467 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.636 ' O ' ' C ' ' A' ' 22' ' ' PRO . 36.2 Cg_endo -68.88 125.41 12.57 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.557 2.171 . . . . 0.0 111.18 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -63.41 118.53 44.85 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.809 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.636 ' C ' ' O ' ' A' ' 20' ' ' PRO . 1.6 Cg_endo -81.71 143.67 57.91 Favored 'Cis proline' 0 C--N 1.309 -1.537 0 C-N-CA 123.615 -1.41 . . . . 0.0 111.966 -0.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.56 161.06 43.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -133.58 117.54 14.29 Favored Pre-proline 0 C--N 1.332 -0.183 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.131 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.38 157.31 61.58 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 123.058 2.506 . . . . 0.0 111.467 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.161 ' CG1' ' HB3' ' A' ' 4' ' ' ALA . 1.7 p -57.37 142.61 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.761 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 30' ' ' GLN . . . -82.89 100.41 2.2 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.601 ' HB2' ' CG1' ' A' ' 2' ' ' VAL . 21.4 tp -47.15 -43.12 20.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.725 0.298 . . . . 0.0 110.317 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.8 -35.34 80.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.021 0.439 . . . . 0.0 109.946 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.784 ' O ' HD13 ' A' ' 34' ' ' LEU . 93.5 mt-30 -61.38 -41.73 97.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.097 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 34' ' ' LEU . 10.3 mt -69.49 -34.41 74.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.43 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -42.12 65.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 33' ' ' ARG . 19.9 ttp180 -64.8 -31.21 72.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.018 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 30' ' ' GLN . 10.3 mp -65.3 -18.13 65.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.026 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.88 23.13 11.03 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.28 132.24 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 0.0 110.742 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 55.3 mt -108.75 141.21 41.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.633 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -118.01 123.55 45.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.623 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.859 ' HZ3' ' HG1' ' A' ' 126' ' ' THR . 2.3 m-90 -121.23 132.3 54.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.179 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -105.84 104.98 14.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.062 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.634 ' C ' ' OH ' ' A' ' 97' ' ' TYR . 1.3 mp -140.58 153.34 46.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.95 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 46' ' ' TYR . 85.9 m-20 -102.92 133.07 48.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.532 ' O ' ' HD1' ' A' ' 46' ' ' TYR . . . -49.52 -43.98 45.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.69 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.683 ' OD2' ' N ' ' A' ' 45' ' ' LYS . 56.6 p30 -65.79 -31.6 72.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.673 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.683 ' N ' ' OD2' ' A' ' 44' ' ' ASP . 12.0 ttmm -85.38 -19.39 31.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.268 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.721 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -61.56 -56.48 19.47 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.822 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.721 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 84.9 tt0 -72.01 -40.86 68.18 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.584 -0.446 . . . . 0.0 109.984 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.618 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 17.8 m120 -66.77 -22.92 66.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.806 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.659 ' O ' ' N ' ' A' ' 51' ' ' GLU . 23.4 t0 -124.32 84.64 56.09 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.305 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 53' ' ' GLU . 75.0 Cg_exo -41.05 -8.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.59 2.86 . . . . 0.0 112.584 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 49' ' ' ASP . 12.4 tm-20 -41.87 -32.53 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -54.28 -41.03 68.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 96.9 mt-10 -60.97 -35.89 77.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.266 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -59.64 -44.73 93.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.949 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.0 mt -62.01 -32.82 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.654 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . 27.2 ttt180 -55.74 -42.02 74.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.702 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -61.42 -41.46 97.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.779 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -67.48 -44.79 77.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.536 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.642 HH12 HG21 ' A' ' 126' ' ' THR . 46.7 mtp85 -76.38 -19.48 58.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.534 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 56' ' ' ARG . 14.5 t-20 60.34 44.5 12.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.932 ' HA ' HG22 ' A' ' 150' ' ' VAL . 4.2 p90 -112.0 126.15 54.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.094 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.572 ' C ' HH21 ' A' ' 56' ' ' ARG . 51.8 p -94.51 0.2 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.311 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.772 ' CE3' ' CE2' ' A' ' 149' ' ' PHE . 49.1 t90 -123.35 133.39 54.13 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.72 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.659 ' HB3' HD22 ' A' ' 148' ' ' LEU . 8.6 ptm -154.49 145.37 22.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.256 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.589 ' HB3' ' CH2' ' A' ' 63' ' ' TRP . 49.9 t0 -159.27 162.9 36.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 0.0 110.83 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.504 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 65.7 mt -114.06 127.96 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.505 HG12 ' N ' ' A' ' 68' ' ' THR . 5.3 tt -130.69 154.37 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 111.496 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.626 HG23 ' HG2' ' A' ' 144' ' ' LYS . 42.0 m -117.02 142.14 47.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.331 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.615 ' C ' ' SG ' ' A' ' 70' ' ' CYS . 2.2 mt -104.22 125.71 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.147 0.499 . . . . 0.0 111.168 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.615 ' SG ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -171.12 128.27 0.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.459 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -57.32 -46.03 83.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.889 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -67.72 -40.83 84.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.848 0.356 . . . . 0.0 111.033 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 70' ' ' CYS . 30.5 tttt -69.51 -41.22 76.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.034 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.741 HD23 ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -133.47 87.41 37.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.777 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 74' ' ' LEU . 72.3 Cg_exo -41.01 176.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.22 1.947 . . . . 0.0 110.418 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.662 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 59.5 t-20 69.94 36.48 1.98 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.322 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.649 ' CE2' HG13 ' A' ' 81' ' ' ILE . 24.2 t80 -65.33 -51.45 60.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.567 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.647 ' O ' ' CD ' ' A' ' 82' ' ' LYS . 97.0 mt-10 -69.35 -46.97 65.74 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.662 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 98.7 mt-10 -65.17 -42.26 93.88 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.443 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.657 ' HE3' ' CE2' ' A' ' 155' ' ' TRP . 14.4 tptt -71.71 -45.73 60.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.15 0.5 . . . . 0.0 109.933 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.916 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 14.1 mm -61.56 -58.13 8.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.799 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.647 ' CD ' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -54.21 -32.64 56.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.488 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.63 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 76.8 mmm -59.47 -61.15 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.254 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.916 ' CZ ' HD13 ' A' ' 81' ' ' ILE . 46.0 p90 -86.96 -16.31 36.21 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.695 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.673 ' CB ' ' O ' ' A' ' 81' ' ' ILE . 19.9 t80 -61.92 -46.26 90.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.14 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -65.47 142.49 58.14 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.231 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.6 139.47 31.7 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.149 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -164.79 170.36 15.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.032 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -133.08 171.83 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.529 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.631 ' HE1' ' CD2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -170.41 154.68 4.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.673 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.563 HD11 ' HG3' ' A' ' 173' ' ' LYS . 0.3 OUTLIER -74.55 5.05 5.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.916 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 49.7 p30 -108.98 152.2 25.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.474 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.607 ' OD2' ' O ' ' A' ' 93' ' ' ASP . 50.1 p30 -81.76 146.96 29.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.653 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.556 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 7.3 mm-40 -105.88 116.07 31.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.826 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.016 HD13 ' OG1' ' A' ' 126' ' ' THR . 6.3 tp -127.78 119.95 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.353 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.53 ' HE ' ' HB3' ' A' ' 145' ' ' ALA . 63.4 ttt180 -134.65 137.41 43.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.478 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.933 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.6 t80 -114.61 129.02 56.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.179 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.711 HG22 ' HA ' ' A' ' 121' ' ' LYS . 20.0 mm -86.08 99.87 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.423 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 97' ' ' TYR . 1.7 mt -82.81 -43.87 16.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.893 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.625 ' OD2' ' O ' ' A' ' 99' ' ' LEU . 91.3 m-20 -144.88 -21.08 0.51 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.896 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.659 ' O ' ' CG2' ' A' ' 98' ' ' ILE . . . -82.8 -176.7 51.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.525 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 49.0 m -151.23 158.05 43.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.547 ' C ' ' CD2' ' A' ' 104' ' ' TYR . . . 176.45 178.37 46.17 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.287 -0.958 . . . . 0.0 111.694 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.765 ' CE2' ' CD1' ' A' ' 118' ' ' PHE . 2.8 m-85 -124.32 140.4 52.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.613 0.244 . . . . 0.0 110.384 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.771 ' CD1' ' SD ' ' A' ' 119' ' ' MET . 18.5 m-30 -109.09 128.92 55.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 110.723 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.699 ' OD1' ' CE3' ' A' ' 114' ' ' TRP . 23.8 t70 -93.6 121.32 34.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.472 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.542 ' CG1' HD11 ' A' ' 117' ' ' ILE . 13.0 p -131.85 145.92 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.626 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.657 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 20.8 ttp180 -116.81 143.2 45.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 110.749 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD2' ' C ' ' A' ' 109' ' ' ASP . 49.3 p30 -101.55 174.41 5.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.423 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.98 -31.66 65.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.046 0.451 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 112' ' ' ASP . 84.5 tt0 -59.81 -9.14 2.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.105 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 111' ' ' GLU . 85.2 m-20 69.33 38.36 1.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.473 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.591 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 95.5 mm-40 -120.62 154.39 35.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.87 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.699 ' CE3' ' OD1' ' A' ' 106' ' ' ASP . 98.6 m95 -104.25 137.23 42.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.17 0.51 . . . . 0.0 111.387 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.758 HG23 ' O ' ' A' ' 5' ' ' TRP . 72.3 mt -119.07 134.19 63.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.981 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.556 ' NH2' ' HD1' ' A' ' 104' ' ' TYR . 13.5 tpt180 -90.49 124.67 35.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.917 HG22 ' HE3' ' A' ' 119' ' ' MET . 21.9 mt -113.33 134.18 56.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.878 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.765 ' CD1' ' CE2' ' A' ' 104' ' ' TYR . 65.1 t80 -101.48 129.87 47.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.953 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.917 ' HE3' HG22 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -115.13 123.9 50.13 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.446 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 123' ' ' ASP . 12.7 pt-20 -102.75 169.99 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.568 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.711 ' HA ' HG22 ' A' ' 98' ' ' ILE . 18.3 ptpt -64.79 123.7 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.953 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 95.93 -1.94 63.66 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.577 ' O ' HG12 ' A' ' 98' ' ' ILE . 60.2 t0 -93.89 119.96 33.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 0.0 111.007 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.66 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . 21.7 ttt -108.52 132.4 53.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.304 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 14.8 p -135.65 146.53 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 110.83 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 1.016 ' OG1' HD13 ' A' ' 95' ' ' ILE . 42.1 m -119.72 139.37 52.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.336 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.933 HD22 ' HB2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -114.71 143.36 29.86 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.005 0.431 . . . . 0.0 110.841 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.599 ' CG ' HD12 ' A' ' 131' ' ' ILE . 32.4 Cg_endo -66.65 154.39 74.59 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.053 2.502 . . . . 0.0 112.238 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.524 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -94.14 138.95 31.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.586 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.62 -0.18 61.11 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.599 HD12 ' CG ' ' A' ' 128' ' ' PRO . 70.6 mt -116.82 142.38 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.684 0.278 . . . . 0.0 110.277 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.699 ' CD2' HD21 ' A' ' 89' ' ' LEU . 99.7 m-85 -52.2 131.94 33.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.419 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.933 ' HB2' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -156.09 134.57 11.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.449 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 85' ' ' TYR . 23.3 ttp180 -139.81 136.81 34.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.871 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.66 ' CD2' ' CD2' ' A' ' 105' ' ' PHE . 21.6 m-30 -112.68 134.07 54.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.351 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 56.9 m -126.6 136.28 52.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.926 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.3 m -147.83 6.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.189 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.621 ' O ' ' OD1' ' A' ' 141' ' ' ASN . 22.2 t70 -55.65 -38.23 69.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.398 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.48 -42.6 96.63 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.227 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 102' ' ' SER . 10.6 mmtm -66.59 -33.23 75.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.725 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.621 ' OD1' ' O ' ' A' ' 138' ' ' ASP . 87.5 m-20 68.32 -10.99 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.616 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.49 ' H ' ' C ' ' A' ' 140' ' ' LYS . 49.4 t80 -151.55 117.38 5.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.367 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.569 HG23 ' HA3' ' A' ' 101' ' ' GLY . 46.4 m -136.22 127.25 27.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.874 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.626 ' HG2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -117.54 103.1 9.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.933 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.82 154.58 45.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.596 ' SD ' ' HE3' ' A' ' 64' ' ' MET . 0.1 OUTLIER -97.48 143.14 28.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.618 ' NH2' ' CD2' ' A' ' 149' ' ' PHE . 67.5 ttp85 -115.61 140.69 48.94 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.819 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.835 HD13 ' CE1' ' A' ' 61' ' ' TYR . 48.2 mt -118.57 134.26 55.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.721 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.772 ' CE2' ' CE3' ' A' ' 63' ' ' TRP . 6.3 p90 -149.8 160.46 43.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.374 . . . . 0.0 110.597 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.932 HG22 ' HA ' ' A' ' 61' ' ' TYR . 31.1 t -115.87 130.69 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.1 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.433 ' O ' ' CE1' ' A' ' 149' ' ' PHE . . . 80.08 -164.17 47.84 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 153' ' ' PRO . 2.4 pt-20 -73.11 126.45 90.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.452 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 149' ' ' PHE . 25.1 Cg_exo -58.94 124.23 15.25 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.79 2.327 . . . . 0.0 112.295 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.4 -34.13 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.447 . . . . 0.0 109.973 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' ' CE3' ' A' ' 155' ' ' TRP . 1.7 t-105 -58.94 -29.95 67.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.759 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.567 ' OG1' ' HB2' ' A' ' 153' ' ' PRO . 38.3 m -44.49 -46.31 9.66 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.291 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.93 100.89 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.453 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.69 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -157.0 166.64 32.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.709 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.594 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 86.7 m-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.994 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.782 0.325 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 5.1 p -54.84 -34.58 31.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.416 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.563 ' HG3' HD11 ' A' ' 91' ' ' LEU . 47.2 mttt -58.22 -35.1 71.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.509 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.34 -41.19 75.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.754 ' O ' HG22 ' A' ' 178' ' ' THR . 0.2 OUTLIER -61.28 -35.07 76.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.505 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.02 72.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.603 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -63.83 -32.95 74.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.754 HG22 ' O ' ' A' ' 175' ' ' LEU . 1.7 t . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.584 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.856 ' HB ' HD12 ' A' ' 28' ' ' LEU . 14.6 p . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.801 0.334 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -102.72 115.77 31.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 1.111 ' HB3' ' CG1' ' A' ' 26' ' ' VAL . . . -163.88 155.96 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.758 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.637 ' CZ3' ' HB3' ' A' ' 25' ' ' PRO . 0.9 OUTLIER -128.24 141.22 51.52 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.191 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.931 ' CE1' HD11 ' A' ' 115' ' ' ILE . 2.1 t80 -96.13 -6.01 39.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.11 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.597 ' CE ' ' HG3' ' A' ' 20' ' ' PRO . 85.4 mmm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.265 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.553 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.146 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.423 ' HA ' ' HE1' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -61.81 107.42 1.13 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.854 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.68 ' O ' ' N ' ' A' ' 23' ' ' GLY . 35.1 Cg_endo -68.0 159.45 52.93 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.864 2.376 . . . . 0.0 111.62 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -112.27 107.39 55.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.697 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 21' ' ' ASP . 63.2 Cg_endo -78.11 150.02 88.1 Favored 'Cis proline' 0 C--N 1.309 -1.55 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.355 -0.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -95.85 173.49 30.73 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -152.91 117.65 2.89 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 111.08 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.637 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 55.7 Cg_endo -74.11 152.8 45.98 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.158 2.572 . . . . 0.0 111.756 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.111 ' CG1' ' HB3' ' A' ' 4' ' ' ALA . 1.3 p -58.66 144.75 11.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 30' ' ' GLN . . . -94.69 104.56 3.16 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.856 HD12 ' HB ' ' A' ' 2' ' ' VAL . 8.4 tt -45.27 -44.29 11.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.73 -34.55 77.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 27' ' ' GLY . 50.3 tt0 -61.89 -40.85 96.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.264 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.796 HD11 ' CG2' ' A' ' 26' ' ' VAL . 9.0 mp -63.39 -39.41 94.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.636 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.754 ' NH1' HD22 ' A' ' 37' ' ' LEU . 54.2 ttt85 -57.23 -44.05 83.43 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.521 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -75.17 -30.51 60.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.627 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 34' ' ' LEU . 30.8 tp -68.73 -7.24 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.127 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.561 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . 102.65 -0.3 49.25 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 32' ' ' ARG . 93.1 t -101.8 126.56 55.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.362 . . . . 0.0 110.557 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.754 HD22 ' NH1' ' A' ' 32' ' ' ARG . 79.8 mt -111.53 147.56 35.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.605 ' CD2' ' HE2' ' A' ' 40' ' ' LYS . 32.8 t80 -114.22 124.28 51.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.142 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.683 ' CZ3' ' OG1' ' A' ' 126' ' ' THR . 1.5 m0 -113.1 138.63 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.757 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.605 ' HE2' ' CD2' ' A' ' 38' ' ' TYR . 61.8 mmtt -98.65 105.92 18.12 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.888 HD13 ' HE1' ' A' ' 46' ' ' TYR . 31.8 mt -138.27 139.11 39.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.207 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 46' ' ' TYR . 87.6 m-20 -108.46 128.72 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 99' ' ' LEU . . . -50.36 -42.8 53.77 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.956 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.14 -33.69 76.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.573 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 49' ' ' ASP . 2.2 mtpt -88.07 -17.53 30.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.001 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.888 ' HE1' HD13 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -58.55 -49.1 78.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.764 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -82.8 -44.18 15.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.057 0.456 . . . . 0.0 109.927 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -66.78 -23.38 66.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.612 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 45' ' ' LYS . 1.9 t0 -127.18 84.34 63.7 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.567 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.7 Cg_endo -49.47 -8.69 0.1 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 123.083 2.522 . . . . 0.0 111.288 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 49' ' ' ASP . 84.5 tt0 -43.81 -35.96 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.47 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.052 HD13 ' H ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -59.17 -33.31 70.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 1.052 ' H ' HD13 ' A' ' 52' ' ' LEU . 1.5 tp10 -64.74 -35.82 82.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.925 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -58.64 -40.18 82.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.069 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.89 -44.47 90.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.667 ' NE ' ' O ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -66.62 -36.47 82.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.439 179.332 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.625 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 70.3 ttp85 -62.52 -42.78 99.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.297 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.18 -35.62 80.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.614 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -85.03 0.33 51.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.429 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.49 42.3 14.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.181 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.68 ' CZ ' ' HB3' ' A' ' 59' ' ' ARG . 19.3 m-85 -80.22 122.67 27.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.971 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.26 -31.74 12.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.203 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.708 ' CH2' ' CG ' ' A' ' 65' ' ' ASP . 37.7 t90 -113.07 121.47 44.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 111.3 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.816 ' SD ' HD23 ' A' ' 148' ' ' LEU . 83.4 mmm -146.61 139.48 25.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.523 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.708 ' CG ' ' CH2' ' A' ' 63' ' ' TRP . 21.1 p30 -163.13 165.04 25.04 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.841 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.759 HD13 HD22 ' A' ' 99' ' ' LEU . 65.8 mt -115.17 131.8 66.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.267 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.673 ' CG2' ' NH1' ' A' ' 147' ' ' ARG . 10.7 tp -129.15 158.87 41.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.403 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 144' ' ' LYS . 5.5 t -123.55 153.15 41.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.533 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.733 HG21 HG21 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -104.09 103.48 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.433 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 72' ' ' ASP . 20.9 t -172.06 110.18 0.26 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 77' ' ' TYR . 0.8 OUTLIER -58.65 -35.32 72.36 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.295 -179.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 90.3 m-20 -59.19 -39.42 82.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.444 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -97.36 -41.29 8.31 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.313 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -123.95 85.69 54.05 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.99 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.591 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 2.7 Cg_exo -40.74 172.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.451 2.1 . . . . 0.0 110.316 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.643 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 62.6 t-20 72.4 29.53 2.13 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.358 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.918 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.6 t80 -64.23 -45.83 86.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.58 ' O ' HG13 ' A' ' 81' ' ' ILE . 20.1 pt-20 -71.44 -47.52 55.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.643 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 98.2 mt-10 -66.78 -40.12 88.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.386 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.538 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 57.4 tttp -67.99 -47.75 67.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.557 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.092 HD13 ' CE1' ' A' ' 85' ' ' TYR . 2.7 pp -67.4 -42.41 87.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.568 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.81 ' N ' HD12 ' A' ' 81' ' ' ILE . 55.4 tttp -55.87 -39.57 71.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.132 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.593 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 61.8 mtt -59.78 -44.25 94.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.94 0.4 . . . . 0.0 110.695 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.672 ' CE2' ' CZ2' ' A' ' 155' ' ' TRP . 95.5 m-85 -73.51 -33.57 64.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.615 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 1.092 ' CE1' HD13 ' A' ' 81' ' ' ILE . 11.4 m-30 -60.04 -45.66 92.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.542 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 83' ' ' MET . 20.4 pt-20 -64.66 129.74 40.95 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.329 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.633 ' OE2' ' CH2' ' A' ' 114' ' ' TRP . 96.1 mt-10 -63.61 137.9 58.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.552 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.666 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.5 OUTLIER -150.91 171.94 16.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.452 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.171 HD22 ' CE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.81 -179.91 5.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.273 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.939 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -170.71 146.48 2.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 179.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 91' ' ' LEU . 6.3 mp -65.82 -24.77 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.329 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.581 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 48.6 p30 -108.22 150.54 27.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 111.261 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.747 ' OD2' HG22 ' A' ' 126' ' ' THR . 49.2 t0 -84.32 128.9 34.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.967 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.631 ' OE2' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -107.93 140.38 41.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.87 0.367 . . . . 0.0 110.667 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.826 HD12 ' HE3' ' A' ' 124' ' ' MET . 15.3 pt -113.75 133.2 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.478 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.728 ' NH1' ' CZ ' ' A' ' 105' ' ' PHE . 42.3 ttm180 -123.27 138.89 54.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.382 . . . . 0.0 110.686 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.687 ' CD2' ' CZ ' ' A' ' 46' ' ' TYR . 17.5 t80 -118.49 129.84 55.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.474 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.825 HG12 ' HE2' ' A' ' 119' ' ' MET . 11.4 mm -91.14 94.22 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.169 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.759 HD22 HD13 ' A' ' 66' ' ' ILE . 12.8 tp -80.15 -33.21 38.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.524 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.684 ' CG ' ' N ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -66.53 -68.64 0.36 Allowed 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.633 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.684 ' N ' ' CG ' ' A' ' 100' ' ' ASP . . . 157.86 -28.11 0.47 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.517 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 1.122 ' O ' HG23 ' A' ' 143' ' ' THR . 97.1 p -113.64 141.72 46.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.681 0.741 . . . . 0.0 111.237 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.546 ' HA2' ' CZ ' ' A' ' 135' ' ' PHE . . . -173.75 125.41 1.12 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.561 ' OH ' ' HG3' ' A' ' 116' ' ' ARG . 81.1 t80 -115.89 131.29 56.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.727 0.298 . . . . 0.0 110.815 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.728 ' CZ ' ' NH1' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -137.73 157.01 47.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.707 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.572 ' OD1' ' HG2' ' A' ' 134' ' ' ARG . 49.5 p30 -144.88 151.27 38.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.358 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.61 141.96 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.967 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.651 ' HB2' ' CH2' ' A' ' 114' ' ' TRP . 38.2 ttt180 -106.4 137.35 44.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.406 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 56.7 t0 -103.35 156.56 17.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.552 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 26.6 mttp -59.28 -30.74 68.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.058 0.456 . . . . 0.0 110.328 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.631 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 96.0 mt-10 -68.99 -0.63 5.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.214 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.648 ' OD2' ' C ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER 76.62 32.09 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.52 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.631 ' NE2' ' OE1' ' A' ' 111' ' ' GLU . 54.8 mt-30 -110.19 146.0 36.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.046 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.651 ' CH2' ' HB2' ' A' ' 108' ' ' ARG . 82.7 m95 -113.66 139.54 48.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.969 0.414 . . . . 0.0 111.175 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.931 HD11 ' CE1' ' A' ' 6' ' ' TYR . 60.5 mt -114.14 125.19 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.224 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 71.6 ttp85 -93.3 114.1 26.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.24 128.3 73.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.602 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.48 ' CE2' ' OE2' ' A' ' 139' ' ' GLU . 67.8 t80 -103.33 131.04 50.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.267 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.825 ' HE2' HG12 ' A' ' 98' ' ' ILE . 88.4 mtp -100.11 127.57 46.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.627 ' OE2' ' OD2' ' A' ' 123' ' ' ASP . 3.6 mp0 -110.76 159.65 17.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 0.0 110.76 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.629 ' CA ' ' HA2' ' A' ' 101' ' ' GLY . 8.0 pttm -45.67 121.2 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.143 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.656 ' CA ' ' O ' ' A' ' 41' ' ' LEU . . . 89.25 6.56 71.09 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.774 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.627 ' OD2' ' OE2' ' A' ' 120' ' ' GLU . 87.4 m-20 -92.18 119.46 31.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.826 ' HE3' HD12 ' A' ' 95' ' ' ILE . 1.2 tpt -113.88 129.78 56.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.182 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 37' ' ' LEU . 12.6 p -134.28 144.68 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.836 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.747 HG22 ' OD2' ' A' ' 93' ' ' ASP . 82.8 m -105.51 132.7 51.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.043 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.625 HD22 ' CE1' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -102.49 122.68 45.52 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.9 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.61 ' HG2' HD12 ' A' ' 131' ' ' ILE . 20.7 Cg_endo -63.89 144.51 88.48 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.954 2.436 . . . . 0.0 112.107 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.939 ' HB1' ' O ' ' A' ' 90' ' ' HIS . . . -75.9 142.33 42.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.058 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.12 11.3 61.48 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 128' ' ' PRO . 1.2 mt -115.47 148.78 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.766 0.317 . . . . 0.0 110.716 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 1.171 ' CE2' HD22 ' A' ' 89' ' ' LEU . 7.8 m-30 -94.75 131.31 40.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.179 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.63 ' HE1' ' CE1' ' A' ' 90' ' ' HIS . 20.0 p-80 -154.64 167.74 29.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.58 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.572 ' HG2' ' OD1' ' A' ' 106' ' ' ASP . 16.1 ptp180 -149.41 150.78 32.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.632 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.69 ' O ' ' CD2' ' A' ' 85' ' ' TYR . 68.8 t80 -114.42 132.41 56.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 138' ' ' ASP . 46.5 m -125.54 137.11 53.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.023 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.759 HG22 ' OH ' ' A' ' 85' ' ' TYR . 15.3 m -117.77 12.0 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.594 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.657 ' H ' HG22 ' A' ' 136' ' ' THR . 56.3 t0 -57.61 -23.19 49.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.151 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.592 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 84.4 tt0 -44.71 -34.77 2.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.289 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 19.6 mtpt -159.95 4.28 0.08 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.6 m120 58.71 33.27 22.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.902 0.382 . . . . 0.0 110.555 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.473 ' O ' ' OG ' ' A' ' 102' ' ' SER . 62.3 t80 -151.99 97.65 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.178 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 1.122 HG23 ' O ' ' A' ' 102' ' ' SER . 53.3 m -135.25 130.76 35.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.386 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.639 ' HB3' ' CB ' ' A' ' 100' ' ' ASP . 29.3 tttt -130.43 117.16 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.656 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.51 156.88 45.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.704 ' SD ' ' HE3' ' A' ' 64' ' ' MET . 44.2 ttm -92.19 135.17 34.21 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.673 ' NH1' ' CG2' ' A' ' 67' ' ' ILE . 50.2 mtm-85 -111.27 149.23 31.34 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.084 0.469 . . . . 0.0 111.256 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.946 HD13 ' C ' ' A' ' 148' ' ' LEU . 1.8 tm? -119.92 119.32 33.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.862 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.658 ' N ' HD22 ' A' ' 148' ' ' LEU . 98.1 m-85 -129.8 153.55 48.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.984 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.48 129.86 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.074 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.32 -159.43 38.99 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.47 148.37 98.1 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 110.633 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.69 ' HB2' HG23 ' A' ' 156' ' ' THR . 38.0 Cg_endo -69.51 95.25 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.884 2.39 . . . . 0.0 112.294 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.32 -27.41 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.688 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.672 ' CZ2' ' CE2' ' A' ' 84' ' ' PHE . 43.6 t90 -56.3 -34.05 66.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.69 HG23 ' HB2' ' A' ' 153' ' ' PRO . 53.7 p -46.32 -43.83 16.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.56 100.55 3.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.25 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CD2' ' O ' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -151.12 159.99 44.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.67 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.98 179.166 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.6 t80 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.824 0.345 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 73.2 t -58.26 -38.98 71.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.602 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.589 ' HD2' ' CD2' ' A' ' 91' ' ' LEU . 60.5 mtpt -57.75 -34.89 70.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.678 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -56.72 -41.33 77.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.499 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.0 tp -57.26 -37.68 72.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.632 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.34 72.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.655 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -63.59 -33.06 74.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.527 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.019 ' HB ' HD12 ' A' ' 28' ' ' LEU . 10.5 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.733 0.301 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.567 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 13.2 mm-40 -94.25 114.58 26.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.497 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 1.158 ' HB3' ' CG1' ' A' ' 26' ' ' VAL . . . -163.55 162.7 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.891 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.519 ' HE3' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -126.95 148.21 50.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.064 0.459 . . . . 0.0 111.685 -178.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.599 ' CE2' HG12 ' A' ' 115' ' ' ILE . 1.2 t80 -108.71 77.29 1.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.238 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.1 ptm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.566 -178.49 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 62.0 m-70 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.91 0.386 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.493 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -89.48 100.56 2.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.253 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.629 ' O ' ' C ' ' A' ' 22' ' ' PRO . 16.1 Cg_endo -60.91 153.68 61.7 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.608 2.205 . . . . 0.0 111.73 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -105.55 112.31 64.71 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.622 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.629 ' C ' ' O ' ' A' ' 20' ' ' PRO . 37.8 Cg_endo -73.33 156.76 99.5 Favored 'Cis proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.144 -1.607 . . . . 0.0 112.348 -0.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 20' ' ' PRO . . . -68.57 143.64 40.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HG3' ' HG2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -152.71 121.05 3.18 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.222 0.534 . . . . 0.0 111.225 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.73 156.32 63.74 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.161 2.574 . . . . 0.0 111.327 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.158 ' CG1' ' HB3' ' A' ' 4' ' ' ALA . 1.2 p -57.33 144.7 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.54 103.02 2.92 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.019 HD12 ' HB ' ' A' ' 2' ' ' VAL . 9.2 tt -48.64 -40.34 27.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.809 0.337 . . . . 0.0 110.348 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -59.37 -36.98 76.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.168 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.574 ' OE1' ' HA ' ' A' ' 30' ' ' GLN . 15.1 mm-40 -61.33 -43.59 98.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.693 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.59 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 18.2 mt -71.77 -34.54 69.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.22 -43.11 70.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.286 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.544 ' CG ' HH11 ' A' ' 33' ' ' ARG . 2.6 ttt-85 -65.29 -31.05 71.99 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.59 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 28.2 tp -65.13 -18.55 65.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.888 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.553 ' O ' ' HG3' ' A' ' 128' ' ' PRO . . . 102.83 17.24 19.44 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.51 128.97 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.263 0.554 . . . . 0.0 110.979 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 126' ' ' THR . 35.5 mt -123.89 143.0 50.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.15 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.814 ' CE1' HD11 ' A' ' 28' ' ' LEU . 30.6 p90 -144.46 150.97 38.52 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.871 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.6 ' HB2' ' CB ' ' A' ' 124' ' ' MET . 24.3 m-90 -123.13 141.21 52.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.575 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.442 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 4.1 ttpm? -99.37 104.42 16.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.898 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.666 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 1.1 mt -141.32 150.83 43.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.288 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.639 ' OD1' ' NZ ' ' A' ' 45' ' ' LYS . 84.4 m-20 -102.23 132.54 48.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.545 ' HB2' ' CA ' ' A' ' 99' ' ' LEU . . . -47.09 -44.1 20.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.16 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -62.57 -33.22 74.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.738 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.639 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 18.0 mttp -86.6 -8.18 57.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.319 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.692 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -71.42 -56.09 6.63 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.692 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 48.8 tp10 -76.09 -42.23 47.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.555 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.482 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -66.85 -23.51 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.633 ' CB ' ' O ' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -124.02 85.29 54.51 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.829 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.1 Cg_endo -44.06 -9.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.395 2.73 . . . . 0.0 112.008 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.644 ' HG3' ' NZ ' ' A' ' 54' ' ' LYS . 83.7 tt0 -42.9 -35.55 1.24 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.458 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.877 HD13 ' C ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -57.31 -38.23 73.71 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.662 ' N ' HD13 ' A' ' 52' ' ' LEU . 84.0 tt0 -59.51 -34.35 72.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.709 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.644 ' NZ ' ' HG3' ' A' ' 51' ' ' GLU . 7.8 ttpm? -57.28 -45.44 84.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.768 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.2 mt -62.19 -39.87 85.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.629 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 64' ' ' MET . 69.4 ttt180 -60.84 -44.29 97.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.336 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -64.29 -42.06 96.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.537 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -62.95 -41.07 99.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.643 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.729 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 38.5 mmt180 -82.97 -12.02 57.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.019 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 65.4 50.12 1.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.866 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.729 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 25.9 m-85 -99.48 115.53 29.53 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.117 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.549 ' C ' HH21 ' A' ' 56' ' ' ARG . 59.9 p -88.04 -16.9 32.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.218 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.694 ' CH2' ' HB2' ' A' ' 65' ' ' ASP . 1.6 t-105 -114.07 110.6 20.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.002 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.646 ' CE ' HD11 ' A' ' 52' ' ' LEU . 25.0 ttt -146.15 138.23 25.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.35 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.694 ' HB2' ' CH2' ' A' ' 63' ' ' TRP . 21.9 t70 -159.98 179.21 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.583 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.544 ' HA ' ' HG2' ' A' ' 146' ' ' MET . 52.8 mt -106.85 126.2 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 mm -117.15 135.6 57.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.337 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.517 ' OG1' ' HG3' ' A' ' 144' ' ' LYS . 47.6 m -125.43 141.18 52.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.656 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 142' ' ' TYR . 45.8 mt -109.74 122.03 63.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.199 0.524 . . . . 0.0 111.128 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.663 ' O ' ' N ' ' A' ' 74' ' ' LEU . 1.1 t -164.63 118.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.612 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -57.4 -42.79 82.94 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.093 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -62.94 -40.3 97.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.738 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -105.2 1.65 28.42 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.427 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.961 HD21 ' HD3' ' A' ' 80' ' ' LYS . 0.7 OUTLIER -130.25 83.08 64.04 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.838 0.351 . . . . 0.0 111.227 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.593 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 14.1 Cg_endo -59.23 161.37 16.68 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.194 1.929 . . . . 0.0 109.607 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 56.7 t-20 70.86 38.03 1.23 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.169 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.66 ' CZ ' HG13 ' A' ' 81' ' ' ILE . 7.4 t80 -64.97 -48.03 75.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.602 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.588 ' CG ' ' HE3' ' A' ' 82' ' ' LYS . 84.1 tt0 -61.89 -56.74 16.18 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.655 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 97.8 mt-10 -64.92 -41.5 95.51 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.214 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.961 ' HD3' HD21 ' A' ' 74' ' ' LEU . 26.3 tttp -67.08 -37.97 84.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.173 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.856 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -71.3 -54.41 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.119 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.647 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 98.3 mttt -50.1 -30.1 10.37 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.424 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.646 ' HE3' ' HA ' ' A' ' 80' ' ' LYS . 74.0 mtm -74.46 -58.77 3.08 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.856 ' CZ ' HD13 ' A' ' 81' ' ' ILE . 18.3 p90 -87.29 -49.75 7.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.692 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.771 ' CB ' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -52.72 -47.12 67.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.039 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.722 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 84.6 tt0 -55.64 141.62 37.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 110.813 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -57.44 136.02 56.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.645 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -157.46 -172.25 3.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.786 HD22 ' CE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -145.33 178.97 7.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.416 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.661 ' CE1' ' CE1' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -170.7 140.71 1.73 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.044 0.449 . . . . 0.0 110.676 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.3 mt -80.67 2.33 26.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.421 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -108.89 153.36 23.64 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.551 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -61.33 134.95 57.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.412 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -108.32 116.99 32.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.748 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.856 HG12 HG23 ' A' ' 126' ' ' THR . 10.1 mt -129.24 129.84 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.4 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.435 ' CZ ' ' CZ ' ' A' ' 105' ' ' PHE . 14.0 ptm180 -139.72 148.41 42.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.015 0.435 . . . . 0.0 110.721 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.666 ' CZ ' ' HB2' ' A' ' 41' ' ' LEU . 2.2 t80 -122.75 138.71 54.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.593 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 122' ' ' GLY . 12.5 mm -104.1 114.55 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.143 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.723 HD21 ' CE ' ' A' ' 146' ' ' MET . 17.3 mt -84.22 -43.61 14.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.159 0.504 . . . . 0.0 109.971 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.47 162.41 38.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.33 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.55 173.93 45.85 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.682 ' OG ' ' CZ ' ' A' ' 118' ' ' PHE . 33.3 t -123.2 141.2 52.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.814 0.34 . . . . 0.0 110.492 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.92 150.04 20.04 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.72 ' CE1' ' CE1' ' A' ' 118' ' ' PHE . 88.8 m-85 -116.82 127.36 54.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.478 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.665 ' CE2' ' CD1' ' A' ' 135' ' ' PHE . 98.6 m-85 -123.77 149.22 45.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.002 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.602 ' OD2' ' O ' ' A' ' 106' ' ' ASP . 53.8 p30 -133.35 144.48 49.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.462 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.61 146.38 31.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.701 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.66 ' HB2' ' CH2' ' A' ' 114' ' ' TRP . 76.2 ttt180 -113.06 125.67 54.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.008 0.432 . . . . 0.0 110.737 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.76 156.69 22.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -56.23 -32.67 64.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 110.417 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.541 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 85.1 tt0 -66.35 -2.52 4.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.217 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 111' ' ' GLU . 59.8 t0 76.17 40.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.31 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.497 ' NE2' ' CD ' ' A' ' 111' ' ' GLU . 93.9 mt-30 -113.8 144.3 43.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.183 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.66 ' CH2' ' HB2' ' A' ' 108' ' ' ARG . 87.1 m95 -111.2 130.65 55.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.014 0.435 . . . . 0.0 111.182 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.611 HG22 HD11 ' A' ' 117' ' ' ILE . 64.9 mt -117.95 133.96 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.524 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.564 ' C ' HD13 ' A' ' 117' ' ' ILE . 59.4 ttp180 -91.94 116.7 29.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 115' ' ' ILE . 11.9 mm -112.0 127.23 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.422 . . . . 0.0 110.539 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 104' ' ' TYR . 80.1 t80 -106.32 133.13 51.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.917 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.643 ' HG3' ' CE1' ' A' ' 105' ' ' PHE . 16.2 mmt -107.0 126.28 52.12 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.443 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 84.8 tt0 -108.35 148.51 29.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.703 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -44.68 138.03 3.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.123 0.487 . . . . 0.0 111.072 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 79.12 1.04 84.83 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 98' ' ' ILE . 57.2 t0 -94.92 119.7 33.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.867 0.365 . . . . 0.0 111.266 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.644 ' HG3' ' CB ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -97.32 136.49 37.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.663 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.32 143.72 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.303 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.856 HG23 HG12 ' A' ' 95' ' ' ILE . 95.9 m -122.54 131.54 53.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.006 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.9 120.05 41.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.553 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 38.9 Cg_exo -57.11 155.47 28.74 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.806 2.338 . . . . 0.0 111.877 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.6 147.43 29.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 131' ' ' ILE . . . 94.88 9.25 58.62 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.76 HD12 ' N ' ' A' ' 131' ' ' ILE . 3.4 mp -114.55 151.26 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.786 ' CE2' HD22 ' A' ' 89' ' ' LEU . 51.6 m-85 -101.26 135.76 42.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.225 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.661 ' CE1' ' CE1' ' A' ' 90' ' ' HIS . 13.4 p-80 -148.0 158.63 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.123 0.487 . . . . 0.0 111.188 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.566 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 74.0 ttp85 -134.02 132.68 40.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.0 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.665 ' CD1' ' CE2' ' A' ' 105' ' ' PHE . 17.1 t80 -106.38 131.03 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.896 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.552 ' OG1' ' NH1' ' A' ' 134' ' ' ARG . 41.5 m -126.39 131.09 51.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.975 0.417 . . . . 0.0 110.913 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 141' ' ' ASN . 15.0 m -126.9 13.68 3.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.213 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.59 ' HA ' ' OD1' ' A' ' 141' ' ' ASN . 91.6 m-20 -63.32 -23.08 67.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.47 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.658 ' HG3' ' CE2' ' A' ' 104' ' ' TYR . 75.2 mm-40 -56.57 -35.53 68.29 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.286 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.583 ' HG3' ' H ' ' A' ' 142' ' ' TYR . 0.8 OUTLIER -140.66 -22.89 0.8 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.525 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 137' ' ' VAL . 87.0 m-20 59.12 38.5 23.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.715 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.606 ' HD2' ' HG ' ' A' ' 70' ' ' CYS . 65.9 t80 -157.71 97.0 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.6 m -133.44 143.17 48.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.0 110.907 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.517 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 66.7 tttt -126.41 109.83 12.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.746 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.88 154.4 45.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.184 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.723 ' CE ' HD21 ' A' ' 99' ' ' LEU . 69.8 mtm -94.74 146.68 24.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.184 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.574 ' HB3' ' CE2' ' A' ' 149' ' ' PHE . 19.4 mmm-85 -113.91 140.43 48.38 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.378 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 148' ' ' LEU . 5.1 mp -113.85 115.35 27.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.532 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.586 ' HB2' ' CD1' ' A' ' 63' ' ' TRP . 94.5 m-85 -135.25 156.19 49.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.614 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 150' ' ' VAL . 1.3 p -127.7 74.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.945 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.62 -173.0 43.26 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.556 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 71.3 tt0 -73.1 143.4 83.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.901 0.382 . . . . 0.0 110.672 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.556 ' HD2' ' CG ' ' A' ' 152' ' ' GLU . 36.6 Cg_exo -57.53 71.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.867 2.378 . . . . 0.0 112.11 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 152' ' ' GLU . 8.6 p -61.63 -32.78 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.152 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.658 ' HA ' ' CD1' ' A' ' 158' ' ' TYR . 5.2 t90 -54.88 -29.29 55.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.786 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 42.7 m -45.61 -43.11 11.98 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.33 100.89 3.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.366 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.658 ' CD1' ' HA ' ' A' ' 155' ' ' TRP . 21.6 p90 -151.91 164.8 36.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.608 ' O ' ' CD2' ' A' ' 158' ' ' TYR . 85.7 m-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.119 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.1 t80 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.938 0.399 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.0 m -67.84 -26.12 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.798 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.584 ' HD2' ' C ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -60.59 -29.69 69.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.664 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.49 ' N ' ' HG3' ' A' ' 173' ' ' LYS . 69.5 t80 -57.01 -41.96 79.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 175' ' ' LEU . 9.6 tt -57.72 -37.72 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.45 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.679 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.68 -32.72 74.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.549 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.558 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.843 ' HB ' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.747 0.308 . . . . 0.0 110.719 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.655 ' OE1' ' CD2' ' A' ' 118' ' ' PHE . 63.4 tt0 -104.35 113.72 27.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.062 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 1.04 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -164.4 157.76 17.79 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.499 ' O ' HG23 ' A' ' 115' ' ' ILE . 1.4 t-105 -133.22 148.91 52.03 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.686 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.669 ' CE2' ' HA ' ' A' ' 26' ' ' VAL . 14.8 m-85 -98.8 87.87 3.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.785 ' SD ' ' CH2' ' A' ' 114' ' ' TRP . 86.1 mtp . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.351 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.472 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 5.9 mtt180 -61.57 112.26 5.74 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.869 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.8 Cg_exo -56.84 161.06 10.93 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.862 2.375 . . . . 0.0 111.71 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -124.3 97.44 40.03 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.496 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' A' ' 20' ' ' PRO . 11.4 Cg_exo -67.32 153.98 85.5 Favored 'Cis proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.484 -0.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -90.8 179.81 43.03 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -152.86 117.52 2.89 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 111.144 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.495 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 73.1 Cg_endo -81.83 158.56 18.58 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.331 2.687 . . . . 0.0 111.745 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.04 HG11 ' HB3' ' A' ' 4' ' ' ALA . 1.4 p -57.99 147.31 6.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.159 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.14 108.93 3.66 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.843 HD13 ' HB ' ' A' ' 2' ' ' VAL . 26.2 tp -47.25 -41.26 18.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.847 0.356 . . . . 0.0 110.269 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -70.16 -31.52 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.248 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.575 ' HG2' ' OH ' ' A' ' 6' ' ' TYR . 66.3 tp60 -62.93 -46.51 87.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.426 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.435 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 9.3 mt -69.44 -34.22 74.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.532 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -52.54 -43.68 65.33 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -66.54 -32.01 73.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.831 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 35.5 tp -64.5 -25.72 68.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.924 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.598 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . 110.04 23.63 6.05 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.792 HG12 ' CZ ' ' A' ' 38' ' ' TYR . 24.4 t -100.76 128.68 52.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.269 0.557 . . . . 0.0 111.138 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.672 ' HB3' ' CH2' ' A' ' 39' ' ' TRP . 3.0 mt -125.59 141.55 51.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.128 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.792 ' CZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -126.84 134.11 50.6 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.853 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 1.032 ' NE1' HG21 ' A' ' 55' ' ' ILE . 1.2 m95 -101.2 128.46 47.3 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -97.84 105.64 17.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.798 HD11 ' HB3' ' A' ' 39' ' ' TRP . 3.1 mp -139.66 147.34 40.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.696 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.671 ' O ' ' N ' ' A' ' 45' ' ' LYS . 84.1 m-20 -97.72 123.81 41.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 46' ' ' TYR . . . -41.88 -44.64 3.45 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.583 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -62.8 -33.91 76.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.048 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 42' ' ' ASP . 66.9 mttm -85.26 -14.8 45.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.318 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.958 ' CE2' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.92 -49.09 74.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -83.14 -41.65 18.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.094 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.525 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 2.8 m120 -67.11 -22.85 65.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.737 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 45' ' ' LYS . 3.1 t0 -127.12 84.65 62.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.961 0.41 . . . . 0.0 111.524 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.0 Cg_endo -48.7 -8.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 123.23 2.62 . . . . 0.0 111.448 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.59 ' CD ' ' HD2' ' A' ' 54' ' ' LYS . 45.6 tp10 -42.59 -33.54 0.72 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.717 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.958 HD22 ' CE2' ' A' ' 46' ' ' TYR . 24.6 tp -55.32 -41.08 71.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.007 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 50' ' ' PRO . 75.3 mm-40 -63.16 -34.18 77.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.306 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.59 ' HD2' ' CD ' ' A' ' 51' ' ' GLU . 37.8 mttm -59.06 -41.82 88.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.527 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.032 HG21 ' NE1' ' A' ' 39' ' ' TRP . 87.6 mt -62.82 -36.26 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.618 ' NH2' ' HA ' ' A' ' 63' ' ' TRP . 72.1 ttt180 -58.09 -41.54 83.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.234 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.494 HH11 ' HA ' ' A' ' 54' ' ' LYS . 77.4 mtt85 -61.82 -36.01 79.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.446 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -60.28 -39.08 85.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.656 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.666 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 8.8 tpt180 -99.99 -11.16 20.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 110.296 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' ARG . 30.5 t-20 58.08 51.58 8.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.531 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.842 ' CD1' HD13 ' A' ' 148' ' ' LEU . 58.9 m-85 -70.05 124.24 23.59 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.228 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.504 ' C ' HH21 ' A' ' 56' ' ' ARG . 24.2 m -60.8 -36.9 80.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.809 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.692 ' O ' ' CD1' ' A' ' 63' ' ' TRP . 0.0 OUTLIER -138.26 149.93 46.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.379 . . . . 0.0 110.854 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.911 ' SD ' HD21 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -145.47 117.57 8.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.321 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.659 ' OD2' ' CZ3' ' A' ' 63' ' ' TRP . 90.1 m-20 -143.03 169.62 17.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.838 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.977 ' CD1' HD22 ' A' ' 99' ' ' LEU . 14.5 tt -121.49 144.44 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.93 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 68' ' ' THR . 9.8 tp -133.91 157.38 41.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.852 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.868 ' O ' HD13 ' A' ' 74' ' ' LEU . 54.3 m -117.06 138.41 51.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.017 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 69' ' ' ILE . 1.1 mp -90.52 96.47 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.335 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.644 ' O ' ' N ' ' A' ' 74' ' ' LEU . 45.8 t -154.53 128.04 8.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.945 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -57.72 -41.5 81.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.953 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.96 -40.17 96.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.437 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.572 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 40.7 tptt -100.12 -6.77 25.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 111.204 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.868 HD13 ' O ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -126.45 76.63 73.45 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.393 . . . . 0.0 111.163 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.537 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 10.8 Cg_endo -56.42 152.5 39.44 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.365 2.043 . . . . 0.0 110.061 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 39.3 t-20 74.65 39.13 0.45 Allowed 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.209 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.655 ' CZ ' HG13 ' A' ' 81' ' ' ILE . 58.1 t80 -59.66 -40.7 88.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.509 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.639 ' O ' ' CB ' ' A' ' 82' ' ' LYS . 97.0 mt-10 -60.13 -56.89 16.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.708 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.609 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 75.6 mm-40 -71.87 -38.21 70.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.589 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.609 ' HZ2' ' HE1' ' A' ' 84' ' ' PHE . 10.2 tptp -64.64 -56.58 12.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.165 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.014 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -71.71 -35.66 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.117 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.639 ' CB ' ' O ' ' A' ' 78' ' ' GLU . 26.1 tptt -59.48 -41.45 89.82 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.74 ' SD ' ' CH2' ' A' ' 155' ' ' TRP . 59.1 mtt -60.02 -42.15 93.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.537 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.609 ' HE1' ' HZ2' ' A' ' 80' ' ' LYS . 80.0 m-85 -69.24 -36.74 77.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.658 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 1.014 ' CE2' HD12 ' A' ' 81' ' ' ILE . 15.0 m-30 -61.0 -45.19 95.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.589 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.75 138.08 58.13 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.87 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.619 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -90.74 121.16 32.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.733 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.719 ' ND1' ' CE1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -141.63 173.92 11.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.04 0.448 . . . . 0.0 111.178 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.08 HD11 ' CD1' ' A' ' 132' ' ' TYR . 3.5 mp -130.38 159.89 35.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.109 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.587 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 4.0 p80 -170.81 153.38 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.095 0.474 . . . . 0.0 110.838 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.046 HD22 ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -67.78 16.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.823 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.759 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 59.0 t0 -108.53 148.32 30.44 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.616 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.637 ' OD2' ' NH2' ' A' ' 59' ' ' ARG . 83.1 m-20 -83.93 142.34 30.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.514 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 16.2 mm-40 -99.35 118.25 35.57 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.697 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.05 ' CD1' HG23 ' A' ' 126' ' ' THR . 32.9 mm -122.2 119.41 58.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.309 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.666 ' HD2' ' CE2' ' A' ' 105' ' ' PHE . 38.8 mtt85 -139.18 138.27 36.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.31 0.576 . . . . 0.0 111.452 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.791 ' CD2' ' CZ ' ' A' ' 46' ' ' TYR . 25.8 t80 -125.82 129.92 50.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 120' ' ' GLU . 14.0 mm -89.02 93.31 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.52 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.977 HD22 ' CD1' ' A' ' 66' ' ' ILE . 10.4 tp -72.65 -38.93 67.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.202 0.525 . . . . 0.0 109.651 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . 54.7 t0 -155.2 154.43 32.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.211 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 100' ' ' ASP . . . 82.14 -166.49 46.35 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 50.2 m -121.01 147.33 45.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.304 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -132.21 149.09 19.35 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.668 ' CE2' ' HG3' ' A' ' 116' ' ' ARG . 81.2 t80 -125.81 131.3 52.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.344 . . . . 0.0 110.615 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.796 ' HB3' HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -122.08 146.25 47.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 133' ' ' HIS . 23.2 t70 -124.67 128.33 48.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.416 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.14 144.4 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.505 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 114' ' ' TRP . 21.3 ttp180 -122.77 130.67 53.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.652 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 110' ' ' LYS . 57.8 t0 -85.73 156.23 20.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.695 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.571 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -60.79 -25.53 66.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.893 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.543 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 96.2 mt-10 -63.77 2.89 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.877 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 111' ' ' GLU . 54.3 t0 76.51 41.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 110.327 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.543 ' NE2' ' OE1' ' A' ' 111' ' ' GLU . 13.4 pt20 -143.37 165.83 26.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.857 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.785 ' CH2' ' SD ' ' A' ' 7' ' ' MET . 25.1 p-90 -133.69 149.84 51.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.025 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.572 HD13 ' HE1' ' A' ' 6' ' ' TYR . 68.7 mt -117.7 136.63 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.186 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.668 ' HG3' ' CE2' ' A' ' 104' ' ' TYR . 56.9 ttt180 -90.25 120.35 31.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.528 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.796 HD11 ' HB3' ' A' ' 105' ' ' PHE . 27.4 pt -120.8 128.67 76.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.655 ' CD2' ' OE1' ' A' ' 3' ' ' GLN . 71.2 t80 -109.79 136.71 48.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.614 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.47 ' SD ' ' HB ' ' A' ' 125' ' ' VAL . 16.0 mmt -106.37 133.44 51.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.724 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' O ' ' HB ' ' A' ' 98' ' ' ILE . 94.6 mt-10 -107.51 168.36 9.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -64.82 127.5 31.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.691 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.594 ' HA2' ' OH ' ' A' ' 97' ' ' TYR . . . 94.4 -15.42 63.3 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -95.98 121.46 37.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.701 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.711 ' CE ' HG22 ' A' ' 95' ' ' ILE . 18.1 ttt -102.64 150.2 23.67 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.47 ' HB ' ' SD ' ' A' ' 119' ' ' MET . 12.7 p -134.91 141.26 43.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.257 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 1.05 HG23 ' CD1' ' A' ' 95' ' ' ILE . 87.9 m -125.31 132.35 52.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.052 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.523 HD23 HG22 ' A' ' 36' ' ' VAL . 4.1 mt -121.18 127.42 26.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.888 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.756 ' HG2' HD12 ' A' ' 131' ' ' ILE . 12.8 Cg_endo -59.36 141.44 97.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.797 2.331 . . . . 0.0 111.902 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.759 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -69.76 148.94 48.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.104 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.89 3.58 56.98 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.756 HD12 ' HG2' ' A' ' 128' ' ' PRO . 70.4 mt -116.25 137.15 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.305 . . . . 0.0 110.635 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 1.08 ' CD1' HD11 ' A' ' 89' ' ' LEU . 88.8 m-85 -58.4 128.3 36.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.145 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 45.0 p-80 -146.15 146.51 30.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.97 0.414 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.619 ' NE ' ' O ' ' A' ' 85' ' ' TYR . 77.9 ttt180 -135.7 134.34 39.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.111 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.574 ' HD2' ' CE2' ' A' ' 105' ' ' PHE . 70.5 t80 -106.7 124.72 50.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.757 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.691 ' O ' HG13 ' A' ' 137' ' ' VAL . 18.5 p -130.81 155.45 46.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.592 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 136' ' ' THR . 34.7 m -164.96 17.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.271 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.641 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 48.1 p30 -70.8 -15.09 62.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 75.7 mm-40 -59.25 -39.45 82.88 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.33 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.521 ' HD3' ' HB2' ' A' ' 102' ' ' SER . 9.5 mtpm? -110.25 -19.33 13.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 138' ' ' ASP . 10.6 m120 59.6 30.47 20.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.347 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 66.3 t80 -172.94 96.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.196 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.543 ' H ' ' HB ' ' A' ' 69' ' ' ILE . 56.9 m -136.16 134.4 38.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.13 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 5.8 ttmt -117.88 114.89 23.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.915 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.713 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -142.07 155.21 45.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.067 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.653 ' SD ' ' HE2' ' A' ' 46' ' ' TYR . 5.9 mtt -93.64 145.82 24.28 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.016 0.436 . . . . 0.0 110.679 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -129.89 138.89 51.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.738 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.911 HD21 ' SD ' ' A' ' 64' ' ' MET . 41.0 mt -110.98 132.49 54.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.78 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.669 ' CE1' ' O ' ' A' ' 152' ' ' GLU . 62.4 t80 -132.97 152.93 51.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 110.878 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.56 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 11.7 t -116.02 129.66 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.763 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.5 -162.35 37.9 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.669 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 1.8 mm-40 -69.08 155.36 93.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.927 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 156' ' ' THR . 27.8 Cg_endo -65.02 78.8 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.909 2.406 . . . . 0.0 112.184 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.498 HG12 ' CE2' ' A' ' 149' ' ' PHE . 7.0 p -60.61 -30.39 46.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.74 ' CH2' ' SD ' ' A' ' 83' ' ' MET . 43.3 t90 -52.5 -35.92 54.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.96 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.605 HG23 ' HB2' ' A' ' 153' ' ' PRO . 47.6 p -48.9 -43.42 39.21 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.61 101.19 3.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.963 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.719 ' CE1' ' ND1' ' A' ' 88' ' ' HIS . 18.9 p90 -136.18 155.62 49.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.356 179.448 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.0 t80 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.71 0.291 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.23 -39.74 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.578 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -58.28 -34.63 70.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.575 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -56.5 -41.49 76.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.646 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.3 tp -57.37 -37.78 73.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.527 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.11 72.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.586 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -63.78 -33.05 74.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.551 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.5 -179.952 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' A' ' 28' ' ' LEU . 11.7 p -127.9 140.98 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.541 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.575 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 11.7 mm-40 -100.22 116.27 31.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.85 0.357 . . . . 0.0 110.443 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.084 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -164.41 157.53 17.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.792 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.705 ' O ' HG23 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -124.89 145.38 49.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.011 0.434 . . . . 0.0 111.67 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.671 ' OH ' ' NE2' ' A' ' 113' ' ' GLN . 1.4 t80 -96.07 76.03 3.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.794 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . 73.7 mtm -61.12 -2.44 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.732 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.628 ' OD1' ' CD ' ' A' ' 113' ' ' GLN . 54.3 t0 -53.1 -34.41 56.5 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.987 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.402 ' CB ' ' HB3' ' A' ' 20' ' ' PRO . 91.2 m-20 -113.03 8.28 18.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.406 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.794 ' HB3' ' HA ' ' A' ' 7' ' ' MET . . . -106.08 156.95 35.91 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.873 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 36.5 Cg_endo -68.26 142.06 53.98 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.834 2.356 . . . . 0.0 112.287 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.38 -30.51 64.84 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.51 ' O ' ' NE2' ' A' ' 18' ' ' HIS . 1.7 m-20 -49.41 115.41 4.84 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.95 0.405 . . . . 0.0 110.512 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 13' ' ' ASP . 27.9 Cg_endo -64.86 -34.67 48.11 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.911 2.407 . . . . 0.0 112.368 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -56.14 -36.05 67.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.571 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.521 ' CD ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -71.54 157.42 89.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.378 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.589 ' HB2' ' CG ' ' A' ' 19' ' ' ARG . 51.2 Cg_endo -75.76 -5.2 16.19 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.624 2.216 . . . . 0.0 111.381 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.723 ' HA ' ' HB1' ' A' ' 10' ' ' ALA . 65.4 m170 62.6 35.56 14.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.118 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.672 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -91.17 102.14 5.1 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.302 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.68 ' O ' ' N ' ' A' ' 23' ' ' GLY . 12.3 Cg_endo -58.74 161.15 15.71 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.77 2.314 . . . . 0.0 111.687 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.599 ' OD1' ' C ' ' A' ' 21' ' ' ASP . 13.5 t0 -119.37 101.68 48.88 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.575 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.536 ' C ' ' O ' ' A' ' 20' ' ' PRO . 12.9 Cg_exo -66.9 158.04 81.88 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.516 -1.452 . . . . 0.0 112.375 -0.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -82.94 152.21 29.67 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.594 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -152.68 119.85 3.09 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 121.296 0.569 . . . . 0.0 111.315 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 56.2 Cg_endo -74.75 157.44 43.81 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 123.028 2.485 . . . . 0.0 111.294 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.084 HG11 ' HB3' ' A' ' 4' ' ' ALA . 0.8 OUTLIER -57.23 147.64 5.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.912 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 30' ' ' GLN . . . -97.89 102.24 2.64 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.752 ' C ' HD23 ' A' ' 28' ' ' LEU . 7.4 tt -46.06 -47.78 17.05 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.834 0.35 . . . . 0.0 110.358 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.52 -34.39 78.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.174 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 27' ' ' GLY . 93.7 mt-30 -62.33 -40.98 98.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.678 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.588 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 6.6 mt -69.8 -38.68 76.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.345 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -55.98 -41.09 74.28 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.319 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -63.32 -32.33 73.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.588 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 26.2 tp -64.91 -23.9 67.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.938 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.649 ' O ' ' CG ' ' A' ' 128' ' ' PRO . . . 112.31 18.26 7.75 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 t -96.21 129.55 46.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.255 0.55 . . . . 0.0 111.054 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.825 HD13 ' NH2' ' A' ' 59' ' ' ARG . 30.9 mt -120.48 141.06 50.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.131 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.689 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -139.78 139.45 36.44 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.836 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.999 ' NE1' HG21 ' A' ' 55' ' ' ILE . 1.9 m95 -109.53 133.65 52.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.497 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' C ' HD12 ' A' ' 41' ' ' LEU . 11.7 mtmt -105.99 102.74 12.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.809 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.629 ' O ' ' OH ' ' A' ' 97' ' ' TYR . 5.1 mp -142.76 156.49 45.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.247 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 45' ' ' LYS . 87.7 m-20 -90.32 122.29 33.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.529 ' HA ' HD22 ' A' ' 99' ' ' LEU . . . -42.01 -43.25 3.11 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.166 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.522 ' OD2' ' HB3' ' A' ' 42' ' ' ASP . 5.5 p-10 -66.88 -32.8 74.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.688 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.648 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 70.4 mttt -85.04 -11.59 55.01 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.2 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.722 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -71.86 -56.7 5.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.639 -0.424 . . . . 0.0 109.925 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.722 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 83.9 tt0 -67.04 -36.81 82.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.44 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.593 ' CG ' ' HA ' ' A' ' 45' ' ' LYS . 17.6 p-10 -78.67 -11.74 59.99 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.497 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' ' O ' ' A' ' 45' ' ' LYS . 10.2 t0 -130.94 83.26 61.66 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.82 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 53' ' ' GLU . 1.1 Cg_endo -46.4 -8.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 123.535 2.824 . . . . 0.0 112.049 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 49' ' ' ASP . 96.9 mt-10 -46.05 -34.46 4.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.397 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.087 HD13 ' N ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -59.06 -32.4 69.74 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 1.087 ' N ' HD13 ' A' ' 52' ' ' LEU . 84.8 tt0 -64.06 -35.26 80.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.685 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -59.18 -40.62 86.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.699 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.999 HG21 ' NE1' ' A' ' 39' ' ' TRP . 84.3 mt -59.85 -37.24 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.505 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.713 ' HG2' HD23 ' A' ' 148' ' ' LEU . 70.5 mtp180 -59.43 -40.83 88.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.603 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.97 -41.14 86.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.07 -32.54 74.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.694 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.825 ' NH2' HD13 ' A' ' 37' ' ' LEU . 39.0 mmt180 -99.41 7.42 45.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.218 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.682 ' O ' ' CG ' ' A' ' 60' ' ' ASN . 0.2 OUTLIER 59.91 46.39 11.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.75 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.723 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 22.7 m-85 -105.49 113.03 26.36 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.279 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.664 ' C ' ' NH2' ' A' ' 56' ' ' ARG . 1.4 t -99.73 -21.45 15.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.248 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.57 ' HB3' ' O ' ' A' ' 149' ' ' PHE . 70.5 t90 -109.42 127.88 54.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.837 0.351 . . . . 0.0 111.041 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 56' ' ' ARG . 8.8 ptm -143.14 147.58 35.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.321 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 66' ' ' ILE . 46.3 t0 -159.47 166.76 30.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.433 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.534 ' HA ' ' HG2' ' A' ' 146' ' ' MET . 59.2 mt -108.39 122.25 62.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.522 HD12 ' HG3' ' A' ' 147' ' ' ARG . 72.6 mt -119.42 138.46 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.372 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.553 ' OG1' ' HG3' ' A' ' 144' ' ' LYS . 36.1 m -119.41 142.48 48.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.617 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.674 ' C ' ' SG ' ' A' ' 70' ' ' CYS . 64.2 mt -105.76 125.7 61.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.0 111.028 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.674 ' SG ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -169.1 135.4 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.657 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -57.96 -45.67 86.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.983 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.675 ' OD1' ' N ' ' A' ' 73' ' ' LYS . 55.6 p30 -77.21 -33.17 56.28 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.675 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 80.3 tttt -98.29 -3.66 36.76 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.459 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.031 HD21 ' HD3' ' A' ' 80' ' ' LYS . 1.1 tp -125.58 73.46 68.75 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.124 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.579 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 48.2 Cg_exo -49.97 154.14 5.55 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 C-N-CA 121.892 1.728 . . . . 0.0 109.611 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.642 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 63.5 t-20 70.18 32.54 2.89 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.34 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.674 ' O ' ' HB ' ' A' ' 81' ' ' ILE . 27.4 t80 -62.38 -45.7 91.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.434 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 49.0 tp10 -54.82 -54.18 45.6 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.642 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 97.7 mt-10 -76.34 -45.13 33.57 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.398 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 1.031 ' HD3' HD21 ' A' ' 74' ' ' LEU . 23.2 tttp -60.45 -49.52 77.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.281 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.907 HD13 ' CE2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -70.46 -37.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.391 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.607 ' CD ' ' HA ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -70.8 -37.22 73.28 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.617 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.611 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 87.0 mtp -56.68 -48.73 76.99 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.663 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.907 ' CE2' HD13 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -87.19 -14.85 40.01 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.653 179.535 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.825 ' CZ ' HD12 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -56.54 -46.32 80.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.97 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' OE2' ' NE ' ' A' ' 160' ' ' ARG . 92.5 mt-10 -75.93 146.42 39.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.959 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.567 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -80.51 135.51 36.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.292 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.442 ' CD2' ' C ' ' A' ' 88' ' ' HIS . 2.5 p-80 -144.87 170.67 15.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.007 0.432 . . . . 0.0 110.979 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.149 HD11 ' C ' ' A' ' 130' ' ' GLY . 28.3 tp -124.55 153.32 42.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.576 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.612 ' HA ' ' CB ' ' A' ' 162' ' ' ALA . 1.7 p80 -170.81 165.85 7.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.992 0.425 . . . . 0.0 110.897 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.54 ' C ' ' HB1' ' A' ' 129' ' ' ALA . 49.0 mt -85.09 16.24 3.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.585 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.71 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 88.2 m-20 -107.65 149.29 28.26 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.369 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.605 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 49.2 p30 -83.88 164.95 19.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.427 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.605 ' OE2' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -125.71 114.83 19.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.918 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.72 ' CD1' ' CZ ' ' A' ' 61' ' ' TYR . 2.7 mp -120.41 116.32 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.149 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.715 ' NH1' ' CG ' ' A' ' 135' ' ' PHE . 68.1 mtt180 -131.62 138.37 48.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.011 0.434 . . . . 0.0 110.77 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.668 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.3 t80 -127.42 128.71 46.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.384 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.866 HG12 ' HE2' ' A' ' 119' ' ' MET . 23.8 mm -96.69 95.64 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.311 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.212 HD11 ' SD ' ' A' ' 146' ' ' MET . 16.9 mt -71.49 -35.62 70.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.0 109.851 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . 20.2 t70 -157.44 162.81 38.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.339 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 143' ' ' THR . . . 90.86 175.68 44.11 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.541 ' OG ' ' HZ ' ' A' ' 118' ' ' PHE . 41.1 t -129.37 142.98 50.67 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.716 0.293 . . . . 0.0 110.696 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.632 ' HA3' HG12 ' A' ' 137' ' ' VAL . . . -173.23 179.24 44.78 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.7 ' CZ ' ' OG1' ' A' ' 136' ' ' THR . 50.3 p90 -140.13 150.13 43.88 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.925 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 133' ' ' HIS . 3.7 t80 -110.52 141.43 43.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.993 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.564 ' HB3' ' H ' ' A' ' 134' ' ' ARG . 60.2 t0 -94.5 124.22 38.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.571 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 117' ' ' ILE . 21.8 m -128.1 154.55 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.602 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.648 ' NH2' ' CD2' ' A' ' 132' ' ' TYR . 24.0 ttp180 -123.71 143.1 50.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.533 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 55.4 t0 -99.51 156.8 16.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.466 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.533 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 0.9 OUTLIER -60.54 -25.06 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.086 0.469 . . . . 0.0 110.48 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 111' ' ' GLU . 46.5 tp10 -76.16 11.1 1.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.043 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 110' ' ' LYS . 83.7 m-20 62.81 42.84 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.367 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.671 ' NE2' ' OH ' ' A' ' 6' ' ' TYR . 25.3 mt-30 -120.46 149.19 42.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.092 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.642 ' CZ2' ' HD3' ' A' ' 108' ' ' ARG . 94.2 m95 -111.44 133.06 54.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.982 0.42 . . . . 0.0 111.134 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 5' ' ' TRP . 69.1 mt -121.05 134.94 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.509 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 116' ' ' ARG . 8.1 ptm180 -91.08 114.37 26.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.787 HD11 HG21 ' A' ' 107' ' ' VAL . 45.0 mt -108.38 129.63 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.678 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.541 ' HZ ' ' OG ' ' A' ' 102' ' ' SER . 74.1 t80 -94.72 128.83 41.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.913 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.866 ' HE2' HG12 ' A' ' 98' ' ' ILE . 89.0 mtp -100.43 122.55 43.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.354 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.552 ' HG2' ' N ' ' A' ' 121' ' ' LYS . 84.7 tt0 -111.61 160.2 17.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.566 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -55.48 133.39 50.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.612 ' HA2' ' O ' ' A' ' 41' ' ' LEU . . . 88.92 -12.91 64.46 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -95.22 123.46 38.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.879 0.371 . . . . 0.0 111.306 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.688 ' CE ' ' CD1' ' A' ' 39' ' ' TRP . 5.1 ttp -107.11 151.38 25.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.609 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.43 143.31 32.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.302 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 41.2 m -126.38 133.22 51.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.046 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.598 ' CD2' ' CG ' ' A' ' 133' ' ' HIS . 7.6 tp -115.59 113.53 42.72 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.918 0.39 . . . . 0.0 110.808 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.649 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 36.9 Cg_exo -52.91 141.57 55.43 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.646 2.231 . . . . 0.0 111.926 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.71 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -67.82 146.07 54.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.908 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 1.149 ' C ' HD11 ' A' ' 89' ' ' LEU . . . 98.36 3.13 57.67 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.609 ' N ' HD11 ' A' ' 89' ' ' LEU . 71.2 mt -119.57 131.61 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.732 0.301 . . . . 0.0 110.616 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.667 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 98.9 m-85 -62.09 146.05 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.201 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.655 ' HB2' ' CZ ' ' A' ' 105' ' ' PHE . 22.7 p-80 -160.42 156.44 26.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.114 0.483 . . . . 0.0 111.247 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.643 ' NE ' ' O ' ' A' ' 85' ' ' TYR . 41.0 ttt180 -141.74 128.21 20.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.065 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.715 ' CG ' ' NH1' ' A' ' 96' ' ' ARG . 68.9 t80 -107.09 124.04 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.836 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.7 ' OG1' ' CZ ' ' A' ' 104' ' ' TYR . 16.5 p -138.06 154.36 49.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.646 ' CG1' ' O ' ' A' ' 136' ' ' THR . 17.2 m -165.05 25.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.198 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.655 ' OD2' ' N ' ' A' ' 139' ' ' GLU . 51.2 p30 -65.0 -24.64 67.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.618 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.655 ' N ' ' OD2' ' A' ' 138' ' ' ASP . 60.2 mp0 -55.17 -34.48 63.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.77 0.319 . . . . 0.0 111.175 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 102' ' ' SER . 0.0 OUTLIER -100.46 -28.18 13.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.581 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 58.18 27.38 15.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.616 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -173.15 96.38 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.437 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.505 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 42.4 m -136.17 139.05 42.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.954 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.553 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 71.2 tttt -117.24 116.03 26.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.668 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.69 154.62 45.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.014 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 1.212 ' SD ' HD11 ' A' ' 99' ' ' LEU . 6.5 mtp -96.16 146.8 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.223 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.66 ' HB3' ' CE1' ' A' ' 149' ' ' PHE . 21.3 mmt85 -120.08 136.55 54.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.535 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.727 ' N ' HD12 ' A' ' 148' ' ' LEU . 5.8 mp -118.6 119.38 34.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.527 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 147' ' ' ARG . 96.7 m-85 -129.98 159.38 36.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.563 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.555 ' CG1' ' HD2' ' A' ' 61' ' ' TYR . 15.7 m -112.23 131.59 63.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.28 -162.08 41.79 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' A' ' 152' ' ' GLU . 0.1 OUTLIER -68.35 144.07 96.22 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.829 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.549 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 31.4 Cg_exo -55.46 96.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.891 2.394 . . . . 0.0 112.172 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.4 -39.33 83.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.254 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.481 ' O ' ' CE3' ' A' ' 155' ' ' TRP . 9.0 t90 -55.1 -33.22 62.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.789 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 153' ' ' PRO . 42.4 m -45.64 -43.88 12.79 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.32 101.01 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.345 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -142.0 158.45 43.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.733 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.698 ' OD1' ' CZ ' ' A' ' 165' ' ' PHE . 20.3 m120 -91.09 139.8 30.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.08 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.668 ' CB ' ' CD ' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -43.26 -74.0 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.533 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.668 ' CD ' ' CB ' ' A' ' 160' ' ' ARG . 49.4 Cg_endo -72.47 130.59 16.31 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.41 2.074 . . . . 0.0 111.884 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.952 ' HB2' ' O ' ' A' ' 89' ' ' LEU . . . -66.07 -33.08 74.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 0.0 110.505 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.538 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 23.4 t70 -65.64 -18.91 65.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.526 ' HB2' ' HG2' ' A' ' 161' ' ' PRO . 12.1 t60 -47.6 -35.06 8.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.588 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.698 ' CZ ' ' OD1' ' A' ' 159' ' ' ASN . 91.8 m-85 -86.24 133.08 33.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.46 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.652 ' O ' ' CB ' ' A' ' 170' ' ' GLN . 97.4 mt-10 -60.0 -45.31 93.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.81 -46.84 62.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.402 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.507 ' HB2' ' HB2' ' A' ' 165' ' ' PHE . 92.9 mtt180 -85.45 -9.85 56.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.564 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 165' ' ' PHE . . . -106.19 -52.44 0.78 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.652 ' CB ' ' O ' ' A' ' 166' ' ' GLU . 63.4 tt0 -55.97 -37.6 69.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.361 . . . . 0.0 110.532 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.529 ' HA ' ' CD2' ' A' ' 174' ' ' PHE . 7.9 t80 -58.42 -37.78 76.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.109 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.68 -38.06 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.604 ' O ' ' OE1' ' A' ' 177' ' ' GLN . 56.2 mttp -55.99 -35.15 66.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.682 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.584 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 96.3 m-85 -58.2 -36.75 73.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.433 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 178' ' ' THR . 60.9 mt -61.33 -35.44 77.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.828 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.515 ' HB3' ' NE2' ' A' ' 177' ' ' GLN . . . -61.37 -41.16 96.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.695 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.604 ' OE1' ' O ' ' A' ' 173' ' ' LYS . 8.2 mp0 -64.35 -32.65 74.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.555 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 175' ' ' LEU . 10.7 m . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.574 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 ttm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.2 p -127.74 143.78 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.624 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -80.68 134.96 35.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.324 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.685 ' CB ' HG13 ' A' ' 26' ' ' VAL . . . -148.54 137.74 21.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.818 ' CA ' HG12 ' A' ' 26' ' ' VAL . 3.5 t-105 -137.87 154.12 49.5 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.681 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.694 ' CE2' ' OD2' ' A' ' 8' ' ' ASP . 0.1 OUTLIER -105.7 110.52 22.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.398 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.767 ' HE2' ' HA2' ' A' ' 12' ' ' GLY . 88.8 mtp -94.33 0.54 55.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.694 ' OD2' ' CE2' ' A' ' 6' ' ' TYR . 52.1 p-10 -56.95 -33.95 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 110.685 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.666 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 59.9 t0 -98.69 -48.6 4.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.488 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.953 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . . . -71.48 149.29 93.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.185 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.82 144.79 78.64 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.885 2.39 . . . . 0.0 112.029 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.767 ' HA2' ' HE2' ' A' ' 7' ' ' MET . . . -58.72 -24.71 57.67 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' O ' ' CE1' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -45.0 111.97 1.41 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.963 0.411 . . . . 0.0 110.488 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -59.29 -30.87 94.0 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.991 2.461 . . . . 0.0 112.166 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -54.27 -38.95 66.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.517 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.2 156.75 73.92 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.481 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.597 ' HB2' ' CD ' ' A' ' 19' ' ' ARG . 47.7 Cg_endo -73.6 -5.12 16.56 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.841 2.361 . . . . 0.0 111.442 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.857 ' HA ' ' HB1' ' A' ' 10' ' ' ALA . 73.3 m-70 68.81 31.4 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.611 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.658 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -126.0 95.63 39.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.953 ' HD3' ' HB2' ' A' ' 10' ' ' ALA . 60.5 Cg_endo -78.09 120.27 4.93 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.749 2.299 . . . . 0.0 111.368 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.578 ' OD2' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -61.59 118.48 38.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.328 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.677 ' C ' ' O ' ' A' ' 20' ' ' PRO . 4.4 Cg_exo -77.04 125.71 12.3 Favored 'Cis proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.37 -1.512 . . . . 0.0 111.43 -1.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -81.76 166.09 46.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.55 ' NH2' ' HD2' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -153.17 117.41 2.82 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 121.11 0.481 . . . . 0.0 111.04 179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.688 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 74.3 Cg_endo -77.42 165.67 27.09 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 123.119 2.546 . . . . 0.0 111.239 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.818 HG12 ' CA ' ' A' ' 5' ' ' TRP . 10.5 p -126.95 159.3 37.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.286 0.565 . . . . 0.0 110.884 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.581 ' N ' HG22 ' A' ' 26' ' ' VAL . . . -128.62 172.03 19.52 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.791 HD11 ' HB2' ' A' ' 38' ' ' TYR . 22.8 tp -53.66 -36.62 62.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.656 0.265 . . . . 0.0 110.774 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -55.08 -41.34 71.41 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.789 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.618 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 99.4 mm-40 -64.12 -40.94 97.27 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.521 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.866 HD21 HD13 ' A' ' 115' ' ' ILE . 25.5 mt -72.61 -32.11 65.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.447 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 19.1 mmm180 -54.7 -41.77 70.66 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -70.99 -27.21 63.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.585 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.648 HD21 ' CG1' ' A' ' 107' ' ' VAL . 13.1 tp -66.47 -9.97 39.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.752 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.637 ' O ' ' CG ' ' A' ' 128' ' ' PRO . . . 95.44 13.29 52.04 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.4 t -97.78 134.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.072 0.463 . . . . 0.0 110.545 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.655 HD11 ' CE2' ' A' ' 39' ' ' TRP . 3.1 tm? -103.95 128.71 51.48 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.951 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.791 ' HB2' HD11 ' A' ' 28' ' ' LEU . 73.8 t80 -116.07 125.26 52.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 0.0 110.893 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.831 ' CE3' ' HE2' ' A' ' 124' ' ' MET . 1.5 m-90 -110.62 134.87 52.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.132 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 1.7 ptpt -99.37 105.3 17.25 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.772 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 43.7 mt -140.2 160.61 39.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.963 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 45' ' ' LYS . 58.5 t0 -119.79 139.28 52.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 46' ' ' TYR . . . -55.07 -43.68 74.1 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.122 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -66.84 -33.69 76.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.784 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.62 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 45.7 mttp -87.26 -6.0 58.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.355 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.723 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -76.72 -58.5 3.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.905 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.723 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 84.3 tt0 -70.68 -38.14 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.65 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 9.8 p-10 -74.1 -16.91 61.0 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.871 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.65 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 2.9 t0 -130.2 83.94 61.54 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.057 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 53' ' ' GLU . 77.7 Cg_exo -42.95 -8.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 123.36 2.707 . . . . 0.0 112.557 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 49' ' ' ASP . 84.2 tt0 -42.69 -34.58 0.93 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.809 HD13 ' C ' ' A' ' 52' ' ' LEU . 2.3 tm? -54.63 -41.03 69.54 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.562 ' OE2' ' HD3' ' A' ' 56' ' ' ARG . 46.7 tp10 -61.06 -34.83 75.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.981 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 25.1 mttm -58.49 -41.79 86.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.407 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 78.6 mt -61.93 -33.75 59.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.658 ' NH2' ' O ' ' A' ' 62' ' ' SER . 60.2 ttt180 -54.98 -42.81 72.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.699 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -67.23 -39.14 86.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.543 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -63.59 -38.53 91.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.262 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.692 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 37.9 mmt180 -92.86 -2.18 56.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 110.527 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 62.33 51.08 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.15 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 1.061 ' CE1' HD12 ' A' ' 95' ' ' ILE . 57.3 m-85 -100.27 112.26 24.58 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.159 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.658 ' O ' ' NH2' ' A' ' 56' ' ' ARG . 61.2 m -83.85 -15.72 47.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.849 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.699 ' CZ2' ' OD2' ' A' ' 65' ' ' ASP . 48.2 t90 -130.65 128.02 40.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.731 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.629 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 16.7 ptm -153.56 133.2 12.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.545 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.699 ' OD2' ' CZ2' ' A' ' 63' ' ' TRP . 97.2 m-20 -145.85 172.04 13.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.527 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.516 HD11 ' OH ' ' A' ' 46' ' ' TYR . 62.7 mt -111.19 123.13 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.048 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.974 HD11 ' CD1' ' A' ' 74' ' ' LEU . 19.8 tt -133.0 148.36 31.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.019 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.627 ' OG1' ' O ' ' A' ' 143' ' ' THR . 5.1 t -127.04 148.02 50.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.186 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.711 ' N ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -83.02 107.95 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 74' ' ' LEU . 12.8 t -170.11 113.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.082 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HB3' ' CB ' ' A' ' 77' ' ' TYR . 7.4 pttm -59.87 -30.97 69.34 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.386 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -61.79 -40.29 94.7 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.639 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -109.66 -41.19 4.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.861 0.362 . . . . 0.0 111.174 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.974 ' CD1' HD11 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -113.3 90.68 17.41 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.771 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.631 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 5.6 Cg_endo -51.18 166.84 0.38 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.581 2.187 . . . . 0.0 110.587 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.631 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 61.3 t-20 86.1 22.13 0.08 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.861 0.362 . . . . 0.0 110.593 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.841 ' O ' HG23 ' A' ' 81' ' ' ILE . 15.2 t80 -59.82 -40.36 88.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.084 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 59.4 mp0 -59.3 -56.04 27.21 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.531 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.654 ' O ' ' CG ' ' A' ' 83' ' ' MET . 96.9 mt-10 -73.59 -30.56 63.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.49 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 8.3 tptt -56.85 -55.53 33.22 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.569 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.841 HG23 ' O ' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -71.6 -44.71 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.759 179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 20.5 mttt -57.33 -35.99 70.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.126 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.73 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . 0.0 OUTLIER -57.84 -45.05 86.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.145 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 97.6 m-85 -77.61 -27.52 51.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.566 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.806 ' HE2' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -54.09 -47.32 71.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.555 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -87.56 132.62 33.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.775 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.556 ' HG2' ' HB2' ' A' ' 134' ' ' ARG . 98.0 mt-10 -61.77 135.72 57.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.137 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.594 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -136.0 155.92 49.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.001 0.429 . . . . 0.0 110.697 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.092 HD11 ' C ' ' A' ' 130' ' ' GLY . 43.9 tp -121.45 164.24 17.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.293 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.932 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 0.1 OUTLIER -168.03 142.83 3.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.237 0.541 . . . . 0.0 110.515 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.768 HD11 HG22 ' A' ' 172' ' ' VAL . 0.5 OUTLIER -65.78 -19.54 65.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.096 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 1.137 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 58.4 t0 -107.79 148.36 29.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.226 0.536 . . . . 0.0 111.36 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.62 ' OD2' ' O ' ' A' ' 127' ' ' LEU . 61.2 t0 -84.48 128.29 34.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.651 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.613 ' OE2' ' CB ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -100.95 139.49 36.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.707 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.061 HD12 ' CE1' ' A' ' 61' ' ' TYR . 67.8 mt -115.19 132.34 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.446 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 124' ' ' MET . 0.0 OUTLIER -133.33 146.02 50.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.399 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 41' ' ' LEU . 1.2 t80 -127.72 127.53 43.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.97 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.87 ' N ' HD12 ' A' ' 98' ' ' ILE . 1.5 mp -93.91 99.09 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 111.0 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.588 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 19.0 mt -74.82 -34.44 62.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.482 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.573 ' HA ' ' HG3' ' A' ' 121' ' ' LYS . 58.6 t0 -146.8 -31.79 0.33 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.226 -0.59 . . . . 0.0 112.062 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.678 ' O ' ' CG2' ' A' ' 98' ' ' ILE . . . -56.57 161.83 7.06 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.609 ' HB2' ' CD ' ' A' ' 140' ' ' LYS . 66.8 m -145.95 148.7 33.06 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.184 -0.508 . . . . 0.0 109.888 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.532 ' HA3' HG12 ' A' ' 137' ' ' VAL . . . 170.92 -168.07 41.21 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.687 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.61 ' CE2' ' HD2' ' A' ' 118' ' ' PHE . 94.6 m-85 -113.91 133.22 55.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.748 0.308 . . . . 0.0 110.502 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.944 ' HZ ' HD12 ' A' ' 127' ' ' LEU . 65.5 t80 -106.7 124.96 50.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.289 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.582 ' HB3' ' H ' ' A' ' 134' ' ' ARG . 61.2 t0 -91.14 121.34 32.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.815 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.816 HG22 ' CE2' ' A' ' 105' ' ' PHE . 28.7 t -121.87 138.61 51.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.589 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.643 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 29.2 ttp180 -113.55 137.99 50.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.525 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 56.8 t0 -97.74 156.72 16.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.704 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.561 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 0.8 OUTLIER -61.49 -24.07 66.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.557 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.657 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 86.0 tt0 -77.41 11.33 2.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.319 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 111' ' ' GLU . 84.2 m-20 64.85 43.88 3.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.966 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.657 ' NE2' ' OE1' ' A' ' 111' ' ' GLU . 51.9 mt-30 -124.32 149.89 46.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.422 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.643 ' CZ3' ' HB2' ' A' ' 108' ' ' ARG . 95.1 m95 -111.71 136.15 51.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.866 HD13 HD21 ' A' ' 31' ' ' LEU . 64.3 mt -118.61 133.99 63.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.622 ' O ' HD13 ' A' ' 117' ' ' ILE . 69.6 ttt180 -90.68 111.2 22.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.645 HD11 HG22 ' A' ' 115' ' ' ILE . 16.9 mm -115.9 134.58 58.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.937 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.61 ' HD2' ' CE2' ' A' ' 104' ' ' TYR . 83.6 t80 -101.07 132.37 46.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.814 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.55 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . 21.8 mmt -95.33 117.63 30.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.39 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.596 ' O ' ' CG ' ' A' ' 123' ' ' ASP . 84.4 tt0 -108.96 150.43 27.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.177 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 18.0 tttp -51.25 128.96 23.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.254 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 41' ' ' LEU . . . 94.31 -3.38 69.21 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.604 ' OD1' ' O ' ' A' ' 123' ' ' ASP . 41.8 p-10 -95.64 119.18 33.7 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.633 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.831 ' HE2' ' CE3' ' A' ' 39' ' ' TRP . 52.8 ttp -111.52 127.15 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.228 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.06 148.15 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.991 0.424 . . . . 0.0 111.605 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.744 HG23 HG12 ' A' ' 95' ' ' ILE . 93.9 m -113.81 135.49 53.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.282 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.944 HD12 ' HZ ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -112.61 110.2 52.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.746 ' HD2' HD23 ' A' ' 127' ' ' LEU . 33.2 Cg_exo -55.97 142.16 85.33 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.942 2.428 . . . . 0.0 112.013 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 1.137 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -71.61 149.19 45.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 1.092 ' C ' HD11 ' A' ' 89' ' ' LEU . . . 101.38 -1.58 53.77 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.802 ' N ' HD11 ' A' ' 89' ' ' LEU . 69.4 mt -120.57 132.72 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.781 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.668 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 95.6 m-85 -78.29 143.96 36.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.265 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.711 ' CG ' ' CD1' ' A' ' 127' ' ' LEU . 9.0 p-80 -158.03 157.6 33.23 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.162 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.618 ' CD ' ' O ' ' A' ' 85' ' ' TYR . 21.8 ttp180 -131.56 130.66 42.55 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.599 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.711 ' CE1' ' CG1' ' A' ' 137' ' ' VAL . 81.3 t80 -113.76 131.21 56.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.741 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.655 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 17.6 p -127.7 153.64 46.26 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.911 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.711 ' CG1' ' CE1' ' A' ' 135' ' ' PHE . 6.0 m -165.55 18.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.212 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.665 ' OD1' ' N ' ' A' ' 139' ' ' GLU . 51.7 p30 -63.79 -25.41 68.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.627 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.665 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 49.6 mt-10 -56.28 -38.73 71.61 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.609 ' CD ' ' HB2' ' A' ' 102' ' ' SER . 59.7 mtpt -96.69 -7.44 34.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.616 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.0 t30 47.48 11.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.747 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.498 ' N ' ' O ' ' A' ' 140' ' ' LYS . 45.8 t80 -150.02 120.54 7.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.466 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.627 ' O ' ' OG1' ' A' ' 68' ' ' THR . 44.1 m -134.79 132.74 39.06 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.61 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.588 ' H ' ' CA ' ' A' ' 101' ' ' GLY . 31.0 tttt -126.8 108.7 11.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.97 152.21 43.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.0 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.588 ' HG3' ' O ' ' A' ' 65' ' ' ASP . 56.7 ttp -101.27 137.39 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.801 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.715 ' NH2' HG21 ' A' ' 67' ' ' ILE . 81.6 mtm-85 -123.35 146.6 47.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 111.158 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 148' ' ' LEU . 5.1 mp -115.37 134.39 55.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.41 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' TRP . 2.3 m-85 -152.72 161.78 42.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.756 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.29 140.22 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.402 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.23 -166.25 40.18 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 5.3 pm0 -65.73 149.61 97.21 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 110.473 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.642 ' O ' ' CG2' ' A' ' 156' ' ' THR . 35.2 Cg_exo -53.15 125.75 19.36 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.721 2.28 . . . . 0.0 112.035 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 155' ' ' TRP . 5.6 p -92.41 -43.95 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.514 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.73 ' CZ2' ' CB ' ' A' ' 83' ' ' MET . 3.3 t90 -57.44 -36.47 71.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.619 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.642 ' CG2' ' O ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -36.92 -53.84 0.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.471 ' H ' HG23 ' A' ' 156' ' ' THR . . . -147.07 101.75 3.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.304 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -134.51 158.71 43.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.407 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.733 ' ND2' ' CZ ' ' A' ' 165' ' ' PHE . 81.5 m-20 -91.47 137.21 32.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.098 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.621 ' CG ' ' HD3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -46.1 -64.53 0.91 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.572 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.621 ' HD3' ' CG ' ' A' ' 160' ' ' ARG . 52.1 Cg_endo -76.3 133.77 15.03 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.531 2.154 . . . . 0.0 112.263 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.681 ' HB2' ' C ' ' A' ' 89' ' ' LEU . . . -65.37 -30.73 71.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.655 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.517 ' HA ' ' HA2' ' A' ' 169' ' ' GLY . 48.1 p30 -91.68 13.49 17.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.506 ' HB2' ' HG2' ' A' ' 161' ' ' PRO . 6.3 t-160 -52.23 -37.96 56.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.295 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.733 ' CZ ' ' ND2' ' A' ' 159' ' ' ASN . 97.4 m-85 -86.22 134.0 33.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.316 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -59.71 -45.83 90.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.856 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.63 ' O ' ' CD1' ' A' ' 171' ' ' TYR . . . -71.39 -46.75 59.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.389 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 70.2 ttt180 -85.96 -4.07 59.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.591 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 165' ' ' PHE . . . -107.18 -57.67 0.59 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.508 HE21 ' HA ' ' A' ' 170' ' ' GLN . 0.8 OUTLIER -56.38 -37.87 70.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 0.0 110.564 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.63 ' CD1' ' O ' ' A' ' 167' ' ' ALA . 13.8 m-30 -63.49 -32.33 73.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.768 HG22 HD11 ' A' ' 91' ' ' LEU . 71.4 t -60.7 -39.79 82.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.615 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.57 -34.85 71.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.627 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -56.61 -41.58 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.522 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.673 ' N ' ' CD2' ' A' ' 175' ' ' LEU . 0.2 OUTLIER -60.92 -35.33 76.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.571 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.74 -32.78 73.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.562 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.75 -32.64 74.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.519 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.5 m . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.585 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.3 ttm . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 14.7 p -128.18 142.43 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.579 ' OE1' ' CD2' ' A' ' 118' ' ' PHE . 49.6 tt0 -100.18 114.7 28.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.878 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.161 ' HB3' ' CG1' ' A' ' 26' ' ' VAL . . . -164.3 171.82 14.35 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.758 ' O ' HG23 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -121.24 142.15 50.19 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.659 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.674 ' CE2' ' HB2' ' A' ' 8' ' ' ASP . 22.8 t80 -104.42 68.58 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.463 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.591 ' HB2' ' O ' ' A' ' 114' ' ' TRP . 87.8 mtp -55.71 -26.53 45.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.753 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.674 ' HB2' ' CE2' ' A' ' 6' ' ' TYR . 86.0 m-20 -53.93 -34.59 60.07 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.583 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.627 ' CG ' ' CE2' ' A' ' 6' ' ' TYR . 92.3 m-20 -104.42 5.35 34.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.494 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.762 ' HB1' ' HB3' ' A' ' 18' ' ' HIS . . . -75.27 148.54 83.82 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.933 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.649 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 28.1 Cg_exo -57.65 142.09 95.64 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.698 2.265 . . . . 0.0 111.518 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.55 29.89 0.59 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 11' ' ' PRO . 10.2 m-20 -114.71 97.81 47.99 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.962 0.41 . . . . 0.0 110.59 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HA ' ' CE1' ' A' ' 18' ' ' HIS . 20.4 Cg_exo -61.89 -12.74 27.16 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.938 2.425 . . . . 0.0 111.97 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.6 ttt-85 -56.61 -38.38 71.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.03 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.508 ' C ' ' H ' ' A' ' 18' ' ' HIS . 22.1 mt-30 -107.96 168.44 7.89 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.046 0.45 . . . . 0.0 111.242 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.643 ' HB2' ' NE ' ' A' ' 19' ' ' ARG . 25.4 Cg_exo -59.5 2.29 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.185 2.59 . . . . 0.0 111.884 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.762 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 17.5 m80 74.8 29.67 1.04 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.173 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.643 ' NE ' ' HB2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -121.88 96.2 47.13 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.467 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.636 ' O ' ' C ' ' A' ' 22' ' ' PRO . 36.2 Cg_endo -68.88 125.41 12.57 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.557 2.171 . . . . 0.0 111.18 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -63.41 118.53 44.85 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.809 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.636 ' C ' ' O ' ' A' ' 20' ' ' PRO . 1.6 Cg_endo -81.71 143.67 57.91 Favored 'Cis proline' 0 C--N 1.309 -1.537 0 C-N-CA 123.615 -1.41 . . . . 0.0 111.966 -0.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.56 161.06 43.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -133.58 117.54 14.29 Favored Pre-proline 0 C--N 1.332 -0.183 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.131 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.38 157.31 61.58 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 123.058 2.506 . . . . 0.0 111.467 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.161 ' CG1' ' HB3' ' A' ' 4' ' ' ALA . 1.7 p -57.37 142.61 12.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.761 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 30' ' ' GLN . . . -82.89 100.41 2.2 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.601 ' HB2' ' CG1' ' A' ' 2' ' ' VAL . 21.4 tp -47.15 -43.12 20.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.725 0.298 . . . . 0.0 110.317 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.8 -35.34 80.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.021 0.439 . . . . 0.0 109.946 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.784 ' O ' HD13 ' A' ' 34' ' ' LEU . 93.5 mt-30 -61.38 -41.73 97.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.097 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 34' ' ' LEU . 10.3 mt -69.49 -34.41 74.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.43 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -42.12 65.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 33' ' ' ARG . 19.9 ttp180 -64.8 -31.21 72.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.018 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.784 HD13 ' O ' ' A' ' 30' ' ' GLN . 10.3 mp -65.3 -18.13 65.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.026 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.88 23.13 11.03 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.28 132.24 45.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.02 0.438 . . . . 0.0 110.742 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 125' ' ' VAL . 55.3 mt -108.75 141.21 41.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.633 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -118.01 123.55 45.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.623 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.859 ' HZ3' ' HG1' ' A' ' 126' ' ' THR . 2.3 m-90 -121.23 132.3 54.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.179 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -105.84 104.98 14.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.062 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.634 ' C ' ' OH ' ' A' ' 97' ' ' TYR . 1.3 mp -140.58 153.34 46.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.95 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 46' ' ' TYR . 85.9 m-20 -102.92 133.07 48.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.532 ' O ' ' HD1' ' A' ' 46' ' ' TYR . . . -49.52 -43.98 45.97 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.69 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.683 ' OD2' ' N ' ' A' ' 45' ' ' LYS . 56.6 p30 -65.79 -31.6 72.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.673 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.683 ' N ' ' OD2' ' A' ' 44' ' ' ASP . 12.0 ttmm -85.38 -19.39 31.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.268 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.721 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -61.56 -56.48 19.47 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.822 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.721 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 84.9 tt0 -72.01 -40.86 68.18 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.584 -0.446 . . . . 0.0 109.984 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.618 ' OD1' ' O ' ' A' ' 44' ' ' ASP . 17.8 m120 -66.77 -22.92 66.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.806 179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.659 ' O ' ' N ' ' A' ' 51' ' ' GLU . 23.4 t0 -124.32 84.64 56.09 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.305 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 53' ' ' GLU . 75.0 Cg_exo -41.05 -8.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.59 2.86 . . . . 0.0 112.584 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 49' ' ' ASP . 12.4 tm-20 -41.87 -32.53 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tp -54.28 -41.03 68.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 96.9 mt-10 -60.97 -35.89 77.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.266 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -59.64 -44.73 93.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.949 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.0 mt -62.01 -32.82 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.654 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . 27.2 ttt180 -55.74 -42.02 74.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.702 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -61.42 -41.46 97.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.779 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -67.48 -44.79 77.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.536 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.642 HH12 HG21 ' A' ' 126' ' ' THR . 46.7 mtp85 -76.38 -19.48 58.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.534 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' N ' ' O ' ' A' ' 56' ' ' ARG . 14.5 t-20 60.34 44.5 12.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.932 ' HA ' HG22 ' A' ' 150' ' ' VAL . 4.2 p90 -112.0 126.15 54.83 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.094 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.572 ' C ' HH21 ' A' ' 56' ' ' ARG . 51.8 p -94.51 0.2 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.311 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.772 ' CE3' ' CE2' ' A' ' 149' ' ' PHE . 49.1 t90 -123.35 133.39 54.13 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.72 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.659 ' HB3' HD22 ' A' ' 148' ' ' LEU . 8.6 ptm -154.49 145.37 22.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.256 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.589 ' HB3' ' CH2' ' A' ' 63' ' ' TRP . 49.9 t0 -159.27 162.9 36.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.833 0.349 . . . . 0.0 110.83 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.504 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 65.7 mt -114.06 127.96 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.505 HG12 ' N ' ' A' ' 68' ' ' THR . 5.3 tt -130.69 154.37 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 111.496 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.626 HG23 ' HG2' ' A' ' 144' ' ' LYS . 42.0 m -117.02 142.14 47.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.331 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.615 ' C ' ' SG ' ' A' ' 70' ' ' CYS . 2.2 mt -104.22 125.71 58.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.147 0.499 . . . . 0.0 111.168 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.615 ' SG ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -171.12 128.27 0.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.459 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -57.32 -46.03 83.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.889 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -67.72 -40.83 84.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.848 0.356 . . . . 0.0 111.033 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 70' ' ' CYS . 30.5 tttt -69.51 -41.22 76.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.034 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.741 HD23 ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -133.47 87.41 37.6 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.777 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 74' ' ' LEU . 72.3 Cg_exo -41.01 176.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.22 1.947 . . . . 0.0 110.418 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.662 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 59.5 t-20 69.94 36.48 1.98 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.322 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.649 ' CE2' HG13 ' A' ' 81' ' ' ILE . 24.2 t80 -65.33 -51.45 60.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.567 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.647 ' O ' ' CD ' ' A' ' 82' ' ' LYS . 97.0 mt-10 -69.35 -46.97 65.74 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.662 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 98.7 mt-10 -65.17 -42.26 93.88 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.443 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.657 ' HE3' ' CE2' ' A' ' 155' ' ' TRP . 14.4 tptt -71.71 -45.73 60.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.15 0.5 . . . . 0.0 109.933 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.916 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 14.1 mm -61.56 -58.13 8.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.799 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.647 ' CD ' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -54.21 -32.64 56.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.488 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.63 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 76.8 mmm -59.47 -61.15 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.254 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.916 ' CZ ' HD13 ' A' ' 81' ' ' ILE . 46.0 p90 -86.96 -16.31 36.21 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.695 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.673 ' CB ' ' O ' ' A' ' 81' ' ' ILE . 19.9 t80 -61.92 -46.26 90.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.14 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -65.47 142.49 58.14 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.231 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.6 139.47 31.7 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.149 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -164.79 170.36 15.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.032 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.134 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -133.08 171.83 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.529 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.631 ' HE1' ' CD2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -170.41 154.68 4.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.673 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.563 HD11 ' HG3' ' A' ' 173' ' ' LYS . 0.3 OUTLIER -74.55 5.05 5.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.916 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 92' ' ' ASP . 49.7 p30 -108.98 152.2 25.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.474 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.607 ' OD2' ' O ' ' A' ' 93' ' ' ASP . 50.1 p30 -81.76 146.96 29.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.653 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.556 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 7.3 mm-40 -105.88 116.07 31.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.826 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.016 HD13 ' OG1' ' A' ' 126' ' ' THR . 6.3 tp -127.78 119.95 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.353 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.53 ' HE ' ' HB3' ' A' ' 145' ' ' ALA . 63.4 ttt180 -134.65 137.41 43.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.478 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.933 ' O ' ' HB1' ' A' ' 145' ' ' ALA . 1.6 t80 -114.61 129.02 56.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.179 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.711 HG22 ' HA ' ' A' ' 121' ' ' LYS . 20.0 mm -86.08 99.87 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.423 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 97' ' ' TYR . 1.7 mt -82.81 -43.87 16.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.893 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.625 ' OD2' ' O ' ' A' ' 99' ' ' LEU . 91.3 m-20 -144.88 -21.08 0.51 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.896 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.659 ' O ' ' CG2' ' A' ' 98' ' ' ILE . . . -82.8 -176.7 51.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.525 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 49.0 m -151.23 158.05 43.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.547 ' C ' ' CD2' ' A' ' 104' ' ' TYR . . . 176.45 178.37 46.17 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.287 -0.958 . . . . 0.0 111.694 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.765 ' CE2' ' CD1' ' A' ' 118' ' ' PHE . 2.8 m-85 -124.32 140.4 52.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.613 0.244 . . . . 0.0 110.384 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.771 ' CD1' ' SD ' ' A' ' 119' ' ' MET . 18.5 m-30 -109.09 128.92 55.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 110.723 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.699 ' OD1' ' CE3' ' A' ' 114' ' ' TRP . 23.8 t70 -93.6 121.32 34.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.472 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.542 ' CG1' HD11 ' A' ' 117' ' ' ILE . 13.0 p -131.85 145.92 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.626 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.657 ' HB2' ' CZ3' ' A' ' 114' ' ' TRP . 20.8 ttp180 -116.81 143.2 45.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 110.749 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD2' ' C ' ' A' ' 109' ' ' ASP . 49.3 p30 -101.55 174.41 5.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.423 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -56.98 -31.66 65.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.046 0.451 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 112' ' ' ASP . 84.5 tt0 -59.81 -9.14 2.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.105 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 111' ' ' GLU . 85.2 m-20 69.33 38.36 1.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.473 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.642 ' CB ' ' CG ' ' A' ' 8' ' ' ASP . 95.5 mm-40 -120.62 154.39 35.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.87 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.699 ' CE3' ' OD1' ' A' ' 106' ' ' ASP . 98.6 m95 -104.25 137.23 42.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.17 0.51 . . . . 0.0 111.387 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.758 HG23 ' O ' ' A' ' 5' ' ' TRP . 72.3 mt -119.07 134.19 63.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.981 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.556 ' NH2' ' HD1' ' A' ' 104' ' ' TYR . 13.5 tpt180 -90.49 124.67 35.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.917 HG22 ' HE3' ' A' ' 119' ' ' MET . 21.9 mt -113.33 134.18 56.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.878 -178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.765 ' CD1' ' CE2' ' A' ' 104' ' ' TYR . 65.1 t80 -101.48 129.87 47.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.953 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.917 ' HE3' HG22 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -115.13 123.9 50.13 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.446 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 123' ' ' ASP . 12.7 pt-20 -102.75 169.99 8.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.568 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.711 ' HA ' HG22 ' A' ' 98' ' ' ILE . 18.3 ptpt -64.79 123.7 20.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.953 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 95.93 -1.94 63.66 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.577 ' O ' HG12 ' A' ' 98' ' ' ILE . 60.2 t0 -93.89 119.96 33.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 0.0 111.007 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.66 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . 21.7 ttt -108.52 132.4 53.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.304 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 14.8 p -135.65 146.53 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 0.0 110.83 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 1.016 ' OG1' HD13 ' A' ' 95' ' ' ILE . 42.1 m -119.72 139.37 52.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.336 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.933 HD22 ' HB2' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -114.71 143.36 29.86 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.005 0.431 . . . . 0.0 110.841 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.599 ' CG ' HD12 ' A' ' 131' ' ' ILE . 32.4 Cg_endo -66.65 154.39 74.59 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.053 2.502 . . . . 0.0 112.238 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.524 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -94.14 138.95 31.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.586 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.604 ' O ' ' NE2' ' A' ' 170' ' ' GLN . . . 96.62 -0.18 61.11 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.599 HD12 ' CG ' ' A' ' 128' ' ' PRO . 70.6 mt -116.82 142.38 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.684 0.278 . . . . 0.0 110.277 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.699 ' CD2' HD21 ' A' ' 89' ' ' LEU . 99.7 m-85 -52.2 131.94 33.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.419 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.933 ' HB2' HD22 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -156.09 134.57 11.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.449 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 85' ' ' TYR . 23.3 ttp180 -139.81 136.81 34.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.871 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.66 ' CD2' ' CD2' ' A' ' 105' ' ' PHE . 21.6 m-30 -112.68 134.07 54.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.351 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 56.9 m -126.6 136.28 52.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.926 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.3 m -147.83 6.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.189 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.621 ' O ' ' OD1' ' A' ' 141' ' ' ASN . 22.2 t70 -55.65 -38.23 69.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.398 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.48 -42.6 96.63 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.227 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 102' ' ' SER . 10.6 mmtm -66.59 -33.23 75.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.725 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.621 ' OD1' ' O ' ' A' ' 138' ' ' ASP . 87.5 m-20 68.32 -10.99 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.616 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.49 ' H ' ' C ' ' A' ' 140' ' ' LYS . 49.4 t80 -151.55 117.38 5.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.367 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.569 HG23 ' HA3' ' A' ' 101' ' ' GLY . 46.4 m -136.22 127.25 27.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.874 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.626 ' HG2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -117.54 103.1 9.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.933 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.82 154.58 45.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.596 ' SD ' ' HE3' ' A' ' 64' ' ' MET . 0.1 OUTLIER -97.48 143.14 28.49 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.618 ' NH2' ' CD2' ' A' ' 149' ' ' PHE . 67.5 ttp85 -115.61 140.69 48.94 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.819 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.835 HD13 ' CE1' ' A' ' 61' ' ' TYR . 48.2 mt -118.57 134.26 55.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.721 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.772 ' CE2' ' CE3' ' A' ' 63' ' ' TRP . 6.3 p90 -149.8 160.46 43.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.374 . . . . 0.0 110.597 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.932 HG22 ' HA ' ' A' ' 61' ' ' TYR . 31.1 t -115.87 130.69 70.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.1 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.433 ' O ' ' CE1' ' A' ' 149' ' ' PHE . . . 80.08 -164.17 47.84 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 153' ' ' PRO . 2.4 pt-20 -73.11 126.45 90.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 110.452 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 149' ' ' PHE . 25.1 Cg_exo -58.94 124.23 15.25 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.79 2.327 . . . . 0.0 112.295 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.4 -34.13 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.447 . . . . 0.0 109.973 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.701 ' O ' ' CE3' ' A' ' 155' ' ' TRP . 1.7 t-105 -58.94 -29.95 67.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.759 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.567 ' OG1' ' HB2' ' A' ' 153' ' ' PRO . 38.3 m -44.49 -46.31 9.66 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.291 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.93 100.89 3.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.453 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.69 ' C ' ' CD1' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -157.0 166.64 32.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.709 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.594 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 86.7 m-20 -91.08 156.62 17.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.994 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.606 ' CB ' ' HD3' ' A' ' 161' ' ' PRO . 0.3 OUTLIER -36.73 -61.73 0.61 Allowed Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.178 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.606 ' HD3' ' CB ' ' A' ' 160' ' ' ARG . 74.1 Cg_endo -81.38 98.54 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.856 2.37 . . . . 0.0 111.697 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 1.134 ' HB3' ' O ' ' A' ' 89' ' ' LEU . . . -63.32 -33.73 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.78 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.588 ' OD1' ' HB2' ' A' ' 89' ' ' LEU . 88.5 m-20 -77.87 -5.23 50.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.553 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.531 ' HB2' ' HG2' ' A' ' 161' ' ' PRO . 28.5 t-80 -56.61 -32.55 65.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.626 ' O ' ' N ' ' A' ' 169' ' ' GLY . 97.6 m-85 -85.29 133.65 34.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.006 0.431 . . . . 0.0 110.982 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.14 -45.05 83.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.02 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.594 ' O ' ' CG2' ' A' ' 172' ' ' VAL . . . -70.22 -45.74 65.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.324 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.481 ' HB2' ' HB2' ' A' ' 165' ' ' PHE . 94.5 mtt-85 -87.74 -1.91 58.27 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.434 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.663 ' O ' HG12 ' A' ' 172' ' ' VAL . . . -86.7 176.07 47.56 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.604 ' NE2' ' O ' ' A' ' 130' ' ' GLY . 94.7 mt-30 -61.37 -31.46 71.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -58.93 -28.06 65.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.599 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 169' ' ' GLY . 5.1 p -54.84 -34.58 31.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.416 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.563 ' HG3' HD11 ' A' ' 91' ' ' LEU . 47.2 mttt -58.22 -35.1 71.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.509 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.34 -41.19 75.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.588 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.754 ' O ' HG22 ' A' ' 178' ' ' THR . 0.2 OUTLIER -61.28 -35.07 76.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.505 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.02 72.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.603 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -63.83 -32.95 74.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.754 HG22 ' O ' ' A' ' 175' ' ' LEU . 1.7 t . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.584 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.7 mtm . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.856 ' HB ' HD12 ' A' ' 28' ' ' LEU . 14.6 p -127.96 140.47 49.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.541 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -102.72 115.77 31.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.211 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.111 ' HB3' ' CG1' ' A' ' 26' ' ' VAL . . . -163.88 155.96 17.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.758 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.637 ' CZ3' ' HB3' ' A' ' 25' ' ' PRO . 0.9 OUTLIER -128.24 141.22 51.52 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.191 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.931 ' CE1' HD11 ' A' ' 115' ' ' ILE . 2.1 t80 -96.13 -6.01 39.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.11 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.597 ' CE ' ' HG3' ' A' ' 20' ' ' PRO . 85.4 mmm -94.15 13.03 24.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.265 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.93 -33.77 57.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.911 0.386 . . . . 0.0 110.919 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.661 ' OD1' ' N ' ' A' ' 10' ' ' ALA . 53.6 p30 -57.89 -29.52 65.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.103 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.661 ' N ' ' OD1' ' A' ' 9' ' ' ASP . . . -57.87 130.31 82.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 110.397 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.644 ' O ' ' NE2' ' A' ' 18' ' ' HIS . 19.3 Cg_endo -61.33 134.68 53.29 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.695 2.263 . . . . 0.0 112.164 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.81 -177.61 34.49 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.421 ' OD2' ' NE2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -74.39 135.05 76.02 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 0.0 110.324 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.17 -25.84 79.57 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.617 2.211 . . . . 0.0 111.995 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.483 HH11 ' HA ' ' A' ' 15' ' ' ARG . 7.7 mmm180 -57.73 -34.78 69.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.832 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.421 ' NE2' ' OD2' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -100.2 155.17 36.72 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.033 0.444 . . . . 0.0 110.693 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.59 ' HG2' ' CG ' ' A' ' 19' ' ' ARG . 46.9 Cg_endo -85.8 -3.55 9.02 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 123.247 2.632 . . . . 0.0 112.112 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.644 ' NE2' ' O ' ' A' ' 11' ' ' PRO . 0.2 OUTLIER 47.28 44.97 16.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.028 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.59 ' CG ' ' HG2' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -61.81 107.42 1.13 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.854 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.68 ' O ' ' N ' ' A' ' 23' ' ' GLY . 35.1 Cg_endo -68.0 159.45 52.93 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.864 2.376 . . . . 0.0 111.62 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -112.27 107.39 55.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.697 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 21' ' ' ASP . 63.2 Cg_endo -78.11 150.02 88.1 Favored 'Cis proline' 0 C--N 1.309 -1.55 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.355 -0.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -95.85 173.49 30.73 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -152.91 117.65 2.89 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 111.08 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.637 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 55.7 Cg_endo -74.11 152.8 45.98 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.158 2.572 . . . . 0.0 111.756 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.111 ' CG1' ' HB3' ' A' ' 4' ' ' ALA . 1.3 p -58.66 144.75 11.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 30' ' ' GLN . . . -94.69 104.56 3.16 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.856 HD12 ' HB ' ' A' ' 2' ' ' VAL . 8.4 tt -45.27 -44.29 11.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.73 -34.55 77.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 27' ' ' GLY . 50.3 tt0 -61.89 -40.85 96.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.264 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.796 HD11 ' CG2' ' A' ' 26' ' ' VAL . 9.0 mp -63.39 -39.41 94.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.636 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.754 ' NH1' HD22 ' A' ' 37' ' ' LEU . 54.2 ttt85 -57.23 -44.05 83.43 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.521 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -75.17 -30.51 60.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.627 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 34' ' ' LEU . 30.8 tp -68.73 -7.24 31.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.127 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.561 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . 102.65 -0.3 49.25 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 32' ' ' ARG . 93.1 t -101.8 126.56 55.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.362 . . . . 0.0 110.557 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.754 HD22 ' NH1' ' A' ' 32' ' ' ARG . 79.8 mt -111.53 147.56 35.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.605 ' CD2' ' HE2' ' A' ' 40' ' ' LYS . 32.8 t80 -114.22 124.28 51.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.142 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.683 ' CZ3' ' OG1' ' A' ' 126' ' ' THR . 1.5 m0 -113.1 138.63 49.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.757 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.605 ' HE2' ' CD2' ' A' ' 38' ' ' TYR . 61.8 mmtt -98.65 105.92 18.12 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.888 HD13 ' HE1' ' A' ' 46' ' ' TYR . 31.8 mt -138.27 139.11 39.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.207 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 46' ' ' TYR . 87.6 m-20 -108.46 128.72 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 99' ' ' LEU . . . -50.36 -42.8 53.77 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.956 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.14 -33.69 76.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.573 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 49' ' ' ASP . 2.2 mtpt -88.07 -17.53 30.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.001 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.888 ' HE1' HD13 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -58.55 -49.1 78.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.764 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -82.8 -44.18 15.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.057 0.456 . . . . 0.0 109.927 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -66.78 -23.38 66.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.612 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 45' ' ' LYS . 1.9 t0 -127.18 84.34 63.7 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.567 ' O ' ' HB3' ' A' ' 53' ' ' GLU . 3.7 Cg_endo -49.47 -8.69 0.1 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 C-N-CA 123.083 2.522 . . . . 0.0 111.288 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 49' ' ' ASP . 84.5 tt0 -43.81 -35.96 2.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.47 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.052 HD13 ' H ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -59.17 -33.31 70.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 1.052 ' H ' HD13 ' A' ' 52' ' ' LEU . 1.5 tp10 -64.74 -35.82 82.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.925 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -58.64 -40.18 82.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.069 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.89 -44.47 90.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.667 ' NE ' ' O ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -66.62 -36.47 82.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.439 179.332 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.625 ' N ' ' HG3' ' A' ' 56' ' ' ARG . 70.3 ttp85 -62.52 -42.78 99.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.297 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.18 -35.62 80.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.614 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.68 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -85.03 0.33 51.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.429 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.49 42.3 14.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.181 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.68 ' CZ ' ' HB3' ' A' ' 59' ' ' ARG . 19.3 m-85 -80.22 122.67 27.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.971 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.26 -31.74 12.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.203 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.708 ' CH2' ' CG ' ' A' ' 65' ' ' ASP . 37.7 t90 -113.07 121.47 44.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.419 . . . . 0.0 111.3 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.816 ' SD ' HD23 ' A' ' 148' ' ' LEU . 83.4 mmm -146.61 139.48 25.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.523 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.708 ' CG ' ' CH2' ' A' ' 63' ' ' TRP . 21.1 p30 -163.13 165.04 25.04 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.841 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.759 HD13 HD22 ' A' ' 99' ' ' LEU . 65.8 mt -115.17 131.8 66.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.267 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.673 ' CG2' ' NH1' ' A' ' 147' ' ' ARG . 10.7 tp -129.15 158.87 41.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.403 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 144' ' ' LYS . 5.5 t -123.55 153.15 41.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.533 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.733 HG21 HG21 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -104.09 103.48 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.433 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 72' ' ' ASP . 20.9 t -172.06 110.18 0.26 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.723 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 77' ' ' TYR . 0.8 OUTLIER -58.65 -35.32 72.36 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.295 -179.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 90.3 m-20 -59.19 -39.42 82.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.444 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -97.36 -41.29 8.31 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.313 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -123.95 85.69 54.05 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.99 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.591 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 2.7 Cg_exo -40.74 172.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.451 2.1 . . . . 0.0 110.316 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.643 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 62.6 t-20 72.4 29.53 2.13 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.358 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.918 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.6 t80 -64.23 -45.83 86.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.58 ' O ' HG13 ' A' ' 81' ' ' ILE . 20.1 pt-20 -71.44 -47.52 55.28 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.643 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 98.2 mt-10 -66.78 -40.12 88.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.386 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.538 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 57.4 tttp -67.99 -47.75 67.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.557 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.092 HD13 ' CE1' ' A' ' 85' ' ' TYR . 2.7 pp -67.4 -42.41 87.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.568 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.81 ' N ' HD12 ' A' ' 81' ' ' ILE . 55.4 tttp -55.87 -39.57 71.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.132 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.593 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 61.8 mtt -59.78 -44.25 94.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.94 0.4 . . . . 0.0 110.695 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.672 ' CE2' ' CZ2' ' A' ' 155' ' ' TRP . 95.5 m-85 -73.51 -33.57 64.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.615 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 1.092 ' CE1' HD13 ' A' ' 81' ' ' ILE . 11.4 m-30 -60.04 -45.66 92.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.542 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 83' ' ' MET . 20.4 pt-20 -64.66 129.74 40.95 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.329 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.633 ' OE2' ' CH2' ' A' ' 114' ' ' TRP . 96.1 mt-10 -63.61 137.9 58.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.552 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.666 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.5 OUTLIER -150.91 171.94 16.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.452 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.171 HD22 ' CE2' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -133.81 -179.91 5.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.273 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.939 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -170.71 146.48 2.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.737 179.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 91' ' ' LEU . 6.3 mp -65.82 -24.77 66.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.329 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.581 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 48.6 p30 -108.22 150.54 27.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 111.261 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.747 ' OD2' HG22 ' A' ' 126' ' ' THR . 49.2 t0 -84.32 128.9 34.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.967 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.631 ' OE2' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -107.93 140.38 41.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.87 0.367 . . . . 0.0 110.667 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.826 HD12 ' HE3' ' A' ' 124' ' ' MET . 15.3 pt -113.75 133.2 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.478 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.728 ' NH1' ' CZ ' ' A' ' 105' ' ' PHE . 42.3 ttm180 -123.27 138.89 54.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.382 . . . . 0.0 110.686 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.687 ' CD2' ' CZ ' ' A' ' 46' ' ' TYR . 17.5 t80 -118.49 129.84 55.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.474 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.825 HG12 ' HE2' ' A' ' 119' ' ' MET . 11.4 mm -91.14 94.22 4.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.169 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.759 HD22 HD13 ' A' ' 66' ' ' ILE . 12.8 tp -80.15 -33.21 38.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.524 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.684 ' CG ' ' N ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -66.53 -68.64 0.36 Allowed 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.633 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.684 ' N ' ' CG ' ' A' ' 100' ' ' ASP . . . 157.86 -28.11 0.47 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.517 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 1.122 ' O ' HG23 ' A' ' 143' ' ' THR . 97.1 p -113.64 141.72 46.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.681 0.741 . . . . 0.0 111.237 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.546 ' HA2' ' CZ ' ' A' ' 135' ' ' PHE . . . -173.75 125.41 1.12 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.561 ' OH ' ' HG3' ' A' ' 116' ' ' ARG . 81.1 t80 -115.89 131.29 56.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.727 0.298 . . . . 0.0 110.815 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.728 ' CZ ' ' NH1' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -137.73 157.01 47.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.707 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.572 ' OD1' ' HG2' ' A' ' 134' ' ' ARG . 49.5 p30 -144.88 151.27 38.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.358 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.4 t -131.61 141.96 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.967 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.651 ' HB2' ' CH2' ' A' ' 114' ' ' TRP . 38.2 ttt180 -106.4 137.35 44.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.406 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 110' ' ' LYS . 56.7 t0 -103.35 156.56 17.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.474 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.552 ' N ' ' OD2' ' A' ' 109' ' ' ASP . 26.6 mttp -59.28 -30.74 68.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.058 0.456 . . . . 0.0 110.328 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.631 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 96.0 mt-10 -68.99 -0.63 5.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.214 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.648 ' OD2' ' C ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER 76.62 32.09 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.52 -179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.631 ' NE2' ' OE1' ' A' ' 111' ' ' GLU . 54.8 mt-30 -110.19 146.0 36.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.046 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.651 ' CH2' ' HB2' ' A' ' 108' ' ' ARG . 82.7 m95 -113.66 139.54 48.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.969 0.414 . . . . 0.0 111.175 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.931 HD11 ' CE1' ' A' ' 6' ' ' TYR . 60.5 mt -114.14 125.19 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.224 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 4' ' ' ALA . 71.6 ttp85 -93.3 114.1 26.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.24 128.3 73.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.602 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.48 ' CE2' ' OE2' ' A' ' 139' ' ' GLU . 67.8 t80 -103.33 131.04 50.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.267 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.825 ' HE2' HG12 ' A' ' 98' ' ' ILE . 88.4 mtp -100.11 127.57 46.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.627 ' OE2' ' OD2' ' A' ' 123' ' ' ASP . 3.6 mp0 -110.76 159.65 17.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 0.0 110.76 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.629 ' CA ' ' HA2' ' A' ' 101' ' ' GLY . 8.0 pttm -45.67 121.2 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.143 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.656 ' CA ' ' O ' ' A' ' 41' ' ' LEU . . . 89.25 6.56 71.09 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.774 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.627 ' OD2' ' OE2' ' A' ' 120' ' ' GLU . 87.4 m-20 -92.18 119.46 31.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.826 ' HE3' HD12 ' A' ' 95' ' ' ILE . 1.2 tpt -113.88 129.78 56.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.182 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 37' ' ' LEU . 12.6 p -134.28 144.68 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.836 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.747 HG22 ' OD2' ' A' ' 93' ' ' ASP . 82.8 m -105.51 132.7 51.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.043 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.625 HD22 ' CE1' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -102.49 122.68 45.52 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.9 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.61 ' HG2' HD12 ' A' ' 131' ' ' ILE . 20.7 Cg_endo -63.89 144.51 88.48 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.954 2.436 . . . . 0.0 112.107 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.939 ' HB1' ' O ' ' A' ' 90' ' ' HIS . . . -75.9 142.33 42.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.058 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.12 11.3 61.48 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 128' ' ' PRO . 1.2 mt -115.47 148.78 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.766 0.317 . . . . 0.0 110.716 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 1.171 ' CE2' HD22 ' A' ' 89' ' ' LEU . 7.8 m-30 -94.75 131.31 40.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.179 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.63 ' HE1' ' CE1' ' A' ' 90' ' ' HIS . 20.0 p-80 -154.64 167.74 29.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.58 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.572 ' HG2' ' OD1' ' A' ' 106' ' ' ASP . 16.1 ptp180 -149.41 150.78 32.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.632 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.69 ' O ' ' CD2' ' A' ' 85' ' ' TYR . 68.8 t80 -114.42 132.41 56.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 138' ' ' ASP . 46.5 m -125.54 137.11 53.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.023 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.759 HG22 ' OH ' ' A' ' 85' ' ' TYR . 15.3 m -117.77 12.0 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.594 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.657 ' H ' HG22 ' A' ' 136' ' ' THR . 56.3 t0 -57.61 -23.19 49.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.151 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.592 ' O ' ' HG3' ' A' ' 140' ' ' LYS . 84.4 tt0 -44.71 -34.77 2.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.289 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 19.6 mtpt -159.95 4.28 0.08 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.6 m120 58.71 33.27 22.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.902 0.382 . . . . 0.0 110.555 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.473 ' O ' ' OG ' ' A' ' 102' ' ' SER . 62.3 t80 -151.99 97.65 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.178 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 1.122 HG23 ' O ' ' A' ' 102' ' ' SER . 53.3 m -135.25 130.76 35.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.386 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.639 ' HB3' ' CB ' ' A' ' 100' ' ' ASP . 29.3 tttt -130.43 117.16 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.656 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.51 156.88 45.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.022 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.704 ' SD ' ' HE3' ' A' ' 64' ' ' MET . 44.2 ttm -92.19 135.17 34.21 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.673 ' NH1' ' CG2' ' A' ' 67' ' ' ILE . 50.2 mtm-85 -111.27 149.23 31.34 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.084 0.469 . . . . 0.0 111.256 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.946 HD13 ' C ' ' A' ' 148' ' ' LEU . 1.8 tm? -119.92 119.32 33.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.862 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.658 ' N ' HD22 ' A' ' 148' ' ' LEU . 98.1 m-85 -129.8 153.55 48.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.984 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.48 129.86 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.074 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 82.32 -159.43 38.99 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.47 148.37 98.1 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 110.633 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.69 ' HB2' HG23 ' A' ' 156' ' ' THR . 38.0 Cg_endo -69.51 95.25 0.52 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.884 2.39 . . . . 0.0 112.294 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.32 -27.41 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.688 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.672 ' CZ2' ' CE2' ' A' ' 84' ' ' PHE . 43.6 t90 -56.3 -34.05 66.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.557 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.69 HG23 ' HB2' ' A' ' 153' ' ' PRO . 53.7 p -46.32 -43.83 16.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.56 100.55 3.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.25 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.654 ' CD2' ' O ' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -151.12 159.99 44.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.67 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.704 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . 41.9 t-20 -91.23 161.07 15.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.98 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.59 ' HG2' ' CD ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -32.7 -60.16 0.38 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.381 . . . . 0.0 110.547 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 160' ' ' ARG . 37.5 Cg_endo -69.42 137.47 36.53 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.838 2.358 . . . . 0.0 112.317 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.959 ' HB2' ' O ' ' A' ' 89' ' ' LEU . . . -66.72 -29.29 69.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.48 ' C ' ' OD1' ' A' ' 163' ' ' ASP . 48.5 p30 -85.84 14.24 6.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.704 ' CD2' ' CB ' ' A' ' 159' ' ' ASN . 54.0 t-80 -54.26 -39.25 66.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.029 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.696 ' CZ ' ' O ' ' A' ' 162' ' ' ALA . 0.5 OUTLIER -87.36 126.71 35.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 110.814 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 171' ' ' TYR . 73.8 mm-40 -65.83 -45.89 80.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.461 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 171' ' ' TYR . . . -71.27 -46.62 60.47 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.918 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.589 ' C ' ' CD2' ' A' ' 165' ' ' PHE . 74.4 mtt85 -89.4 7.01 38.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.812 0.339 . . . . 0.0 110.706 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.559 ' N ' ' HD2' ' A' ' 165' ' ' PHE . . . -108.57 -114.9 3.8 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -58.4 -35.3 71.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.752 0.311 . . . . 0.0 110.668 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.53 ' HB3' ' O ' ' A' ' 167' ' ' ALA . 71.6 t80 -55.4 -39.11 69.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' A' ' 168' ' ' ARG . 73.2 t -58.26 -38.98 71.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.602 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.589 ' HD2' ' CD2' ' A' ' 91' ' ' LEU . 60.5 mtpt -57.75 -34.89 70.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.678 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -56.72 -41.33 77.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.499 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.0 tp -57.26 -37.68 72.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.632 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.34 72.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.655 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -63.59 -33.06 74.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.602 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.527 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.019 ' HB ' HD12 ' A' ' 28' ' ' LEU . 10.5 p -127.83 141.58 46.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.53 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.567 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 13.2 mm-40 -94.25 114.58 26.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.497 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.158 ' HB3' ' CG1' ' A' ' 26' ' ' VAL . . . -163.55 162.7 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.891 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.519 ' HE3' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -126.95 148.21 50.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.064 0.459 . . . . 0.0 111.685 -178.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.697 ' CZ ' ' OD2' ' A' ' 8' ' ' ASP . 1.2 t80 -108.71 77.29 1.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.238 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.55 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . 17.1 ptm -72.47 5.72 2.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.566 -178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.697 ' OD2' ' CZ ' ' A' ' 6' ' ' TYR . 89.7 m-20 -54.34 -34.36 60.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.206 0.527 . . . . 0.0 110.037 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -107.09 5.81 28.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.303 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.55 ' HB3' ' HA ' ' A' ' 7' ' ' MET . . . -105.99 153.96 39.82 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.806 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.495 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 32.5 Cg_endo -66.86 141.04 57.42 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.811 2.341 . . . . 0.0 112.171 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.44 33.28 0.69 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.591 ' OD2' ' N ' ' A' ' 15' ' ' ARG . 2.3 t0 -100.1 110.21 58.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.942 0.401 . . . . 0.0 110.532 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.64 -33.24 86.52 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.749 2.299 . . . . 0.0 112.297 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.591 ' N ' ' OD2' ' A' ' 13' ' ' ASP . 26.8 mmt180 -53.98 -34.76 60.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.583 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 63.7 mt-30 -100.06 139.28 20.62 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.258 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.606 ' HB2' ' CG ' ' A' ' 19' ' ' ARG . 23.6 Cg_exo -60.27 -6.77 5.66 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 122.827 2.351 . . . . 0.0 111.325 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.604 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 62.0 m-70 71.71 39.03 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.121 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.606 ' CG ' ' HB2' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -89.48 100.56 2.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.253 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.629 ' O ' ' C ' ' A' ' 22' ' ' PRO . 16.1 Cg_endo -60.91 153.68 61.7 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.608 2.205 . . . . 0.0 111.73 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -105.55 112.31 64.71 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.622 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' C ' ' O ' ' A' ' 20' ' ' PRO . 37.8 Cg_endo -73.33 156.76 99.5 Favored 'Cis proline' 0 N--CA 1.493 1.466 0 C-N-CA 123.144 -1.607 . . . . 0.0 112.348 -0.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 20' ' ' PRO . . . -68.57 143.64 40.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HG3' ' HG2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -152.71 121.05 3.18 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.222 0.534 . . . . 0.0 111.225 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.73 156.32 63.74 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.161 2.574 . . . . 0.0 111.327 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.158 ' CG1' ' HB3' ' A' ' 4' ' ' ALA . 1.2 p -57.33 144.7 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.54 103.02 2.92 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.019 HD12 ' HB ' ' A' ' 2' ' ' VAL . 9.2 tt -48.64 -40.34 27.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.809 0.337 . . . . 0.0 110.348 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -59.37 -36.98 76.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.168 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.574 ' OE1' ' HA ' ' A' ' 30' ' ' GLN . 15.1 mm-40 -61.33 -43.59 98.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.693 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.59 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 18.2 mt -71.77 -34.54 69.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.22 -43.11 70.56 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.286 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.544 ' CG ' HH11 ' A' ' 33' ' ' ARG . 2.6 ttt-85 -65.29 -31.05 71.99 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.59 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 28.2 tp -65.13 -18.55 65.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.888 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.553 ' O ' ' HG3' ' A' ' 128' ' ' PRO . . . 102.83 17.24 19.44 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 t -88.51 128.97 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.263 0.554 . . . . 0.0 110.979 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 126' ' ' THR . 35.5 mt -123.89 143.0 50.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.15 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.814 ' CE1' HD11 ' A' ' 28' ' ' LEU . 30.6 p90 -144.46 150.97 38.52 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.871 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.6 ' HB2' ' CB ' ' A' ' 124' ' ' MET . 24.3 m-90 -123.13 141.21 52.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.575 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.442 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 4.1 ttpm? -99.37 104.42 16.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.414 -0.514 . . . . 0.0 109.898 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.666 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 1.1 mt -141.32 150.83 43.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.288 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.639 ' OD1' ' NZ ' ' A' ' 45' ' ' LYS . 84.4 m-20 -102.23 132.54 48.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.545 ' HB2' ' CA ' ' A' ' 99' ' ' LEU . . . -47.09 -44.1 20.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.16 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -62.57 -33.22 74.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.738 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.639 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 18.0 mttp -86.6 -8.18 57.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.319 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.692 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -71.42 -56.09 6.63 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.692 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 48.8 tp10 -76.09 -42.23 47.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.555 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.482 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -66.85 -23.51 66.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.633 ' CB ' ' O ' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -124.02 85.29 54.51 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.829 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.1 Cg_endo -44.06 -9.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.395 2.73 . . . . 0.0 112.008 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.644 ' HG3' ' NZ ' ' A' ' 54' ' ' LYS . 83.7 tt0 -42.9 -35.55 1.24 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.458 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.877 HD13 ' C ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -57.31 -38.23 73.71 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.662 ' N ' HD13 ' A' ' 52' ' ' LEU . 84.0 tt0 -59.51 -34.35 72.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.709 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.644 ' NZ ' ' HG3' ' A' ' 51' ' ' GLU . 7.8 ttpm? -57.28 -45.44 84.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.768 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.2 mt -62.19 -39.87 85.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.629 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 64' ' ' MET . 69.4 ttt180 -60.84 -44.29 97.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.336 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -64.29 -42.06 96.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.537 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -62.95 -41.07 99.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.643 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.729 ' CB ' ' CE1' ' A' ' 61' ' ' TYR . 38.5 mmt180 -82.97 -12.02 57.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.019 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 65.4 50.12 1.77 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.866 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.729 ' CE1' ' CB ' ' A' ' 59' ' ' ARG . 25.9 m-85 -99.48 115.53 29.53 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.117 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.549 ' C ' HH21 ' A' ' 56' ' ' ARG . 59.9 p -88.04 -16.9 32.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.218 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.694 ' CH2' ' HB2' ' A' ' 65' ' ' ASP . 1.6 t-105 -114.07 110.6 20.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.002 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.646 ' CE ' HD11 ' A' ' 52' ' ' LEU . 25.0 ttt -146.15 138.23 25.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.35 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.694 ' HB2' ' CH2' ' A' ' 63' ' ' TRP . 21.9 t70 -159.98 179.21 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.583 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.544 ' HA ' ' HG2' ' A' ' 146' ' ' MET . 52.8 mt -106.85 126.2 62.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 mm -117.15 135.6 57.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.337 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.517 ' OG1' ' HG3' ' A' ' 144' ' ' LYS . 47.6 m -125.43 141.18 52.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.656 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 142' ' ' TYR . 45.8 mt -109.74 122.03 63.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.199 0.524 . . . . 0.0 111.128 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.663 ' O ' ' N ' ' A' ' 74' ' ' LEU . 1.1 t -164.63 118.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.612 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -57.4 -42.79 82.94 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.093 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -62.94 -40.3 97.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.738 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -105.2 1.65 28.42 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.427 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.961 HD21 ' HD3' ' A' ' 80' ' ' LYS . 0.7 OUTLIER -130.25 83.08 64.04 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.838 0.351 . . . . 0.0 111.227 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.593 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 14.1 Cg_endo -59.23 161.37 16.68 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.194 1.929 . . . . 0.0 109.607 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 56.7 t-20 70.86 38.03 1.23 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.169 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.66 ' CZ ' HG13 ' A' ' 81' ' ' ILE . 7.4 t80 -64.97 -48.03 75.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.602 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.588 ' CG ' ' HE3' ' A' ' 82' ' ' LYS . 84.1 tt0 -61.89 -56.74 16.18 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.655 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 97.8 mt-10 -64.92 -41.5 95.51 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.214 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.961 ' HD3' HD21 ' A' ' 74' ' ' LEU . 26.3 tttp -67.08 -37.97 84.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.173 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.856 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -71.3 -54.41 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.119 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.647 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 98.3 mttt -50.1 -30.1 10.37 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.424 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.646 ' HE3' ' HA ' ' A' ' 80' ' ' LYS . 74.0 mtm -74.46 -58.77 3.08 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.856 ' CZ ' HD13 ' A' ' 81' ' ' ILE . 18.3 p90 -87.29 -49.75 7.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.751 -0.779 . . . . 0.0 110.692 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.771 ' CB ' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -52.72 -47.12 67.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.039 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.722 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 84.6 tt0 -55.64 141.62 37.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.923 0.392 . . . . 0.0 110.813 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -57.44 136.02 56.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.329 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.645 ' C ' ' CD2' ' A' ' 88' ' ' HIS . 0.9 OUTLIER -157.46 -172.25 3.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.613 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.818 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -145.33 178.97 7.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.416 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.661 ' CE1' ' CE1' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -170.7 140.71 1.73 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.044 0.449 . . . . 0.0 110.676 179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 66.3 mt -80.67 2.33 26.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.421 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -108.89 153.36 23.64 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.551 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -61.33 134.95 57.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.412 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -108.32 116.99 32.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.748 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.856 HG12 HG23 ' A' ' 126' ' ' THR . 10.1 mt -129.24 129.84 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.4 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.435 ' CZ ' ' CZ ' ' A' ' 105' ' ' PHE . 14.0 ptm180 -139.72 148.41 42.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.015 0.435 . . . . 0.0 110.721 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.666 ' CZ ' ' HB2' ' A' ' 41' ' ' LEU . 2.2 t80 -122.75 138.71 54.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.593 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 122' ' ' GLY . 12.5 mm -104.1 114.55 44.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.143 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.723 HD21 ' CE ' ' A' ' 146' ' ' MET . 17.3 mt -84.22 -43.61 14.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.159 0.504 . . . . 0.0 109.971 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -157.47 162.41 38.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.33 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.55 173.93 45.85 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.682 ' OG ' ' CZ ' ' A' ' 118' ' ' PHE . 33.3 t -123.2 141.2 52.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.814 0.34 . . . . 0.0 110.492 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.92 150.04 20.04 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.72 ' CE1' ' CE1' ' A' ' 118' ' ' PHE . 88.8 m-85 -116.82 127.36 54.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.478 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.665 ' CE2' ' CD1' ' A' ' 135' ' ' PHE . 98.6 m-85 -123.77 149.22 45.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.002 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.602 ' OD2' ' O ' ' A' ' 106' ' ' ASP . 53.8 p30 -133.35 144.48 49.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.462 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.61 146.38 31.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.701 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.66 ' HB2' ' CH2' ' A' ' 114' ' ' TRP . 76.2 ttt180 -113.06 125.67 54.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.008 0.432 . . . . 0.0 110.737 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.76 156.69 22.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -56.23 -32.67 64.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 110.417 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.541 ' O ' ' HB3' ' A' ' 112' ' ' ASP . 85.1 tt0 -66.35 -2.52 4.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.217 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 111' ' ' GLU . 59.8 t0 76.17 40.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.31 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.601 ' HB3' ' CG ' ' A' ' 8' ' ' ASP . 93.9 mt-30 -113.8 144.3 43.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.183 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.66 ' CH2' ' HB2' ' A' ' 108' ' ' ARG . 87.1 m95 -111.2 130.65 55.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.014 0.435 . . . . 0.0 111.182 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.611 HG22 HD11 ' A' ' 117' ' ' ILE . 64.9 mt -117.95 133.96 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.524 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.564 ' C ' HD13 ' A' ' 117' ' ' ILE . 59.4 ttp180 -91.94 116.7 29.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 115' ' ' ILE . 11.9 mm -112.0 127.23 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.985 0.422 . . . . 0.0 110.539 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.72 ' CE1' ' CE1' ' A' ' 104' ' ' TYR . 80.1 t80 -106.32 133.13 51.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.917 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.643 ' HG3' ' CE1' ' A' ' 105' ' ' PHE . 16.2 mmt -107.0 126.28 52.12 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.443 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 84.8 tt0 -108.35 148.51 29.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.703 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -44.68 138.03 3.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.123 0.487 . . . . 0.0 111.072 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 79.12 1.04 84.83 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 98' ' ' ILE . 57.2 t0 -94.92 119.7 33.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.867 0.365 . . . . 0.0 111.266 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.644 ' HG3' ' CB ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -97.32 136.49 37.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.663 178.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 p -137.32 143.72 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.303 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.856 HG23 HG12 ' A' ' 95' ' ' ILE . 95.9 m -122.54 131.54 53.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.006 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.9 120.05 41.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.553 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 38.9 Cg_exo -57.11 155.47 28.74 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.806 2.338 . . . . 0.0 111.877 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.6 147.43 29.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.829 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 131' ' ' ILE . . . 94.88 9.25 58.62 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.76 HD12 ' N ' ' A' ' 131' ' ' ILE . 3.4 mp -114.55 151.26 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.703 0.287 . . . . 0.0 110.639 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.786 ' CE2' HD22 ' A' ' 89' ' ' LEU . 51.6 m-85 -101.26 135.76 42.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.225 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.661 ' CE1' ' CE1' ' A' ' 90' ' ' HIS . 13.4 p-80 -148.0 158.63 44.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.123 0.487 . . . . 0.0 111.188 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.566 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 74.0 ttp85 -134.02 132.68 40.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.0 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.665 ' CD1' ' CE2' ' A' ' 105' ' ' PHE . 17.1 t80 -106.38 131.03 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.896 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.552 ' OG1' ' NH1' ' A' ' 134' ' ' ARG . 41.5 m -126.39 131.09 51.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.975 0.417 . . . . 0.0 110.913 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 141' ' ' ASN . 15.0 m -126.9 13.68 3.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.213 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.59 ' HA ' ' OD1' ' A' ' 141' ' ' ASN . 91.6 m-20 -63.32 -23.08 67.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.47 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.658 ' HG3' ' CE2' ' A' ' 104' ' ' TYR . 75.2 mm-40 -56.57 -35.53 68.29 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.286 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.583 ' HG3' ' H ' ' A' ' 142' ' ' TYR . 0.8 OUTLIER -140.66 -22.89 0.8 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.525 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 137' ' ' VAL . 87.0 m-20 59.12 38.5 23.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.715 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.606 ' HD2' ' HG ' ' A' ' 70' ' ' CYS . 65.9 t80 -157.71 97.0 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.6 m -133.44 143.17 48.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.0 110.907 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.517 ' HG3' ' OG1' ' A' ' 68' ' ' THR . 66.7 tttt -126.41 109.83 12.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.746 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -141.88 154.4 45.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.184 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.723 ' CE ' HD21 ' A' ' 99' ' ' LEU . 69.8 mtm -94.74 146.68 24.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.184 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.574 ' HB3' ' CE2' ' A' ' 149' ' ' PHE . 19.4 mmm-85 -113.91 140.43 48.38 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.378 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 148' ' ' LEU . 5.1 mp -113.85 115.35 27.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.532 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.586 ' HB2' ' CD1' ' A' ' 63' ' ' TRP . 94.5 m-85 -135.25 156.19 49.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.614 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 150' ' ' VAL . 1.3 p -127.7 74.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.945 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 168.62 -173.0 43.26 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.556 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 71.3 tt0 -73.1 143.4 83.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.901 0.382 . . . . 0.0 110.672 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.556 ' HD2' ' CG ' ' A' ' 152' ' ' GLU . 36.6 Cg_exo -57.53 71.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.867 2.378 . . . . 0.0 112.11 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.548 HG11 ' HG2' ' A' ' 168' ' ' ARG . 8.6 p -61.63 -32.78 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.152 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.658 ' HA ' ' CD1' ' A' ' 158' ' ' TYR . 5.2 t90 -54.88 -29.29 55.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.786 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 42.7 m -45.61 -43.11 11.98 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.654 ' O ' ' CZ ' ' A' ' 165' ' ' PHE . . . -147.33 100.89 3.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.366 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.658 ' CD1' ' HA ' ' A' ' 155' ' ' TRP . 21.6 p90 -151.91 164.8 36.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.681 ' HB2' ' CG ' ' A' ' 164' ' ' HIS . 85.7 m-20 -89.4 160.59 16.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.119 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.613 ' CB ' ' HD3' ' A' ' 161' ' ' PRO . 2.1 mpp_? -32.99 -57.02 0.53 Allowed Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.426 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 160' ' ' ARG . 18.2 Cg_exo -65.34 132.35 31.17 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.757 2.305 . . . . 0.0 111.79 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 89' ' ' LEU . . . -67.41 -29.61 69.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.838 0.351 . . . . 0.0 110.609 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.489 ' C ' ' OD1' ' A' ' 163' ' ' ASP . 48.1 p30 -92.01 7.26 43.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.451 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.681 ' CG ' ' HB2' ' A' ' 159' ' ' ASN . 2.1 t-80 -64.77 -32.92 74.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.757 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.654 ' CZ ' ' O ' ' A' ' 157' ' ' ALA . 0.4 OUTLIER -77.19 132.13 38.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.405 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -59.54 -45.17 92.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.002 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.407 ' O ' ' CG1' ' A' ' 172' ' ' VAL . . . -70.69 -46.06 63.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.276 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.557 ' HE ' ' CA ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -86.77 3.61 44.36 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.884 0.373 . . . . 0.0 110.61 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.553 ' O ' HG22 ' A' ' 172' ' ' VAL . . . -80.35 -168.71 38.71 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -42.44 -21.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 110.508 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 169' ' ' GLY . 72.1 t80 -51.85 -38.51 56.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.225 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 169' ' ' GLY . 8.0 m -67.84 -26.12 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.584 ' HD2' ' C ' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -60.59 -29.69 69.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.664 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.49 ' N ' ' HG3' ' A' ' 173' ' ' LYS . 69.5 t80 -57.01 -41.96 79.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.461 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 175' ' ' LEU . 9.6 tt -57.72 -37.72 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.45 72.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.679 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.68 -32.72 74.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.549 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.558 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.843 ' HB ' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -126.5 124.69 65.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.719 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.655 ' OE1' ' CD2' ' A' ' 118' ' ' PHE . 63.4 tt0 -104.35 113.72 27.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.062 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 1.04 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -164.4 157.76 17.79 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.499 ' O ' HG23 ' A' ' 115' ' ' ILE . 1.4 t-105 -133.22 148.91 52.03 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.686 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.669 ' CE2' ' HA ' ' A' ' 26' ' ' VAL . 14.8 m-85 -98.8 87.87 3.87 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.785 ' SD ' ' CH2' ' A' ' 114' ' ' TRP . 86.1 mtp -86.89 3.09 46.93 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.351 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.611 ' CB ' ' HB2' ' A' ' 113' ' ' GLN . 14.5 p-10 -58.78 -33.85 70.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.547 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.567 ' OD2' ' HD3' ' A' ' 24' ' ' ARG . 89.8 m-20 -68.55 -67.11 0.49 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.592 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.44 103.08 44.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -66.08 141.39 63.59 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.689 2.259 . . . . 0.0 111.763 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.46 -177.48 40.06 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -71.87 147.94 91.84 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-O 120.879 0.371 . . . . 0.0 110.536 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.646 ' O ' ' NH1' ' A' ' 116' ' ' ARG . 19.4 Cg_endo -60.88 -28.21 86.01 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.736 2.291 . . . . 0.0 112.13 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -54.78 -39.65 68.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.658 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -108.16 155.69 39.72 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.409 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.603 ' HG2' ' CG ' ' A' ' 19' ' ' ARG . 57.4 Cg_endo -87.53 -6.85 6.85 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.1 2.533 . . . . 0.0 111.876 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 45.56 45.62 10.76 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.603 ' CG ' ' HG2' ' A' ' 17' ' ' PRO . 5.9 mtt180 -61.57 112.26 5.74 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.869 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 23' ' ' GLY . 38.8 Cg_exo -56.84 161.06 10.93 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.862 2.375 . . . . 0.0 111.71 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -124.3 97.44 40.03 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.496 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' A' ' 20' ' ' PRO . 11.4 Cg_exo -67.32 153.98 85.5 Favored 'Cis proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.484 -0.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -90.8 179.81 43.03 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.567 ' HD3' ' OD2' ' A' ' 9' ' ' ASP . 5.6 ptm180 -152.86 117.52 2.89 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 111.144 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' HB3' ' CZ3' ' A' ' 5' ' ' TRP . 73.1 Cg_endo -81.83 158.56 18.58 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.331 2.687 . . . . 0.0 111.745 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.04 HG11 ' HB3' ' A' ' 4' ' ' ALA . 1.4 p -57.99 147.31 6.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.159 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.14 108.93 3.66 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.843 HD13 ' HB ' ' A' ' 2' ' ' VAL . 26.2 tp -47.25 -41.26 18.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.847 0.356 . . . . 0.0 110.269 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -70.16 -31.52 69.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.248 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.575 ' HG2' ' OH ' ' A' ' 6' ' ' TYR . 66.3 tp60 -62.93 -46.51 87.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.426 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.435 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 9.3 mt -69.44 -34.22 74.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.532 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -52.54 -43.68 65.33 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -66.54 -32.01 73.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.831 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 31' ' ' LEU . 35.5 tp -64.5 -25.72 68.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.924 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.598 ' O ' ' HD3' ' A' ' 128' ' ' PRO . . . 110.04 23.63 6.05 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.792 HG12 ' CZ ' ' A' ' 38' ' ' TYR . 24.4 t -100.76 128.68 52.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.269 0.557 . . . . 0.0 111.138 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.672 ' HB3' ' CH2' ' A' ' 39' ' ' TRP . 3.0 mt -125.59 141.55 51.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.128 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.792 ' CZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -126.84 134.11 50.6 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.853 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 1.032 ' NE1' HG21 ' A' ' 55' ' ' ILE . 1.2 m95 -101.2 128.46 47.3 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -97.84 105.64 17.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.798 HD11 ' HB3' ' A' ' 39' ' ' TRP . 3.1 mp -139.66 147.34 40.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.696 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.671 ' O ' ' N ' ' A' ' 45' ' ' LYS . 84.1 m-20 -97.72 123.81 41.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 46' ' ' TYR . . . -41.88 -44.64 3.45 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.583 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -62.8 -33.91 76.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.048 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 42' ' ' ASP . 66.9 mttm -85.26 -14.8 45.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.318 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.958 ' CE2' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.92 -49.09 74.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -83.14 -41.65 18.27 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.094 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.525 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 2.8 m120 -67.11 -22.85 65.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.737 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 45' ' ' LYS . 3.1 t0 -127.12 84.65 62.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.961 0.41 . . . . 0.0 111.524 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 53' ' ' GLU . 2.0 Cg_endo -48.7 -8.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 123.23 2.62 . . . . 0.0 111.448 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.59 ' CD ' ' HD2' ' A' ' 54' ' ' LYS . 45.6 tp10 -42.59 -33.54 0.72 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.717 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.958 HD22 ' CE2' ' A' ' 46' ' ' TYR . 24.6 tp -55.32 -41.08 71.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.007 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 50' ' ' PRO . 75.3 mm-40 -63.16 -34.18 77.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.306 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.59 ' HD2' ' CD ' ' A' ' 51' ' ' GLU . 37.8 mttm -59.06 -41.82 88.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.527 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.032 HG21 ' NE1' ' A' ' 39' ' ' TRP . 87.6 mt -62.82 -36.26 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.618 ' NH2' ' HA ' ' A' ' 63' ' ' TRP . 72.1 ttt180 -58.09 -41.54 83.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.234 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.494 HH11 ' HA ' ' A' ' 54' ' ' LYS . 77.4 mtt85 -61.82 -36.01 79.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.446 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -60.28 -39.08 85.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.656 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.666 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 8.8 tpt180 -99.99 -11.16 20.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 110.296 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' ARG . 30.5 t-20 58.08 51.58 8.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.531 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.842 ' CD1' HD13 ' A' ' 148' ' ' LEU . 58.9 m-85 -70.05 124.24 23.59 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.228 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.504 ' C ' HH21 ' A' ' 56' ' ' ARG . 24.2 m -60.8 -36.9 80.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.809 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.692 ' O ' ' CD1' ' A' ' 63' ' ' TRP . 0.0 OUTLIER -138.26 149.93 46.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.379 . . . . 0.0 110.854 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.911 ' SD ' HD21 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -145.47 117.57 8.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.321 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.659 ' OD2' ' CZ3' ' A' ' 63' ' ' TRP . 90.1 m-20 -143.03 169.62 17.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.838 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.977 ' CD1' HD22 ' A' ' 99' ' ' LEU . 14.5 tt -121.49 144.44 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.93 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 68' ' ' THR . 9.8 tp -133.91 157.38 41.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.852 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.868 ' O ' HD13 ' A' ' 74' ' ' LEU . 54.3 m -117.06 138.41 51.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.017 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 69' ' ' ILE . 1.1 mp -90.52 96.47 6.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.335 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.644 ' O ' ' N ' ' A' ' 74' ' ' LEU . 45.8 t -154.53 128.04 8.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.945 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -57.72 -41.5 81.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.953 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.96 -40.17 96.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.437 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.572 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 40.7 tptt -100.12 -6.77 25.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 111.204 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.868 HD13 ' O ' ' A' ' 68' ' ' THR . 0.2 OUTLIER -126.45 76.63 73.45 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.393 . . . . 0.0 111.163 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.537 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 10.8 Cg_endo -56.42 152.5 39.44 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.365 2.043 . . . . 0.0 110.061 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 79' ' ' GLU . 39.3 t-20 74.65 39.13 0.45 Allowed 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.209 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.655 ' CZ ' HG13 ' A' ' 81' ' ' ILE . 58.1 t80 -59.66 -40.7 88.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.509 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.639 ' O ' ' CB ' ' A' ' 82' ' ' LYS . 97.0 mt-10 -60.13 -56.89 16.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.708 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.609 ' HB2' ' OD1' ' A' ' 76' ' ' ASN . 75.6 mm-40 -71.87 -38.21 70.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.589 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.609 ' HZ2' ' HE1' ' A' ' 84' ' ' PHE . 10.2 tptp -64.64 -56.58 12.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.165 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.014 HD12 ' CE2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -71.71 -35.66 56.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.117 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.639 ' CB ' ' O ' ' A' ' 78' ' ' GLU . 26.1 tptt -59.48 -41.45 89.82 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.985 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.74 ' SD ' ' CH2' ' A' ' 155' ' ' TRP . 59.1 mtt -60.02 -42.15 93.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.537 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.609 ' HE1' ' HZ2' ' A' ' 80' ' ' LYS . 80.0 m-85 -69.24 -36.74 77.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.658 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 1.014 ' CE2' HD12 ' A' ' 81' ' ' ILE . 15.0 m-30 -61.0 -45.19 95.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.589 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.75 138.08 58.13 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.87 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.619 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -90.74 121.16 32.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.733 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.719 ' ND1' ' CE1' ' A' ' 158' ' ' TYR . 0.9 OUTLIER -141.63 173.92 11.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.04 0.448 . . . . 0.0 111.178 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.08 HD11 ' CD1' ' A' ' 132' ' ' TYR . 3.5 mp -130.38 159.89 35.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.109 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.587 ' O ' ' HB1' ' A' ' 129' ' ' ALA . 4.0 p80 -170.81 153.38 3.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.095 0.474 . . . . 0.0 110.838 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.046 HD22 ' O ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -67.78 16.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.823 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.759 ' C ' ' HB2' ' A' ' 129' ' ' ALA . 59.0 t0 -108.53 148.32 30.44 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.616 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.637 ' OD2' ' NH2' ' A' ' 59' ' ' ARG . 83.1 m-20 -83.93 142.34 30.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.514 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.608 ' OE2' ' HA ' ' A' ' 94' ' ' GLU . 16.2 mm-40 -99.35 118.25 35.57 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.697 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.05 ' CD1' HG23 ' A' ' 126' ' ' THR . 32.9 mm -122.2 119.41 58.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.309 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.666 ' HD2' ' CE2' ' A' ' 105' ' ' PHE . 38.8 mtt85 -139.18 138.27 36.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.31 0.576 . . . . 0.0 111.452 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.791 ' CD2' ' CZ ' ' A' ' 46' ' ' TYR . 25.8 t80 -125.82 129.92 50.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.674 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.563 ' HB ' ' O ' ' A' ' 120' ' ' GLU . 14.0 mm -89.02 93.31 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.52 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.977 HD22 ' CD1' ' A' ' 66' ' ' ILE . 10.4 tp -72.65 -38.93 67.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.202 0.525 . . . . 0.0 109.651 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . 54.7 t0 -155.2 154.43 32.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.211 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.479 ' N ' ' OD2' ' A' ' 100' ' ' ASP . . . 82.14 -166.49 46.35 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 50.2 m -121.01 147.33 45.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.304 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -132.21 149.09 19.35 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.668 ' CE2' ' HG3' ' A' ' 116' ' ' ARG . 81.2 t80 -125.81 131.3 52.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.344 . . . . 0.0 110.615 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.796 ' HB3' HD11 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -122.08 146.25 47.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.671 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 133' ' ' HIS . 23.2 t70 -124.67 128.33 48.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.416 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p -132.14 144.4 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.505 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 114' ' ' TRP . 21.3 ttp180 -122.77 130.67 53.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.652 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 110' ' ' LYS . 57.8 t0 -85.73 156.23 20.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.695 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.571 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 1.0 OUTLIER -60.79 -25.53 66.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.893 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.543 ' OE1' ' NE2' ' A' ' 113' ' ' GLN . 96.2 mt-10 -63.77 2.89 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.877 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 111' ' ' GLU . 54.3 t0 76.51 41.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.03 0.443 . . . . 0.0 110.327 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.611 ' HB2' ' CB ' ' A' ' 8' ' ' ASP . 13.4 pt20 -143.37 165.83 26.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.857 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.785 ' CH2' ' SD ' ' A' ' 7' ' ' MET . 25.1 p-90 -133.69 149.84 51.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.025 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.572 HD13 ' HE1' ' A' ' 6' ' ' TYR . 68.7 mt -117.7 136.63 54.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.186 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.668 ' HG3' ' CE2' ' A' ' 104' ' ' TYR . 56.9 ttt180 -90.25 120.35 31.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.528 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.796 HD11 ' HB3' ' A' ' 105' ' ' PHE . 27.4 pt -120.8 128.67 76.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.655 ' CD2' ' OE1' ' A' ' 3' ' ' GLN . 71.2 t80 -109.79 136.71 48.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.614 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.47 ' SD ' ' HB ' ' A' ' 125' ' ' VAL . 16.0 mmt -106.37 133.44 51.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.724 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' O ' ' HB ' ' A' ' 98' ' ' ILE . 94.6 mt-10 -107.51 168.36 9.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -64.82 127.5 31.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.691 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.594 ' HA2' ' OH ' ' A' ' 97' ' ' TYR . . . 94.4 -15.42 63.3 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -95.98 121.46 37.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.701 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.711 ' CE ' HG22 ' A' ' 95' ' ' ILE . 18.1 ttt -102.64 150.2 23.67 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.47 ' HB ' ' SD ' ' A' ' 119' ' ' MET . 12.7 p -134.91 141.26 43.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.257 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 1.05 HG23 ' CD1' ' A' ' 95' ' ' ILE . 87.9 m -125.31 132.35 52.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.052 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.523 HD23 HG22 ' A' ' 36' ' ' VAL . 4.1 mt -121.18 127.42 26.18 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.888 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.756 ' HG2' HD12 ' A' ' 131' ' ' ILE . 12.8 Cg_endo -59.36 141.44 97.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.797 2.331 . . . . 0.0 111.902 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.759 ' HB2' ' C ' ' A' ' 92' ' ' ASP . . . -69.76 148.94 48.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.104 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.89 3.58 56.98 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.756 HD12 ' HG2' ' A' ' 128' ' ' PRO . 70.4 mt -116.25 137.15 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.305 . . . . 0.0 110.635 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 1.08 ' CD1' HD11 ' A' ' 89' ' ' LEU . 88.8 m-85 -58.4 128.3 36.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.145 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.572 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 45.0 p-80 -146.15 146.51 30.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.97 0.414 . . . . 0.0 111.136 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.619 ' NE ' ' O ' ' A' ' 85' ' ' TYR . 77.9 ttt180 -135.7 134.34 39.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.111 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.574 ' HD2' ' CE2' ' A' ' 105' ' ' PHE . 70.5 t80 -106.7 124.72 50.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.757 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.691 ' O ' HG13 ' A' ' 137' ' ' VAL . 18.5 p -130.81 155.45 46.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.592 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 136' ' ' THR . 34.7 m -164.96 17.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.271 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.641 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 48.1 p30 -70.8 -15.09 62.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 75.7 mm-40 -59.25 -39.45 82.88 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.33 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.521 ' HD3' ' HB2' ' A' ' 102' ' ' SER . 9.5 mtpm? -110.25 -19.33 13.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 138' ' ' ASP . 10.6 m120 59.6 30.47 20.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.347 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.58 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 66.3 t80 -172.94 96.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.196 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.543 ' H ' ' HB ' ' A' ' 69' ' ' ILE . 56.9 m -136.16 134.4 38.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.13 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 100' ' ' ASP . 5.8 ttmt -117.88 114.89 23.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.915 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.713 ' HB1' ' O ' ' A' ' 97' ' ' TYR . . . -142.07 155.21 45.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.067 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.653 ' SD ' ' HE2' ' A' ' 46' ' ' TYR . 5.9 mtt -93.64 145.82 24.28 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.016 0.436 . . . . 0.0 110.679 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -129.89 138.89 51.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.738 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.911 HD21 ' SD ' ' A' ' 64' ' ' MET . 41.0 mt -110.98 132.49 54.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.78 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.669 ' CE1' ' O ' ' A' ' 152' ' ' GLU . 62.4 t80 -132.97 152.93 51.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 110.878 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.56 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 11.7 t -116.02 129.66 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.763 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.5 -162.35 37.9 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.669 ' O ' ' CE1' ' A' ' 149' ' ' PHE . 1.8 mm-40 -69.08 155.36 93.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.927 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 156' ' ' THR . 27.8 Cg_endo -65.02 78.8 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.909 2.406 . . . . 0.0 112.184 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.498 HG12 ' CE2' ' A' ' 149' ' ' PHE . 7.0 p -60.61 -30.39 46.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.007 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.74 ' CH2' ' SD ' ' A' ' 83' ' ' MET . 43.3 t90 -52.5 -35.92 54.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.96 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.605 HG23 ' HB2' ' A' ' 153' ' ' PRO . 47.6 p -48.9 -43.42 39.21 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -147.61 101.19 3.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.963 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.719 ' CE1' ' ND1' ' A' ' 88' ' ' HIS . 18.9 p90 -136.18 155.62 49.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.717 ' ND2' ' CZ ' ' A' ' 165' ' ' PHE . 89.8 m-20 -92.07 137.85 32.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.356 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.611 ' CB ' ' HD3' ' A' ' 161' ' ' PRO . 0.0 OUTLIER -50.41 -57.79 11.91 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.699 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 160' ' ' ARG . 14.6 Cg_exo -64.02 131.97 32.68 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.529 2.153 . . . . 0.0 111.929 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.57 ' HB2' ' C ' ' A' ' 89' ' ' LEU . . . -68.61 -31.69 71.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.509 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.577 ' OD2' ' HG2' ' A' ' 170' ' ' GLN . 89.8 m-20 -98.28 13.44 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.842 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.715 ' CD2' ' ND2' ' A' ' 159' ' ' ASN . 61.0 t60 -54.03 -38.35 65.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.567 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.717 ' CZ ' ' ND2' ' A' ' 159' ' ' ASN . 97.4 m-85 -86.68 127.32 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.477 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 172' ' ' VAL . 11.8 tm-20 -61.6 -46.43 89.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.007 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.59 -45.85 61.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.58 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.593 ' CZ ' ' HA ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -85.0 0.33 51.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.706 -179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 165' ' ' PHE . . . -64.89 147.39 50.98 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.577 ' HG2' ' OD2' ' A' ' 163' ' ' ASP . 99.7 mm-40 -58.79 -32.14 69.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.704 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -55.15 -39.67 69.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.633 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 166' ' ' GLU . 73.7 t -59.23 -39.74 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.578 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.466 ' HE2' HE22 ' A' ' 170' ' ' GLN . 9.8 mttp -58.28 -34.63 70.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.575 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -56.5 -41.49 76.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.646 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 27.3 tp -57.37 -37.78 73.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.527 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.11 72.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.586 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -63.78 -33.05 74.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.551 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.5 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' FE2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_